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1.0 INTRODUCTION AND BACKGROUND 
Crew health and performance is critical to successful human exploration beyond low Earth orbit.  
The Human Research Program (HRP) is essential to enabling extended periods of space 
exploration because it provides knowledge and tools to mitigate risks to human health and 
performance.  Risks include physiological and behavioral effects from radiation and hypogravity 
environments, as well as unique challenges in medical support, human factors, and behavioral or 
psychological factors.  The Human Research Program (HRP) delivers human health and 
performance countermeasures, knowledge, technologies and tools to enable safe, reliable, and 
productive human space exploration.  Without HRP results, NASA will face unknown and 
unacceptable risks for mission success and post-mission crew health. 
This Integrated Research Plan (IRP) describes HRP’s approach and research activities that are 
intended to address the needs of human space exploration and serve HRP customers and how 
they are integrated to provide a risk mitigation tool. The scope of the IRP is limited to the 
activities that can be conducted with the resources available to the HRP; it does not contain 
activities that would be performed if additional resources were available. The timescale of 
human space exploration is envisioned to take many decades.  The IRP illustrates the program’s 
research plan through the timescale of early lunar missions of extended duration. 
The IRP serves several purposes for the Human Research Program.  The IRP… 
• provides a means to assure that the most significant risks to human space explorers are 
being adequately mitigated and/or addressed; 
• shows the relationship of research activities to expected outcomes and need dates; 
• shows the interrelationships among research activities that may interact to produce 
products that affect multiple HRP Element, Project or research disciplines; 
• accommodates the uncertain outcomes of research and technology activities by including 
decision points that lead to potential follow-on activities; 
• shows the assignments of responsibility within the program organization and, as 
practical, the proposed acquisition strategy; 
• shows the intended use of research platforms such as the International Space Station 
(ISS), NASA Space Radiation Laboratory (NSRL), and various space flight analog 
environments; and 
• shows the budgeted research activities of the Human Research Program, but does not 
show all budgeted activities, as some of these are enabling functions, such as 
management, facilities, and infrastructure. 
1.1 CONTEXT OF THE INTEGRATED RESEARCH PLAN 
There are three foundational documents to the HRP:  
1. Program Requirements Document (PRD) 
2. Evidence Book 
3. Integrated Research Plan (IRP) 
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The PRD describes the high-level requirements that the program must meet.  The Evidence Book 
provides the scientific basis for the risks that are contained in the PRD, and the IRP describes the 
approach to addressing the requirements in the PRD.  The relationship of these HRP documents 
is illustrated in Figure 1.1.   
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Figure 1.1: HRP Requirements and Content Alignment 
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1.2 PROGRAM REQUIREMENTS DOCUMENT 
The HRP’s top-level requirements are maintained in the Exploration Systems Mission Directorate 
(ESMD) Exploration Architecture Requirements Document (EARD), ESMD-EARD-08-07, Rev.-.  
The purpose of the EARD is to translate the expectations of stakeholders, both inside and outside 
NASA, for the next generation U.S. Space Exploration mission, into requirements that will flow 
down to the implementing organizations.  The EARD allocates the following top requirements to the 
HRP. 
• [Ex-0061] NASA's Human Research Program (HRP) shall develop knowledge, capabilities, 
countermeasures, and technologies to mitigate the highest risks to crew health and 
performance and enable human space exploration 
• [Ex-0062] NASA's HRP shall provide data and analysis to support the definition and 
improvement of human spaceflight medical, environmental and human factors standards 
• [Ex-0063] HRP shall develop technologies to reduce medical and environmental risks and to 
reduce human systems resource requirements (mass, volume, power, data, etc.) 
The PRD decomposes those requirements into lower level requirements that are then allocated to the 
HRP Elements.  The requirements in the PRD are divided into three categories: requirements related 
to human system standards, requirements related to human health and performance risks, and 
requirements related to provision of enabling capabilities. The HRP comprises the following major 
Program Elements: Behavioral Health and Performance (BHP), Exploration Medical Capability 
(ExMC), Human Health Countermeasures (HHC), ISS Medical Project (ISSMP), Space Human 
Factors and Habitability (SHFH), and Space Radiation (SR).  Each element incorporates their 
respective PRD requirements into their specific element management plans. The research elements 
subsequently derive a research plan to address the requirements. 
1.2.1 STANDARDS 
The PRD requires that the HRP make recommendations for updates to the Space Flight Human 
System Standards (SFHSS).  The SFHSS, Volume 1 (NASA-STD-3001, Vol. 1), describes Levels of 
Care required for human spaceflight missions, Permissible Exposure Limits, Permissible Outcomes, 
and Fitness for Duty Standards for crewmembers on exploration missions, among other things, and 
was first baselined on March 5, 2007, by the Office of the Chief Health and Medical Officer 
(OCHMO).  Essentially, these are the definition of acceptable levels of risk for human health and 
performance associated with spaceflight.  By comparing these standards with the existing evidence 
and knowledge base, the HRP can identify and quantify the risks associated with human exploration 
missions, and derive the research necessary to lower the risk. 
SFHSS, Volume 2 (Spaceflight Habitability and Human Standards) provides the comprehensive set 
of requirements associated with Human Factors and Habitability.  These standards must be met by 
the Constellation program in development of each vehicle and supporting equipment utilized in 
space exploration.  Through comparison of these standards with the state of the art in engineering 
design, the HRP can identify areas where research is necessary to help the Constellation program 
meet these requirements. 
The HRP has two main responsibilities concerning the standards.  In some cases, the SFHSS has a 
wide band of uncertainty.  The HRP must conduct research to help refine and narrow the uncertainty 
associated with the standard.  In other cases, emerging evidence or knowledge may indicate that the 
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standards are not written in a way that captures a complete set of relevant considerations.  The HRP 
is required to address the modification of such standards.  Additional research may be required to 
facilitate this.  The PRD decomposes the top-level requirement into the specific standards and 
allocates the requirement to inform these standards to the appropriate HRP Element. 
1.2.2 RISKS 
The HRP identifies risks relevant to the Chief Health and Medical Officer and to the health and 
human performance aspects of the Constellation Program. The HRP utilizes the Chief Medical 
Officer’s Human System Risk Board (HSRB) to identify risks requiring research.  The PRD 
allocates requirements to quantify, mitigate, or monitor these human system risks to the appropriate 
Element within the HRP.  The PRD, however, does not establish priority for the risks. 
The risks in the PRD are arranged in two groups based on the level of available evidence.  Risks for 
which substantial evidence exists are listed in Table 1 while those that cannot be supported or 
refuted by available information at this time are in Table 2.  This IRP addresses each of the risks in 
the priority order described in Section 2.0 in the PRD. 
1.3 EVIDENCE BOOK 
The HRP Evidence Book documents WHY the risks are contained in the PRD.  It is a record of the 
state of knowledge for each risk in the PRD and, therefore, provides bases for analyses of the 
likelihoods and consequences for each of the risks.  As such, the Evidence Book, a compilation of all 
the evidence-based risk reports, makes important data accessible and available for periodic review. 
The Evidence Book is publicly available at the following internet address - 
http://humanresearch.jsc.nasa.gov/elements/smo/hrp_evidence_book.asp 
The documentation of evidence for each risk in the PRD is in the form of a review article that is 
aimed at a scientifically-educated, non-specialist reader.  The documentation is broken into the 
following parts: 
The body of each risk review contains a narrative discussion of the risk and its supporting evidence. 
1. Declarative statements concerning the risk are supported by a description of the evidence, 
whether published or unpublished. 
2. Relevant published references are listed at the end of the report. 
3. Data that are significant or pivotal are summarized in text, tables, and charts in sufficient 
detail to allow the reader to critique and draw conclusions, especially when a published 
reference is not available.   
4. In a similar fashion, the authors indicate, as appropriate, whether the data are from human, 
animal, or tissue/cell/molecular studies.   
5. Evidence from space flight (including biomedical research, Medical Requirements 
Integration Document [MRID] data, and operational performance or clinical observations) is 
presented first, followed by ground-based evidence (including space analog research and 
non-space analog biomedical or clinical research).   
6. When evidence is from ground-based studies, authors discuss why these results are likely to 
be applicable in the space environment, offering available validation information for the use 
of these ground-based systems.  
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The National Academies of Sciences Institute of Medicine reviewed the risk reports to validate that 
they provide sufficient evidence that the risk is relevant to long-term space missions.  Their 
conclusions and recommendations are given in the IOM publication, Review of NASA’s Human 
Research Program Evidence Books. A Letter Report, Washington DC: The National Academies 
Press, 2008. 
Some Risk Reports will be published through refereed journals specific to the appropriate 
disciplines.  In some cases, when the evidence reports are not published in a journal, the HRP will 
publish them in NASA Technical Reports.  Further, all evidence reports will be made available on 
the HRP external website. 
As new evidence is gathered, the Risk Reports will be updated.  If new evidence indicates that a risk 
should be retired or that a new risk should be added, the HRP will, after thorough review with the 
HSRB, take the appropriate action to modify the PRD and update the Evidence Book accordingly. 
1.4 THE INTEGRATED RESEARCH PLAN 
The IRP documents the CRITICALITY of each risk: 
• WHAT tasks are necessary to fill gaps,  
• WHEN those tasks will be accomplished and their deliverables provided to the stakeholder,  
• WHERE they will be accomplished (e.g., use the International Space Station, use a ground 
analog, etc.), WHO will accomplish them (which project or organization within the HRP), 
and  
• what is being PRODUCED. 
1.4.1 Criticality to Missions 
Three categories of criticality have been developed for the mitigation of each of the risks:  
1) Critical, 2) Important, and 3) Desirable.   
Each of the three categories is applied to two different mission scenarios, the lunar mission(s) 
(including the lunar outpost missions) and the Mars mission.   
The criticality of a risk for either a lunar or a Mars mission alone is not sufficient to determine the 
optimum level of activity (or budget) or timing for research investments.  Other factors combine to 
determine the research approach, such as limited availability (of certain necessary resources like the 
Space Shuttle and the ISS), exceptionally long lead times (needed to improve understanding and 
mitigation of radiation risks), or the amount of risk reduction that can be obtained with a specific set 
of resources.  All of the factors needed to determine the research approach are not explicitly 
represented in the IRP, only the resultant research plan. 
For reference, each risk heading in this document is labeled with an abbreviated version of the Lunar 
and Mars criticalities. 
Criteria for criticality of the risks applicable to the lunar outpost and Mars mission(s) are: 
• Critical to Quantify and Reduce Prior to the Lunar Outpost or Mars Missions.   
Absence of additional data or risk mitigation countermeasures (beyond what is available at the 
approval date of this document) would likely delay Lunar Outpost or Mars Missions, even if all 
other elements of the mission were ready (e.g., if the launch systems, Extravehicular Activity 
(EVA) systems, landing and life support systems were ready).  The lack of this data or an 
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adequate additional mitigation would leave NASA with unacceptable uncertainty in the residual 
risk, and/or with unacceptable absolute risk to human health and performance, thus precluding 
NASA’s ability to embark on the mission.  Critical risks for lunar outpost are identified by the 
abbreviation LUNAR OUTPOST-C and for Mars by the abbreviation MARS-C. 
 
• Important to Quantify and Reduce Prior to the Lunar Outpost or Mars Missions.   
Absence of additional data or risk mitigation countermeasures in this area (beyond what is 
available at the approval date of this document) would likely not delay lunar outpost or Mars 
missions, if all other elements of the mission were ready (e.g., if the launch systems, EVA 
systems, landing and life support systems were ready).  This would leave the mission with 
significant residual or unknown risk however.  Mission loss or major impact to post-mission 
crew health could occur if this risk is not quantified and reduced.  Important risks for lunar 
outpost are abbreviated LUNAR OUTPOST-I, and for Mars as MARS-I. 
 
• Desirable to Quantify and Reduce Prior to the Lunar Outpost or Mars Missions. 
The absence of data or risk mitigation countermeasures in this area (beyond what is available at 
the approval date of this document) would not delay the lunar outpost or Mars missions if all 
other elements of the mission were ready (e.g., if the launch systems, EVA systems, landing and 
life support systems were ready).  However, quantifying and reducing the risk would reduce the 
risk for that particular discipline.  Engineering or operational workarounds/constraints could be 
avoided if this risk were quantified and/or reduced.  Desirable risks for lunar outpost are 
abbreviated LUNAR OUTPOST-D, and Mars as MARS-D. 
Ultimately, assessment of the criticality is based on the likelihood and consequence of the risks, the 
gaps, and the tasks, coupled with the uncertainty in risk projections.  Assessment involves 
integration and comparison of risk factors and the impact each task may have on the reduction of the 
overall risk to the mission or the crew, given different mission scenarios, research approaches, and 
outcomes.   
The HRP will use the Risk Management Analysis Tool (RMAT) to categorize and document the 
assessment of the risks and to document priority.  At present, the RMAT is a two-dimensional tool.  
There is no integrated or validated assessment tool that will allow the use of the RMAT for cross-
comparison or prioritization of risks or gaps now.  Until the availability of such a tool, the HRP will 
rely on expert opinion, with consideration of the RMAT and existing evidence.  The HRP’s Science 
Management Office has the responsibility of prioritizing the HRP’s research portfolio as described 
in the HRP Science Management Plan (HRP-47053 Rev. C), Paragraph 3.1. 
1.4.2 TASKS REQUIRED TO FILL THE GAPS (WHAT) 
For each risk, the appropriate HRP Elements identified gaps in the risk’s state of knowledge and 
NASA’s ability to mitigate the risk.  Further, the HRP Elements identified specific research tasks 
required to fill each gap and the product(s) resulting from the tasks.  This Integrated Research Plan 
lays out the risk, gaps, tasks, and resulting products in a notional schedule tied to the appropriate 
Exploration milestones for which the products will be needed.  The rationale for the selected 
approach is documented in the text portions of the IRP.   
This plan includes activities that are more than “Research or Technology Development.”  In some 
cases, the activities reported in this document are not explicitly “research” or “technology 
development,” but are included to ensure logical completeness in describing those activities 
necessary to mitigate the risks.  Examples are data mining activities, the results of which are pivotal 
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in defining further steps in the research path, and hardware evaluations that would further the 
engineering approach to risk mitigation. 
Key Decision Points are built into the IRP, wherein the HRP will evaluate data with respect to 
closing the research gap, as well as the impact on the overall likelihood or consequence of the risk.  
The results of this analysis help formulate the next steps.  In some cases, likelihood with existing 
countermeasures will not be high enough to warrant proceeding with more research.  This risks-
gaps-tasks-deliverables detail is required to ensure completeness in addressing the risks. 
1.4.3 Schedule Drivers (WHEN) 
The Integrated Research Plan describes a plan of knowledge production and technology 
development to address risks associated with human space flight. As new knowledge is gained, the 
required approach to research and development may change. The IRP attempts to describe a plan of 
research looking forward many years into the future. The fidelity of the IRP is quite high in the near 
term (2009-2010), but decreases with time.  The IRP will be revised and updated annually based on 
available resources, Constellation mission development, other schedule constraints, achievement of 
key milestones, and consideration of new evidence gained from the previous year. 
1.4.4 RESEARCH PLATFORMS (WHERE) 
The HRP uses various research platforms and data sources to address gaps in knowledge.  Historical 
data derived from ground and spaceflight studies form the basis of the HRP Evidence Reports, with 
the intention of ensuring that the HRP does not duplicate effort already expended.  Many of these 
activities appear in this IRP as “data mining,” although not explicitly “research.”   
Data mining involves gathering and analyzing data from historical space flights via the Longitudinal 
Study of Astronaut Health and other sources, spaceflight operational data such as landing 
performance and simulator performance data to identify possible correlation with physiologic or 
psychological function, and relevant data from ground studies (NASA sponsored and otherwise). 
The HRP utilizes the Space Shuttle and the International Space Station to conduct research requiring 
the unique environment of space.  The spaceflight data primarily identify and/or quantify 
physiological and behavioral changes to the human system occurring in the microgravity 
environment. The ISS is utilized to both validate potential countermeasures and as an analog for 
long-duration Mars missions. 
NASA has laid out specific schedule milestones/constraints for implementation of the Vision for 
Space Exploration (VSE).  The Shuttle retirement in 2010, the Orion vehicle use in 2014, and the 
first lunar sortie by 2020 together create urgency for the acquisition of knowledge.  The use of the 
Shuttle and ISS platforms, in several cases, is critical to obtaining the required knowledge to build 
products supporting longer, more challenging missions.  The Shuttle retirement in 2010 and the 
uncertainty in the completion of ISS operations levies significant constraints on available flight 
resources, thus some research is accelerated to take advantage of these vehicles while available.  
Where possible, the HRP will utilize analog environments to perform the research required to fill 
gaps in knowledge, preserving the limited flight resources for only those that cannot be addressed 
elsewhere.  These data are used as an analog to a long-duration Mars mission because the ISS is the 
only resource of its kind.  The HRP will accelerate some of the research from this resource to 
facilitate future long-term stays in microgravity on exploration missions that could otherwise be 
delayed pending such a mission design.   
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There are several analog environments utilized by the HRP, some owned and operated by HRP, 
some by NASA, and others operated by other agencies.  Each analog environment is assessed for its 
characteristics that mimic portions of the flight environment, the fidelity of the analog.  No ground-
based analog can serve to simulate the flight environment completely, thus each analog use is 
selected based on its important flight-like characteristics specific to the task objectives.  Several 
analogs often will be required to fill a gap, and, in all cases, analog findings are validated in the 
space flight environment. 
The Flight Analogs Project coordinates utilization of ground based research analogs to complement 
space research.  Throughout the IRP, tasks requiring the use of specific analogs are identified.  The 
bed rest analog mimics some of the physiological changes induced by weightlessness, using a bed 
rest model with a 6o head-down tilt.  The NASA Extreme Environment Mission Operations 
(NEEMO) analog and Antarctic missions provide mission-like settings and interactions that 
incorporate the constraints of working in extreme environments.  The Haughton-Mars and Devon 
Island analogs to provide rugged terrain and mission-like interactions to address specific lunar 
surface system concepts related to EVA and other factors related to behavioral health and 
performance. In some cases, the HRP also utilizes operational mission environments, such as the 
Phoenix Mars Scout Lander, to obtain data relevant to the behavioral health and performance of the 
ground crews supporting long duration spaceflight missions. Such data provide valuable lessons for 
future exploration missions. Isolation chambers also provide mission-like ground-to-crew and crew-
to-crew interactions that facilitate behavioral studies of team cohesion, workload, fatigue, and sleep.  
The NASA Space Radiation Laboratory (NSRL) is a unique ground-based analog.  This facility is 
owned and operated by the Department of Energy’s (DoE) Brookhaven National Laboratory, under a 
contract with the HRP.  HRP utilization of the NSRL is managed by the Space Radiation Program 
Element. 
As NASA prepares to send crewmembers back to explore the Moon for periods of up to six months, 
questions arise regarding the impacts of the lunar environment on the health, safety, and 
performance of the explorers.  Among the environmental characteristics of concern is the relatively 
small force of gravity on the Moon, which is approximately one-sixth of that on Earth.  “Space 
normal” is defined for this document as the normal human response to prolonged space flight. While 
the normal human response to prolonged microgravity exposure has been fairly well characterized 
during (and after) orbital space flight missions, little is known about the human physiological 
responses to prolonged fractional gravity exposure.  Thresholds, non-linearities, and system-system 
interactions/dependencies are all likely to affect these responses.  These things will certainly be 
studied in crewmembers participating in Lunar missions; however, it would be useful to know ahead 
of time whether any of the effects could be severe enough to cause functionally significant 
decrements in crew health, safety, or performance during these missions, so that appropriate 
countermeasures could be provided from the outset.  
Various lunar gravity simulation techniques were developed during the Apollo era (e.g., parabolic 
flight, mechanical off-loading, vertical counter-weighting, underwater activities); these techniques 
can be used only for short-term simulations (seconds-to-hours).  All are capable of simulating the 
musculoskeletal loading on the Moon, but only parabolic flight can provide a high-fidelity 
simulation of the physiological loading for the cardiovascular and sensory-motor systems.  The long-
term exposures (weeks-to-months) required to simulate lunar outpost missions have been attempted 
in humans only by using head-up-tilt (HUT) bed rest models.  While such models can provide 
accurate static loading along the long body axis, they cannot eliminate the (nearly) orthogonal 
components of the gravity vector, nor can they allow for high-fidelity dynamic simulations.  
Nevertheless, within limits, they might provide insight into the expected adaptive responses of the 
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bone, muscle, and cardiovascular systems to prolonged lunar gravity exposure.  The Flight Analogs 
Project is investigating the HUT model as a potential analog to physiological changes induced by the 
partial gravity environment of the lunar surface.   
1.4.5 ELEMENTS AND PROJECTS RESPONSIBLE FOR THE RESEARCH (WHO) 
Each risk is allocated to one of the five research elements within the HRP, and the IRP identifies 
which Element is responsible for the identified risk.  Three of the HRP Elements are single project 
elements: Behavioral Health and Performance (BHP), Exploration Medical Capability (ExMC) and 
Space Radiation, and the responsible Element is identified at the risk level, but they are responsible 
also for all gaps and tasks addressing the risks.  Two HRP Elements, Human Health 
Countermeasures (HHC) and Space Human Factors and Habitability (SHFH) are multi-project 
Elements.  Thus, the Element is identified at the risk level, and the responsible project within the 
Element is identified at the Gap level.  The following HHC abbreviations are used throughout the 
IRP to designate the responsible project: EPSP (EVA Physiology and Systems Performance), ECP 
(Exercise Countermeasure Project), NxPCM (Non-Exercise Physiological Countermeasures), and 
FAP (Flight Analogs Project).  The following abbreviations are used to designate the responsible 
SHFH project: AEH (Advanced Environmental Health), AFT (Advanced Food Technology), and 
SHFE (Space Human Factors Engineering). 
The HRP’s intent is that each study is procured through competitive means, i.e., a NASA Research 
Announcement (NRA), Request for Proposal (RFP), etc.  In some cases, due to timeliness of data, or 
close interconnectedness with operations or other NASA entities, the HRP will direct a specific 
study be done.  Criteria for these decisions are given in the HRP Science Management Plan.  The 
current and planned procurement method for each task in this research plan is identified. 
Identification of any investigation as a directed study within the IRP does not signify a commitment 
on the part of the HRP to implement that study as a directed study without further consideration by 
the Program Scientist as specified in the Science Management Plan.  
It is the HRP’s policy that all investigations sponsored by the program will undergo independent 
scientific merit review.  This includes proposals submitted in response to NASA Research 
Announcements, all directed study proposals, and all unsolicited proposals.   
Each Element or Project within an HRP will be reviewed by an independent Standing Review Panel.  
The Panel’s primary responsibility is to review the Element Research Plan and provide 
recommendations on the scientific or technological approach and portfolio content.  Those element 
research plans ultimately serve as the input to the IRP.  Modifications to element research plans will 
result in modifications to the annual update of the IRP. 
1.4.6 DELIVERABLES OF THE RESEARCH (DELIVERABLES) 
The focus of this document is to identify deliverables necessary to complete the exploration (lunar 
and Mars) missions. This plan is NOT intended to mitigate risks associated with the ISS.  The ISS is 
used as a platform to conduct research aimed at mitigating risks to the exploration missions.  Some 
of the research may identify countermeasures, engineering, or operational solutions that would 
enhance the ISS and reduce risk in use (including to users) of that platform.  In those cases, the HRP 
identifies the necessary deliverables and insertion points for the ISS.   
Human health and performance risks can best be mitigated through the space system design.  The 
HRP works closely with the Constellation program to communicate the areas of human health and 
performance risks, and to help inform engineering and development of the Constellation systems.  
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Mitigation of many human health and performance risks can be accomplished through engineering 
design and operational constraints, and do not need further research.  Decision points in the research 
schedules are placed to evaluate the adequacy of the approach, research results, and deliverables to 
meet the intended application.  
The first and most desirable approach to mitigating a human health and performance risk is to 
engineer the risk out of the system.  HRP research is intended to reduce the uncertainty in the risk 
and free mission timelines and design from unnecessary conservatism.  To facilitate risk avoidance, 
the HRP identifies requirements for crew selection, vehicle or mission design. 
Some human health and performance risks can be mitigated through application of special space 
medicine operations procedures.  The HRP works closely with the Space Medicine Division at JSC 
to evaluate the relative risks and to determine if the risks can be mitigated through known 
procedures.  This coordination occurs through HRP participation on the HSRB, and interaction at the 
Human Systems Risk Forum (HSRF).  This board and forum have been set up by the Chief Health 
and Medical Officer with chairmanship delegated to the JSC Chief Medical Officer.  Members of 
this board consider the range of human health and performance risks, and identify those that can be 
mitigated through operational procedures vs. those that require further research.  The risks addressed 
in this IRP are those identified by the HSRB as requiring research.  The “inform medical operations” 
deliverables are the results of forum discussions, and research results are integrated into medical 
requirements or flight operations procedures.  The HSRB is also used to evaluate the “deliver 
countermeasure” deliverable to ensure countermeasures can be adequately transitioned to medical 
practice.  
The HSRB/HSRF is also used to evaluate data at various decision points in the research.  The 
deliverables identified in the plan for “HSRB” utilize the board to concur with the next steps in the 
research plan.  
Several other deliverables are identified throughout this IRP.  Two designations are used for 
standards deliverables.  The deliverable to “inform standards” represents the HRP’s intent to 
communicate information to the OCHMO and medical operations that may help interpret the 
existing standard.  The “recommend update for standard” deliverable is used when the research 
results are expected to change the standard. 
2.0 ORIENTATION SUMMARY OF THE RESEARCH PLAN 
The IRP describes a plan of research that addresses both human physiology and the interconnected 
system of the human and spacecraft in a highly integrated manner. It is often not possible to address 
the risks simply as stand-alone units. The knowledge or mitigation gaps often appear in multiple 
risks. Many of the specific research tasks address multiple gaps.  As such, it is instructive to 
rearrange the PRD risks into top-level themes characterizing the expected outcome.  Sections 2.1 
through 2.5 provide a high-level view of the research approach to the risks in these themes.  Section 
3.0 arranges the detailed research plans, including text and graphics, for each PRD risk (according to 
the themes with which the risks are most closely associated).  The themes are: 
1) Ensure the crew can accomplish the physical tasks of the mission. 
2) Ensure the crew can accomplish the cognitive, behavioral, and team aspects of the mission. 
3) Ensure the crew receives adequate nutrition. 
4) Protect the crew from environmental hazards. 
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5) Provide adequate medical care for the crew.   
Appendix A gives the risks for each theme, and shows which gaps address multiple risks. 
The interactions between the risks, gaps, and tasks are not readily shown in a printed book.  The 
HRP intends to include the IRP in a publicly accessible database (the Human Research Roadmap).  
In this database, the user will be able to identify quickly the gaps associated with a risk, the tasks 
associated with a given gap, the cross-integration of a task across multiple gaps or risks, deliverables 
associated with a gap or task, etc. 
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2.1 ENSURE THE CREW CAN ACCOMPLISH THE PHYSICAL TASKS OF THE 
MISSION  
(Return to Table of Contents)  
2.1.1 Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and Endurance 
2.1.2 Risk of Reduced Physical Performance Capabilities Due to Reduced Aerobic Capacity 
2.1.3 Risk of Compromised EVA Performance and Crew Health Due to Inadequate EVA 
Suit Systems 
2.1.4 Risk of Reduced Safety and Efficiency Due to an Inadequately Designed Vehicle, 
Environment, Tools, or Equipment 
Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and Endurance and  
Risk of Reduced Physical Performance Capabilities Due to Reduced Aerobic Capacity  
Sections 2.1.1 through 2.1.2 are highly interrelated.  Occurrence or mitigation of a risk can be a 
contributing factor affecting another. Their research approaches are given together. 
Human physiology’s “normal” response to spaceflight has not been determined for these risks.  
Several studies have been implemented to determine how muscle and aerobic capacity are affected 
by microgravity; these studies include the new ISS Exercise Prescription study, the Functional Task 
Test and the ISS VO2max study.   
The ISS Prescription study will apply principles learned from ground-based flight analogs to an in-
flight platform in order to improve exercise countermeasures efficacy and efficiency by increasing 
exercise intensity and reducing exercise volume.   Data will guide decision of whether current 
exercise countermeasures are protective or if improved countermeasures requiring flight validation 
studies are needed.   
The Functional Task Test will be implemented as a flight study as well as a bed rest study.   The goal 
of this study is to develop and evaluate an integrated set of functional and physiological tests and 
then use these tests to determine how postflight changes in sensorimotor, cardiovascular and muscle 
physiology impact postflight functional performance.  These tests will be performed pre and 
postflight on astronauts exposed to short and long-duration space flight. The Functional Task Test 
will assess operational relevance of these changes by measuring the performance of specific 
exploration tasks (e.g., simulated seat egress, ladder climb, hatch opening, etc.). Additionally 
changes in functional performance will be mapped standard muscular, neurological, and 
cardiovascular measures. Data obtained from this study will facilitate the design of countermeasures 
that specifically target the physiological systems responsible for impaired functional performance.    
The specific aims of the ISS VO2max study are to measure VO2max during and following long 
duration missions and to assess the validity of using submaximal measurements of heart rate (HR), 
oxygen consumption (VO2) to track changes in aerobic capacity. In addition, non-invasive 
measurements of cardiac output (Qc) will be performed during exercise to determine if measurement 
of Qc will improve the accuracy of the submaximal estimations of VO2max.  Results from this study 
will determine if the current countermeasures are protective and need only optimization (e.g., 
reduced volume, time) or if improved countermeasures and flight validation studies are needed.  
HRP-47065 
14 
 Due to scheduling constraints with the loss of the Mars transit analog in 2020, several concurrent 
studies are ongoing. 
Risk of Compromised EVA Performance and Crew Health Due to Inadequate EVA Suit Systems 
To ensure completion of the physical tasks of the mission, the EVA suit system must allow safe and 
efficient performance of critical mission activities outside the habitat or vehicle.  The Human 
Research Program has tasked the EVA Physiology, Systems and Performance (EPSP) Project to 
work with the Constellation EVA Systems Project Office to develop and execute an integrated 
human testing program across multiple environments to collect objective data needed to make 
informed design decisions in creating an EVA suit system that will optimize human health and 
performance.  The research approach is to evaluate various parameters affecting human EVA 
performance, such as metabolic cost and biomechanics of different suit designs and operational 
concepts; impacts of suit weight, mass, pressure, center of gravity (cg), and the quantities of 
consumables required to support EVA.  Other research tasks will determine biomedical monitoring 
requirements, methods to minimize suit-induced trauma, and operational concepts to improve work 
and task efficiency.  This work will be done as a series of inter-related ground studies using multiple 
analog environments including, but not limited to, the Partial Gravity Simulator (Pogo) and Neutral 
Buoyancy Laboratory (NBL) at the Johnson Space Center, parabolic flight, Desert Research and 
Technology Studies (D-RATS), the Haughton Mars Project (HMP), and NEEMO. 
Risk of Reduced Safety and Efficiency Due to Inadequately Designed Vehicles, Environments, 
Tools, or Equipment 
This risk focuses on the overall environment in which the crew lives and works, which influences 
the development of hardware and interfaces, as well as how those interfaces will facilitate human 
performance and efficiency.  Displays, controls, and procedures need to be appropriately designed 
and developed to allow for safe and efficient execution of tasks.  Specific studies investigate the 
environment(s) surrounding the crew, namely the acoustic environment that can influence both 
health and performance.  Other studies focus upon the vibration, acceleration, and microgravity 
environments, again all having potential to impact human health and performance.  The approach to 
mitigating this risk is to develop a thorough understanding of the operational concepts, determine the 
methods, the metrics, and the verification strategies to ensure that both hardware and environment 
are designed for human safety and productivity. 
2.2 ENSURE THE CREW CAN ACCOMPLISH THE COGNITIVE, BEHAVIORAL, 
AND TEAM ASPECTS OF THE MISSION 
 (Return to Table of Contents) 
2.2.1 Risk of Behavioral and Psychiatric Conditions 
2.2.2 Risk of Performance Errors Due to Sleep Loss, Circadian Desynchronization, Fatigue, 
and Work Overload 
2.2.3 Risk of Performance Errors Due to Poor Team Cohesion and Performance, Inadequate 
Selection/Team Composition, Inadequate Training, and Poor Psychosocial Adaptation 
2.2.4 Risk of Errors Due to Poor Task Design 
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2.2.5 Risk of Error Due to Inadequate Information 
2.2.6 Risk of Impaired Ability to Maintain Control of Vehicles and Other Complex Systems 
Risk of Behavioral and Psychiatric Conditions,  
Risk of Performance Errors Due to Sleep Loss, Circadian Desynchronization, Fatigue, and  
Work Overload 
Risk of Performance Errors Due to Poor Team Cohesion and Performance, Inadequate 
Selection/Team Composition, Inadequate Training, and Poor Psychosocial Adaptation 
Sections 2.2.1 through 2.2.3 are highly interrelated.  Occurrence or mitigation of a risk can be a 
contributing factor affecting another.  
Risk of Behavioral and Psychiatric Conditions 
Early detection of stress or other risk factors during spaceflight is imperative to deter development 
of behavioral or psychiatric conditions which could seriously harm and negatively impact the 
individual or the crew, and pose serious consequences for accomplishing mission objectives or 
jeopardizing the mission altogether.  Toward this end, BHP is developing methods for monitoring 
behavioral health during a Lunar and Mars Mission, and adapting and refining various tools and 
technologies for use in the spaceflight environment.  These measures and tools will be used to 
monitor, detect, and treat early risk factors.  BHP will utilize analogs to test, further refine, and 
validate these measures for Exploration Missions.  BHP also develops countermeasures for 
maintaining behavioral health and enhancing performance during long duration isolated, confined, 
and highly autonomous missions and provides updates for behavioral health and performance 
standards.   
Risk of Performance Errors Due to Sleep Loss, Circadian Desynchronization, Fatigue, and  
Work Overload 
Ground evidence clearly demonstrates that performance impairments can occur when sleep is 
attained in quantities similar to that attained by astronauts in flight.  A correlation between sleep 
quantity and performance during spaceflight however has not been documented.  BHP research aims 
to accurately characterize and quantify this Risk by implementing studies on ISS that utilize 
validated measures for assessing performance relative to fatigue. 
BHP research efforts further investigate contributors to sleep loss, fatigue, circadian 
desynchronization, and work overload, by evaluating environmental factors, individual 
vulnerabilities, and various aspects of mission operations.  Such investigations help to inform the 
optimal countermeasure strategy for mitigating the health and performance effects of sleep loss and 
related issues in flight.  As an example, preliminary studies indicate that light exposure can correct 
difficulties in sleep patterns that occur with shift work, jet lag and sleep disorders.  Current efforts 
aim to investigate optimal lighting requirements for the space vehicle, as well as safe and efficacious 
methods for implementing lighting as a countermeasure.  Other countermeasures that are currently 
being investigated include recommendations around sleep hygiene, optimal work-rest schedules, 
flight rules and requirements, and the effectiveness and safety of sleep-wake medication use in 
flight. 
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Risk of Performance Errors Due to Poor Team Cohesion and Performance, Inadequate 
Selection/Team Composition, Inadequate Training, and Poor Psychosocial Adaptation 
While little empirical data have been collected regarding the impact of interpersonal and 
intrapersonal factors on spaceflight performance, it is possible that crew conflict could jeopardize 
long duration Exploration Missions.  Reports from Mir reveal that several missions may have been 
terminated earlier than planned due to interpersonal frictions between crewmembers, and some 
veteran NASA astronauts have reported crew conflict during previous space travels.  Understanding 
the potential negative impacts of interpersonal and intrapersonal issues from spaceflight and 
relevant, high fidelity analog environments is important for identifying countermeasures to aid 
crewmembers (ground and space) during exploration missions (e.g., moon and Mars) where 
operations will require more autonomy. 
BHP will conduct literature reviews and interviews of crew and operations personnel to determine 
the most likely and most serious threats to crew cohesion, crew performance, and crew-ground 
interaction that might be expected for exploration missions. 
The interviews will be used to formulate objective measures for monitoring crew cohesion and 
develop approaches to enhance current training and build upon the current highly successful in-flight 
support services and countermeasures.  These measures will be tested for feasibility and 
acceptability in the appropriate analog environment(s).  These tests will be followed by studies of 
ISS crew composition and crew cohesion/performance. 
As crews begin operations for long duration missions beyond low Earth orbit, they will need to 
exercise increasing command and control of their daily activities.  The distance for Mars Missions 
will result in loss of capability for real-time communication, downlink, and commanding.  Likewise, 
the crew will have to augment and adapt their schedules based on real time changes in their 
schedules.  The extreme distance and the duration of the planned Mars mission, are at the boundaries 
of our current knowledge. A better understanding of how to approach and address autonomous 
operations and its impact on crew dynamics and performance will help inform standards and 
countermeasures. BHP is collaborating with Space Medicine in a study of crew autonomy while we 
are still in low Earth orbit, to identify the impact (if any) of increased autonomy on crew dynamics 
and performance. 
The BHP will test conflict management approaches in ground and analog environments, and 
subsequently on the ISS. 
Risk of Error Due to Poor Task Design, 
Risk of Error Due to Inadequate Information, and 
Risk of Impaired Ability to Maintain Control of Vehicles and Other Complex Systems 
Sections 2.2.4 through 2.2.6 are highly interrelated.  Occurrence or mitigation of a risk can be a 
contributing factor affecting another.  
The strategies for addressing these three risks are intertwined. The work described under the first 
risk (Task Design) focuses on planning how a given task or mission objective will be accomplished, 
as well as on how  to decide what skills, tools, equipment, and information are needed to accomplish 
a task.  It also provides tools and guidelines for determining optimal combinations of automation and 
human involvement.  Work under the second risk (Inadequate Information) contributes to the crew 
having adequate knowledge, skills, and information at the time the task needs to be performed.  The 
third risk, (Impaired Ability to Maintain Control) specifically addresses impairment in the 
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sensorimotor system due to changes in gravity, and searches for means to minimize the impact of 
these changes on performance.    
Risk of Error Due to Poor Task Design 
The risk associated with designing tasks focuses specifically on the process of assigning roles and 
responsibilities to individual crewmembers, a group of crewmembers, automation, ground support or 
various combinations of actors.  SHFE specifically studies issues in designing tasks to be performed 
jointly by humans and automation, and deciding how much responsibility to assign to an automated 
system.  The approach to mitigating this risk is to develop and specify “best practices” for human-
automation function allocation, crew/automation interface design, incorporation considerations for 
crew workload and situational awareness in mixed-initiative operations concept design, and 
determination methods that ensure effective levels of trust between the crew and automation while 
avoiding unacceptable levels of crew complacency. 
To mitigate this risk, it is necessary to develop an adequate understanding of human characteristics 
with respect to automation, determine optimal workload levels, and understand situational 
awareness.   Mitigations to this risk will include requirements and guidelines for human interfaces to 
automation.  This leads into the Risk of Error Due to Inadequate Information. 
Risk of Error Due to Inadequate Information 
The risk focuses on identifying the sources of crew performance errors.  The lack of situational 
awareness that might be due to poorly designed interfaces or tasks is such an example.  The 
subsequent development of information-presentation standards reduces operator errors in spaceflight 
through adequate understanding of the causes and mitigations of the errors.  As the topic of 
inadequate information is comprehensive, the approach to mitigating this risk is to focus on the 
display of information, the types of controls that interface between the human and the displays, and 
the procedures to accomplish tasks. 
It is not possible to separate the strategy for mitigating this risk from the strategy for dealing with the 
risk of Errors due to Poor Task Design.  The information that is needed to perform a task at a given 
time depends substantially on the nature of the task and the crewmembers’ roles and responsibilities.  
The work described under this risk presumes the task is well designed, and focuses on the problems 
of ensuring the necessary information is presented so a timely, accurate performance is 
accomplished. 
Risk of Impaired Ability to Maintain Control of Vehicles and Other Complex Systems 
New evidence regarding landing performance indicates that research into these types of issues is not 
a high priority for Shuttle or ISS.  However, since Mars operational scenarios are still TBD, it is 
agreed that the ISS should be utilized to gather the data required to define the research that might be 
needed to enable future Mars mission operations.  It first must be determined what relevant 
spaceflight data exist and if it is accessible.  If so, this data must be analyzed; if not, the data must be 
collected.  In addition, performance related to neurosensory dysfunction should be used to determine 
the need for further research and countermeasure development.   
Space normal must first be defined for this risk; data mining tasks are ongoing.  Once the definition 
is in place, the data will be presented to the HSRF, and a determination made on whether 
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countermeasures need to be developed.  In addition, the NRA solicitation process was utilized to 
obtain proposals to determine any manual and visual control deficits. 
2.3 ENSURE THE CREW RECEIVES ADEQUATE NUTRITION 
 (Return to Table of Contents) 
2.3.1 Risk Factor of Inadequate Nutrition 
2.3.2 Risk of Inadequate Food System 
Risk Factor of Inadequate Nutrition 
As mission duration increases, the risk of nutrient deficiencies becomes greater.  Nutrient 
requirements, delivery requirements, and the need to preserve the nutrient content in food will 
increase as the frequency and duration of EVAs increase and long Mars missions.  Nutritional 
countermeasures can influence all systems. 
Space normal must be defined for this risk; the Nutrition SMO is ongoing.  Once space normal is 
defined, the data will be presented to the HSRF and it will be decided if countermeasures need to be 
developed.  In addition, several studies are ongoing to determine the optimal dose of vitamin D. 
Risk of Inadequate Food System 
Studies of the stability of food nutrients will identify vitamins and amino acids at risk for 
degradation in space food supply; identify changes in fatty acids of foods flown on ISS, and 
characterize degradation profiles of the unstable nutrients.  A ground study uses radiation exposure 
to test the stability of various food and pharmaceutical components; the results of the study will be 
compared to ongoing flight data being collected.  The shelf life of the current thermostabilized food 
products have never been determined. Food items with varied formulations and bulk ingredients are 
now in accelerated shelf life testing.  The approach will provide critical information about the 
susceptibility of vitamins in the space food system to adverse environmental factors and storage 
encountered during space missions. 
The Advanced Food Technology Project is responsible for optimizing methods required to preserve, 
package, and ship, stow, and prepare the food while still preserving the nutritional value.  The 
nutritional content of the flight food items is not currently measured.  However the retort, irradiation, 
and freeze-drying processes used to produce shelf stable products, reduce the nutrient content.  The 
nutrient levels in prepared foods will be measured to ensure that they meet the requirements of 
nutrition as specified by the nutrition standards and as determined through the Nutrition SMO 
mentioned above.  If the nutrient levels are not adequate, other preservation methods that maintain 
the nutrient content of the foods will be investigated. 
Reducing the flight resources required for the food system is a major goal due to the significant 
ratios of rocket size to mass per pound of cargo delivered on an exploration mission.  Methods to 
reduce packaging mass and volume overhead will be studied.  These studies must overcome 
challenges such as storing food for extended periods (i.e., 18 months for ISS, up to 5 years for a long 
duration mission having pre-positioned food).  Food packaging materials must be developed that 
minimize the mass required, while providing an adequate oxygen and moisture barrier to maintain 
the required shelf lives. 
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2.4 PROTECT THE CREW FROM ENVIRONMENTAL HAZARDS 
 (Return to Table of Contents) 
2.4.1 Risk of Carcinogenesis from Space Radiation 
2.4.2 Risk of Acute Radiation Syndromes Due to Solar Particle Events 
2.4.3 Risk of Acute or Late Central Nervous System Affects from Radiation Exposure 
2.4.4 Risk of Degenerative Tissue or Other Health Effects from Radiation Exposure 
2.4.5 Risk of Adverse Health Effects from Lunar Dust Exposure 
2.4.6 Risk of Accelerated Osteoporosis 
2.4.7 Risk of Bone Fracture 
2.4.8 Risk of Renal Stone Formation 
2.4.9 Risk of Cardiac Rhythm Problems  
2.4.10 Risk of Adverse Health Effects Due to Alterations in Host-Microorganism Interactions 
2.4.11 Risk of Crew Adverse Health Event Due to Altered Immune Response   
2.4.12 Risk of Intervertebral Disc Damage 
2.4.13 Risk of Orthostatic Intolerance during Re-Exposure to Gravity 
Risk of Carcinogenesis from Space Radiation, 
Risk of Acute Radiation Syndromes Due to Solar Particle Events, 
Risk of Acute or Late Central Nervous System Effects from Radiation Exposure, and 
Risk of Degenerative Tissue or Other Health Effects from Radiation Exposure 
Sections 2.4.1 through 2.4.4 are highly interrelated.  The occurrence or mitigation of one risk can be 
a contributing factor affecting another, so the research approaches are given together.   
Radiation research does not follow the standard Risk-Gap-Task-Deliverable approach defined 
elsewhere in this document.  The radiation element uses data from all funded studies and provides 
the integrating component through development of risks assessment tools and design tools.  When 
critical deliverables are needed such as at mission or vehicle SRR/SDR, crew selection, or for key 
development of operational products, the radiation element will serve as an advisory function, using 
the output of the latest independently verified and validated tools. Thus, the many deliverables will 
not usually map to the end of a specific study, but rather are planned to occur at the key milestones 
when they are needed.  However, tools utilized in the design and development of vehicles will be 
delivered prior to PDR and CDR to be utilized during the design and analysis cycles. 
Near-term goals for cancer research focus on reducing the uncertainties in risk projections through 
the development of tissue specific models of cancer risks, the underlying mechanistic understanding 
of these models, and appropriate data collection at the NSRL.  In the long-term, extensive validation 
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of these models with mixed radiation fields is envisioned and research on biological 
countermeasures and biomarkers will be pursued if needed.  Research on improving cancer 
projections has two major emphases: 1) testing the correctness of the National Council on Radiation 
Protection (NCRP) model and 2) reducing the uncertainties in the coefficients that enter into the 
cancer projection model.  Research on the validity of the NCRP model relies on studies at the NSRL 
observing qualitative differences in biological damage between HZE nuclei and gamma rays and the 
establishment of how these differences relate to cancer risk.  There are distinct mechanisms of 
cancer induction across and within major tissue sites, and uncertainty reduction requires tissue 
specific risk estimates.  NRA and NASA Specialized Center of Research (NSCOR) selections focus 
on these major sites: lung, breast, colon, stomach, esophagus, the blood system (leukemias), liver, 
bladder, skin, and brain.  There are differences in radiation sensitivity based on genetic and 
epigenetic factors and research in these areas aids the development of tissue specific cancer models.  
The approach to risk quantification and uncertainty reduction is based on modifying the current 
model for projecting cancer incidence and mortality risks for space missions.  The cancer rate is the 
key quantity in the evaluation, representing the probability at a given age and years since exposure 
of observing a cancer.  The life-span study of the Japanese survivors of the atomic bomb is the 
primary source for gamma ray data.  More recently, however, meta-analysis data of patients exposed 
to radiation or reactor workers for several tissue types has become available.  This newer data is 
being used to check or replace the Japanese data.  Other assumptions in the model are made with 
regard to the transfer of risk across populations, the use of average rates for the U.S. population, age, 
and age-after exposure dependence of risk on radiation quality and dose-rate, etc. 
Collaborative research with the DoE Low Dose Research Program is a key component of the 
strategy.  The DoE program focus is on low Linear Energy Transfer (LET) irradiation; collaborative 
grants are also being selected from proposals that contain one or more Specific Aims addressing 
NASA interests using the NSRL.  This research augments SR research with a large number of grants 
that use state-of-the art approaches, i.e., genetics, proteomics, and transgenic animal models, etc.  
The DoE research is an important part of the goal to identify biomarkers of cancer risk.  
Determining the shape of the dose-response model for cancer induction is a near-term focus that is 
enumerated in biological terms through various cancer Gaps.  In the NCRP model, the dose-response 
is linear and the slope coefficient is modulated by radiation shielding.  Non-targeted models of 
cancer risk describe processes where cells traversed by HZE nuclei or protons produce cancer 
phenotypes in regions of tissue not limited to the traversed cells.  Non-targeted effects are the major 
mechanism that has been identified that is in disagreement with the NCRP model, and leads to a sub-
linear dose response.  The implications of such a dose response for cancer risk are large since such a 
model predicts a reduced effectiveness for radiation shielding.  The importance of mission length is 
also affected by the sub-linear dose response.  Research in this area is a major focus of studies at 
NSRL.  For some cancer sites and exposure conditions, for proton exposures, the NCRP model may 
be adequate.  NSRL research is focused on reducing the uncertainties in the model through the 
establishment of tissue-specific models of human cancers, and collection of data at NSRL for a 
variety of ground-based analogs for Solar Particle Event (SPE) and Galactic Cosmic Rays (GCR).   
Systems biology models provide a framework to integrate mechanistic studies of cancer risk across 
multiple levels of understanding (molecular, cellular, and tissues), and are the most likely approach 
to replace the NCRP model.  Systems biology models are being developed by the Risk Assessment 
Project and several NSCORs, and, in conjunction with data collection, will improve the descriptions 
of cancer risk, laying a framework for future biological countermeasure evaluations and biomarker 
identification. 
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A critical question for the current phase of research is to establish possible threshold doses for 
specific CNS risks.  Central Nervous System (CNS) risks from GCR are a concern due to the 
possibility of single HZE nuclei traversals causing tissue damage as evidenced by the light-flash 
phenomenon first observed during the Apollo missions.  Also, as survival prognosis for patients 
irradiated for brain tumor treatment has improved, patients have shown persistent CNS changes at 
long times after treatment with gamma rays suggesting a possible CNS risk for a large SPE.  
Furthermore, animal studies of behavior and performance with HZE radiation suggest detrimental 
changes may occur during long-term GCR exposures.  Currently, there is no projection model for 
CNS risks of concern to NASA.  The values of possible thresholds for CNS risks and knowledge on 
how to extrapolate possible thresholds to individual astronauts is a key milestone in the long-term 
research plan.   
Cataracts have long been a research focus of SR.  More recently, several epidemiological studies, 
including results from the atomic-bomb survivors and nuclear reactor workers, have identified an 
increased risk of stroke and coronary heart disease (CHD) for low LET radiation at doses 
comparable to those of a Mars mission, or a lunar mission incurring a large SPE.  Because the risk of 
heart disease is a recent finding, preliminary studies in these areas are seeking to establish possible 
distinctions in mechanisms for this risk between protons, HZE nuclei, and gamma rays.  As an 
adjunct, SRPE will take advantage of studies by the European Union in this area, wherein the Union 
is supporting large-scale mouse studies of CHD.  These studies should present new insights into the 
nature of the low LET (gamma-ray) risk at low dose-rates comparable to space conditions, and 
identify appropriate mouse strains to be used in future SR studies.  
An increased risk of cataracts associated with low dose space radiation has been reported from past 
NASA missions, and is being followed up with a clinical study of cataract progression rates in 
current or retired astronauts.  Several NSRL studies of risks are supported to improve the 
understanding of how protons and HZE nuclei induce cataracts, and to identify possible 
countermeasure approaches.  
A variety of acute radiation syndromes are of concern following a large SPE exposure.  Radiation 
sicknesses, i.e., the prodromal risks, include nausea, vomiting, diarrhea, and fatigue.  These effects 
are manifested within 4 to 24 hours post-exposure for sub-lethal doses, with a latency time inversely 
correlated with dose.  Furthermore, there is a reasonable concern of a compromised immune system, 
due to high skin doses from a SPE leading to burns, or other flight factors, albeit the possibility of 
acute death through the collapse of the blood forming systems is negligible.  One research emphasis 
is to pursue the role of the immune system in acute risks.  Animal and cell culture models and 
possible countermeasure approaches to acute risks are expected to be distinct from cancer and other 
radiation risks. 
In the long-term, the SR will consider research on fertility, sterility, and hereditary risks from space 
radiation, and may request the NSBRI support these areas because of their unique nature.  
Risk of Adverse Health Effects from Lunar Dust Exposure 
The toxicological effects of lunar dusts have not been studied in sufficient depth to develop an 
exposure standard for operations on the lunar surface. Lunar dust is somewhat similar to volcanic 
ash, which is used by NASA as a lunar-dust stimulant; however, dusts on the lunar surface have 
worrisome properties in regards to human health. Lunar dusts have a high content in the respirable 
size range, they have a high surface area that is chemically reactive, and elemental iron "nano-
particles" are imbedded in the dust. These unusual properties may cause the respirable dusts to be at 
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least moderately toxic to the respiratory system, and the larger grains to be abrasive to the skin & 
eye. NASA needs to set airborne exposure standards based on scientific evidence so that vehicle 
designs can effectively control exposure. Operations must be designed to minimize the risk of 
abrasion to skin and eyes. 
The research approach is to evaluate and characterize each factor contributing to toxicity of the lunar 
dust, and then synthesize these data into a recommended standard via the Lunar Airborne Dust 
Toxicity Assessment Group (LADTAG).  The HRP has committed to recommending this standard in 
2010, when it is needed prior to development of Lunar Operations concepts. 
Focused studies have already commenced to determine size distributions, shape characteristics, and 
chemical composition of lunar particulates.  Lunar dust surface activation studies will attempt to 
replicate solar wind and micrometeorite bombardment.,  Understanding the process of both 
activation and of passivation in a habitable environment (water vapor and oxygen) will determine 
potential health effects and exposure limits occurring during mission-related tasks, as well as the 
mode of action within the human system. The generation of reactive oxygen species (ROS) will be 
one marker of potential toxicity.  Active vs. non-active dust will be tested to determine the 
differences in toxicity due to chemical activation. 
In vivo studies include inhalation toxicity and intratrachael instillation (ITI) testing of lunar dust.  
Gross pathology and histopathology will be performed to gather evidence of the degree and nature 
of lunar dust toxicity. Lung lavage will be used to determine the biochemical and cellular response 
of the lung to insult by lunar dust. 
Several crewmembers reported dermal and ocular issues resulting from lunar dust exposure during 
Apollo missions.  Other than these anecdotal reports, there is no objective scientific data to support 
an understanding of the dermal and ocular toxicity of lunar dusts.  Ground studies will determine the 
extent to which dermal and ocular hazards may be present for visual decrement and vapor barrier 
loss during lunar operations, especially EVAs with dust inside. Periodic cleaning of the EVA suit is 
expected to mitigate this hazard.   
Risk of Accelerated Osteoporosis and  
Risk of Bone Fracture 
The two risks listed above comprise Sections 2.4.6 and 2.4.7, and are highly interrelated; the 
occurrence or mitigation of one risk possibly affects the other.  The combined research risk 
approaches are presented below. 
It is currently possible to 1) track the course of changes in bone mineral density and bone quality 
during long duration missions, 2) determine if bone losses will occur during a Mars visit, and 3) 
know such information to determine the risk of fracture upon return to Earth after a Mars mission.  
However, these capabilities are not a part of any requirements documents for Lunar or Mars 
missions.  Even after 6-month missions, currently there are indications that bone quality/strength 
does not recover as quickly as bone mineral density.  This may represent a long-term health effect 
(increased osteoporosis and fracture risk) related to this discordant recovery dynamic.  This 
information is required to assess long-term health risks to returning crew. 
While bone atrophy during spaceflight is known and requires mitigation; the time course of in-flight 
bone changes, the time course of post-flight recovery, and individual susceptibilities have not been 
determined.  The 2007 NASA Research Announcement was utilized to solicit and select proposals to 
gather these space normal data.  In addition, work is ongoing with the Space Medicine Division to 
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obtain long-term recovery data.  The long-term goals are to develop and deliver countermeasures for 
long-term missions while tracking the efficacy of these countermeasures to prevent increased 
lifetime health risk.  Due to schedule constraints, countermeasure development has been started in 
parallel with space normal data collection and technology development. 
The fracture risk for bone is related to the applied load-to-bone ratio and to the fracture load of bone.  
Thus, the increased fracture risk induced by spaceflight is suggested collectively as an adaptive 
response by the accelerated loss of bone mass, by weightlessness, and by reduced gravity fields 
experienced during missions, as well as by the loads and torques that the skeleton is subjected to 
during tasks performed during the missions.  The most critical work needed for this risk is the 
measures of in-flight changes in bone mass over the course of ISS missions.  This allows the 
prediction of temporal changes in bone mass during Mars missions.  Those data will provide a basis 
for evaluating whether the expected loads/torques to bone during human performance on a mission 
will exceed the failure load of bone (i.e., fracture load).  This knowledge will drive mission 
operations planning. 
The Risk of Bone Fracture deals with a fracture occurring during a mission.  A fracture considered 
of “high” risk is characteristic of osteoporosis, a disease characterized by losses in bone mass and in 
structural deterioration.  Therefore, gaps and tasks that fall under the Risk of Accelerated 
Osteoporosis are also mapped to the Risk of Bone Fracture.  The only current independent gap for 
the Risk of Bone Fracture is the unknown incidence of vertebral compression fractures.  The task 
associated with this independent gap is being completed by the Space Medicine Division. 
Risk of Renal Stone Formation 
Space normal must first be defined for this risk.  Data mining tasks are ongoing.  Once space 
“normal” is defined, the data will be presented to the HSRF and a decision of whether 
countermeasures need to be developed will be made. 
The evidence establishing the risk factors and/or the likelihood of risk occurrence for renal stone 
formation is either known or in-progress.  The activities in this area are intended to compile data 
related to the risk of renal stone formation, from medical data and from raw research data used for 
previously published reports.  From this data, the task is to determine primary and other risk factors 
for renal stone formation, particularly regarding the types of stones formed (to identify the specific 
risk factor and appropriate countermeasure), the correlation with diet, and the time course for 
formation.  Ground data mining and final analysis of the previous Renal Stone Flight Study will be 
used to determine if further work is warranted for this risk. 
Risk of Cardiac Rhythm Problems 
Heart rhythm disturbances have been seen among astronauts.  Most have been related to 
cardiovascular disease, but it is unclear whether this was due to pre-existing conditions or to the 
effects of space flight.  It is believed that advanced screening for coronary disease has greatly 
mitigated this risk.  Other heart rhythm problems, such as atrial fibrillation, can develop over time, 
necessitating periodic screening of crewmembers’ heart rhythms.  Beyond these terrestrial heart 
risks, some concern exists that prolonged exposure to microgravity may lead to heart rhythm 
disturbances.  Although this has not been observed to date, further surveillance is warranted. 
Space normal must first be defined for this risk and data mining tasks are ongoing.  Once the 
definition is determined, the data will be presented to the HSRF and it will be decided if 
countermeasures need to be developed. 
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The HRP will conduct a comprehensive study that integrates the objectives of two NRA 
investigations and a SMO, involving both intramural and extramural investigators.  In-flight testing 
will require Holter monitoring, two-dimensional (2D) echocardiography, and ambulatory blood 
pressure monitoring.  After completion of the study, the clinical expression of cardiac atrophy during 
long duration spaceflight will be defined clearly, and its significance for cardiac systolic and 
diastolic function at rest and during gravitational transitions will be elucidated.  In addition, 
preliminary information will be obtained regarding ventricular conduction and re-polarization that 
will provide either strong clinical reassurance, or pathophysiologic insight into the risk for cardiac 
arrhythmias.  Based on the outcome of this investigation, the HRP will determine if countermeasures 
are necessary to prevent these conditions. 
Risk of Adverse Health Effects Due to Alterations in Host-Microorganism Interactions 
Current preventative measures limit the presence of many of the medically significant 
microorganisms during a mission, although infections are not completely eradicated.  Alterations in 
some microbial characteristics have been observed in organisms grown in flight, including virulence 
(disease-causing potential), as indicated by recent evidence.  Due to the evidence, the HRP plans to 
compare samples collected on the ground samples with on-orbit samples collected aboard ISS.  
Particular attention will be paid to equipment, the SHFH element, and air and water systems.  This 
comparison will clarify the extent of possible alteration by microbes in spaceflight.  Given 
operational controls that are in place onboard spacecraft now, the HRP will determine if potential 
microbial changes warrant retaining this risk, whether the existing controls are adequate, and 
whether additional mitigation techniques should be developed. 
Risk of Crew Adverse Health Event Due to Altered Immune Response  
There are no procedures currently in place to monitor immune function or its effect on crew health.  
Immune dysregulation has been demonstrated to occur during spaceflight, yet little in-flight immune 
data has been generated to assess whether or not this may be a clinical problem.  Thus, HRP will 
conduct the “Integrated Immune SMO” to assess the clinical risks resulting from the adverse effects 
of space flight on the human immune system and will validate a flight-compatible immune 
monitoring strategy.  The correlation between in-flight immunity, physiological stress and a 
measurable clinical outcome (viral reactivation) will be determined for long- vs. short-duration 
space flight.  Data from this study will be combined with the Shuttle-based immune studies to 
inform and update health standards.  Additionally, ground analogs such as NEEMO will be 
evaluated to determine if they represent a good analog for short-duration spaceflight.  This immune 
dysregulation analog will be validated for some aspects of that dysregulation if it is observed in the 
NEEMO crews (similar to that already observed in flight crews during/following spaceflight).  Data 
from ground studies and the Integrated Immune SMO will be assessed to determine countermeasure 
development needs. 
Risk of Intervertebral Disk Damage 
Evidence from medical operations indicates that astronauts have a higher incidence of intervertebral 
disk damage than the general population.  Additional work to determine the extent of this problem 
should be done.  Once completed, the findings will be used to guide the design of re-entry and post-
flight protocols, as well as future re-entry spacecraft, as appropriate. 
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Space normal must first be defined for this risk; hence, data mining tasks are ongoing.  Once space 
normal is defined, the data will be presented to the HSRF and it will be decided if countermeasures 
need to be developed. 
Risk of Orthostatic Intolerance due to Re-Exposure to Gravity  
Twenty percent of Shuttle crewmembers and up to 83% of returning ISS crewmembers suffer 
hypotension and presyncope or syncope during 10 minutes of upright tilt on landing day.  This may 
constitute a risk when crewmembers experience Earth's gravity after exposure to microgravity.  
Currently available countermeasures are not effective in all crewmembers; in particular, women are 
more susceptible than men are.  While it is well known that crewmembers can be incapacitated by 
orthostatic intolerance after six-month missions when they return to Earth’s gravity, it is not known 
the degree to which this may be ameliorated in the gravity environment on the Martian surface.  
Early surface operations may require astronauts to be upright and active soon after landing on Mars.  
A combination of countermeasures, both physical and pharmaceutical, should be pursued for this 
risk.  It is not known if exposure to 1/6 g and 3/8 g will cause orthostatic intolerance or will have 
mitigating effects on orthostatic intolerance upon return to 1 g. 
Space normal has been defined for this risk.  Current research efforts are investigations for the 
efficacy of new countermeasures (i.e., Jobst stockings and pharmacological agents).  The new lunar 
analog currently under development will be utilized to understand the role of the lunar gravity as 
protection from orthostatic intolerance.  In addition, gender effects and the possibility for gender-
specific countermeasures are also being investigated. 
2.5 PROVIDE ADEQUATE MEDICAL CARE FOR THE CREW 
 (Return to Table of Contents) 
2.5.1 Risk of Inability to Adequately Treat and Ill or Injured Crew Member 
2.5.2 Risk of Therapeutic Failure Due to Ineffectiveness of Medication 
Risk of Inability to Adequately Treat an Ill or Injured Crew Member 
To address this broad risk, the ExMC has broken it down into seven categories that correspond with 
the seven requirements allocated to the ExMC from the HRP Program Requirements Document 
(PRD).  Each of the seven categories is then analyzed individually to determine where gaps exist in 
satisfying the PRD requirements.  Below are the seven categories into which the risk has been 
separated and an explanation of the strategy for addressing the different categories of gaps. 
1.0 Validate Standards:  The NASA HQ OCHMO Standards for Crew Selection and Retention 
will require changes as new medical information and spaceflight technology becomes 
available.  Additionally, NASA exploration missions may require new knowledge and/or 
new technology development either to support current standards or to modify standards for 
mission success.  In either situation, the ExMC Element Scientist, through Space Medicine, 
will determine research needs and develop the research requirements and/or tasks necessary 
to fulfill this responsibility.  The NASA HQ OCHMO standards that pertain to this risk are 
Crew Selection and Retention Criteria.  The Space Medicine Medical Operations Lead for 
standards, working with the ExMC Element Scientist, determines gaps in knowledge in the 
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current Crew Selection and Retention Criteria.  Tasks are then identified to close those 
knowledge gaps. 
2.0 Quantify the Risk:  Because of the limited available operational and research data, 
incidence rates and outcomes for relevant medical conditions have large uncertainties 
associated with them.  The Space Medicine Exploration Condition List is analyzed to 
determine gaps in our knowledge about medical conditions’ incidence rates and outcomes in 
spaceflight.  Tasks are then assigned to further study, model, and use analog population data 
to better quantify the medical conditions.  
3.0 Mitigate the Risk:  Gaps in this section deal with our knowledge about effective training 
and telementoring programs for Exploration missions.  The Space Medicine Medical 
Operations Lead for training, working with the ExMC Element Scientist, determines gaps in 
knowledge and techniques for developing future crew, flight surgeon and biomedical ground 
controller training and telementoring programs.  Tasks are then identified to close those 
knowledge gaps. 
4.0 Monitor and Treat the Unmitigated Risk:  Based on the Space Medicine Exploration 
Condition List, each condition is analyzed for each Constellation Design Reference Mission 
(DRM) for the capabilities required to monitor and treat the condition.  An analysis is 
performed to determine where gaps exist in current technologies or where efficiencies could 
be realized in the future.  Based on when a technology needs to come online, a technology 
watch is implemented or a technology development project is initiated to deliver the 
technology to enable the mission. 
5.0 Provide Enabling Capabilities:  Provide data integration and management for HRP to 
ensure proper handling of data (e.g. Life Sciences Data Archive, Mission Extended Medical 
Enterprise).  Gaps exist where these capabilities are either insufficient or incomplete. 
6.0 Comply with Agency Standards:  Follow best practices and programmatic guidelines as 
levied by the HRP PRD.  There are currently no gaps associated with this requirement. 
7.0 Reduce Resource Requirements:  Wherever possible, reduce in flight and funding 
resources.  There are currently no gaps associated with this requirement. 
Risk of Therapeutic Failure due to Ineffectiveness of Medication  
Better recordkeeping of medication use, its effectiveness, and the side effects produced (if any) 
should be instituted.  This will provide evidence for or and should be a precursor to a formal 
assessment of Pharmacokinetics/Pharmacodynamics (PK/PD) on-orbit.  It is thought that the 
reduction in gastrointestinal (GI) motility and function, is not an issue after the first few days of 
flight, and is offered as the first piece of evidence for this gap.  In general, Space Medicine avoids 
prescribing oral medications during this period of the mission.  It is not known to what extent 
different volumes of distribution might be a factor in flight.  Drugs selected for the PK/PD studies 
should be commonly used, have few side effects, and different metabolic pathways.  External 
consultants should be used to determine which drugs to test and to design testing protocols.  Space 
Medicine needs to develop a process and procedures to systematically track crew medication use, 
including subjective comments on efficacy and side effects, particularly for ISS.  It is very important 
to know what pharmaceuticals are taken prior to in-flight tasks. 
The overarching strategy for this risk is to obtain better record keeping of medication use, efficacy, 
and side effects.  This includes several data mining tasks, which will provide evidence for or against 
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this risk.  If evidence indicates the ineffectiveness of medications, a pharmacokinetics/ 
pharmacodynamics study will be performed in flight to obtain further information. 
3.0 ELEMENTS INPUT DESCRIPTION LOCATED IN APPENDIX A 
The format for the Elements’ inputs includes graphical depiction via Gantt charts and written 
discourse to clarify the Element approach.  Each input follows the same form.  The Risk is reported, 
along with the criticality to the Lunar Outpost mission and the Mars mission; the Operational 
Relevance is described; the strategy for mitigation is given; the gaps in knowledge are reported with 
a brief description; and the activity or activities necessary to address the gap are described.  For each 
activity, the resulting product/deliverable, the required delivery milestone for the deliverable, the 
required platform, and the Project or organization responsible for implementing the activity are all 
defined. 
3.1 RISKS 
Each text description has a description of the risk.  These descriptions are verbatim from the PRD, 
and are reprinted in the IRP as a matter of convenience for the reader.  With the title of each risk, the 
criticality is given.  Criticality ratings correspond to the criteria given in Section 1.4.1 of this 
document. 
3.2 CONTEXT OF RISK FOR EXPLORATION 
After each risk and description, a paragraph occurs entitled “Operational Relevance and Risk 
Context.”  In this paragraph, a description of the relevance to the exploration mission is given.  This 
section also provides the context of how the research plan is built for that risk and describes the need 
for the research at a very high level. 
3.3 STRATEGY FOR MITIGATION 
The approach strategy for the mitigation of the risk is outlined in this section.  For instance, the 
strategy may be to first determine space normal physiology, then identify specific countermeasures.  
3.4 GAPS 
Gaps in our knowledge or in the evidence base exist for each risk.  These gaps have several different 
forms.  A gap may exist in our evidence base, which leaves greater uncertainty regarding the 
likelihood of the risk.  A gap may exist in the identification of the appropriate countermeasure.  For 
others, the gap may be in the flight validation of the appropriate countermeasure.  For the purposes 
of this IRP, the gaps are not delineated by type; rather they are simply identified as a gap that must 
be filled before the risk is mitigated.  In some cases, the gap may not require research to close it; the 
gap can be avoided altogether through specific Constellation design selection. 
3.5 TASKS 
For each gap, the task (s) required to fill that gap are listed.  The task is named and a short 
description is given.  In some cases, a task can address multiple gaps across multiple risks.  To limit 
the size of this document, a task that addresses more than one gap is named and described once and 
the description is referred to in the other gaps that it is intended to fill.  In addition, the project 
responsible for implementation of the task is listed, along with the anticipated procurement method.  
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In some cases, the project is not within the Element responsible for the risk.  The responsible 
Element will coordinate with the appropriate project in those cases. 
3.6 DELIVERABLES 
Each task is designed to culminate in a deliverable.  These deliverables are structured to feed into the 
Constellation Program, the Office of the Chief Health and Medical Officer, or the Mission 
Operations Directorate.  Several different types of deliverables exist.  The following are the types of 
deliverables used: 
Information for Standards  
An “Information for Standards” deliverable is used for a task that produces part of the information to 
update a standard.  Because this information is incomplete, the program would not be in a position to 
recommend a standard update, but it would represent a significant step toward such a 
recommendation.  These tasks can feed into other tasks that also have information for standards, or 
they can be combined with other “Information for Standards” deliverables to result in a 
recommended standard update (next deliverable) 
Recommended Standard Update  
A “Recommended Standard Update” deliverable is mandated when the program is ready to provide 
the OCHMO with a recommended update to health or performance standards.  This is usually done 
using the results of several tasks and then integrated into one recommendation for update.  A key test 
of when to use this as a deliverable is that the program should be ready to actually write the text for 
the recommended standard update.  Since the standards are applied in a broad spectrum for design 
and operations, these deliverables can be linked to any of the system design or mission operations 
milestones shown in the blue section at the top of the chart.  They should be applied as early in the 
design phase or mission operations development phase as is possible, so, most often, they are 
necessary prior to Systems Requirements Review. 
Informing Mission Operations 
This form of deliverable is needed when the information is directly useful to affect mission planning.  
Examples include when a deliverable may impose mission operations timelining constraints, such as 
a new flight rule for sleep schedules or exercise timelines.  As the name implies, these deliverables 
will most often affect the Mission Operations line shown in the blue section of the top of the Gantt 
charts. 
Countermeasure 
When a specific protocol is developed and validated to prevent or reduce the severity of a negative 
outcome identified in one of the risks, this is the form of deliverable.  A countermeasure may be 
medical, physical, or operational entities, such as pharmaceuticals, a device, or a specific exercise 
routine, respectively.  Note that in some cases the countermeasure will also affect mission operations 
(in areas like timelines).  Though there is no fixed rule on this crossover, the demarcation used for 
the countermeasure deliverable is that the protocol is specific and extensive enough to require 
validation in spaceflight.  For instance, if a ground task results in a spaceflight task that is called 
“flight validation studies,” it likely is a countermeasure.  Similarly, there is no set rule for 
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determining to which Constellation milestone a countermeasure would apply.  Some general 
direction on this, however, is that the countermeasure usually does not affect the design of the 
spacecraft, and is applied in the mission operations phase as a solution to a problem; thus, the 
countermeasure deliverables generally affect the mission operations PDR or CDR phases. 
Information to Other Elements 
This deliverable is used when the task result feeds a gap in some other HRP element.  As the IRP 
matures, we will identify critical dependencies for each gap.  These critical dependencies will 
include, in some cases, information developed under another gap.  The need dates for these 
deliverables are determined by when the other element needs the information, not by Constellation 
milestones. 
Requirements to Other Programs or Elements 
The “Requirements to Other Programs or Elements” deliverable is chosen when a task will result in 
a requirement (or requirements set) given to another program (usually the Constellation Program) or 
to another element.  The task may end up in the requirements on the lighting spectrum in the vehicle, 
or a requirement may apply to the radiation shielding design, or requirements may be identified that 
apply to the food system from nutritional risk work.  These deliverables often feed the design of the 
vehicle and its sub-systems.  As requirements, they primarily are applied in the Systems 
Requirements Review timeframe.  
Updates to the Human Systems Risk Forum 
When a task results in information that must be considered by the medical operations community 
and/or OCHMO, this deliverable is used.  This deliverable is applicable when the rating of the 
likelihood or consequences of the RMAT may be affected.  It is also applied when the results of the 
study are anticipated by the space medical operations community.  As such, the deliverable often is 
applied in conjunction with the “Informing Mission Operations” deliverable. 
3.7 REQUIRED DELIVERY MILESTONE 
Key milestones within the Constellation Program development drive the required date for the HRP 
deliverables.  For instance, design requirements typically must be defined by the appropriate System 
Requirements Review.  Design solutions and technology typically must be defined to a TRL6 level 
by the Preliminary Design Review.  This section documents the schedule drivers for the delivery 
milestones. 
3.8 REQUIRED PLATFORMS 
This section defines the platform required to perform the research.  Platforms can be designated as 
ground analog environments, such as NEEMO, Antarctica, etc., or the platform may be a space-
based one, such as the Shuttle or the ISS.  Also, the lunar surface is a platform that is anticipated in 
some research efforts.  If the ISS is required, a summary of the following resource requirements is 
given: Number of subjects, Initial Upmass, Upmass/Subject, Downmass, Crew Time/Subject, and 
Post-Flight Baseline Data Collection Time. 
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3.9 PROJECT OR ORGANIZATION RESPONSIBLE FOR THE IMPLEMENTATION 
OF ACTIVITY 
Within the HRP elements, there are one or many projects chosen to implement the element research 
plan.  The project is identified in this section.  In some cases, organizations outside the element are 
responsible for implementation of the research, such as the NSBRI or even an international partner.  
These organizations are identified within this section. 
This section indicates the project with primary responsibility for implementing the activity.  In some 
cases, the project is not within the element responsible for the risk.  The element responsible will 
coordinate with the appropriate project in those cases.   
Discipline teams include the participation of operations personnel, the NASA research discipline 
experts, and the NSBRI.  In several cases, the primary responsibility is shown as that of NASA; 
however, that does not mean that the NSBRI is not participating at all.  The NSBRI participates 
through the discipline teams, as well as through future solicitations. 
3.10 GRAPHIC INPUT 
Each graphic is supported with text that provides a more thorough level of detail.  Figure 2 shows an 
example of a Gantt chart, labeling each section of the chart.  Each Gantt chart is associated with one 
of the 27 PRD Risks.  The element to which the risk is allocated is identified in the upper left corner.  
The research gaps are identified by name and number along the left side for each risk.  Under each 
gap are the identified activities required to fill the gap.  Each activity is identified by name and the 
acronym of the project or organization responsible for implementing the activity.  In some cases, the 
organization responsible for implementing the activity may not be directly controlled by the element 
responsible for the risk.  The schedule of each activity is shown on the graphic and an arrow shows 
deliverables resulting from the activity.  The activities are color-coded per the legend given. A 
number on each text deliverable description relates the deliverable to the need date, shown by the 
gray numbered arrows at the top of the chart.  
3.11 DECISION POINTS 
Several key decision points have been placed in the plan.  At these key decision points, the 
appropriate forward path for the research will be reevaluated.  The decision points are cast in a 
“Yes/No” form, and it is anticipated that at these points, the responsible element will review the 
overall, current state of the evidence, and review the appropriate approach to the forward plan.  
Where applicable, the Science Management Office will concur and, if necessary, the appropriate 
Project Standing Review Panel may be convened to deliberate and make recommendations.  Criteria 
for making the decision will be determined on a case-by-case basis and will be consistent with the 
overall management structure documented in the Science Management Plan.  In many cases, a task 
addresses more than one risk.   
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The Risks in this part of the Appendix are aligned with  
Section 2.1 –  
Ensure That the Crew Can Complete the Physical Tasks of the Missions 
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RISK OF IMPAIRED PERFORMANCE DUE TO REDUCED MUSCLE MASS, 
STRENGTH AND ENDURANCE –  
CRITICALITY: LUNAR OUTPOST – I, MARS – C 
There is a growing research database that suggests that skeletal muscles, particularly postural muscles of 
the lower limb, undergo atrophy and structural and metabolic alterations during space flight.  However, 
the relationships between in-flight exercise, muscle changes, and performance levels are not well 
understood.  Efforts should be made to try to understand the current status of in-flight and post-flight 
exercise performance capability and what the goals/target areas for protection are with the current in-
flight exercise program. 
Context of Risk for Exploration 
Successful lunar outpost and Mars missions will be dependent on the performance of human tasks that 
will require an adequate level of physical fitness.  These tasks may range from simple intra-vehicular 
activities, to ambulation on a planetary surface, to construction of long standing outpost habitats.  The 
decrements that occur to skeletal muscle strength and endurance in response to reduced gravitational 
forces could potentially make associated tasks difficult to perform.  Thus, impaired muscle performance 
may affect crew performance and mission success, and in worst-case off-nominal scenarios may impact 
crewmember health and safety (e.g., muscle soreness, muscle injury).  It is therefore essential to identify 
Critical Mission Tasks, evaluate the muscle performance costs of these tasks (as related to provided tools 
and equipment), quantify the expected muscle performance decrements during lunar and Mars missions, 
and design effective exercise countermeasures (exercise hardware and exercise prescriptions) that 
maintain physical fitness at a levels that allow for mission success and safety with minimal time cost to 
additional mission operations. 
Strategy for Mitigation 
This muscle performance data will be taken to the HSRF for review and direction.  Due to scheduling 
constraints with the loss of the Mars transit analogue in 2020, concurrent exercise prescription 
optimization studies are ongoing on the ground and will be validated in flight. 
Similarly, research is ongoing to characterize activities of different mission scenarios to help determine 
the fitness levels required to perform those tasks and therefore, determine the exercise prescription for 
crewmembers.  Current research is defining metabolic costs of some of the critical tasks.  In addition, 
gender effects, hydration effects and lunar EVA effects are all being examined as well as the possibility 
for gender specific countermeasures.   
Gaps 
M1: What is the current state of knowledge regarding exercise performance?  This gap is closed; the 
deliverable has been met. 
M7: Can the current in-flight performance be maintained with reduced exercise volume?  This gap 
should determine the effects of reduced in-flight exercise; this is a high priority gap.  Efforts should be 
made to try to improve efficiency of the current ISS regime.  Identification of which combinations of 
CEVIS, TVIS, and RED will result in the optimum balance of fitness in the least amount of time could 
decrease the amount of required exercise time.  These studies should be performed in combination with 
in-flight measurements of exercise performance, and will give broader insight into what is truly required 
for the maintenance of fitness with the current devices, as well as into what exercise hardware and 
exercise prescriptions will be required for the moon and Mars. 
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M8: What is the minimum exercise regimen needed to maintain fitness levels for tasks?  This gap is 
also asking if exercise, in addition to EVA tasks, is required during 6-month stays on the moon.  If 
exercise is required, what exercise hardware would be required and what would be the correct exercise 
prescription?  In addition, assessment of reduced exercise volume on in-flight performance should be 
completed.  The following questions should also be examined: a) how can suit/task related injuries be 
prevented  b) is the current exercise regimen appropriate for 1/6g and c) is the current exercise regimen 
appropriate for 3/8g – this is a lower priority question for future work. 
M9: What is the minimum set of exercise hardware needed to maintain those (M8) fitness levels?  
This gap should be filled in three parts.  The second treadmill that is being built for ISS can be assessed 
for performance and reliability.  New hardware should be developed as soon as possible for lunar 
missions.  Development of hardware for Mars can be developed using information from the ISS and 
Lunar hardware.  The Moon will serve as a test bed for the equipment that is selected for Mars. 
M10: What is the correct set of ground-based studies (bed rest and others) to optimize exercise 
prescriptions for Lunar Outpost and Mars?  Ground-based work should be conducted to carefully 
build and test potential exercise equipment.  In addition to the physiologic outcomes, equipment should 
be designed and tested so that hardware reliability and functionality are ensured.  A series of bed rest and 
other ground-based studies should be designed to supplement the work discussed above.  All bed rest 
studies should employ a multi-discipline, multi-project approach.  The studies should include appropriate 
multi-disciplinary performance measures.  Listed are some suggestions for issues that could be addressed 
in bed rest studies: optimum loading on treadmill; optimum volume vs. intensity of exercise; 
multidisciplinary performance enhancers (pharmaceutical/diet, mechanical, etc.); develop EVA tasks 
during bed rest and test effects on physiological and performance measures; 1/6 g bed rest and 
performance measures; 3/8 g bed rest and performance measures. 
Task: (ECP – via directed study) 
Flywheel Prescription Optimization – TBD  
A flywheel exercise device has been shown to be an effective countermeasure for muscle mass and strength in 
multiple ground-based flight analogs (lower limb suspension and bed rest), although to date it has not prevented 
the atrophy of the soleus muscle in humans during prolonged periods of unloading.  Currently, the flywheel-based 
exercise device has only been used as a resistance exercise device.  Recent modifications to the flywheel exercise 
device now accommodate aerobic exercise in a rowing machine configuration.  New bed rest studies will compare 
a multi-functional flywheel to a flywheel for resistance exercise alone with the addition of traditional modes of 
aerobic exercise (e.g., flywheel for resistance exercise and cycle ergometer for aerobic exercise). 
Deliverables: Results will determine if a single multifunctional flywheel device can adequately protect muscle 
function, bone health, and aerobic capacity or whether multiple pieces of exercise hardware will be required.  The 
initial results will determine if follow-on flight validation studies to optimize the prescription further are required. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: The bed rest ground analog (6° head down tilt) is required for ground studies for 
countermeasure optimization.  ISS will be required to validate any optimized countermeasures. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
12 (bed rest and 
ISS) 
75 kg (if ISS 
required) 
none (if ISS 
required) 
none (if ISS 
required) 
9 hours (if ISS 
required) 
2 hours (if ISS 
required) 
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Task: (ECP – via directed study) 
ISS Exercise Prescription Study 
This study will apply principles learned from ground-based flight analogs to an in-flight platform in order to 
improve exercise countermeasures efficacy and efficiency by increasing exercise intensity and reducing exercise 
volume. 
Deliverables: Data will guide decision of whether current exercise countermeasures are protective or if improved 
countermeasures requiring flight validation studies are needed.  Data will be taken to HSRF for decisions 
regarding the exercise prescription and will be used to provide information to the muscle standard. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: ISS is required for prescription validation 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject (hrs) 
Post-Flight BDC 
Time (hrs) 
12 None None None 9 2 
 
Task: (Glenn Research Center ECL/ECP – via directed study) 
A New Harness for Use with Exercise Countermeasures – Validation of Improved Comfort and Loading with the 
Center for Space Medicine (CSM) Harness 
Treadmill use in microgravity requires the use of a harness and a system to provide a subject load to keep the 
crewmember in contact with the treadmill belt.  A common complaint from returning ISS crewmembers is that the 
current harness is uncomfortable.  The pain and chafing that occurs with the use of the current harness contributes 
to sub-optimal subject loading (approximately 65% of body weight).  A new harness design will be tested to 
determine if it is more comfortable than the current harness and will allow for greater loading which is expected to 
result in better maintenance of muscle mass and bone density of the lower extremities 
Deliverables: Decision to change to newer CSM harness or continue with current harness during treadmill 
activities 
Required Delivery Milestone: N/A 
Required Platforms: ISS is required for use of the TVIS on orbit to evaluate loading and comfort of the new 
harness. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject (hrs) 
Post-Flight BDC 
Time (hrs) 
12 None 2kg/Inc None None None 
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Task: (ECP – via directed study) 
Integrated Countermeasure Study – TBD  
Studies will be conducted to examine the effects of combining non-exercise countermeasures (e.g. nutritional or 
pharmacological) with established exercise countermeasures.  The integrated countermeasures approach has a goal 
of improving both the efficacy and efficiency of exercise countermeasures.  An integrated countermeasure will 
result in the most effective protection of muscle strength, bone quality, and aerobic capacity while requiring the 
minimal amount of crew time performing exercise countermeasures. 
Deliverables: Data will guide decision of whether current countermeasures are protective or if improved 
countermeasures requiring flight validation studies are needed.  Data will be taken to HSRF for decisions 
regarding the prescription and will be used to provide information to the muscle standard. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: Bed rest is required for this task for evaluation of new exercise prescriptions.  If necessary, 
this data will feed in with the ISS Exercise Prescription Study into a final flight validation study using the ISS as 
the Mars transit analog 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject (hrs) 
Post-Flight BDC 
Time (hrs) 
12 None None None None None 
 
Task: (ECP – via directed study) 
New Hardware Development – TBD  
ECP will evaluate novel hardware concepts for use in the crew exploration vehicle and lunar outpost.  Expertise 
will be leveraged from multiple NASA centers and from external entities via Small Business Innovation Research 
(SBIR) initiatives.  Candidate hardware will be evaluated in ambulatory individuals, flight-analogs and in then in 
flight if effective on the ground. 
Deliverables: New exercise hardware will be delivered. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This will be a ground-based study to develop the hardware; if required, a follow-on ISS 
flight validation study will occur. 
 
Task: (NSRBI) 
Integrated Endurance and Resistance Exercise Countermeasures Using a Gravity-Independent Training Device 
Extended spaceflight as well as existence on the moon and Mars will require exercise equipment and training 
protocols designed to maintain physical fitness and general health.  NASA has determined that current flight-rated 
exercise hardware is not appropriate for use on the future Crew Exploration Vehicle.  These studies will 
investigate protocols designed to maintain both cardiovascular and musculoskeletal fitness using a gravity-
independent multi-mode exercise device (M-MED), which has been identified by NASA as potential flight 
hardware.  M-MED can provide high-resistance either strength or low-resistance endurance-mode exercises.  
Phase I will include ground-based integrated strength and cardiovascular exercise training under normal weight-
bearing conditions.  Phases II and III will include application of this protocol with progressive levels of inactivity.  
Deliverables: Data will guide the decision of whether the exercise prescription should be validated in flight. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
HRP-47065 
 
40 
Task: (NSRBI) 
Integrated Endurance and Resistance Exercise Countermeasures Using a Gravity-Independent Training Device 
(cont’d) 
Required Platforms: Initially this will be a ground-based study conducted at the PI institution.  If a prescription 
should be validated, then ISS is required as the Mars transit analog. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject (hrs) 
Post-Flight BDC 
Time (hrs) 
12 75 None None 9 (if ISS required) 2 (if ISS 
required) 
 
Task: (ECP – via NRA) 
Hydration Effects on Muscle – TBD  
Proposals were solicited in the 2008 NRA to answer the following questions.  What are the effects of dehydration 
on muscle mass, strength, power, and fatigability?  What are the mechanisms of those effects?  What is the effect 
of gender?  How do the effects of dehydration contribute to the muscle "deconditioning" associated with long-
duration bed rest or hind limb suspension?   
Deliverables: This data will feed into the ISS Exercise Prescription Study. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: TBD 
 
Task: (ECP – via NRA) 
Gender Effects on Muscle – TBD  
Proposals were solicited in the 2008 NRA to answer the following questions.  What are the mechanisms of the 
gender effects on loss of exercise capacity and muscle function (including muscle mass, strength, power, and 
fatigability) during long-duration bed rest?  Are gender specific countermeasures needed?  If so, what are the best 
countermeasures to protect both men and women? 
Deliverables: This data will feed into the ISS Exercise Prescription Study. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: TBD 
M3: What tasks will be required for Exploration missions?  The muscle discipline should be part of a 
larger, multi-disciplinary group to define these tasks.  They will be primarily EVA tasks, and study 
groups are currently evaluating these proposed EVA tasks.    
M4: What are the physiologic costs of Exploration mission tasks?  Much of this data exists within 
other groups (Desert Research and Technology Study (D-RATS), EPSP EVA Physiology, Systems and 
Performance, etc).  The fitness effort for given tasks can be bracketed with available information.  This 
information can be used to assess fitness requirements. 
M6:  Can a standardized performance measure of readiness for Exploration mission tasks be 
developed?  This should be a cross-disciplinary protocol that includes sub-tasks and measures that cover 
all affected disciplines.  Work should be done in conjunction with ongoing EPSP activities.  The team 
emphasizes that the testing of individual should not be continued unless this data can be directly related to 
performance and function. 
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Task: (ECP – via directed study; collaborators include Constellation Program Ground and Mission Ops SIG and 
Constellation Program working groups (e.g., CEV Cockpit Working Group, etc.)) 
Critical Mission Task (CMT) Assessment 
The human performance tasks that will be required in order to assure mission success and safety will be identified 
(e.g., post landing egress, suited 10-kilometer walk-back, and emergency crewmember rescue).  The muscle 
performance requirements to perform these tasks will then be determined by biomechanical and metabolic 
analyses obtained during performance of these tasks. 
Deliverables: Results from this study will feed into the Function Task Test task as well as the Lunar EVA task.  It 
will also be used to provide information regarding the muscle standard. 
Required Delivery Milestone: FY2013 – performance decrements information needed to support mission 
operations definition. 
Required Platforms: Ground based studies utilizing the partial gravity simulator (POGO) and the Neutral 
Buoyancy Lab.  Bed rest facilities including the lunar analog will be utilized if required.  Validation of the tasks 
will require lunar surface operations. 
M10: What is the correct set of ground-based studies (bed rest and others) to optimize exercise 
prescriptions for Lunar Outpost and Mars?  Ground-based work should be conducted to carefully 
build and test potential exercise equipment.  In addition to the physiologic outcomes, equipment should 
be designed and tested so that hardware reliability and functionality are ensured.  A series of bed rest and 
other ground-based studies should be designed to supplement the work discussed above.  All bed rest 
studies should employ a multi-discipline, multi-project approach.  The studies should include appropriate 
multi-disciplinary performance measures.  Listed are some suggestions for issues that could be addressed 
in bed rest studies: optimum loading on treadmill; optimum volume vs. intensity of exercise; 
multidisciplinary performance enhancers (pharmaceutical/diet, mechanical, etc.); develop EVA tasks 
during bed rest and test effects on physiological and performance measures; 1/6 g bed rest and 
performance measures; 3/8 g bed rest and performance measures. 
Tasks:  
Lunar EVA Study – TBD  
This task is referenced within the HHC Infrastructure section – see gaps HHC1 and HHC2. 
Lunar Analog Bed Rest Development 
This task is referenced within the HHC Infrastructure section – see gaps HHC1 and HHC2. 
An Integrated Musculoskeletal Countermeasure Battery for Long-Duration Lunar Missions  
This task is referenced within the Risk of Accelerated Osteoporosis section – see gap B15. 
SM7: Can an integrated post-flight functional task performance test be used on returning ISS 
crewmembers to obtain performance decrements?  This gap is meant to develop and validate 
operational tests to define the linkage between functional capabilities and physiological changes.  This 
test should include planetary EVA-like activities  The goal of this product is to define crewmembers’ 
post-flight capabilities and disabilities, and to educate them about their risk of injuries, which will help 
them consciously avoid potentially dangerous activities.  This might also define capabilities during early 
days on a planetary surface.  This product will also provide crewmembers and the rehabilitation team 
members with more objective information regarding their recovery.  This test is not germane to 
understanding how crewmembers will perform during Lunar EVAs since the conditions (duration of 
microgravity exposure) during this testing are dissimilar to the Lunar surface. 
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Task: (ECP – via directed study) 
STS/ISS Functional Task Test  
During space flight, astronauts experience alterations in multiple physiological systems due to exposure to 
microgravity.  These physiological changes include sensorimotor disturbances, cardiovascular deconditioning, loss 
of muscle mass, and strength.  These changes lead to disruption in the ability to ambulate and perform functional 
tasks during the initial reintroduction to a gravitational environment and may cause significant impairments in 
performance of operational tasks immediately following landing on a planetary surface.  To date changes in 
functional performance that result from physiological changes have not been systematically documented.  
Therefore, the goal of this study is to develop and evaluate an integrated set of functional and physiological tests 
and then use these tests to determine how post-flight changes in sensorimotor, cardiovascular and muscle 
physiology impact post-flight functional performance.  These tests will be performed pre and post-flight on 
astronauts exposed to short and long-duration space flight.  The STS/ISS Functional Task Test will assess 
operational relevance of these changes by measuring the performance of specific exploration tasks (e.g., simulated 
seat egress, ladder climb, hatch opening, etc.).  Additionally changes in functional performance will be mapped 
standard muscular, neurological, and cardiovascular measures.  Data obtained from this study will facilitate the 
design of countermeasures that specifically target the physiological systems responsible for impaired functional 
performance.   
Deliverables: Crew performance space normal data and physiological systems that require countermeasures in 
order to preserve performance of functional tasks will be identified.  Information will also be provided to the 
muscle standard as well as to HSRF. 
Required Delivery Milestone: FY2013 – performance decrements information and a validated countermeasure 
are needed to support mission operations definition. 
Required Platforms: STS (short term flights) 
ISS (long term flights) 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight BDC 
Time (hrs) 
26 (13 Shuttle 
and 13 ISS) 
None None None None 6.3 
 
Task: (ECP – via directed study) 
Bed Rest Functional Task Test 
A battery of functional tasks (see STS/ISS Functional Task Test above) will be assessed before and after bed rest 
(simulated micro/partial gravity).  The ability of targeted countermeasures to maintain performance of functional 
tasks will be examined. 
Deliverables: Crew performance space normal data and physiological systems that require countermeasures in 
order to preserve performance of functional tasks will be identified.  Information will also be provided to the 
muscle standard as well as to HSRF. 
Required Delivery Milestone: FY2013 – performance decrements information and a validated countermeasure 
are needed to support mission operations definition. 
Required Platforms: The bed rest ground analog (6° head down tilt) is required for ground studies.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight BDC 
Time (hrs) 
15 None None None None None 
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Task: (ECP – via directed study) 
Hypovolemia Factors of Influence Studies – TBD  
The effects of specific human factors such as gender, initial fitness level and hydration status on the ability to 
perform functional mission tasks will be assessed as supplemental studies. 
Deliverables: Results will feed into the Functional Task Test Study. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: This is a ground-based study.   
 
Task: (ECP – via directed study) 
Gender Factors of Influence Studies – TBD  
The effects of specific human factors such as gender, initial fitness level and hydration status on the ability to 
perform functional mission tasks will be assessed as supplemental studies. 
Deliverables: Results will feed into the Functional Task Test Study. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: This is a ground-based study.   
 
Task: (ECP – via directed study) 
Level of Fitness Factors of Influence Studies – TBD  
The effects of specific human factors such as gender, initial fitness level and hydration status on the ability to 
perform functional mission tasks will be assessed as supplemental studies. 
Deliverables: Results will feed into the Functional Task Test Study. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: This is a ground-based study.   
N9: Can nutritional countermeasures mitigate muscle loss?  This is a medium priority gap.  Proposals 
for nutritional supplementation are appropriate for bed rest studies.  They should contain protocols that 
can be easily implemented in an operational environment.  All groups working on this gap should 
standardize their techniques and measurements.  The team should rely on the clinical literature in support 
of this gap. 
N15: Can nutrition/nutrients mitigate O2/radiation risks?  This is a low priority gap; flight work 
should not go forward until the nutrition SMO and related ground studies are complete.  Expanded 
collaboration with the radiation team is recommended. 
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Task: (NSBRI) 
Redox Modulation of Skeletal Muscle Function in Microgravity   
The current project evaluates selected compounds, nutritional supplements, and pharmacologic agents that may 
oppose oxidative stress in muscle and protect against weakness and fatigue.  The experimental approach is 
designed to identify and develop countermeasures for human testing in the near-to-mid term.  Initial experiments 
will define the loss of oxidant regulation that occurs with muscle unloading.  Subsequent studies will evaluate 
compounds for protective effects on muscle function.  The efficacy of each compound tested in this project is 
supported by preliminary data from animal studies, human trials or both.  Each compound is approved for 
systemic administration to humans. 
Deliverables: Based on results of this activity; HHC is determine if any future work will be done in this area. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: This is a ground-based study.   
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RISK OF REDUCED PHYSICAL PERFORMANCE CAPABILITIES DUE TO 
REDUCED AEROBIC CAPACITY –  
CRITICALITY: LUNAR OUTPOST – L, MARS – C 
Astronauts’ physical performance during a mission, including tasks in microgravity and fractional gravity, 
is critical to mission success   Setting minimum fitness standards and measuring whether crew can 
maintain these standards will document the effectiveness of maintenance regimens.   
Context of Risk for Exploration 
In addition to reduced skeletal muscle strength and endurance, reduced aerobic capacity may put mission 
success at risk.  Evidence demonstrates that aerobic capacity is markedly reduced in response to space 
flight and space flight analogs.  Sustained sub-maximal activities (even walking on a planetary surface) 
could become difficult to perform given large enough decrements in aerobic capacity.  As outlined for 
muscle performance it will also be essential to identify Critical Mission Tasks and associated aerobic 
costs in order to design and validate effective exercise countermeasures for mission success.  Current 
collaborative efforts with ESA are obtaining in-flight measurements of VO2max aboard ISS.  These 
measurements can be used as a baseline for future research to “optimize” or reduce the amount of in-
flight exercise necessary to maintain performance.  It was also recommended that VO2max should be 
obtained during 6° head down tilt bed rest for comparison purposes.   
Strategy for Mitigation 
Although the strategy to mitigate this risk will follow the general strategy of defining space normal, 
determining mechanisms and then developing countermeasures, the research planned will be closely tied 
to efforts investigating impaired performance due to reduced muscle mass, strength and endurance as well 
as hardware development.   
Gaps 
M1: What is the current state of knowledge regarding exercise performance?  This gap is closed; the 
deliverable has been met and can be referenced in the TBR HRP Deliverables Database. 
M7: Can the current in-flight performance be maintained with reduced exercise volume?  This gap 
should determine the effects of reduced in-flight exercise; this is a high priority gap.  Efforts should be 
made to try to improve efficiency of the current ISS regime.  Identification of which combinations of 
CEVIS, TVIS, and RED will result in the optimum balance of fitness in the least amount of time could 
decrease the amount of required exercise time.  These studies should be performed in combination with 
in-flight measurements of exercise performance, and will give broader insight into what is truly required 
for the maintenance of fitness with the current devices, as well as into what exercise types will be 
required for the Moon and Mars. 
M8: What is the minimum exercise regimen needed to maintain fitness levels for tasks?  This gap is 
also asking if exercise, in addition to EVA tasks, is required during 6-month stays on the Moon.  If 
exercise were required, what would be the correct prescription?  In addition, assessment of reduced 
exercise volume on in-flight performance should be completed.  The following questions should also be 
examined: a) how can suit/task related injuries be prevented  B) is the current exercise regimen 
appropriate for 1/6g and c) is the current exercise regimen appropriate for 3/8g – this is a lower priority 
question for future work. 
M9: What is the minimum set to equipment needed to maintain those (M8) fitness levels?  This gap 
should be filled in three parts.  The second treadmill that is being built for ISS can be assessed for 
performance and reliability.  New hardware should be developed as soon as possible for lunar missions.  
HRP-47065 
 
50 
Development of hardware for Mars can be developed using information from the ISS and Lunar 
hardware.  The Moon will serve as a test bed for the equipment that is selected for Mars. 
M10: What is the correct set of ground-based studies (bed rest and others) to optimize exercise 
prescriptions for Lunar Outpost and Mars?  Ground-based work should be conducted to carefully 
build and test potential exercise equipment.  In addition to the physiologic outcomes, equipment should 
be designed and tested so that hardware reliability and functionality are ensured.  A series of bed rest and 
other ground-based studies should be designed to supplement the work discussed above.  All bed rest 
studies should employ a multi-discipline, multi-project approach.  The studies should include appropriate 
multi-disciplinary performance measures.  Listed are some suggestions for issues that could be addressed 
in bed rest studies: optimum loading on treadmill; optimum volume vs. intensity of exercise; 
multidisciplinary performance enhancers (pharmacological, diet, mechanical, etc.); develop EVA tasks 
during bed rest and test effects on physiological and performance measures; 1/6 g bed rest and 
performance measures; 3/8 g bed rest and performance measures. 
Tasks: 
Flywheel Prescription Optimization – TBD  
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
ISS Exercise Prescription Study 
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
Integrated Countermeasure Study – TBD  
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
New Hardware Development – TBD  
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
Integrated Endurance and Resistance Exercise Countermeasures Using a Gravity-Independent Training Device 
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
M3: What tasks will be required for Exploration missions?  The muscle discipline should be part of a 
larger, multi-disciplinary group to define these tasks.  They will be primarily EVA tasks, and study 
groups are currently evaluating these proposed EVA tasks.    
M4: What are the physiologic costs of Exploration mission tasks?  Much of this data exists within 
other groups (Desert RATS, EPSP, etc).  The fitness effort for given tasks can be bracketed with available 
information.  This information can be used to assess fitness requirements. 
M6:  Can a standardized performance measure of readiness for Exploration mission tasks be 
developed?  This should be a cross-disciplinary protocol that includes sub-tasks and measures that cover 
all affected disciplines.  Work should be done in conjunction with ongoing EPSP activities.  The team 
emphasizes that the testing of individual should not be continued unless this data can be directly related to 
performance and function. 
Task:  
Critical Mission Task (CMT) Assessment 
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M3, M4 and M6 
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M10: What is the correct set of ground-based studies (bed rest and others) to optimize exercise 
prescriptions for Lunar Outpost and Mars?  Ground-based work should be conducted to carefully 
build and test potential exercise equipment.  In addition to the physiologic outcomes, equipment should 
be designed and tested so that hardware reliability and functionality are ensured.  A series of bed rest and 
other ground-based studies should be designed to supplement the work discussed above.  All bed rest 
studies should employ a multi-discipline, multi-project approach.  The studies should include appropriate 
multi-disciplinary performance measures.  Listed are some suggestions for issues that could be addressed 
in bed rest studies: optimum loading on treadmill; optimum volume vs. intensity of exercise; 
multidisciplinary performance enhancers (pharmacological, diet, mechanical, etc.); develop EVA tasks 
during bed rest and test effects on physiological and performance measures; 1/6 g bed rest and 
performance measures; 3/8 g bed rest and performance measures. 
Tasks: 
Lunar EVA Study – TBD  
This task is referenced within the HHC Infrastructure section – see gaps HHC1 and HHC2. 
Lunar Analog Bed Rest Development 
This task is referenced within the HHC Infrastructure section – see gaps HHC1 and HHC2. 
An Integrated Musculoskeletal Countermeasure Battery for Long-Duration Lunar Missions  
This task is referenced within the Risk of Accelerated Osteoporosis section – see gap B15. 
CV2: What is VO2max in-flight and immediately post-flight?  It has been discouraged to measure 
VO2max on R+0, because of the possibility of injury to the crewmember, so it has been suggested that a 
reasonable compromise would be to obtain in-flight measurements as late as feasible and obtain plasma 
volume measurements after landing.  Also, the cardiovascular laboratory should work with the exercise 
physiology laboratory to ensure that muscle performance is measured in a similar timeframe as VO2max 
is measured.  No further research into this area is recommended until this gap is filled.  However, it is 
recommended that the cardiovascular discipline work with the muscle discipline and the Exercise 
Physiology Laboratory to find the minimum exercise prescription necessary to maintain in-flight 
VO2max. 
M2: What is the current status of in-flight and post-flight exercise performance capability?  What 
are the goals/targets for protection with the current in-flight exercise program?  The relationships between 
in-flight exercise and fitness and performance levels are not well understood.  It is not clear how the 
combination of the three types of available exercise (Crew Exercise Vibration Isolation System (CEVIS), 
Treadmill Vibration Isolation System (TVIS), and Resistive Exercise Device (RED)) lead to maintenance 
of fitness.  Factors that limit understanding of crewmember fitness are: 1) the ISS exercise equipment has 
not been uniformly available to all crewmembers; 2) exercise programs are individualized for each 
crewmember, based on their individual preferences; 3) in-flight VO2max has not been possible; and 4) an 
arbitrary minimum amount of daily exercise time (2.5 hours) has been set and enforced.  The impact of 
this limited knowledge is that it is difficult to make detailed recommendations about what types of 
exercise will be needed for future missions to the Moon and Mars, other than to recommend that the same 
suite of exercise equipment be manifested for these missions.   
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Task: (ECP – via directed study) 
Evaluation of Maximal Oxygen Uptake (VO2max) and Submaximal Estimates of VO2max Before, During and 
After Long Duration International Space Station Missions 
The specific aims of this evaluation are to measure VO2max during and following long duration missions and to 
assess the validity of using submaximal measurements of heart rate (HR), oxygen consumption (VO2) to track 
changes in aerobic capacity.  In addition, non-invasive measurements of cardiac output (Qc) will be performed 
during exercise to determine if measurement of Qc will improve the accuracy of the submaximal estimations of 
VO2max.  For this proposed evaluation, crew members participating in ISS missions of ≥ 90 days will perform 
graded cycle exercise tests to their volitional maximum effort prior to, every 30 days during, and following flight.  
Measurements obtained during these tests will include HR, VO2 and Qc.  During these tests, ECG will be 
monitored real-time as a safety precaution.  Expected results from this evaluation will include accurate VO2max 
measurements from astronauts participating in long duration space flight and observation of the pattern of change 
across mission duration.  Additionally, the evaluation will allow NASA to determine if submaximal exercise 
testing data will provide results that allow accurate estimation of the crewmembers’ aerobic capacity status during 
and after space flight. 
Deliverables: Results from this study will determine if the current countermeasures are protective and need only 
optimization (e.g., reduced volume, time) or if improved countermeasures and flight validation studies are needed.  
In addition, results will be used to provide information to the aerobic capacity standard as well as inform the 
HSRF. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: ISS is required for the initial flight study; a concurrent ground-based flight analog bed rest 
will be initiated if initial results indicate an improved countermeasure is needed.  The improved countermeasures 
will be validated on board the ISS. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight BDC 
Time (hrs) 
12 None 9.5kg/Inc None 9 3 
 
Task: (ECP – via directed study) 
Hypovolemia as A Model Of Space Flight: Cardiovascular Exercise Effects 
Loss of plasma volume is hypothesized to be a major contributing factor to reduced aerobic capacity in response to 
space flight.  An established ground-based model of microgravity-induced hypovolemia will be used to determine 
the effect of reduced plasma volume on VO2max. 
Deliverables: Results from this study will feed into the VO2max flight study. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: Ground-based hypovolemia model 
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RISK OF COMPROMISED EVA PERFORMANCE AND CREW HEALTH DUE TO 
INADEQUATE EVA SUIT SYSTEMS –  
CRITICALITY: LUNAR OUTPOST – I, MARS – I 
Improperly designed EVA suits can result in the inability of the crew to perform as expected, and can 
cause mechanical and decompression injury.  Suit developers must fully understand the impact of the suit 
design on crew performance and health to ensure properly designed mobility, pressures, nutrition, life 
support, etc. 
Operational Relevance and Risk Context  
Constellation Missions to the moon and Mars will include frequent EVAs involving exploration, science, 
construction and maintenance tasks.  These missions may include up to 30 times more EVA hours than 
during the Apollo era.  The effectiveness and success of these missions is dependent on designing EVA 
systems and protocols that maximize human performance capabilities.  It would not be feasible to perform 
the Constellation EVAs using Apollo suit designs.  Limited mobility, dexterity, center of gravity and 
other features of the suit required significant crew compensation to accomplish mission objectives.   
Strategy for Mitigation 
The Human Research Program has recommended that the EVA Physiology, Systems and Performance 
Project work with the Constellation EVA Systems Project to develop and execute an integrated human 
testing program across multiple environments.  The testing program will collect the objective data needed 
to make informed design decisions to create EVA systems that optimize human health and performance 
across the spectrum of anticipated exploration operational concepts.    
Gaps 
EVA1 (new):  What models & techniques are required to evaluate various suit designs and 
operational concepts to optimize crew health and performance? 
Replaces old gaps: 
EPSP6: What work efficiency indices (WEI) metrics of EVA can be used to measure evolution of EVA 
systems? 
EPSP7: What surface ops concepts could maximize human performance of mission tasks as well as 
protect crew health? 
M3:  What tasks will be required for lunar sortie, outpost, and Mars missions? 
SM8:  No functional requirements for lunar and Mars surface ambulation have been devised 
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Task: (EPSP some studies will be in collaboration with Constellation EVA Systems Project Office (ESPO)) 
EVA Human Performance Data Collection Series I – Mark-III Suit 
Conduct a series of studies to examine factors that may affect human performance while working in an EVA suit.  
Parameters to be examined include suit weight, mass, center of gravity (CG), pressure, biomechanics and mobility.  
Studies will be performed in a number of analog environments in both unsuited/’shirt-sleeve’ conditions and using 
the Mark-III technology demonstrator suit.  Multiple analog environments are required because no single analog 
environment adequately simulates the range of partial gravity conditions required to evaluate all aspects of human 
performance contributing to EVA success.  Each analog will provide a piece of the puzzle that will allow a more 
thorough understanding of EVA performance.  
 
 
 
Test activities will include characterizations of ambulation and exploration type activities, such as ambulation on 
level and inclined surfaces, ambulation while carrying a load, rock collection, shoveling, kneeling, recovery from a 
fall, and simple exploration and construction tasks using hand tools and power tools.  Data collected will include 
metabolic rates, subject anthropometrics, time series motion capture, ground reaction forces, subjective ratings of 
perceived exertion (RPE) and operator compensation using the modified Cooper-Harper rating scale.  Any 
conditions that result in suit-induced trauma will also be noted. 
Data collected in these studies will be used to create an EPSP human performance database, a repository in which 
data from a variety of operational concepts and testing conditions can be accessed and shared with other projects 
and Elements as necessary.  Data from these studies will also be used to generate the suit controllability predictive 
algorithm, which is a model that can be used to predict several human performance variables based on suit 
characteristics, subject anthropometrics, and operations concepts.  The algorithm is planned as a design tool to 
enable development of suits that increase efficiency in crew health and performance.   
Deliverables:  
EPSP human performance database and database inputs 
Post-test reports resulting from individual tests within the data collection series 
Suit controllability predictive algorithm 
Data delivery to ECP, NxPCM, and SHFH per TBD data sharing agreements 
Required Delivery Milestone: A majority of the studies will be completed by the end of FY09 in order to provide 
inputs to Suit Configuration 1 (initial capability: launch/abort/entry (LAE) and microgravity EVA) Preliminary 
Design Review (PDR) (TBD FY09-10) and Suit Configuration 2 (lunar surface operations) Systems Design 
Review (SDR) (FY11).  Follow-on studies to validate the algorithm will be conducted as needed to provide inputs 
to subsequent design reviews.   
Studies to refine requirements for Mars suits may be performed during lunar operations (FY20 and beyond). 
 
 
NBL      
Parabolic  
Flight 
NEEMO 
Pogo 
Field Analogs 
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Task: (EPSP some studies will be in collaboration with Constellation EVA Systems Project Office (ESPO)) 
Human Performance Data Collection Series I – Mark-III Suit (cont’d) 
Required Platforms:  
Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS), Neutral Buoyancy Laboratory (NBL), parabolic 
flight, and NASA Extreme Environment Mission Operations (NEEMO) 
Lunar surface operations 
Resources Required: 
Crew and Thermal Systems Division (CTSD) personnel support and facility usage are required for all tests and 
provision of Mark-III suit is required for suited testing.  Crewmembers assigned to the EVA Branch of the 
astronaut office are required as test subjects for all suited and matched shirtsleeve control tests and are desired for 
all other tests. 
 
Task: (EPSP some studies will be in collaboration with Constellation ESPO) 
EVA Human Performance Data Collection Series II – I-Suit or Alternate Suit 
Where possible, EPSP will collect data comparable to the Mark-III testing series in using the I-Suit or alternate 
suit and during selected unsuited trials.  The anthropometric range (95th percentile male) that the Mark-III suit 
effectively accommodates is limited due to the suit’s structure and weight.  According to JSC Committee for the 
Protection of Human Subjects (CPHS) recommendations, further testing is required to allow expansion of subject 
population demographics.  Use of the I-Suit or alternate will permit subjects of smaller build to complete the series 
of tests, thereby enhancing statistical power of the data set.  In addition, data collection using a second suit will 
help to verify that Series I data truly reflect human performance parameters and not suit design characteristics, and 
will permit initiation of algorithm validation to specific analogs. 
As with Series I, data collected in these studies will be used to populate the EPSP human performance database 
and, in turn, to generate the suit controllability predictive algorithm. 
Deliverables:  
EPSP human performance database and database inputs 
Post-test reports resulting from individual tests within the data collection series 
Suit controllability predictive algorithm 
Data delivery to ECP, NxPCM, and SHFH per TBD data sharing agreements 
Required Delivery Milestone: This test series is dependent upon the availability of the I-Suit or a comparable 
alternate suit.  Due to delays in suit contractor selection, this series may be performed using a Constellation suit 
prototype.  Series II data must be acquired and input into the suit controllability predictive algorithm with 
sufficient lead time to provide valid algorithm to Constellation by Suit 2 PDR (FY12).  Additional follow-on 
studies to validate the algorithm may be conducted as needed to provide inputs to subsequent design reviews.  
Studies to refine requirements for Mars suits may be performed during lunar operations (FY20 and beyond). 
Required Platforms:  
Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS), Neutral Buoyancy Laboratory (NBL), parabolic 
flight, and NASA Extreme Environment Mission Operations (NEEMO) 
Lunar surface operations 
Resources Required: 
CTSD personnel support and facility usage are required for all tests and provision of Mark-III suit is required for 
suited testing.  Crewmembers assigned to the EVA Branch of the astronaut office are required as test subjects for 
all suited and matched shirtsleeve control tests and are desired for all other tests. 
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Task: (EPSP some studies will be in collaboration with Constellation ESPO) 
Work Efficiency Index (WEI) Studies  
Total EVA work efficiency index (WEI) is defined as: 
 
_________________________EVA Time_________________________ 
(Total suit, airlock prep + pre-breathe + airlock depress, repress + post EVA) 
 
Current NASA EVA Total WEI is 0.39 – 0.51.  Constellation EVA Systems Project documentation contains 
requirements stating that EVA WEI shall be 3.0 or greater.  Many factors contribute to WEI, including vehicle 
systems, suit systems, and operational protocols.   
To address this gap, EPSP will perform evaluations of WEI based on current knowledge and concepts of 
operations.  WEI evaluations will be performed during existing lunar analog studies and will measure the 
efficiency of different operations concepts and trends in WEI as operational concepts evolve.  WEI evaluations 
will also be performed to address gaps EVA 4 and EVA 5 & 6. 
Deliverables:  
Recommendations for WEI metrics for EVA and methods to improve WEI per TBR Customer Service 
Agreements with Constellation ESPO. 
WEI indices to inform Operational Concepts studies for optimizing human performance, crew safety, and mission 
operations. 
Required Delivery Milestone: Inputs were provided in FY07 to EVA Level III SRR based on studies performed 
during NEEMO missions.  Additional studies will continue through FY17, with inputs to Suit Configuration 2 and 
Surface Operations design reviews.  Follow-on flight validation and optimization studies will occur during lunar 
surface operations.   
Required Platforms:  
Lunar analog testing environments, such as Neutral Buoyancy Laboratory (NBL), NASA Extreme Environment 
Mission Operations (NEEMO), Desert Research and Technology Study (D-RATS), and Haughton Mars Project 
(HMP) 
Lunar surface operations 
 
Task: (EPSP) 
Operations Concepts Studies 
Conduct analyses of studies performed in lunar analog environments to evaluate the impacts to human 
performance of various exploration EVA operations concepts provided by Constellation and/or Constellation 
Architecture Team – Lunar (formerly LAT-2).  Results of these analyses, combined with data from the EPSP 
human performance database, will be used to generate Life Sciences Implications Reports pertaining to given 
design reference missions.  Flight validation and optimization studies will occur during lunar surface operations.   
Deliverables:  
Inputs to Life Sciences Implications Reports which will include (but may not be limited to) metabolic and life 
support consumables profiles of lunar mission tasks. 
Reviews of Constellation operational documents and comments via Review Item Discrepancies. 
Required Delivery Milestone: Studies will be performed through FY17, with inputs to Suit Configuration 2 and 
EVA Mission Operations design reviews, including, respectively, SRR (FY10, 13), PDR (FY12, 14), Critical 
Design Review (CDR) (FY16, 15), and Suit 2 System Acceptance Review (SAR) (FY18).  Follow-on flight 
validation and optimization studies will occur during lunar surface operations.   
Required Platforms:  
Lunar analog testing environments, such as NASA Extreme Environment Mission Operations (NEEMO), Desert 
Research and Technology Study (D-RATS), and Haughton Mars Project (HMP) 
Statistical analysis and modeling capability 
Lunar surface operations 
EVA 2 (new):  What are the physiological and biomechanical stimuli associated with various suit 
designs and EVA tasks? 
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Replaces old gaps: 
EPSP1: What parameters of EVA suit design affect human performance, and how can these designs be 
modified to increase efficiency in crew health & performance? 
EPSP2:  How much cardiovascular and resistive exercise and ground reaction force (GRF) dose does 
EVA provide? 
EPSP3: What are the metabolic costs and ground reaction force (GRF) doses associated with EVA tasks? 
M4:  What are the physiological costs of tasks required? 
EPSP13:  How can heat rejection/suit cooling capability be improved to enhance contingency responses? 
B12:  How does the EVA suit influence characteristics of falling? 
B13:  What are the acceptable load and torque ranges a crewmember can experience during a specific 
mission? 
Task: (EPSP in collaboration with ECP) 
Characterize EVA Stimuli 
Assimilate all physiologic data collected during Human Performance Data Collection Series I & II studies (see gap 
EVA1) into EPSP human performance database and share data within HRP.  Calculate cardiovascular exercise and 
resistive exercise doses provided by exploration EVA tasks.  Calculate ground reaction forces and estimate 
impacts to bone and other human systems for a variety of operations concepts and suit designs.   
Deliverables:  
Quantified cardiovascular & resistive exercise 
Quantified ground reaction forces  
Identified maximum acceptable joint loads and torque ranges 
Identified maximum acceptable heat storage capacity 
TBD bone modeling 
Required Delivery Milestone: Metabolic rate requirements were provided to the Human Systems Integration 
Requirements (HSIR) document (CxP 70024) in FY07.  Data deliveries will be provided to ECP based upon TBD 
data sharing agreements.  Other inputs will be to Constellation documents via change request (CR) and Review 
Item Discrepancy (RID) processes for design reviews according to TBR customer service agreements. 
Required Platforms: Statistical analyses and modeling capability; Biomechanics analysis software packages 
 
EVA 3 (new):  What suit characteristics, systems, and consumables requirements are needed to 
optimize crew performance, health & safety? 
Replaces old gaps: 
EPSP1: What parameters of EVA suit design affect human performance, and how can these designs be 
modified to increase efficiency in crew health & performance? 
M5:  How will suit limit performance of lunar sortie, lunar outpost, and Mars missions? 
SM9:  Idealize design of EVA suit for optimized surface ambulation characteristics 
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EPSP4: What are the quantities of consumables required to support EVA in lunar sortie, lunar outpost, 
and Mars missions?  How can these consumables be managed best? 
EPSP5: What are the energy/hydration requirements and associated waste management requirements of 
EVA and what kind of integrated delivery/management systems can be supported in an EVA suit? 
N8: What are the energy/nutrient requirements of EVA?  What is the best delivery system for these 
nutrients?" 
EPSP6: What work efficiency indices (WEI) metrics of EVA can be used to measure evolution of EVA 
systems? 
EPSP8: What are the biomedical monitoring requirements of an EVA suit for each phase of lunar & Mars 
missions? 
EPSP9: What suit-human biomechanical interaction aspects of the EVA suit design affect protection of 
crew health, and what design changes or countermeasures can be implemented to protect crew health? 
EPSP13:  How can heat rejection/suit cooling capability be improved to enhance contingency responses? 
SM8:  No functional requirements for lunar and Mars surface ambulation have been devised 
B12:  How does the EVA suit influence characteristics of falling? 
B13:  What are the acceptable load and torque ranges a crewmember can experience during a specific 
mission? 
Where replaced gaps overlap with those gaps replaced by new EVA4, the intent is that tasks for EVA3 
are PERTINENT TO REQUIREMENTS DEFINITION. 
Task: (EPSP some studies will be in collaboration with Constellation ESPO) 
Human Performance Data Collection Series I – Mark-III Suit 
Human Performance Data Collection Series II – I-Suit or Alternate Suit 
In addition to addressing gap EVA1, data provided by the Human Performance Data Collection Series’ will allow 
identification of suit characteristics, systems, and consumables that optimize human performance during 
performance of EVA tasks.  These tests also provide a methodical, scientific approach to hardware evaluations 
such that future evaluations of suited human performance may be consistently performed. 
Deliverables:  
EVA Suit Test Standard Measures per TBR customer service agreements with Constellation ESPO. 
Recommended requirements (pertaining to performance and crew health during EVA) for Level III & Level IV 
Constellation documents: 
Suit design parameters (weight, mass, cg, pressure, kinematics, joint torques and loads) 
Nutrition, hydration, and waste management 
Physiological data sensors 
Thermal regulation and consumables usage 
Required Delivery Milestone: EPSP will provide task deliverables to Suit 1 and Suit 2 design reviews and 
appropriate corresponding Constellation documents per TBR Customer Service Agreements with Constellation 
EVA Systems Project Office. 
Required Platforms: Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS), Neutral Buoyancy 
Laboratory (NBL), parabolic flight, and NASA Extreme Environment Mission Operations (NEEMO) 
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Resources Required: 
CTSD personnel support and facility usage are required for all tests and provision of I-Suit, alternate, or prototype 
suit is required for suited testing.  Crewmembers assigned to the EVA Branch of the astronaut office are required 
as test subjects for all suited and matched shirtsleeve control tests and are desired for all other tests. 
 
Task: (EPSP with NBL and AFT) 
Determine Energy, Nutrient, Hydration and Waste Management Requirements 
Work with Flight Surgeons and with experts in the JSC Nutritional Biochemistry Laboratory (NBL) and Advanced 
Food Technology (AFT) Project to analyze data collected in the Human Performance Data Collection series’ to 
quantify the water, nutrients, and anticipated waste products required for surface EVA operations.  These data will 
then drive requirements for waste management systems and EVA nutrition/hydration systems (see EVA4). 
Deliverables: The results of this analysis will be compared with Level II requirements addressing nutrition, 
hydration, and waste management that are currently in the HSIR document and will be used to generate 
recommendations for Level III and Level IV requirements.   
Required Delivery Milestone: Analysis will be complete by FY10 to provide inputs to Suit Configuration 2 SRR 
(~FY11).   
Required Platforms: Statistical analysis and modeling 
 
 
Task: (EPSP) 
CG and Stability Evaluations 
Augment Human Performance Data Collection Series testing with specific measures to understand the role of suit 
center of gravity (CG) on stability and fall avoidance and recovery and in partial gravity environments.  Studies 
will identify the cg location under varying conditions and measure the forces imparted to the body due to falling in 
an EVA suit.  Prototype suits will also be evaluated. 
Deliverables:  
Recommendations for suit center of gravity to avoid falling 
Recommendations to operational concepts to avoid falling 
Data for fall frequency and contact forces model 
Required Delivery Milestone: Work will be complete by FY10 to provide inputs to Suit Configuration 2 SRR 
(~FY11).  Follow-on studies will be performed as needed to evaluate prototype suits’ impact on stability/falling. 
Required Platforms: Partial Gravity Simulator (Pogo/ARGOS), Neutral Buoyancy Laboratory (NBL), NEEMO, 
parabolic flight 
Resources Required: Statistical analysis; modeling capability 
 
Task: (EPSP) 
Apollo Video Fall Frequency Analysis 
Analyze Apollo EVA video to estimate percentage of falls.  Create model to analyze worst-case falls, such as from 
a ladder.  Combine results with data collected in CG and fall forces studies to develop model of fall frequency and 
contact forces based on surface ops concepts. 
Deliverables:  
Model of fall frequency and contact forces based on operations concepts 
Operations concepts to limit falls 
Required Delivery Milestone: Initial modeling will be complete by FY11 to provide inputs to Surface Ops 
Systems Design Review.  Model will be updated based on results from evaluation of prototype suites.  Additional 
analysis will be performed as needed. 
HRP-47065 
 
62 
Required Platforms: Statistical analysis and modeling capability 
Resources Required: Statistical analysis; modeling capability 
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Task: (EPSP) 
Develop Mission Metabolic Profiles 
Project metabolic loads and determine mission metabolic profiles based on operational concepts provided by 
Constellation Program and/or Constellation Architecture Team – Lunar team.  Profiles will be created for suited 
intravehicular operations and surface EVA tasks.  Metabolic data collected in Human Performance Data Collection 
studies will be used to determine consumables quantities needed to support mission operations. 
Studies and analyses will be performed to develop recommendations for suit design and operational concepts 
requirements.  For example, an oronasal mask will be evaluated as a solution to minimize consumable usage.   
Deliverables:  
Mission metabolic profiles 
Recommendations for consumables requirements 
Recommendations for operational concepts regarding consumables usage and management 
Required Delivery Milestone: Preliminary studies and analyses will be completed in FY09 to provide inputs to 
Suit Configuration 1 PDR (TBD FY09).  Additional inputs will be provided to Surface Operations and Suit 
Configuration 2 SRRs (~FY10) and PDRs (~FY12).  Additional studies may be performed as operational concepts 
are updated.  Validation studies will be performed during mission operations. 
Required Platforms:  
Modeling capability, such as MATLAB 
Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS), Neutral Buoyancy Laboratory (NBL), Rockpile, 
and Haughton Mars Project (HMP) 
Lunar surface operations 
 
Task: (EPSP) 
Biomedical Monitoring Requirements 
Work with flight surgeons and biosensor technology experts to identify biomedical monitoring requirements for 
suited operations: launch/entry/abort, microgravity EVA, and surface EVA. 
Deliverables:  
Recommendations for biomedical monitoring requirements 
Required Delivery Milestone: Inputs were provided during FY07 to Level II documentation (HSIR) and ESPO 
documentation during the Level III and Level IV SRRs.  Additional inputs will be provided as necessary during 
EVA Suit Configuration 1 and Configuration 2 PDRs (TBD FY09, FY12, respectively). 
Required Platforms: Workshops, teleconferences/videoconferences 
 
Task: (EPSP in collaboration with Space Medicine and EVA Systems Project Office) 
Suit-Induced Trauma Data Mining 
Perform retrospective data mining to identify suit-induced trauma that has occurred during NBL training and 
during microgravity EVAs.  Create searchable database to track suit injury and populate with historical data.  
Continue to monitor suit-induced trauma in future Shuttle and ISS training and flight activities and enter cases in 
database.  In addition, identify suit-induced trauma that occurs during suit development/ evaluation tests and 
concept of operation studies for exploration missions.   
Deliverables:  
Identify mechanisms of suit-induced injury/trauma 
Suit Injury Database 
Required Delivery Milestone: Phase I of the database will be complete in FY09; implementation of phase II is 
TBD. 
Required Platforms: N/A (data mining) 
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Task: (EPSP) 
Suit/Human Biomechanical Interactions Studies 
Conduct a series of studies to identify mechanism of suit-induced injury.  Studies currently in progress include the 
following: 1) EMU shoulder harness assessment to investigate shoulder injuries due to limited range of motion; 2) 
studies to measure fingertip pressure and blood flow while working in suit gloves; 3) assessing the role of 
moisture in fingernail damage sustained while working in suit gloves; 4) studies to determine the magnitude of 
oxidative stress in EVA crewmembers.  Additional studies will be performed as necessary if new injuries are 
encountered during development of Constellation EVA suits. 
Deliverables:  
Recommendations for suit design to mitigate suit-induced trauma 
Required Delivery Milestone: A majority of the studies will be completed by FY10 in order to provide inputs to 
Suit Configuration 2 SRR (~FY11).  Follow-on studies will be conducted as needed to provide inputs to 
subsequent design reviews in FY11-FY15, according to TBR customer service agreements with ESPO.   
Required Platforms: Lunar analogs, including Partial Gravity Simulator (Pogo/ARGOS), Neutral Buoyancy 
Laboratory (NBL), parabolic flight, glove box 
 
Task: (EPSP in collaboration with CTSD personnel, Constellation ESPO and external consultants) 
Occupant Protection – Biodynamics Modeling 
EPSP will work with a team of experts to determine appropriate methods for modeling and prediction of potential 
crew injuries.  Activities include conducting data mining of injury databases (NASCAR, CIREN, IRL, military, 
etc); assessment of impact simulation and injury prediction methodologies, and cross-validation of multiple 
biodynamics models (MADYMO, LsDYNA, THUMS and the Brinkley Model) using data from 6 driving CEV 
load cases and automotive racing crashes.  The team will generate design concepts that implement automotive 
racecar occupant protection principles to a space suit/craft system which increasingly uses features of the suit for 
occupant protection.  The objective of this task is to deliver a verified and validated operational model to support 
development of the best occupant protection system possible that maximizes crew safety during Orion vehicle 
ascent, ascent aborts, landing (water and contingency land landing), and through the post landing and recovery 
phase.   
Deliverables:  
Verification tool for occupant protection requirements 
Recommend occupant injury prediction and impact simulation techniques (and limitations) appropriate for Orion 
command module 
Recommend analysis techniques and models appropriate for use by Orion command module 
Recommend and provide appropriate human mass properties data for use by Orion command module 
Recommend appropriate impact acceleration/occupant injury criteria 
Required Delivery Milestone: Preliminary results will be complete in early FY09 to provide inputs to Orion and 
Suit Configuration 1 PDRs (FY09).  Follow-on analyses will be performed as needed through Suit Configuration 1 
Critical Design Review (FY11).   
Required Platforms: Modeling capability 
Resources Required: 
Availability of valid crash data from NASCAR and Indy Racing League 
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Task: (EPSP in collaboration with Space Medicine, Constellation ESPO and external consultants) 
Occupant Protection – Definition of Acceptable Risk  
EPSP will work with Space Medicine crew surgeons and other experts to systematically define the highest level of 
acceptable injury risk during CEV landings consistent with a successful program based on key mission drivers 
such as: 
crew health, safety and performance considerations in the immediate landing environment; long-term crew health 
considerations including medical policy and future flight status; programmatic success criteria in context of all 
mission phases; public opinion and ethical considerations; and balancing the risk vs. reward (utility) for the 
landing environment in context of all mission phases.  The team will also provide context to put CEV landing risk 
in perspective with other military and civilian vehicle operations 
Deliverables:  
Define operationally relevant injury scale 
Define acceptable injury risk within programmatic and operational constraints 
Required Delivery Milestone: Preliminary results will be complete in early FY09 to provide inputs to Orion and 
Suit Configuration 1 PDRs (FY09).  Follow-on analyses will be performed and HSIR requirements updated as 
needed through Suit Configuration 1 CDR (FY11).   
Required Platforms: Workshops, teleconferences/videoconferences, modeling capability 
 
Task: (EPSP   Studies using an EVA suit will be performed in collaboration with CTSD and Constellation ESPO) 
Liquid Cooling Garment Studies 
Conduct studies to evaluate current US and Russian liquid cooling and ventilation garments (LCVG) and 
prototype liquid cooling garments.  Evaluations will be conducted during suit tests and in thermal chambers. 
Deliverables:  
Post-test report detailing thermal performance and comparison of LCVG garments  
Recommendations for design of advanced liquid cooling garments to improve heat rejection/cooling capability 
Recommendations for improved thermal control to enhance contingency responses 
Required Delivery Milestone: Preliminary studies will be complete by the end of FY09 in order to provide inputs 
to Suit Configuration 1 PDR (TBD FY09) and provide updates to HSIR document, Rev. D (FY09-10).  Follow-on 
studies will be conducted as needed to provide inputs to subsequent design reviews in FY11-FY15 and according 
to TBR customer service agreements with Constellation ESPO.   
Required Platforms: Partial Gravity Simulator (Pogo/ARGOS) and thermal chamber 
Resources Required: 
CTSD personnel support and facility usage are required for all tests and provision of EVA suit is required for 
suited testing.  Crewmembers assigned to the EVA Branch of the astronaut office are required as test subjects for 
all tests performed in an EVA suit. 
EVA4 (new): What technologies and in-suit countermeasures can be integrated into the EVA suit to 
optimize crew performance, health & safety? 
Replaces old gaps: 
EPSP4: What are the quantities of consumables required to support EVA in lunar sortie, lunar outpost, 
and Mars missions?  How can these consumables be managed best? 
EPSP5: What are the energy/hydration requirements and associated waste management requirements of 
EVA and what kind of integrated delivery/management systems can be supported in an EVA suit? 
N8: What are the energy/nutrient requirements of EVA?  What is the best delivery system for these 
nutrients?" 
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EPSP6: What work efficiency indices (WEI) metrics of EVA can be used to measure evolution of EVA 
systems? 
EPSP9: What suit-human biomechanical interaction aspects of the EVA suit design affect protection of 
crew health, and what design changes or countermeasures can be implemented to protect crew health? 
EPSP13:  How can heat rejection/suit cooling capability be improved to enhance contingency responses? 
Where replaced gaps overlap with those gaps replaced by new EVA3, the intent is that tasks for EVA4 
are PERTINENT TO MEETING OR IMPROVING UPON REQUIREMENTS (i.e. new technologies). 
Task: (EPSP Studies using an EVA suit will be performed in collaboration with CTSD and Constellation ESPO) 
Suit Trauma Countermeasures Concepts 
Following work to identify mechanisms of suit-induced trauma (see EVA3), work with materials experts in 
CTSD to develop concepts and prototype of suit trauma countermeasure garment.  Candidate concepts include 
airbags, strain-aligning material and crushable foam.  Garment will be evaluated in tests conducted by EVA 
Systems Project Office to simulate landing loads and during suit tests conducted at lunar analogs.  Subsequent 
studies will be performed to evaluate iterations of and improvements to garment design and to validate the 
countermeasures in suit prototypes, qualification units, and flight articles and during lunar surface operations. 
Deliverables:  
Recommendations for design of countermeasures to mitigate suit-induced trauma 
Required Delivery Milestone: Development and testing of preliminary concept will be complete in FY09 prior 
to Suit Configuration 1 PDR (TBD FY09-10).  Results from further testing will be complete and 
recommendations provided prior to the Suit Configuration 2 PDR (FY12). 
Required Platforms:  
Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS) and parabolic flight 
Lunar surface operations 
Resources Required: 
CTSD personnel support and facility usage are required for all tests and provision of EVA suit is required for 
suited testing.  Crewmembers assigned to the EVA Branch of the astronaut office are required as test subjects for 
all tests performed in an EVA suit. 
 
Task: (EPSP   Studies using an EVA suit will be performed in collaboration with CTSD and Constellation ESPO) 
Advanced LCVG Studies 
Based on results of existing LCVG studies (see EVA3), provide recommendations for and evaluate advanced 
liquid cooling garments in Mark-III and prototype suits, qualification units, and flight articles.  Validation studies 
with flight suits will occur during lunar surface operations. 
Deliverables:  
Post-test reports detailing performance of advanced liquid cooling garments using Mark-III, prototype, 
qualification units, and flight article EVA suits per standard measures, with inputs to design updates as needed 
Required Delivery Milestone: Suit Configuration 1 development and qualification testing will be complete by the 
System Acceptance Review in 2012.  Suit Configuration 2 development and qualification testing will be complete 
by the System Acceptance Review in 2017.  Evaluation of flight article suits will occur during lunar surface 
operations. 
Required Platforms:  
Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS) and parabolic flight 
Lunar surface operations 
Resources Required: 
CTSD personnel support and facility usage are required for all tests and provision of EVA suit is required for 
suited testing.  Crewmembers assigned to the EVA Branch of the astronaut office are required as test subjects for 
all tests performed in an EVA suit. 
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Task: (EPSP with NBL, AFT Project, and Constellation ESPO) 
Evaluate Concepts for Nutrient and Water Delivery System 
Work with experts in Advanced Food Technology Project and the JSC Nutritional Biochemistry Lab to develop 
concepts for the format of nutrition and hydration sources (energy bar, gel, etc.).  Work with crew office to 
evaluate concepts and obtain crew consensus.  Work with suit design team to develop concepts for nutrition and 
hydration delivery systems and waste management systems.  Evaluate concepts in ground tests.   
Deliverables:  
Recommendations for nutrient and water delivery systems 
Recommendations for waste management systems 
Required Delivery Milestone: Preliminary studies will be completed by the end of FY09 in order to provide 
inputs to Suit Configuration 1PDR (TBD FY09-10) and further evaluations will result in recommendations prior to 
Suit Configuration 2 SRR (~FY11).  Follow-on studies will be conducted as needed to provide inputs to 
subsequent design reviews in FY11-FY15 and according to TBD customer service agreements with Constellation 
ESPO.   
Required Platforms: Lunar analog testing environments 
Resources Required: 
Astronaut test subjects or representatives to provide input to Crew Consensus Report 
 
Task: (EPSP in collaboration with Constellation EVA Systems Project Office) 
In-Suit Nutrient Delivery and Waste Management System Evaluations 
Evaluate nutrition/hydration delivery systems and waste management systems in prototype and qualification unit 
suits.  Work with crew office to evaluate delivery systems and obtain crew consensus.  Work with suit design team 
to integrate systems for nutrition and hydration delivery systems and waste management into EVA suits.  Follow-
on flight validation and optimization studies with flight suits will occur during lunar surface operations. 
Deliverables:  
Evaluation of prototype, qualification unit and flight article suits per standard measures with inputs to design 
updates as needed.   
Required Delivery Milestone: Suit Configuration 1 development and qualification testing will be complete by the 
System Acceptance Review (SAR) in 2012.  Suit Configuration 2 development and qualification testing will be 
complete by the System Acceptance Review in 2017.  Evaluation of flight article suits will occur during lunar 
surface operations. 
Required Platforms: Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS) and parabolic flight; Lunar 
surface operations 
Resources Required: 
Astronaut test subjects or representatives to provide input to Crew Consensus Report 
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Task: (EPSP in collaboration with Exploration Medical Capability (ExMC)) 
Biomedical Sensor Evaluations 
Work with Exploration Medical Capability (ExMC) Project to evaluate candidate biomedical sensors and 
integrated sensor systems during suit tests at lunar analog environments, such as Partial Gravity Simulator 
(Pogo/ARGOS), Desert Research and Technology Studies (D-RATS), Haughton Mars Project (HMP) or parabolic 
flight.  Biomedical sensors to be evaluated may include non-adhesive electrodes, heart rate sensors, temperature 
sensors, CO2 sensors and accelerometers.   
Deliverables:  
Recommendations for integrated biomedical sensor system concept 
Required Delivery Milestone: A majority of the studies will be completed by the end of FY09 in order to provide 
inputs to Suit Configuration 1 PDR (TBD FY09-10) and Suit Configuration 2 SRR (~FY11).  Follow-on studies 
will be conducted as needed to provide inputs to subsequent design reviews in FY11-FY15.   
Required Platforms: Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS) and parabolic flight 
 
Task: (EPSP in collaboration with Constellation ESPO) 
Integrated Biomedical Sensor Systems Evaluations  
Evaluate integrated biomedical sensor systems provided by ExMC in existing and prototype suits, qualification 
units and flight articles.  Validation studies with flight suits will occur during lunar surface operations. 
Deliverables:  
Post-test report, data from evaluations of sensor systems  
Recommendations for integrated biomedical sensor system 
Required Delivery Milestone: Suit Configuration 1 development and qualification testing will be complete by the 
System Acceptance Review in 2012.  Suit Configuration 2 development and qualification testing will be complete 
by the System Acceptance Review in 2017.  Evaluation of flight article suits will occur during lunar surface 
operations. 
Required Platforms:  
Lunar analogs such as Partial Gravity Simulator (Pogo/ARGOS) and parabolic flight 
Lunar surface operations 
Resources Required: 
Astronaut test subjects or representatives to provide input to Crew Consensus Report 
 
Task: (EPSP) 
Bioadvisory Algorithm Laptop Demonstrator 
Develop bioadvisory algorithm laptop demonstrator that monitors biomedical and suit parameters, calculates 
metabolic rate, and uses voice recognition capability to interact with the crewmember.  The algorithm will be 
evaluated using data collected during Human Performance Data Collection Series I & II and other suitable lunar 
analogs tests.  Additional work will refine the algorithm equations and user notifications. 
Deliverables:  
Bioadvisory algorithm laptop demonstrator, with equations and logic flowchart describing functions of the 
algorithm 
Required Delivery Milestone: Work will be completed by the end of FY09 in order to provide inputs to Suit 
Configuration 2 Systems Requirements Review (~FY11).  Follow-on studies will be conducted as needed to 
provide inputs to subsequent design reviews in FY11-FY15 and according to TBR customer service agreements 
with Constellation ESPO.   
Required Platforms: Statistical analysis, EPSP human performance database 
 
Task: (EPSP in collaboration with Constellation EVA Systems Project Office) 
Work Efficiency Index (WEI) Studies 
HRP-47065 
 
69 
In addition to the WEI activities to address gaps EVA1 and EVA5-6, EPSP will evaluate suit components and 
systems that may improve WEI, such as integrated biosensor systems that are quick don/doff and drink bags that 
require less preparation time. 
Deliverables: Recommendations for EVA WEI metrics and methods to improve WEI per TBR Customer Service 
Agreements with Constellation ESPO. 
Required Delivery Milestone: Inputs were provided in FY07 to EVA Level III SRR based on studies performed 
during NEEMO missions.  Additional studies will continue through FY17, with inputs to Suit Configuration 2 and 
Surface Operations design reviews.  Follow-on flight validation and optimization studies will occur during lunar 
surface operations.   
Required Platforms:  
Lunar analog testing environments, such as Neutral Buoyancy Laboratory (NBL), NASA Extreme Environment 
Mission Operations (NEEMO), Desert Research and Technology Study (D-RATS), and Haughton Mars Project 
(HMP) 
Lunar surface operations 
Resources Required: 
Astronaut test subjects or representatives to provide input to Crew Consensus Report 
EVA 5 (new):  How can decompression sickness (DCS) risk be characterized, mitigated, and/or 
treated? 
Replaces old gaps 
EPSP10: What are the risks and risk definitions of decompression sickness (DCS)?  How can DCS risk be 
managed? 
EPSP11: What is the best way to acclimate to slightly hypoxic LSAM and lunar habitat environments? 
Task: (EPSP) 
Define Acceptable DCS Risk  
Define acceptable DCS risk for different phases of lunar architecture (e.g. short-duration vs. long-duration 
missions) based on concept of operations.  This activity will include several meetings with external experts to 
discuss DCS policy and definitions of mission success as well as predictive modeling. 
Deliverables:  
Inputs/updates to DCS requirements HSIR document (CxP70024) 
Exploration DCS Risk and Contingency Plan 
Recommendations to operational concepts for mitigating DCS risk 
Required Delivery Milestone: This work will be complete by mid-FY09, with annual updates to the Exploration 
DCS Risk and Contingency Plan 
Required Platforms: Statistical analysis and modeling 
 
Task: (EPSP) 
Integrated DCS Predictive Model 
Develop Integrated DCS Predictive Model, which is a tissue gas bubble dynamics model.  The model will 
incorporate parameters such as: pre-breathe conditions, suit pressure, breathing gas composition, depress/repress 
rates, and duration of exposure.  Data used to develop this model will be provided by numerous EPSP studies.  The 
model will in turn be used to develop operations concepts to manage DCS risk and contingencies.  Operational 
concepts will be validated during lunar surface operations 
Deliverables:  
Integrated DCS Predictive Model 
Operational concepts/protocols to manage and treat DCS risk 
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Required Delivery Milestone: Concepts of operations will be defined and inputs provided to the Mission 
Operations SRR (FY13).  Additional studies and analysis will be performed as needed to provide inputs to 
subsequent reviews and according to TBR customer service agreements with Constellation ESPO. 
Required Platforms:  
Statistical analysis and modeling 
Lunar surface operations 
 
Task: (EPSP) 
Pre-breathe Protocol Development  
Conduct a series of tests to develop a pre-breathe protocol for lunar surface operations that minimizes DCS risk 
while meeting WEI requirements.  Initial studies will test accept criteria for worst-case scenario, and will involve a 
36-hr saturation protocol.  Subsequent studies will utilize an exercise-equivalent saturation protocol to evaluate 
intermittent recompression.  Saturation procedure will be performed again to optimize the pre-breathe protocol and 
to validate procedures.  Operational validation will also be performed during lunar surface operations.   
Deliverables: Validated pre-breathe protocol(s) 
Required Delivery Milestone: Testing will begin in FY10 and will be complete by FY17 for the Suit 
Configuration 2 / Surface Ops SARs (FY18). 
Required Platforms:  
Hypobaric chambers 
Lunar surface operations 
 
Task: (EPSP) 
Work Efficiency Index (WEI) Studies 
In addition to the WEI activities to address gaps EVA1 and EVA4, EPSP will perform WEI evaluations during 
development of improved pre-breathe protocols 
Deliverables: Recommendations for EVA pre-breathe protocol WEI metrics and methods to improve WEI per 
TBR Customer Service Agreements with Constellation ESPO. 
Required Delivery Milestone: WEI studies will augment pre-breathe protocol development testing and will be 
complete by FY17 for the Suit Configuration 2 / Surface Ops SARs (FY18). 
Follow-on flight validation and optimization studies will occur during lunar surface operations.   
Required Platforms:  
Hypobaric chambers 
Lunar surface operations 
 
Task: (EPSP) 
Hypoxia Studies 
Conduct studies to evaluate operations concepts and determine how human performance is affected due to 
transitions within and long-term exposures to hypoxic environments.  Concepts will be validated during lunar 
surface operations. 
Deliverables: Recommendations for concept of operations to acclimate to the Lunar Surface Access Module 
(LSAM) and lunar habitat environment 
Required Delivery Milestone: Work to be complete by FY17 for the Suit Configuration 2 / Surface Ops SARs 
(FY18) 
HRP-47065 
 
71 
Required Platforms:  
Hypobaric chambers 
Lunar surface operations 
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RISK OF REDUCED SAFETY AND EFFICIENCY DUE TO AN INADEQUATELY 
DESIGNED VEHICLE, ENVIRONMENT, TOOLS OR EQUIPMENT –  
CRITICALITY: LUNAR OUTPOST – D, MARS – I 
The habitability of the architecture, pressurized environment, tools, and equipment is critical for the 
existence of humans in space.  Any inadequacies in the design of the environment or architecture can 
restrict or prevent the user from surviving in such extreme conditions and may impact safety and 
performance.  Factors that affect the habitability must be assessed and properly addressed to ensure all 
potential hazards are mitigated or monitored.  If the workspace, equipment and tools are not designed to 
be usable by the full range of crewmembers, and are not properly laid out, the likelihood of errors or crew 
inability to complete a task in a timely manner increases.  Inconsistent design among subsystems and 
vehicles leads to negative transfer of training and increased likelihood of errors. 
Operational Relevance and Risk Context  
One of the most critical components for human presence in space has been ensuring that there are human 
systems standards in place that will provide for crew health as well as standards for habitability, 
environmental, and human factors.  The Space Flight Human System Standards – SFHSS – (and the 
companion Human Integration Design Handbook – HIDH) require that each human spaceflight program 
derive program-specific, verifiable requirements to comply with the standards, and require that each 
human spaceflight program establish a human factors process involving health and human factors experts.  
This is to ensure that there will be identification of any standards in the SFHSS that are not applicable (or 
altered) and the rationale for non-applicability; that all program level health and human factors 
requirements are based on the HIDH, cited empirical evidence, or known best practices; and that end-
items are in compliance with SFHSS, and agency and program level requirements and specifications.  
The activities cited reflect the need to work toward the mitigation of identified SHFE risks by continuing 
to inform the standards, by engagement in the development of the requirements that will implement the 
standards based upon the resulting products, as well as providing content to the HIDH that will serve as 
the implementation guide.  In addition, products resulting from these activities may provide valuable 
information to spaceflight programs that can inform the requests for trade studies.  
To ensure operational relevance of the deliverables from the tasks, all tasks leaders will identify 
stakeholders who will work with them in framing the questions and approach.  The stakeholders will 
participate by identifying specific issues requiring research or technology development, by reviewing 
progress, and by suggesting operational evaluations.  Depending on the specific tasks, stakeholders may 
include engineers or operations personnel.  
Strategy for Mitigation 
The approach to mitigating this risk is to develop an understanding of the factors that contribute to this 
risk, identify gaps in our knowledge about these factors, and prioritize these gaps based on various criteria 
systematically applied.  Then the highest priority gaps are addressed through directed or solicited research 
depending on the time frame and the complexity and specificity of the gap.  Where there is a disconnect 
between critical gaps requiring addressing and a lack of funding, efforts are made to re-examine the 
programmatic priorities to ensure those of highest concern are being investigated.  
The risk associated with reduced safety and efficiency due to inadequately designed vehicles, 
environments, tools or equipment focuses on the overall environment that the crew will live and work in.  
The focus can surround the development of hardware and interfaces, and how those interfaces will 
facilitate human performance and efficiency.  Displays, controls, and procedures need to be appropriately 
designed and developed to allow for safe and efficient execution of tasks.  Specific studies investigate the 
environment surrounding the crew, namely the acoustic environment, which can impact both health and 
performance.  Other studies focus upon the vibration, acceleration and microgravity environment, again 
all having potential to impact human health and performance.  The approach to mitigating this risk is to 
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develop a thorough understanding of the operational concepts, and determine methods, metrics and 
verification strategies to ensure that the hardware and environment are designed for human safety and 
productivity. 
The strategy for mitigating this risk is closely connected to the strategy for addressing the Risk of Errors 
Due to Poor Task Design.  The work captured under this risk contributes to understanding the capabilities 
and limits of human performance, which is essential to appropriate task design.  When a task is designed, 
it is critical to determine if it can be accomplished by a single person or requires additional personnel, or 
assistance from robots or automation.  When the spacecraft and equipment are designed, both the 
requirements of the task and the capabilities and limits of the crew have to be considered. 
The specific selection choices of the highest priority gaps and tasks are based primarily on gap analyses.  
The SHFE project updates its gap analyses on an annual basis.  This is necessary as research results and 
continual information drawn from crew debriefings has the potential of discovering additional gaps in 
knowledge.  These updates assist in the preparation for the annual Science Review Panel.  The original 
analysis carried out in 2006 was published as NASA/TP-2007-213739 (“Space Human Factors 
Engineering Gap Analysis Project Final Report,” C. Hudy and B. Woolford, 2007).  An update was 
completed in spring 2007.  The gaps are identified through reviews of the literature, of crew debrief 
summaries, and through interviews with more than a hundred users of human factors results, representing 
Engineering, Mission Operations, Flight Medicine, Training, the Crew Office, and others.  We place 
particular emphasis on interviewing representatives from Constellation Program Office, the Human-
System Integration Group, the Orion Project Office, the Cockpit Display Working Group, and other 
programmatic users of our products.  The ‘small’ gaps or specific concerns identified from these sources 
are aggregated into more appropriate levels for which a specific task can be designed.  For example, 
numerous users report gaps in design for workload:  lack of consistency of definition; lack of easy to use 
methods to assess workload; lack of a way to verify that a requirement for workload has been met.  These 
various individual-level concerns are captured in a gap, “There is no standardized non-intrusive measure 
of workload.”   
After all concerns are mapped to gaps, the gaps are prioritized according to a number of criteria.  Key 
criteria are importance to Constellation Program and need date.  When we identify ‘TBRs’ or ‘TBDs” in 
the Human Systems Integration Requirements, for example, these are assigned a very high priority.  
Ratings are solicited from management representatives of the offices from which gaps were identified.   
After prioritization, the gaps that can be addressed within the budget are initiated through directed 
research or solicited through research announcements.  Directed research is chosen for time critical 
results.  Solicitations are used for gaps that are longer term and that can benefit from wider participation. 
Gaps  
SHFE 2.1.8.1:  How can we determine the effects of combined vibration and acceleration on task 
performance? 
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Tasks: (SHFE – Directed) 
Examining Human Performance Under Vibration and G-Load 
Unmitigated Ares first stage thrust oscillation produces unacceptably high vibrations to the crew in the Orion 
Command Module (CM).  The health effects are well documented and requirements in CxP 70024 Human System 
Integration Requirements (HSIR) (Requirement HS3105) defines the ISO-weighted RMS values for allowable 
exposure. 
Vibration also affects crew performance, and impacts reading, reaction time, and fine motor control.  Specific 
vibration performance requirements are not provided in HSIR.  Performance under vibration also depends on crew 
interfaces, tasks, and other induced environments.  The task to conduct studies with:  
sixteen general population completed word or number reading task on fixed-base vibration platform 
sixteen general population trained and baselined on fixed-base platform, then completed number reading task on 
20-G Centrifuge (G + Vibration) 
thirteen astronaut office subjects trained and baselined on fixed-base platform, then completed number reading and 
display rating tasks on 20-G (G + Vibration) 
Deliverables:  
Data collection of astronaut office subjects 
Data Analysis and determination of effects of vibration and acceleration on performance  
Required Delivery Milestone:  
FY09 :Orion PDR  Final Report on Centrifuge Study Results 
FY09: CR to NASA Standard and HIDH prior to Orion PDR 
Required Platforms:  
Ground: Laboratory Test beds 
 
Tasks: (SHFE – New Directed Study or NRA) 
Examining Human Performance Under Vibration  
Unmitigated Ares first stage thrust oscillation produces unacceptably high vibrations to the crew in the Orion 
command module.  The health effects are well documented and requirements in CxP 70024, Human System 
Integration Requirements (HSIR) (Requirement HS3105), defines the ISO-weighted RMS values for allowable 
exposure. 
Vibration also affects crew performance, and impacts reading, reaction time, and fine motor control.  Specific 
vibration performance requirements are not provided in HSIR.  Performance under vibration also depends on crew 
interfaces, tasks, and other induced environments.  The task to conduct studies with:  
A simulated environment of the Lander vehicle and Lander Rover to assess the effect of vibration on performance 
in varying environments. 
Deliverables:  
Data collection, analysis and determination of effects of vibration and acceleration on performance in each 
multiple, variable environments 
Required Delivery Milestone:  
FY15: CR to NASA Standard and HIDH prior to Lander and Rover CDR 
FY15: Design solutions to Rover and Lander CDR 
Required Platforms:  
Ground: Laboratory Test beds/Simulation Environments 
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Tasks: (SHFE – Directed) 
Examining Human Performance Under Vibration During Launch (SDBI 1904) 
Unmitigated Ares first stage thrust oscillation produces unacceptably high vibrations to the crew in the Orion 
command module.  The health effects are well documented and requirements in CxP 70024, Human System 
Integration Requirements (HSIR) (Requirement HS3105), defines the ISO-weighted RMS values for allowable 
exposure. 
Vibration also affects crew performance, and impacts reading, reaction time, and fine motor control.  Specific 
vibration performance requirements are not provided in HSIR.  Performance under vibration also depends on crew 
interfaces, tasks, and other induced environments.  The task to conduct studies with:   
Astronaut subjects performing specific reading tasks during Shuttle launches to assess effects of vibration.  Data 
will be compared with results from Engineering DSO to measure actual vibration levels on Shuttle seats. 
Deliverables:  
Data collection from astronaut subjects on Shuttle short duration missions 
Data Analysis and determination of effects of vibration on performance during launch conditions 
Required Delivery Milestone:  
FY09: Shuttle data collection activities 
FY09: Design recommendations for Orion PDR 
FY10: Data analysis of Shuttle data sets 
FY10: Design solutions for Orion CDR 
FY10: CR to NASA Standard and HIDH to provide requirements for design solutions that mitigate effects of 
vibration 
Required Platforms:  
Ground: Laboratory Test beds  
Flight:  Shuttle (SDBI 1904)  
SHFE 2.1.9.1:  How do we develop validated tools and models to verify Constellation vehicle 
acoustic design environment requirements? 
Tasks: (SHFE – Directed) 
Acoustic Modeling  
Acoustic modeling can be used to identify key noise sources, determine/analyze sub-allocated requirements, keep 
track of the accumulation of minor noise sources, and to predict vehicle noise levels at various stages in the 
development, first with estimates of noise sources, later with experimental data.  Bench testing of isolated systems 
alone is not sufficient, as the installation effects are often not known.  Acoustic modeling will be used to determine 
installation effects, reverberation (room geometry) effects, and will be used to identify propagation paths and 
possible noise controls, as well as develop an understanding of the resulting acoustic levels in the composite 
environment.  Finally, acoustic modeling will be used to assist with the development and implementation of 
spaceflight acoustic materials and to predict their effectiveness including sound containment, absorption, and 
vibration isolation.   
Deliverables:  
Determine, mockup, and model the effects on the Orion CM noise environment of closeout panel and stowage 
effects on airborne noise.  Understand the relationship between mockup and model.  Increase model fidelity. 
Determine, mockup, and model the effects on the Orion CM acoustic environment of ventilation system noise.  
Understand the relationship between mockup (real fan sources/geometry) and model.  Use inputs of actual Orion 
fan noise to predict real Orion noise and evaluate Orion design.  Increase model fidelity. 
Determine, mockup, and model the effects on the Orion CM noise environment of structure-borne noise.  
Understand the relationship between mockup (real fan vibration sources/geometry) and model.  Increase model 
fidelity. 
Determine if mockup model complexity is adequate to address the needs of the Lander noise environment, and 
increase model fidelity accordingly. 
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Required Delivery Milestone:  
FY09: Progress report on CEV mockup modeling including ventilation system FY09:  Progress report on CEV 
mockup modeling including Environmental Control and Life Support (ECLS) Wall, comparison of predictions 
with measurements 
FY09:  Progress report on CEV mockup modeling including realistic closeouts/stowage  
FY09:  Plan for validating structure borne noise model 
FY09:  Progress report on CEV mockup modeling including structure borne noise with SEA and FEM 
FY09: Provision of mockup models for verification at PDR, detailed design 
FY09: Delivery of Orion Model to Orion Project 
FY10:  SSDR Presentation for Orion ECLS 
FY10:  Submit RIDs and/or comments to Orion PDR based on evaluation using model 
FY10:  Provision of mockup models for verification at CDR, detailed design 
FY10:  Submit RIDs and comments to Orion CDR based on evaluation using 2g Model 
FY10: CR to HIDH prior to Orion CDR to add acoustic requirements  
Required Platforms:  
Laboratory Test beds  
Mockups  
SHFE 2.1a: What are the effects of habitable volume and architecture on safety and performance 
and how can an integrated evaluation of those effects be performed? 
Tasks: (SHFE – Directed) 
Effects of Architecture on Safety and Performance  
One of the first decisions made for any spacecraft module design is, what is the required habitable volume?  This 
task will develop the knowledge to support this decision.  Effects of volume on task efficiency will be one topic of 
study.  Psychological effects of volume and architecture during long missions will be addressed.  A decision 
support tool that organizes the results of this study will be developed.  A standardized approach to evaluation of 
habitability features and to assessing their interactions will be developed in later work. 
Deliverables:  
Development of trade space tool for Lander to evaluate the effects of individual aspects of architecture on safety 
and performance as well as an evaluation of those effects from an integrated perspective 
Refine the tool if needs of Lander necessitate further development 
Develop and validate integrated Habitability evaluation model/tool with a focus on lunar short duration missions 
Refine and modify the tool as required to accommodate 6 month lunar missions 
Refine and modify the tool as required to accommodate lunar missions with a duration longer than 6 months 
Refine and modify the tool as required to accommodate long duration surface system missions 
Required Delivery Milestone:  
FY13: Tradespace and evaluation tool delivery for Lander PDR 
FY15: Evaluation tool for Lander CDR 
FY18: Evaluation tool for Surface Systems 
FY20: Evaluation tool for long duration Surface System missions 
Required Platforms: Ground: Laboratory Test bed 
 
SHFE 2.3.a (SBIR):  How can crews easily document human factors related issues that occur on 
orbit?   
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Tasks: (SHFE – Directed) 
Semantic Language and Tools for Reporting Human Factors Incidents  
Operations in confined, isolated, and foreign environments can lead to impairments of human performance.  This 
subtopic seeks methods for monitoring, modeling, and predicting human performance in the spaceflight 
environment for accurate and valid human system integration into vehicle design and operations.  In particular, the 
Space Human Factors Engineering Project within the HRP is interested in obtaining timely and context-specific 
Human Factors (HF) incident data.  Currently, space HF data come from crew debriefs.  Such debriefs rely on 
retrospective recall, which could suffer delays of up to six months.  Furthermore, opportunities to discuss HF 
issues in detail during these debriefs are limited.  Consequently, the HRP sees the need to develop an automated 
human factors incident-reporting tool. 
Deliverables:  
Design, development, and implementation of informational database for reporting of human factors incidents 
Required Delivery Milestone:  
FY11 Preliminary database tool provided for Lander SRR 
FY13 Final tool delivery for Lander PDR 
Required Platforms: Ground: Laboratory Test bed 
SHFE 2.3.1.1:  How can we determine the effect of microgravity on spinal elongation? 
Tasks: (SHFE – Directed) 
Spinal Elongation and its Effects on Seated Height in a Microgravity Environment  
The purpose of the Spinal Elongation and its Effects on Seated Height in a Microgravity Environment study is to 
provide quantitative data as to the amount of change that occurs in seated height due to spinal elongation in 
microgravity environments.  Spinal elongation has been observed to occur in crewmembers during space flight; 
however, it has only previously been recorded in the standing position with a limited number of subjects.  Seated 
height data in microgravity is considered necessary to identify correctly the seated height projections of the crew 
in the Orion configuration.  Correct projections of seated height should lead to a) proper positioning of the seats 
within the vehicle; b) maintaining adequate clearance for seat stroke in high acceleration impacts; c) providing 
proper fit in seats; d) proper placement of seats with respect to each other; and e) proper orientation to displays and 
controls.  Additionally, data concerning the effects of spinal elongation on seated height would aid in the design of 
suit components as well as requirements for habitations and other vehicles. 
Deliverables:  
Spinal elongation induced seated height data for subjects exposed to microgravity environments. 
Information relating to the seated height rate of change over time for astronauts subjected to microgravity. 
Provide new information concerning seated height forward into the design of Constellation systems. 
Required Delivery Milestone:  
FY09:  Completion of C-9 planning flights for hardware development, procedure validation 
FY09 to FY11: Data collection on Shuttle and ISS subjects  
FY09: Interim results/recommendations to Orion PDR 
FY09: Interim results/recommendations to Orion PDR-Suit 1 
FY09: CR to NASA Standard, HSIR, HIDH, and NASA Crewmember Medical Standards prior to Orion PDR and 
PDR- Suit 1 to add initial requirements based on initial results 
FY10: Design solutions to Orion CDR 
FY09: CR to NASA Standard, HSIR, HIDH, and NASA Crewmember Medical Standards prior to Orion CDR and 
CDR- Suit 1 to add initial requirements based on initial results 
FY11: Design solutions to Orion CDR-Suit 1 
FY11 to FY12:  Data Analysis and Final Report on Results of  Data Collection to Orion 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: C-9 
Flight:  Shuttle  
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SHFE 3.1.2.2.a:  How do we ensure that the displays and control designs and technology developed 
for the operational environments of the Cx Program will improve performance and reduce errors? 
***** This task also addresses the Risk of Error Due to Inadequate Information and the Risk of 
Error Due to Poor Task Design 
Tasks: (SHFE – Directed) 
Information Presentation – Displays (Visual and Auditory)**** 
Optimal displays are critical to crew performance and vehicle operations.  Displays must meet the crew’s needs 
and be easy to use as Exploration missions may face the greatest autonomy challenge to date.  The focus of visual 
displays is readability and usability of text, as well as display navigation.  The focus of auditory displays is alarms.  
This is a requirements development activity, supplemented by some research or validation activities on the ground 
and in flight.  This will result in the development of guidelines, requirements, and validation techniques for 
advanced information display solutions currently contemplated for the various Constellation Program spacecraft 
systems consistent with the smaller cockpit environments of the Orion CEV, the Lander, and surface rovers.  
These requirements and appropriate information will be provided to Orion, Constellation documentation 
(CxP70024 Human System Integration Requirements; Orion Display Standards) and the Space Flight Human 
System Standards Human Integration Design Handbook. 
Deliverables:  
Display design requirements  
Display design recommendations 
Assessment, selection, and test of display design enhancements that will maximize capability of Habitat 
Required Delivery Milestone: 
FY09 Display requirements and design recommendations to Orion PDR 
FY09 CR to HSIR, HIDH, Orion Display Standards documentation prior to Orion CDR 
FY10 Display design recommendations to Orion CDR 
FY11 Display requirements to Lander SRR 
FY13 Display design recommendations to Lander PDR 
FY15 CR to HSIR, HIDH prior to Lander CDR 
FY15 Design solutions to Lander CDR 
FY17 Design enhancement recommendations for Habitat 
FY19 Design enhancement solutions for Habitat displays 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
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***** This task also addresses the Risk of Error Due to Inadequate Information and the Risk of 
Error Due to Poor Task Design 
Tasks: (SHFE – Directed) 
Information Presentation – Controls**** 
The development of proper controls is critical to preventing errors during human spaceflight.  This becomes 
especially important when the majority of the controls will be software based.  Crewmembers must be very aware 
of what they are manipulating on the screen, and must be able to do so under vibration and high-g, as well as in 
microgravity.  They must be able to operate controls ungloved and with pressurized gloved hands.  During launch 
and entry, crews will have no choice other than to use a remote cursor control device.  If devices are inadequate for 
any of the above operational scenarios, crew safety will be compromised and risk loss of productivity.  These 
requirements and appropriate information will be provided to Orion, Constellation documentation (CxP70024 
Human System Integration Requirements; Orion Display Standards) and the Space Flight Human System 
Standards Human Integration Design Handbook. 
Deliverables:  
Control design requirements  
Control design recommendations 
Assessment, selection, and test of control design enhancements that will maximize capability of Habitat 
Required Delivery Milestone: 
FY09 Control requirements and design recommendations for Orion PDR 
FY10 Control design solutions for Orion CDR  
FY10 CR to HSIR, HIDH, Orion Display Standards Documentation prior to Orion CDR 
FY11 Control requirements to Lander SRR 
FY13 CR to update control requirements in HSIR, HIDH prior to Lander PDR 
FY13 Control design recommendations to Lander PDR 
FY15 CR to HSIR, HIDH for update to control requirements prior to Lander CDR 
FY15 Design solutions for Lander CDR 
FY17 Design enhancement recommendations to Habitat controls 
FY19 Design enhancement solutions to Habitat controls 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
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Tasks: (SHFE – Directed) 
Information Presentation – Electronic Procedures and Fault Management 
Constellation Program vehicles will have much smaller interior volumes than the Shuttle, and a higher g and 
vibration profile during dynamic phases of flight.  With crewmembers’ arms strapped to armrests, a “seated” 
operations mode will necessitate all crew-vehicle interactions being accomplished through one or more handheld 
devices.  There will also be considerably less real estate available bringing real pressure to consolidate information 
onto as few displays formats as possible.  Combined, these factors, along with hard pressures on the allowable 
mass of the vehicles, are forcing fundamental changes to the vehicle cockpits, dictating new and different concepts 
of vehicle operations.  The design pressures are being strongly felt on operations that include performing and 
completing checklists of nominal and off-nominal procedures, and all checklists will be accessed and view on a 
customized electronic display format call an electronic procedures viewer (EPV).  This task supports development, 
testing and validating the cockpit users interfaces needed to support procedure-related vehicles operations. 
Deliverables:  
Evaluation of advanced concepts for electronic procedures formatting and fault management 
Summary report on impacts of serial versus parallel access to fault-management related display information on 
fault management performance.  Report will include preliminary recommendations and guidelines for the size and 
content of the EPV window during ascent/entry operations. 
Development of procedure standards for display of electronic procedures 
Investigation and development of enhancements for current designs and capabilities 
Required Delivery Milestone:  
FY09: Report summarizing “look-forward” and “look-back” behavior on the EPV.  
FY09:  Report summarizing impacts of serial versus parallel access to fault-management related display 
information on fault management performance. 
FY09: Procedure design recommendations for Orion PDR 
FY09: CR to HIDH, HSIR, Orion Display Standards Documentation to add initial requirements prior to Orion 
PDR 
FY10: Procedure design solutions for Orion CDR 
FY11: Procedure requirements to Lander SRR 
FY13: Procedure design recommendations for Lander PDR 
FY15: Procedure design recommendations for Lander CDR 
FY17: Design enhancement recommendations for Habitat 
FY19: Design enhancement solutions for Habitat 
Required Platforms:  
Laboratory Test beds  
Mockups  
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Tasks: (SHFE – Directed) 
Information Presentation – Human Performance Modeling  
In next-generation cockpits, there will be the capability to automate a wider spectrum of spacecraft operations that 
is the case today.  When combined with the steady advances that are taking place in human-machine interface 
technologies, for any particular task or vehicle operation, the increasing options for human-machine functional 
allocation, and the increasing suite of interfaces that could support those options, something close to a 
combinatorial explosion in the space of possible operational concepts and supporting interfaces is occurring.  Both 
potential deficiencies with targeted designs, and optimal design solutions, could well be missed in a highly 
resource-limited development environment that targets only a small number of candidate designs for human-in-
the-loop evaluation.  Fully validated Human Performance Modeling tools could be used to more exhaustively 
explore and prune the design space for targeted operational concepts, particularly those that involve performance 
shaping functions (such as vibration or sustained g) that render human-in-the-loop evaluations of more than a 
small handful of point solutions impractical. 
Deliverables:  
Model-based capability to generate complete sequence of behavioral primitives associated with the task of 
detecting, isolating, and recovering from ADAPT test bed malfunctions during dynamic phases of flight. 
Capability to generate variability in number and order of behavioral primitives that replicate levels of intra- and 
inter-participant variability obtained in FY 07 empirical evaluation 
Report on the approach to expanding capabilities of human oculometric model (HOM) to model and predict 
effects of vibration on spacecraft operational tasks. 
Capability to model effects of crewmember and vehicle vibration on fault management performance. 
Capability to model impacts of a variety of display design variables such as font size, color, and display clutter. 
Integrated suite of auditory, visual, and possible haptic interfaces between crewmember and ACAWS (i.e., root-
cause and vehicle impact systems management software), including speech-based alarms, to help minimize time to 
determine root-cause failures and provide more effective aids for off-nominal situation management in high-
vibration (dynamic phase of flight) environments.  Perform human factors evaluations of off-nominal situation 
management with integrated interface display suite. 
Analyses of oculomotor behavior from Activity A to extend the stochastic capabilities of the ARC human 
performance model to the point where the model can accept, as input, a targeted spacecraft operational concept 
(such as fault detection, isolation, and recovery from an onboard systems malfunction) and generate the sequence 
of information acquisition activities (behavioral primitives) associated with performing the task.  Also, initiate the 
process of expanding the model’s capabilities to generate predictions of operational impacts of performance 
shaping functions such as cabin vibration. 
Required Delivery Milestone:  
FY09:  Model-based sequence of behavioral primitives associated with the task of detecting, isolating, and 
recovering from ADAPT test bed malfunctions during dynamic phases of flight. 
FY09:  Capability to generate variability in number and order of behavioral primitives that replicate levels of intra- 
and inter-participant variability  
FY09:  Report on the approach to expanding capabilities of human oculometric model (HOM) to model and 
predict effects of vibration on spacecraft operational tasks. 
FY09: CR to HIDH to add information obtained from human performance modeling research  
FY10:  Fault management performance model of vibration of crew and vehicle. 
FY10:  Modeling of display design variables. 
FY10: Integrated suite of auditory, visual, and (anticipated) haptic interfaces between crew and Advanced Caution 
and Warning System (ACAWS) 
FY10:  Final Report on Analyses of Oculomotor Behavior 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups  
SHFE 2.3.b:  How can existing models be modified to adequately represent the specified user 
population (e.g. field of view, visibility) in reduced gravity and be portable to other simulations 
environments? 
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Tasks: (SHFE – New Directed Study or NRA) 
Model Development and Applicability  
During equipment design and task planning, graphical computer models of humans can save time and avoid 
numerous design flaws by enabling visualization of the human interaction with the physical environment.  Aircraft 
designers, automobile designers, and other industries rely heavily on human modeling.  For NASA’s needs, the 
target population is different than the standard ones used by industry, and the varying gravity environments affect 
stature and posture, and may affect strength.  This task will identify the critical differences that need to be captured 
in adapting commercially available models to NASA’s application. 
Deliverables:  
Determine what population characteristics are critical to model development 
Model modification/test/validation/application 
Required Delivery Milestone: 
FY13: Initial input based on results from model development to Lander PDR 
FY15: Final model delivered for use in Lander CDR 
FY15: CR to HIDH and HSIR based on information obtained from model development and application 
FY16: Final model delivery for use with Habitat 
Required Platforms: 
Ground: Laboratory Test beds  
Ground: Mockups 
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The Risks in this part of the Appendix are aligned with  
Section 2.2 – 
Ensure That the Crew Can Accomplish the Cognitive,  
Behavioral, and Team Aspects of the Mission 
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RISK OF BEHAVIORAL AND PSYCHIATRIC CONDITIONS – CRITICALITY: 
LUNAR OUTPOST – D, MARS – C  
 
Behavioral issues are inevitable among groups of people, no matter how well selected and trained. 
Spaceflight demands can heighten these issues. The Institute of Medicine (IOM) report, Safe Passage, 
notes that Earth analog studies show an incidence rate of behavioral problems ranging from 3-13 percent 
per person per year. The report transposes these figures to 6-7 person crews on a 3-year mission to 
determine that there is a significant likelihood of psychiatric conditions emerging. Impacts of behavioral 
issues are minimized if they are identified and addressed early. The HRP must provide the best measures 
and tools to monitor and assess mood and to predict risk for and management of behavioral and 
psychiatric conditions prior, during and following spaceflight. 
Operational Relevance Assessment and Recommendations 
BHP research addresses the risk of behavioral and psychiatric conditions developing during or following 
an Exploration Mission.  Early detection of stress or other risk factors during spaceflight is imperative to 
deter development of behavioral or psychiatric conditions which could seriously harm and negatively 
impact the individual or the crew, and pose serious consequences for accomplishing mission objectives or 
jeopardizing the mission altogether. Toward this end, BHP is developing methods for monitoring 
behavioral health during a Lunar and Mars Mission, and adapting/refining various tools and technologies 
for use in the spaceflight environment. These measures and tools will be used to monitor, detect and treat 
early risk factors. BHP will utilize analogs to test, further refine, and validate these measures for 
Exploration Missions. BHP also develops countermeasures for maintaining behavioral health and 
enhancing performance during long duration isolated, confined, and highly autonomous missions; 
provides recommendations regarding space medicine best practices; and, provides updates for behavioral 
health and performance standards.   
The BHP element includes two additional risks – increased human performance errors due to sleep loss, 
fatigue, work overload, and circadian desynchronization; and, increased errors due to poor team cohesion 
and performance, inadequate selection/team composition, inadequate training, and poor psychosocial 
adaptation. The three risks are interrelated; the occurrence or mitigation of one risk can be a contributing 
factor affecting another. As a result, BHP gap-related activities and deliverables may sometimes address 
more than one risk.   
Risk Mitigation Strategy 
The risk mitigation strategy of the BHP Element follows the larger strategy of the HRP “from Evidence to 
Products” principle, while being driven primarily by Medical Operations. BHP holds an annual working 
group meeting of subject matter experts who work with BHP and Medical Operations, and Mission Ops 
to identify gaps in knowledge and gaps in mitigation.  Specific tasks are defined to address the gaps and 
provide clear, deliverables for Constellation, ensuring an evidence and operationally-based end item. 
Working with research and operational experts, BHP systematically identifies the appropriate analog to 
address the gaps prior to validating in spaceflight.  To ensure relevancy, stakeholders are engaged in the 
process at the beginning. Findings from BHP research inform operations and standards as well as update 
the evidence base for the BHP Risks.   
Gaps 
BMed1: What are the optimal methods to prevent decrements in behavioral health (which may 
negatively affect performance) during exploration missions? 
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BMed2: What are the optimal methods to predict decrements in behavioral health (which may 
negatively affect performance) during exploration missions? 
Individuals with the greatest likelihood of having a behavioral and psychiatric emergency in flight are 
eliminated during the selection process; they never become astronauts.  While the current NASA select-
out system is very thorough, the predictive ability of all selection systems diminishes over time.  
Therefore, new criteria may be necessary for astronaut selection for long duration exploration missions.  
Neuropsychiatric assessment may be helpful in this process, as the biological basis of mood disorders 
suggests neural biomarkers may provide a more objective method for assessing some psychiatric 
conditions such as depression.  
Tasks: (NSBRI) 
Near-infrared Neuroimaging (NIN) for Predicting Depression  
2008-2011: Lab Studies: Biomarkers of Depression (Strangman)  
Laboratory study evaluating and validating a flight-capable, noninvasive neuroimaging technology (near-infrared 
spectroscopy and imaging, or NIRS imaging) for its ability to detect biomarkers of depression, and its severity. 
2012: Determine if technology is ready for spaceflight. If no, then define subsequent tasks. If yes:  
2013-2016: Flight feasibility study 
If it is determined that mobile neuroimaging of psychiatric conditions (including, but not limited to, depression) is 
appropriate for in-flight use during long duration exploration missions (as a detection tool), a feasibility/validation 
study will be conducted on the ISS.  If not, additional neuroimaging studies to address other conditions may be 
conducted. 
2023 + Validate in Lunar Long missions 
If not ready for spaceflight, determine which tasks should be conducted 
Deliverables:  
Updates to Human System Risk Forum/Recommendations to Medical Operations regarding biomarkers of 
depression, as select-out criteria for exploration (and possibly for in-flight use) 
Inform Standards 
Based on outcome of flight study, mobile neuroimaging of psychiatric conditions may be delivered as a 
countermeasure for Medical Operations for long duration exploration missions 
Required Delivery Milestone: Updates to Human System Risk Forum / Recommendations for Medical Ops to be 
delivered in 2016 regarding biomarkers for depression diagnosis and depression severity. Mobile neuroimaging 
technology may be delivered as in-flight countermeasure for long duration exploration missions, in 2023 for Lunar 
Ops and Mars Ops Development. 
Required Platforms: Ground and space effort 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2013-2016: Flight Feasibility Study 
20  Very Low  Very Low  
2023 + Validate in Lunar Long Missions 
20  Very Low  Very Low  
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Tasks: (Directed) 
Prediction of Incidence of Depression in Astronauts 
2009-2011: Literature Review and Meta-Analysis 
Literature review and meta-analysis to predict the incidence of depression in astronauts. 
Deliverables: Updates to Human System Risk Forum / Recommendations to Medical Operations regarding 
incidence rates of depression in astronauts. 
Required Delivery Milestone: Updates to Human System Risk Forum / Recommendations for Medical Ops to be 
delivered by 2011. 
Required Platforms: This ground effort primarily involves evidence gathering. Findings from this activity will 
inform what additional tasks need to be conducted to address this gap. 
BMed3: What are the optimal methods to detect and assess decrements in behavioral health (which 
may negatively affect performance) during exploration missions? 
Astronauts must maintain high-level performance while experiencing demanding workload and work 
schedules, extreme environmental risks, and psychosocial stressors in space (for example, isolation and 
confinement). Stress, affect, and fatigue can jeopardize their cognitive performance and neurobehavioral 
status. Due to the delayed communication that will exist between the space crew and the ground during an 
Exploration Missions, flight surgeons have stated the need for unobtrusive monitoring tools that will help 
detect if an astronaut is demonstrating or otherwise evidencing continual high levels of stress, fatigue, and 
negative mood. These tools are to require minimal crew time and effort. The tools should allow the 
crewmember the ability for self-assessment, providing immediate feedback so that countermeasures can 
be administered in a timely manner, if necessary.  
Currently, two monitoring technologies are planned. These technologies are to be adapted specifically for 
Exploration Missions. The facial monitoring tool (known as the optical computer recognition (OCR) 
system) is currently under development through previous work of the researcher with other agencies. 
NASA is able to leverage such technologies, and with some refinement, adaptations, and validation, 
provide these tools for Lunar and Mars Missions.  
Tasks: (NSBRI) 
Unobtrusive Tool – Facial Monitoring Technology (Optical Computer Recognition (OCR) 
2008-2012: Lab Development 
Laboratory studies are evaluating whether optical computer recognition algorithms based on changes in facial 
expressions can discriminate stress induced by low versus high workload. Assess the effectiveness of the tool 
using archival video footage or footage that is streamed from ISS to the ground. This step may allow for the 
validation of the tool for spaceflight operations without the use of ISS crew time.  
2009-2010: NEEMO 
Evaluate technology in high fidelity analogs such as NEEMO that contain neurobehavioral stressors relevant to 
spaceflight. 
2009-2010: RCS-105 
Evaluate technology in high fidelity analogs such as the Russian Chamber Study-105 that contain 
neurobehavioral stressors relevant to spaceflight. 
2013: Prep for Flight 
2014-2018 (or earlier): Flight Validation Studies, if deemed necessary 
Following assessments using flight footage video, and refinement/enhancement of the tool to detect changes 
despite fluid shifts that can occur during spaceflight, determine if the technology is needed to assess behavioral 
health during LDM Exploration missions, and if a flight study is needed. If so, a flight study will be implemented 
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Deliverables: Facial Monitoring Technology as a countermeasure for long duration exploration missions 
Required Delivery Milestone: Countermeasure to be delivered to flight medical operations for long duration 
exploration missions. 
Required Platforms: Ground studies to help adapt technologies for spaceflight; analogs include NEEMO and the 
RCS-105. Require the ISS for validation (either through the use of video footage or flight study) because of the 
parameters being monitored may be affected by microgravity. The ISS will emulate the transit environment to 
Mars. Involves collaboration with NSBRI. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
2014-2018 (or earlier): Flight Validation Studies, if deemed necessary 
24    Low  
2020-2023: Lunar Validation 
24    Low  
 
Tasks: (TBD) 
Unobtrusive Tool – Voice Acoustics Monitoring Technology  
A former NSBRI investigation looked at speech monitoring technology to automatically and unobtrusively 
monitor the effects of stress and neurological impairment on astronauts’ ability to perform in extended missions. 
The system detects cognitive decrements resulting from hypoxia and radiation, and can discriminate between high 
and low stress conditions.  
2009: Review of Technologies 
Review tool developed through the NSBRI and other existing voice acoustic monitoring technologies to 
determine feasibility for spaceflight.  
2011-14: Ground Validation Studies 
If tools are deemed feasible for spaceflight, validate the tool in analog environments. 
2016: Prepare for Flight 
2017-2020: Flight Validation Studies, if deemed necessary 
Following assessments in analog environments, determine if the technology is needed to assess behavioral health 
during LDM Exploration missions, and if a flight study is needed. If so, a flight study will be implemented 
2020-2023: Lunar Validation  
Deliverables: Voice Acoustics Monitoring Technology (unobtrusive, passive technology that assesses individual 
responses to stress, as well as radiation and hypoxia effects) 
Required Delivery Milestone: Countermeasure to be delivered to flight medical operations for long duration 
exploration missions. 
Required Platforms: Ground studies to evaluate existing technologies in analog environments. Require the ISS 
for validation (either through the use of audio footage or flight study) because of the parameters being monitored 
may be affected by spaceflight environment. The ISS will emulate the transit environment to Mars.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
2017-2020: Flight Validation Studies, if deemed necessary 
20    Low  
2020-2023: Lunar Validation 
20    Low  
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BMed4: What aspects, if any, of cognitive performance change during missions?  If there are 
changes –do they persist post-mission?  If so, for how long?  
BMed5: What are the optimal methods for detecting and assessing cognitive performance during 
exploration missions? 
Based on past spaceflight experiences, various types of behavioral and psychiatric conditions are expected 
to be a risk for future exploration missions.  While current selection and countermeasure strategies have 
prevented the occurrence of any behavioral health emergencies that could jeopardize mission success, the 
uniquely long durations and distances of future exploration missions necessitates comparisons with 
analog environments that might indicate what other types of occurrences could be expected. 
Some evidence from Antarctic research suggests clinical cognitive changes may occur in individuals 
exposed to ICE environments, such as space, for long periods of time.  Investigators studying animal 
research have further speculated that behavioral changes in such environments may even be attributable to 
the effects of chronic stress on the hippocampus.  Physical aspects of the environment can also result in 
cognitive changes.  Exposure to radiation, for example, can damage the subcortical basal ganglia and 
hippocampus, both of which are critical to cognitive functioning. 
Tasks: (NRA) 
Changes in Cognition and Psychological Well-Being in Long-Duration Spaceflight 
2009: Literature Review 
Review of validated measurement tools for detecting changes in cognition  
2010: Workshop  
2011: Prep for Flight 
2012-2015: Flight Study 
Data collection to characterize cognition during long duration space missions, and determine measurement tools 
for detecting changes in cognition.  
2016-2019: Additional flight studies and/or ground studies, if needed 
If evidence reveals further studies are needed, assess whether spaceflight duration is sufficient for additional 
studies (i.e. missions lasting a year or more). If so, implement flight study to further evaluate this gap. If not, 
ground based studies in appropriate analog to be conducted. 
2023+ Validate in Lunar Long missions 
Deliverables: Update to HSRF/Medical Operations with recommendations regarding clinical cognition during 
long duration spaceflight missions. 
Required Delivery Milestone: Update HSRF/Medical Operations in 2015 with recommendations for long 
duration exploration missions. 
Required Platforms: Review a ground based effort, with flight study implemented with crews on ISS (to detect 
potential clinical cognitive changes) and validation on Lunar Long mission. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
20    Low  
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Tasks: (NRA) 
Changes in Cognition and Psychological Well-Being in Long-Duration Spaceflight 
2009: Literature Review 
Review of validated measurement tools for detecting changes in cognition  
2010: Workshop  
2011: Prep for Flight 
2012-2015: Flight Study 
Data collection to characterize cognition during long duration space missions, and determine measurement tools 
for detecting changes in cognition.  
2016-2019: Additional flight studies and/or ground studies, if needed 
If evidence reveals further studies are needed, assess whether spaceflight duration is sufficient for additional 
studies (i.e. missions lasting a year or more). If so, implement flight study to further evaluate this gap. If not, 
ground based studies in appropriate analog to be conducted. 
2023+ Validate in Lunar Long missions 
Deliverables: Update to HSRF/Medical Operations with recommendations regarding clinical cognition during 
long duration spaceflight missions. 
Required Delivery Milestone: Update HSRF/Medical Operations in 2015 with recommendations for long 
duration exploration missions. 
Required Platforms: Review a ground based effort, with flight study implemented with crews on ISS (to detect 
potential clinical cognitive changes) and validation on Lunar Long mission. 
 
Tasks:  
CNS1: Radiation Exposure Acute Functional CNS Effects 
As per SRPE IRP 
 
Tasks: (NSBRI (laboratory/animal studies)) 
Evaluate CNS/Neurostructural Changes 
2008-2012: Lab studies- animals- assess neurostructural changes (Hienz) 
Animal studies to assess the likelihood of space radiation producing immediate and/or long-term functional 
changes in the CNS. 
2013- TBD 
Deliverables:  
Update to HSRF/Medical Operations with Recommendations regarding CNS effects/neurostructural changes 
based on evidence  
Information to Radiation Element 
 Inform Standards 
Required Delivery Milestone: Due to the fact that radiation effects may be a current issue, update 
HSRF/Medical Operations with recommendations in 2012.  
Required Platforms: Ground based effort, involving laboratory studies. 
 
Tasks: CogGague (SBIR) 
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2008: Phase I Requirements Development 
Develop requirements for a prototype cognitive assessment tool that is designed specifically for long duration 
exploration missions. The tool will detect clinical cognitive decrements as a result of fatigue or other stressors of 
spaceflight; support crew members with an entertaining assessment activity(s); and support autonomy by 
providing objective feedback directly to the crewmember regarding their behavioral health. CogGague will serve 
as a diagnostic tool, indicating not only if crew members are below baseline, but also potential causes for these 
decrements.  
2009-2010: Phase II Prototype Development 
2011-2012: Prep for spaceflight validation 
2013-2016: Validate technology on ISS 
Collect and analyze data on ISS in order to validate CogGague in spaceflight environment. 
Deliverables:  
Diagnostic Tool for Medical Operations 
Required Delivery Milestone: Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Ground development. Spaceflight feasibility studies to occur on ISS. This deliverable 
requires spaceflight because of issues related to the long duration spaceflight environmental factors, and to ensure 
the test is appropriate for the spaceflight environment.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC Time 
(hrs) 
2009-2013: Validate PVT Self-Test on ISS 
24    Low  
 
BMed6: What psychosocial characteristics predict success in an isolated, confined and extreme 
environment? 
In order to select individuals most likely to be successful in long duration exploration missions, it is 
helpful to understand the psychosocial characteristics (including personality data) of individuals who have 
already proven to be successful in isolated, confined, and extreme environments. These individuals may 
include, but are not necessarily limited to, submariners, navy seals, firemen, and wintering-over Antarctic 
personnel.  Essential to this task is establishing an operationally accurate definition of “success”.  
Training can subsequently be designed to target the traits that are most malleable.   
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Tasks: (TBD) 
Identify Trait/Malleable Characteristics of High-Performing Individuals 
2009-2010: Review of Literature/Assessment of Operations 
Review literature on ICE population groups to define and outline what psychosocial characteristics are most 
predictive of success.   Collaborate with BHP Ops to establish a definition of “success” that most adequately 
captures what is needed in a long duration astronaut.  Assess what is already operational known about the success 
of previous long duration flyers.  Identify traits/malleable characteristics of high performing individuals.   
2011-2015: Revise Gap and Tasks 
Based on the above information, determine whether additional studies are needed. If studies are needed, 
determine whether BHP will be able to gather data needed from previous interviews and sources; or, if it is 
necessary to interview astronauts for additional information.  Revise and define the gap and activities with goal of 
providing training recommendations to Ops by 2015. 
Deliverables: Updates to Human System Risk Forum / Recommendations to Medical Operations regarding 
information that may help determine training criteria. 
Required Delivery Milestone: Updates to Human System Risk Forum / Recommendations for Medical 
Operations to be delivered for long duration exploration missions. 
Required Platforms: Review is ground study, with future tasks/deliverables to be subsequently defined. 
BMed7: What are the optimal countermeasures for maintenance, restoration and enhancement of 
behavioral health during exploration missions? 
As discussed in the B-Med Evidence Book, although the incidence of reported psychiatric disorders on 
short duration missions has not been significant, as the length of the mission increases, the incidence of 
behavioral and psychiatric disorders is also expected to increase. Additionally, the ramifications of a 
disorder developing inflight are severe if left unresolved, particularly for long duration exploration 
missions.  Anecdotal and empirical evidence from spaceflight and incidence rates from space analogs 
suggest that assessing, preventing, and treating behavioral health problems are essential to protecting the 
health of crewmembers, and consequently, the success of the mission. 
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Tasks: (NSBRI) 
Tool: Mitigation of Depression, and  
Task: Tool : Mitigation of Stress and Anxiety 
Currently a computerized “psychologist” is under development through the NSBRI, in conjunction with Medical 
Operations; this “smart” technology allows a crewmember on a long duration Lunar or Mars Mission to evaluate 
signs or symptoms of early depression and anxiety, and receive therapy as desired.  
The computer-based aid for addressing depression (based on problem-solving therapy), is not designed to replace 
the clinician; rather, it will complement the service of the aerospace psychiatrist during a long duration 
Exploration Mission. The tool enhances privacy, confidentiality, and support of the astronaut during autonomous 
missions such as the Mars Mission which will have considerable communication delays between space crew and 
ground support.  It allows the astronaut to educate him/herself, augmenting the one-on-one private physician 
consultation. At times when such consultation is not feasible, it will serve as a diagnostic tool and autonomous 
countermeasure that is available 24/7, with feedback to the individual, aerospace psychiatrist, and the crew 
surgeon.   
There is a second NSBRI task developing self-directed, autonomous, interactive, multi media module to train 
crewmembers how to recognize, assess, prevent and manage stress and anxiety on extended spaceflights. The 
countermeasure could be used in preflight training, with booster sessions on interventions available in orbit as 
needed. In this model of implementation, the skills learned prior to a mission would help to inoculate crews to 
severe stress reactions thereby enhancing flight-task performance and crew health, safety and efficiency. The 
countermeasure will comprise empirically supported stress and anxiety-management strategies. 
2008-2012: Two NSBRI ground based studies (laboratory and Antarctic) to refine and test the effectiveness and 
feasibility of tool.  
2012: Prepare for Flight 
2013-2016: ISS validation/feasibility study 
2017: Determine if additional countermeasure studies are needed 
2017-2020: Conduct ground studies, if needed 
2023+ Validate in Lunar Long environment 
Deliverables:  
Countermeasure: technology to detect and treat depression, as well as stress and anxiety 
Update to HSRF for operationalizing protocol for ISS 
Required Delivery Milestone: Update HSRF/Flight Med Ops in 2016. Provide countermeasure for long duration 
missions to Constellation in 2016.  
Required Platforms: Ground studies, with flight validation on ISS. The ISS will emulate the transit environment 
to Mars.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
20    TBD  
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Tasks: (NRA) 
Journals 
2008-2010: ISS Studies 
This activity involves a systematic analysis of astronaut journals maintained during ISS increments. Findings will 
yield recommendations regarding countermeasures for behavioral health during long duration spaceflight mission, 
making it most applicable for Lunar Habitat and Mars Missions. Findings from this activity will also inform 
knowledge and mitigation gaps within the Sleep, Team, and B-Med Risks.  
2011: Determine if additional studies are needed 
Tasks to be subsequently defined 
Deliverables: Recommendations regarding countermeasures for behavioral health 
Required Delivery Milestone: Updates to HSRF/Med Ops in 2011.  
Required Platforms: Task involves analysis of astronaut journals from ISS, and therefore requires spaceflight. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
10    Low  
 
Tasks: (TBD) 
Architectural Recommendations for Behavioral Health and Performance 
2010: Review  
This activity will help BHP to determine if studies are needed to define architectural requirements for lunar 
habitat design (or other related aims.) 
Deliverables: TBD 
Required Delivery Milestone: TBD 
Required Platforms: TBD 
 
Tasks: (TBD) 
Countermeasures: Adaptation to ICE Environments 
2010: Review  
This activity will help BHP to determine if studies are needed 
Additional Tasks TBD 
Deliverables: TBD 
Required Delivery Milestone: TBD 
Required Platforms: TBD 
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BMed8: What are the most appropriate and effective ways for crews to use behavioral 
health medications in spaceflight?  
Space analogs, such as Antarctica, confirm mood deterioration and increased stress occur in individuals in 
isolated, confined and extreme environments (ICE). Psychotropic medications may be considered helpful 
in mediating these deleterious effects and in treating behavioral or psychiatric conditions that may arise 
during Exploration Missions.  
Over the next decade, the field of psychopharmacology will undoubtedly continue to develop new 
medications for the treatment of behavioral and psychiatric disorders. In preparation for long duration 
Exploration Missions, BHP will collaborate with Medical Operations to review state-of-the-art 
medications and provide a compendium of best practices. A pharmaceutical armamentarium that covers a 
broad range of mental disorders, produces minimal side effects, requires no laboratory monitoring and has 
minimal storage requirements will be needed for long duration Exploration Missions.  
Tasks: (TBD) 
Develop Behavioral Medications Database 
In collaboration with Medical Operations and Subject Matter Experts, workshop and data mining to review 
literature on performance, safety, and side effects of state-of-the-art medications for behavioral and 
psychiatric disorders. 
Deliverables: Behavioral Medications Database.  
Required Delivery Milestone: Update to Lunar and Mars Ops Development for long duration missions.  
Required Platforms: Primarily a ground based effort.  
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RISK OF PERFORMANCE ERRORS DUE TO SLEEP LOSS, CIRCADIAN 
DESYNCHRONIZATION, FATIGUE, AND WORK OVERLOAD – CRITICALITY: 
LUNAR OUTPOST – D, MARS – D 
 
Fatigue occurs during spaceflight and may jeopardize health and performance.  This risk may be 
influenced by artificial and transmitted light exposure, individual vulnerability to sleep loss and circadian 
dynamics, and work/sleep schedules.  Efforts are needed to improve sleep hygiene, and to identify and 
improve conditions that interfere with sleep quality.  Research areas may include: development of a self-
assessment tool for cognitive function and fatigue, light therapy for phase shifting, alertness and mood 
disorders, and other means to improve sleep quality and reduce fatigue. 
Operational Relevance Assessment and Recommendations 
Research demonstrates that aspects of the spaceflight environment may disrupt circadian rhythms and 
reduce sleep; anecdotal evidence from spaceflight reveals that fatigue and work overload can also occur. 
Ground research has consistently demonstrated that lack of adequate amounts of good quality sleep, as 
well as circadian desynchronization, can adversely affect performance capability and safety.  
Lunar surface activities will be both strenuous and fatiguing, and will involve shift work. Furthermore, 
sleep and fatigue are risk factors for the other two Behavioral Health and Performance Risks (Risk of 
Performance Errors Due to inadequate Team Cohesion and Performance, Inadequate Selection/Team 
Composition, Inadequate Training, and Poor Psychosocial Adaptation; Risk of Behavioral and Psychiatric 
Conditions), as well as other aspects related to human health. It is therefore essential to develop 
countermeasures for issues related to sleep loss, fatigue, circadian desynchronization and work overload. 
BHP research activity aims to assess this risk as well as provide adequate standards and countermeasures 
for Exploration Missions.  
Risk Mitigation Strategy 
The risk mitigation strategy of the BHP Element follows the larger strategy of the HRP “from Evidence to 
Products” principle, while being driven by Operations. BHP holds an annual working group of subject 
matter experts who work with BHP and Medical Operations to identify gaps in knowledge and gaps in 
mitigation.  Specific tasks are defined to address the gaps and provide clear, specific deliverables for 
Constellation, ensuring an evidence and operationally-based end item. Working with research and 
operational experts, BHP systematically identifies the appropriate analog to address the gaps prior to 
validating in spaceflight.  To ensure relevancy, stakeholders are engaged in the process at the beginning. 
Findings from BHP research inform operations and standards as well as update the evidence base for the 
BHP Risks.   
Gaps 
Sleep 1: What are the best measures and tools to use for assessing performance relative to fatigue 
and other aspects of spaceflight?  
Ground evidence clearly demonstrates that performance impairments can occur when sleep is attained in 
quantities similar to that attained by astronauts in flight. A correlation between sleep quantity and 
performance in spaceflight however has not been documented.  A means to objectively assess decrements 
during mission operations and provide information to the crew surgeon and astronaut may be helpful, so 
that appropriate countermeasures, if necessary, can be implemented. The assessment of performance in 
space relative to fatigue, using the right measures, will also aid in accurately characterizing and 
quantifying this human health risk. 
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Tasks: (PVT Self Test on ISS is a BHP Directed Study, with NSBRI supporting PVT  Self Test development and validation in 
analogs ) 
Refine, Validate, and Standardize Psychomotor Vigilance Task Self-Test (PVT) 
2007-2008: NEEMO 
Collect data in NEEMO to develop normative database of astronaut performance on PVT. 
2009-2010: Russian Chamber Study 
Validate the PVT in analogous environments, including the Russian –Chamber 105 day study. 
2008-2011: Lab development 
Development and enhancements of the PVT in laboratory studies so that it serves as a self-assessment measure for the astronaut 
and provides automatic feedback to flight surgeons and crews during autonomous missions.  
2009-2013: Validate PVT Self-Test on ISS 
Collect and analyze data on ISS in order to validate the PVT in spaceflight environment. 
2014: Determine if additional tools are needed 
2014-2020: Implement ground/flight studies if applicable 
2020-2023: Validate PVT Self-Test on Lunar Surface 
Collect and analyze data on Lunar Surface in order to validate the PVT in Lunar environment. 
Deliverables:  
PVT Self-Test for Medical Operations 
Information to the SHFH Element  
Update to HSRF/Med Ops with measures validated in Lunar sortie environment. 
Required Delivery Milestone: Update HSRF/Medical Operations by 2014 for Lunar Sortie Medical Operations 
implementation. Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Analogs, including the Russian Chamber Study 105-day and NEEMO. Laboratory development. 
Spaceflight validation to occur on ISS. This deliverable requires spaceflight because of sleep loss and fatigue issues related to 
microgravity and other spaceflight environmental factors, and to ensure the test is appropriate for the spaceflight environment. 
Validate on Lunar surface. 
# of Subjects Initial Upmass (kg) Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew Time/Subject Post-Flight BDC 
Time (hrs) 
2009-2013: Validate PVT Self-Test on ISS 
24    Low  
2020-2023: Validate PVT Self-Test on Lunar Surface 
24    Low  
 
Tasks: Cognitive Assessment Tool (CAT ) (SBIR) 
2008: Phase I Requirements Development 
Develop requirements for a prototype cognitive assessment tool that is designed specifically for long duration 
exploration missions. The tool will detect cognitive decrements as a result of fatigue or other stressors of 
spaceflight; support crew members with an entertaining assessment activity(s); and support autonomy by 
providing objective feedback directly to the crewmember regarding their behavioral health 
2009-2010: Phase II Prototype Development 
2011-2012: Prep for spaceflight validation 
2013-2016: Validate technology on ISS 
Collect and analyze data on ISS in order to validate the CAT in spaceflight environment. 
Deliverables:  
Cognitive Assessment Tool for Medical Operations 
HRP-47065 
 
126 
Required Delivery Milestone: Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Ground development. Spaceflight feasibility studies to occur on ISS. This deliverable 
requires spaceflight because of issues related to spaceflight environmental factors, and to ensure the test is 
appropriate for the spaceflight environment.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC Time 
(hrs) 
2009-2013: Validate PVT Self-Test on ISS 
24    Low  
 
Tasks: (BHP NRA) 
Sleep-Wake Actigraphy Study 
2008-2012: Validate Actiwatch in-flight 
As discussed in the Sleep Evidence Report, studies have shown that self-report of just how much sleep 
an individual actually gets is unreliable and inaccurate. Therefore, to accurately assess to what degree 
sleep is disrupted on-orbit, an unobtrusive, objective measure of sleep-wake activity is needed. 
Objective sleep data during the course of a mission provides important operational feedback for the 
astronaut as well as the flight surgeon, particularly prior to performing critical mission tasks, and 
planning slam shifting during mission operations. 
Deliverables:  
Actiwatch Protocol to ISS Medical Operations  
(See Sleep 6): Recommendations based on evidence 
Required Delivery Milestone: Update HSRF/Medical Operations in 2010 for operationalizing Actiwatch protocol as an ISS 
medical requirement.   
Required Platforms: Spaceflight validation to occur on ISS. This deliverable requires spaceflight to ensure the tool is 
appropriate for monitoring sleep-wake activity and light exposure in the spaceflight environment.  
# of Subjects Initial Upmass (kg) Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew Time/Subject Post-Flight BDC 
Time (hrs) 
20  Very Low  Low  
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Tasks: (SBIR) 
Individualized Fatigue Meter 
While the current Actiwatch technology is useful, it is suspected that is does not gather a very precise assessment 
of light exposure. The Actiwatch also requires a skilled investigator to download, analyze, and interpret the data 
before the feedback can be of use to flight surgeons and astronaut crews. There is a need for an individualized 
meter that precisely measures environmental (e.g., light exposure) and physiological signals (e.g., sleep wake 
activity, heart rate, etc.) to determine individual fatigue levels, and automatically provides the user (e.g., 
astronaut/flight surgeon, MOD/ground support) with feedback about potential decrements in performance ability. 
Such a measure will also provide information on circadian phase to indicate levels of potential risk due to fatigue.  
2009: Phase I, Evaluation/ Requirements Definition 
Market analysis and literature review document to assess physiological and environmental sensors; circadian state 
& sleep assessment; neurobehavioral performance test analysis; a review of existing models and identification of 
any major gaps in current modeling knowledge; and a technical development plan for developing a spaceflight 
ready Individualized Fatigue Meter. 
2010-2011: Phase II, Prototype Development 
Develop spaceflight ready prototype of Individualized Fatigue Meter. 
2012: Prep for Spaceflight 
2013-2017: Phase III, Validate Fatigue Meter in Spaceflight – TBD 
2020-2023: Validate PVT Self-Test on Lunar Surface 
Collect and analyze data on Lunar Surface in order to validate the PVT in Lunar environment. 
Deliverables:  
Individualized Fatigue Meter to become requirement for Medical Operations  
Update Lunar Ops & Input Mars Ops Development 
Update to HSRF/Med Ops with measures validated in Lunar sortie environment 
Required Delivery Milestone: Update HSRF/Medical Operations in 2017 for Lunar Sortie Medical Operations 
implementation. Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Ground evaluations and laboratory development. Spaceflight validation to occur on ISS. 
This deliverable requires spaceflight to ensure the tool is appropriate for the spaceflight environment.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2013-2017: Phase III, Validate Fatigue Meter in Spaceflight – TBD 
24  Very Low  Low  
2020-2023: Validate PVT Self-Test on Lunar Surface 
24  Very Low  Low  
Sleep2: How is performance in spaceflight affected by sleep loss, circadian desynchronization, 
fatigue and work overload?  
As discussed in the Sleep Evidence Book, ground evidence clearly demonstrates that performance 
impairments can occur when sleep is attained in quantities similar to that attained by astronauts in flight. 
A correlation between sleep quantity and performance in spaceflight however has not been documented.  
The assessment of performance in space relative to fatigue, using the right measures, will also aid in 
accurately characterizing and quantifying this human health risk, and helping to determine what 
additional countermeasures need to be developed, as necessary, and/or policies/standards enforced. 
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Tasks: (PVT Self Test on ISS is a BHP Directed Study, with NSBRI supporting PVT Self Test development and 
data collection in analogs) 
PVT ST Performance Data (these tasks are also described in Sleep1) 
2007-2008: NEEMO 
Collect data in NEEMO to develop normative database of astronaut performance on PVT ST. 
2009-2010: Russian Chamber Study 
Collect performance data the in analogous environments, including the Russian –Chamber 105 day study. 
2008-2011: Lab development 
Development and enhancements of the brief PVT self test in laboratory studies so that, based on performance data 
gathered, it serves as a self-assessment measure for the astronaut and provides automatic feedback to astronauts 
and flight surgeons during autonomous missions.  
2009-2013: Collect Performance Data with PVT Self-Test on ISS 
Collect and analyze data on ISS in order to capture performance with the PVT ST in the spaceflight environment. 
2014: Determine if additional performance studies are required 
2014-2020: Implement ground/flight studies if applicable 
2020-2023: Collect PVT ST performance data on Lunar Surface 
Collect and analyze data from Lunar Surface in order to characterize performance with the PVT ST in the Lunar 
environment. 
Deliverables:  
Recommendations for flight and ground crews re: fatigue and performance, based on evidence gathered 
Information to the SHFH and HHC Elements 
Inform Standards 
Update to HSRF/Med Ops regarding cognitive and motor performance in Lunar Sortie environment 
Required Delivery Milestone: Update HSRF/Medical Operations in 2013 for Lunar Sortie Medical Operations 
implementation.  Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Analogs, including the Russian Chamber Study 105-day and NEEMO. Laboratory 
development. Data collection to occur on ISS and Lunar surface. This deliverable requires spaceflight because of 
sleep loss and fatigue issues related to microgravity and other spaceflight environmental factors, and to ensure the 
test is appropriate for the spaceflight environment.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2009-2013: Collect Performance Data with PVT Self-Test on ISS 
24    Low  
2020-2023: Collect PVT performance data on Lunar Surface 
24    Low  
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Tasks: (TBD) 
Motor Performance / Dual Task Tests 
2009: Review of Measures  
Conduct review of validated measures for assessing motor performance inflight. 
2009-2010: Planning for Flight Study 
2010-2014: Motor/Dual Task Performance Data 
Collect motor performance data on ISS. 
2014: Determine if additional performance studies are required 
2014-2020: Implement ground/flight studies if applicable 
2020-2023: Collect motor performance data on Lunar surface 
Collect and analyze data from Lunar Surface in order to characterize motor performance in the Lunar environment.
Deliverables:  
Recommendations for flight and ground crews re: fatigue and performance, based on evidence gathered 
Information to the SHFH and HHC Elements 
Inform Standards 
Update to HSRF/Med Ops regarding motor performance in Lunar Sortie environment 
Required Delivery Milestone: Update HSRF/Medical Operations by 2014 for Lunar Sortie Medical Operations 
implementation. Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Ground assessment of validated measures for assessing motor performance. This deliverable 
requires spaceflight because of sleep loss and fatigue issues related to microgravity and other spaceflight 
environmental factors, and to ensure the test is appropriate for the spaceflight environment.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2010-2014: Motor/Dual Task Performance Data 
20    Low  
2020-2023: Collect motor performance data on Lunar surface 
20    Low  
 
Tasks: (TBD) 
Hypoxia/Altitude/CO2 
2010: Review  
Conduct review of the effects of hypoxia/altitude on sleep and performance.  
2011: Determine if studies are needed. 
Gaps and future activities to be subsequently revised/defined. 
Deliverables: Inform BHP regarding subsequent tasks/gaps. 
Required Delivery Milestone: TBD 
Required Platforms: TBD  
Sleep3: Does sleep loss continue on long duration missions or is there adaptation?  
Previous studies have revealed that space crews are at times not sleeping for the duration of their 
scheduled sleep period.  Crewmembers experience frequent shifts in their sleep/wake schedules, and in 
addition, various environmental factors affect sleep quality and quantity. Studies have shown that self-
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report of just how much sleep one is actually getting can be inaccurate. Therefore, in order to assess 
accurately to what degree sleep is disrupted on-orbit, an unobtrusive, objective measure of sleep-wake 
activity is needed.  Objective sleep data during the course of a mission provides important operational 
feedback for the astronaut as well as the flight surgeon, particularly prior to performing critical mission 
tasks. 
Tasks: (NRA) 
Sleep/Wake Activity Study (Czeisler/Barger) 
2007-2011: ISS/STS Data Collection 
Collect inflight data using an Actigraph watch to objectively document sleep and wake times and capture light 
exposure relative to sleep/wake activity, and a sleep log for subjective information on countermeasure use, and 
factors related to sleep loss during spaceflight. Data are collected during shuttle and ISS missions to quantify 
spaceflight and light-exposure-related sleep disturbances, examine sleep shift schedules on sleep, and use of 
countermeasures (i.e. lighting, medication).  
2012: Determine if, based on evidence, additional countermeasure studies are needed  
2012-2018: Implement ground/flight studies if applicable 
2020-2023: Lunar Surface data collection 
Collect sleep-wake data on the lunar surface (through enhanced actiwatch or individualized fatigue meter 
identified in Sleep1). Data to be collected on Lunar to quantify environmental (i.e. light-exposure-related) sleep 
disturbances, examine sleep shift schedules on sleep, and use of countermeasures. 
Deliverables:  
Operationalize Actiwatch protocol as med requirement to monitor sleep/ wake (Sleep1)  
Recommendations based on objective assessment of sleep on long duration missions 
Data collected also informs modeling efforts outlined in Sleep4, and task in Sleep1 
Inform Standards 
Recommendations based on objective assessment of Sleep on Lunar missions 
If applicable, countermeasures to aid in adaptation, validated in lunar environment 
Required Delivery Milestone: Update HSDR/Med Ops in 2010 regarding operationalizing Actiwatch (see Sleep 
1). Recommendations based on evidence to HSRF/Medical Operations in 2011 for ISS and Lunar Sortie Medical 
Operations implementation. Update Lunar Ops & Input Mars Ops Development by 2023. 
Required Platforms: Requires the STS and ISS because of sleep-related issues associated with spaceflight. 
Requires continued participation by STS crews because of the wide variation across missions. Requires ISS 
because to date, relatively little is known about sleep quantity and quality on the ISS. Will require lunar 
environment to accurately assess the nature of sleep in lunar setting. Study provides information important for 
exploration planning. There is a high acceptability for participating in this study and high compliance among the 
astronauts participating in study.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2007-2011: ISS/STS Data Collection 
See Sleep1-Sleep Wake Actigraphy Study 
2020-2023: Lunar Surface data collection 
See Sleep 1- Enhanced Actiwatch 
Upmass per subject = [Complete if ISS or Lunar Surface is required.  This is the upmass that must be sent for each 
subject (for instance, a specific device that each crewmember wears.)  Specify Very High, High, Medium, Low, 
Very Low where Very High = 100 kg; High = 50 kg; Medium = 25kg; Low = 12 kg; Very Low = 6 kg] 
Sleep4: How can individual astronauts’ vulnerabilities to sleep loss and circadian rhythm 
disruption best be determined?  
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While it is necessary to determine how to best mitigate the impact of environmental factors on sleep and 
performance, individual characteristics also contribute to the quality and quantity of sleep, and the depth 
of disruption to circadian system, in space.  As discussed in the Sleep Evidence Book, recent studies have 
documented that there are large stable (trait-like) differences among individuals in the degree of cognitive 
deficits experienced during sleep loss (Van Dongen, Baynard et al. 2004; Klerman and Dijk 2005). BHP 
therefore is working to determine optimal ways for identifying individual vulnerabilities to sleep loss and 
circadian desynchronization.  
Tasks: (NSBRI) 
Develop Modeling Software (Klerman)  
2009-2012: Refine and validate models; incorporate additional factors 
Using Actigraph data from astronauts on STS and ISS, enhance software based on validated a mathematical model 
of the human circadian pacemaker.  Mathematical model to incorporate individual vulnerabilities, identification of 
the best countermeasure application, optimal timing for implementing countermeasures, etc., to ensure 
performance during critical mission tasks.   
2013: Prep for flight 
2014-2017: Validate modeling software on ISS 
2020-2023: Validate modeling during Lunar Study 
Deliverables:  
Modeling software that provides individualized countermeasure for flight (and ground) crews 
Modeling data for integration with other modeling efforts 
2) Validate integrated model during Lunar sortie 
Required Delivery Milestone: Software to HSRF/Medical Operations in 2017 for Lunar Sortie Medical 
Operations implementation.  Data from modeling software to inform integration efforts.  Validated, integrated 
model to update Lunar Ops and Input to Mars Ops Development. 
Required Platforms: Ground based effort, with validation activity to occur in-flight.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
20    Very Low  
 
Tasks: (TBD) 
Integrate Models 
Several validated models related to sleep and circadian rhythms, and performance exist.  These models each 
capture different factors relevant for spaceflight.  BHP aims to integrate these models into one useful model 
specific to the Mars and Lunar environment.  It is unclear at this time the specific efforts required to enhance and 
integrate these models. 
2009: Conduct a workshop with investigators/operations 
2010- 
Gaps and Activities to be subsequently revised/defined 
Deliverables:  
TBD 
Efforts from this task should help inform flight study of modeling software.   
Required Delivery Milestone: TBD 
Required Platforms: TBD  
 
HRP-47065 
 
132 
Tasks: (ExMC) 
Develop Sleep Module of Integrated Medical Model 
The ExMC Program Element is conducting this task.   
2009-2010: Statistical and Clinical Validation. 
Deliverables:  
ExMC to include sleep module as part of deliverable; 
Modeling information for integration with other modeling efforts 
Required Delivery Milestone: As per ExMC 
Required Platforms: As per ExMC  
 
Tasks: (TBD) 
Biomarkers 
2010: Review  
Conduct a review of assessing biomarkers to determine individual vulnerabilities to sleep loss and circadian 
desynchronization. 
2011: Determine if studies are needed. 
Gaps and future activities to be subsequently revised/defined. 
Deliverables: Inform BHP regarding subsequent tasks/gaps. 
Required Delivery Milestone: TBD 
Required Platforms: TBD  
 
Tasks: (Directed Study) 
Evaluate Individual Risk Factors for Circadian Entrainment to Martian Sol- Ground Crews 
2008-2010: Phoenix Mars Lander Study (Barger) 
Ground crews supporting Mars robotic missions have chosen to maximize the use of the rovers on the surface of 
Mars by adopting the Mars sol. As a result, these engineers and scientists live/work on a 24 hour and 39 minute 
schedule. After 10 days, these individuals are shifted by six and a half hours. Trying to maintain such a schedule 
has proven challenging for crews. Those supporting the Mars Pathfinder, Spirit and Opportunity Rovers have 
struggled with fatigue and other issues. NASA BHP is conducting a directed study with the ground crew 
supporting the Mars Phoenix Scout Lander. This study will evaluate individual vulnerabilities to sleep loss and 
circadian desynchronization. Urine samples for instance will be evaluated in order to observe the relationship 
between melatonin and morningness/eveningness, for instance. Educational material and light exposure will be 
utilized as countermeasures for sleep loss, circadian alignment, fatigue, and workload problems. 
2011: Determine if additional studies are needed.  If so,  
2013-2015: Ground Studies: Crews Supporting Mars Mission 
Follow-up study from Phoenix Mars Lander, implementing “lessons learned” and new relevant aims to protocol. 
Deliverables: Recommendations based on individual risk factors for ground and flight crews during Mars 
missions (manned and robotic), and application for LDM 
Required Delivery Milestone: Recommendations for managing sleep loss, circadian misalignment, fatigue, and 
workload based on individual risk factors and performance related to sleep wake schedules for ground and flight 
crews during Mars missions (manned and robotic), and application for LDM 
Required Platforms: Ground effort.   
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Sleep5: How can light be used to optimally minimize circadian problems in space?  
Preliminary studies indicate that light exposure can correct difficulties in sleep patterns that occur with 
shift work, jet lag, and sleep disorders.  The timing, duration, intensity, geometry and wavelength of the 
light impact countermeasure effectiveness.  Current efforts aim to investigate optimal lighting 
requirements for the space vehicle, as well as safe and efficacious methods for implementing lighting as a 
countermeasure.  
Tasks: (NSBRI) 
Studies to Determine Efficacy of Shorter-Wavelength-Enriched for Phase Shifting (NSBRI/Czeisler) 
2009-2012: Lab Studies, RCS-105 
Research has shown shorter-wavelength-enriched white light to facilitate circadian phase shifts.  This task tests the 
efficacy of exposure to shorter-wavelength-enriched light at a standard intensity for pre-launch and in-flight phase 
shifting.  In addition to a laboratory experiment, a study will also be conducted during the RCS-105. 
2013- 
Follow up tasks to be outlined below 
Deliverables:  
Inform Standards 
Inform Requirements to Constellation for Lander Lighting Characteristics 
Recommendations on best operational approach for utilizing light for circadian entrainment and alertness. 
Required Delivery Milestone: The task will be conducted in ground laboratory studies and in analogs offering 
isolation and lighting challenges, such as RCS-105 will be utilized.   
Required Platforms: Ground effort.   
 
Tasks: (NSBRI, with study aim looking at blue light for enhancing alertness, supported in part through BHP 
Directed Study) 
Studies to Determine Alerting, Hormonal, and Circadian Effects of Artificial and Ambient Light (NSBRI) 
Brainard plus-blue light for enhancing Alertness (Directed) 
2008-2012: Lab Studies 
This task characterizes the alerting, hormonal, and circadian potency of solid-state light sources being considered 
for the planned Crew Exploration Vehicle and the lunar habitat.  Additional studies on human volunteers will 
determine the potency of the ambient light that is transmitted though the spacesuit visor during extravehicular 
activities.  
2013- 
Follow up tasks to be outlined below 
Deliverables:  
Inform Standards 
Inform Requirements to Constellation for Lander Lighting Characteristics  
Inform updates to HRFS/ Medical Operations on best operational approach for utilizing light for circadian 
entrainment and alertness. 
Required Delivery Milestone: Requirements due by 2013 for Lunar Lander PDR.  Updates to HRFS/Medical 
Operations for Lunar Sortie, on the best operational approach for utilizing light in-flight (duration, timing, etc.), 
due by 2014.   
Required Platforms: The task will be conducted in ground laboratory studies.   
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Tasks: (NSBRI) 
Characteristics of Light Exposure Necessary for Development of Optimal Countermeasures (NSBRI/Lockley) 
2009-2012: Lab Studies 
Task to investigate whether effects of bright light (phase-shifting the circadian pacemaker, suppressing pineal 
melatonin, enhancing subjective alertness, improving performance and alertness) that are seen during studies at 
night,  depend on the intensity and duration of light and that the changes in spectral sensitivity during the day.  
While blue light therapy to facilitate circadian adaptation and alertness has been proposed based largely on the 
effects of melatonin suppression at night, these data may not be transferable to the effects at other times of day 
(when melatonin is not produced) or for other effects of light.  
2013- 
Follow up tasks to be outlined below 
Deliverables:  
Inform Standards 
Inform Requirements to Constellation for Lander Lighting Characteristics  
Inform updates to HRFS/ Medical Operations on best operational approach for utilizing light for circadian 
entrainment and alertness. 
Required Delivery Milestone: Requirements due by 2013 for Lunar Lander PDR.  Requirements Updates to 
HRFS/Medical Operations for Lunar Sortie, on the best operational approach for utilizing light in-flight (duration, 
timing, etc.), due by 2014.   
Required Platforms: The task will be conducted in ground laboratory studies.   
 
Tasks: (NSBRI) 
Validation of ISS LED Lighting Efficacy/Effectiveness, Visual and Biological (NASA/NSBRI) 
2009-2011: Lab Studies 
Task to validate the new lighting equipment on ISS, in terms of alertness and entrainment.  
2013- 
Follow up tasks to be outlined below 
Deliverables:  
Inform Standards 
Inform Requirements to Constellation for Lander Lighting Characteristics  
Inform updates to HRFS/ Medical Operations on best operational approach for utilizing light for circadian 
entrainment and alertness. 
Required Delivery Milestone: Requirements due by 2013 for Lunar Lander PDR.  Updates to HRFS/Medical 
Operations for Lunar Sortie, on the best operational approach for utilizing light in-flight (duration, timing, etc.), 
due by 2014.   
Required Platforms: The task will be conducted in ground laboratory studies.   
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Following findings from the Lighting Tasks, 
Follow-on Tasks: (NSBRI) 
2013: Decision regarding if/what additional studies are needed (flight and/or ground) 
2015: Prep for ISS Study, if deemed necessary 
2016-2019: ISS study to validate lighting recommendations.  
2020-2023: Lunar validation studies 
Data collected to validate lighting protocols on lunar environment.  
While there are currently several tasks investigating the use of light as a countermeasure, these tasks will inform 
updates to HSRF/Medical Operations and hardware requirements.  Following these tasks, BHP will determine 
what other research is necessary to close this gap.  One protocol will be implemented on the Lunar surface that 
will validate the findings that result from this task.  Therefore, the details surrounding Lunar validation will be 
described just once, below: 
Deliverables:  
Inform Requirements to Constellation for Habitat Lighting Characteristics 
Validated recommendations on best operational approach for utilizing light for circadian entrainment and alertness 
Recommendations and Requirements validated on Lunar environment 
Required Delivery Milestone: Requirements due by 2020 for Lunar Habitat PDR.  Updates to HRFS/Medical 
Operations for Lunar Sortie, on the best operational approach for utilizing light in-flight (duration, timing, etc.), 
due by 2014.  Validated recommendations for utilizing light in-flight (duration, timing, etc.), delivered in 2020.  
Validated recommendations in lunar environment due by 2023 for update to Lunar and Mars Ops development. 
Required Platforms: The task will be conducted in ground laboratory studies and in analogs offering isolation 
and lighting challenges, such as RCS-105 will be utilized.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2016-2019: ISS study to validate lighting recommendations. 
20    TBD; depends on 
findings related 
to timing and 
duration of light 
exposure, etc. 
 
2020-2023: Lunar validation studies 
20    TBD; depends on 
findings related 
to timing and 
duration of light 
exposure, etc. 
 
Sleep6: What are the performance risk/benefits of specific sleep/wake medications in flight?  
As discussed in the Sleep Evidence Report, spaceflight evidence shows that sleep medications are one of 
the most commonly used medications during spaceflight.  Flight surgeons have requested an electronic 
database that will make information regarding the effects of sleep-wake medications readily available to 
them.  Some medications are suspected to work differently in space than on Earth; other medications may 
be required in-flight, and the potential interactions between these and sleep medications are yet to be 
determined.  
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Tasks: (BHP Directed study) 
Develop Electronic Sleep Wake Medication Database (Dinges) 
2007-2009:  
Develop database and provide to operations. 
Deliverables: Update HSRF/ISS Medical Operations with Electronic Sleep Medication Database 
Required Delivery Milestone: Database to be delivered in 2008 and implemented in 2009, with subsequent 
updates every few years.  Update database for HSRF/Lunar Medical Operations in 2015. 
Required Platforms: This effort, at this time, is primarily data mining and building the database.  Results from 
the planned Crew Quarters Sleep/Wake medications study (see Sleep7) will provide additional information on 
performance effects following medication use.  Involves collaboration with HHC/ Pharmacology and ExMC.   
 
Tasks: (TBD) 
Sleep/Wake Medications- Assess Interactions 
2010: Review 
Conduct a review of the evidence related to potential interactions and carry-over effects. Determine if a study is 
needed. Subsequent tasks following this review to be defined. 
Deliverables:  
Review will help inform BHP in regards to subsequent tasks and deliverables, as well as future updates to database 
deliverable 
TBD 
Required Delivery Milestone: TBD 
Required Platforms: This effort, at this time, involves a ground based evidence review.   
 
Tasks: (TBD) 
Sleep/Wake Medications- Pharmacokinetics/Efficacy 
2010: Review 
Conduct a review of the evidence related to the absorption and effectiveness of sleep/wake medications in 
microgravity.  Determine if a study is needed.  Subsequent tasks following this review to be defined. 
Deliverables:  
Review will help inform BHP in regards to subsequent tasks and deliverables, as well as future updates to database 
deliverable 
TBD 
Required Delivery Milestone: TBD 
Required Platforms: This effort, at this time, involves a ground based evidence review.   
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Sleep7: What are the best individual dosing requirements/protocols for Sleep and alertness 
medications during spaceflight?  
Tasks: (BHP Directed study / Ops (TBD)) 
Individualized Protocols Sleep/Wake Medications 
2009-12: Pilot and Ground Study, Develop and Implement Operational Ground Testing Protocols to Individualize 
Astronaut Sleep Medication Efficacy and Individual Effects (Johnston) 
This task is a ground based study to test the percentage change in sleep inertia from using a medications 
(commonly used during spaceflight) compared to normal sleep inertia. The study will test the feasibility of a 
protocol for use with astronauts and other  NASA personnel (e.g., flight surgeons, flight directors and flight 
controllers) to assess potential carry over effects from sleep medications used during spaceflight operations, 
overseas training periods, and following an abrupt awakening from sleep. This information is needed to establish 
optimal and individually tailored protocols for usage of sleep medications by key personnel relative to operational 
demands.  
2012: Determine if Spaceflight studies are needed 
If so, prepare for spaceflight study 
 2013: Prep for spaceflight 
2014-2017: Validate protocols in-flight 
If not, determine if ground studies are needed 
 If so, 
2013-2016: Additional ground studies  
 If not, stop tasks 
2020-2023: Lunar study to assess effects of medications in Lunar environment 
Deliverables:  
Recommendations for best operational approach for utilizing sleep medications during training / flight; 
individualized recommendations for sleep medications. 
Recommendations for best operational approach for utilizing sleep medications during flight 
Recommendations regarding effects of medication in Lunar environment 
Required Delivery Milestone: Update to HSRF/ISS Med Ops following the findings of the first study, in 2012.  
Update to HSRF/ Med Ops for Lunar Operations in 2016 and/or 2017, following findings of subsequent ground 
and/or flight study.  Update Lunar Ops and Input to Mars Ops Development in 2023. 
Required Platforms: This effort involves ground studies using astronauts.  Possible ISS data collection efforts to 
aid in determining if medications ingested in flight were as effective as when taken on the ground.  Involves 
collaboration with HHC/Pharmacology and ExMC as well as SD and CB. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2014-2017: Validate protocols in flight 
20    Very Low  
2020-2023: Lunar study to assess effects of medications in Lunar environment 
20    Very Low  
Sleep8: How are physical and cognitive workloads managed optimally in space relative to fatigue 
and recovery?  
While the evidence is largely anecdotal, strict adherence to timelines has been reported to be fatiguing 
and stressful for astronauts.  Furthermore, individuals on analog missions where there are unusual light 
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cues (i.e. twenty-four hour sunlight in the Arctic) have reported that they continue to work for hours on 
end without feeling a need for sleep, a potential concern since lack of sleep and fatigue can affect 
performance.  In future space missions to the Moon or Mars, crewmembers will be given more autonomy 
to plan and carry out their activities due to the long distances involved and the tasks that will be needed to 
explore a planetary surface, and they will also be exposed to light cues unlike those on Earth.  
Recommended optimal work rest schedules need to be provided so that crews can make informed 
decisions around work and rest.   
Tasks: (Redirected NRA) 
Impact of Increased Work Autonomy on Performance (Kanas) 
2009: Autonomy Workshop 
2009-2010: Analogs: NEEMO 
Conduct studies in NEEMO to evaluate performance under high autonomy, versus low autonomy, conditions.  
This data will provide insight into optimal work-rest schedules within these conditions, and will serve as a 
feasibility study in preparation for a study on ISS. 
2009-2010: 
Conduct studies in the Russian-Chamber 105 day study.  
2011: Preparation for spaceflight 
2011-2015: Data collection on ISS.  Study will evaluate performance in high autonomy versus a low autonomy 
environment and provide insight into optimal work-rest schedules within both of these conditions.  Requires the 
ISS because of sleep-related issues associated with microgravity, and to emulate accurately the spaceflight high-
tempo, remotely scheduled and controlled environment.  The ISS will emulate the transit environment to Mars.   
2016: Determine if additional studies are needed 
2016-2020: Additional ground task to be defined, if deemed necessary 
2020-2023: Validate recommendations to aid schedules/performance in Lunar environment 
Deliverables: Recommendations for optimal work-rest schedules to prevent mental and physical fatigue during 
operations 
Required Delivery Milestone: Inform Mission Ops in 2015.  Lunar Operations and Input to Mars Operations 
Development due by 2023. 
Required Platforms: Ground analogs, such as NEEMO and RCS, the ISS, and Lunar surface. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2011-2015: Data collection on ISS 
18    Very Low  
2020-2023: Validate recommendations to aid schedules/performance in Lunar environment 
18    Very Low  
 
Tasks: (ITA with Ames.  Involves collaboration with SHFH) 
SPIFe  
2008-2012: Develop scheduling software SPIFe for autonomous operations 
This tool may be incorporated in NEEMO studies and ISS study described above.  Details TBD. 
Deliverables: Scheduling software for operations as part of recommendations for optimal work-rest schedules to 
prevent mental and physical fatigue during operations 
Required Delivery Milestone: Inform Mission Ops in 2015.  Update Lunar Operations and Input to Mars 
Operations Development due by 2023. 
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Required Platforms: As part of study listed above, may be validated in ground analogs such as NEEMO, the ISS, 
and Lunar surface. 
 
Tasks: (TBD) 
Impact of Sleep Loss, Fatigue and Workload on Learning, Memory, and Psychosocial Adaptation  
2010: Review 
Conduct a review of the evidence related to effects of workload, fatigue, sleep loss, etc. 
Deliverables:  
Review will help inform BHP in regards to subsequent tasks and deliverables 
TBD 
Required Delivery Milestone: TBD 
Required Platforms: This effort, at this time, involves a ground based evidence review. 
Sleep9: What are the countermeasures needed to recover from chronic partial sleep loss and/or 
slam shifting? 
Despite medication use, sleep loss does occur during spaceflight, with some crewmembers reporting 
minimal amounts of sleep, particularly prior to conducing critical mission tasks.  Many factors can affect 
sleep quality and quantity in the spaceflight mission environment including high noise levels, shifting 
schedules, high tempo workloads, thermal temperature changes, microgravity adjustment, and close 
proximity to others.  Flight surgeons have requested information that can aid individual astronauts on 
improving their sleep quality and quantity during spaceflight.  Given the complexity of spaceflight 
missions, and the effects of sleep loss on fatigue and performance, such information will be instrumental 
for not only crewmembers, but also their families, ground support teams, and other medical personnel 
regarding strategies to improve sleep quantity and quality.  Information will help inform current standards 
as well as those for future missions. 
Tasks: (NSBRI) 
Sleep Dose Recovery 
2008-2009: Lab studies 
This laboratory effort evaluates the effect of different doses of sleep time on performance and cognition.  The 
knowledge gained has the potential to change work scheduling (Sleep8) and further understand the effect of sleep 
loss and the mitigating impact of naps on neurobehavioral function in spaceflight. 
Deliverables: Data gathered will feed  
Recommendations regarding recovery sleep 
2) Inform Standards.   
Required Delivery Milestone: Update HSRF/Medical Operations in 2009. 
Required Platforms: Laboratory studies. 
 
Tasks: (BHP Directed Study) 
Jet-Lag/Crew Training/MOD Shifting 
2009: Pilot Study 
2010-2013: Ground Studies 
This task is to evaluate effectiveness of countermeasures currently being used for slam shifting and training 
overseas.  This effort will also inform subsequent gaps and tasks to help inform Ops for lunar operations. 
Following this task, future tasks (if any) will be determined. 
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Deliverables: Recommendations for astronauts, management, and ground support on strategies for improving 
sleep quality and quantity during human spaceflight missions.   
Required Delivery Milestone: Update HSRF/Medical Operations by 2014.  
Required Platforms: Ground studies. 
 
Tasks: (TBD) 
Optimal Countermeasures for Lunar  
2009: Review 
Conduct a review of the evidence related to mitigation strategies for shift-workers, etc., in order to assess 
additional countermeasures relevant to the lunar environment 
Deliverables:  
Review will help inform BHP in regards to subsequent tasks and deliverables 
TBD 
Required Delivery Milestone: TBD  
Required Platforms: This effort, at this time, involves a ground based evidence review.  
Sleep10: What flight rules and requirements improve sleep, circadian desynchronization, fatigue 
and work overload, to reduce performance errors? 
Aspects of spaceflight missions and the spaceflight environment can adversely impact sleep and circadian 
rhythms. While some factors (such as noise) cannot be controlled, others (such as lighting and schedules) 
may be informed by research. BHP aims to assess current flight rules and requirements in order to 
develop recommendations for constellation. 
Tasks: (Directed Study/Locke) 
Sleep Quality and Strategies Questionnaire 
2009: Systematic review of flight rules and requirements regarding sleep 
2008-2011: Ground Studies  
Data collection from crews returning from flight regarding their sleep quality on-orbit, and in comparison to their 
terrestrial sleep and during various training activities. This questionnaire is designed to assess what factors impact 
sleep quality and quantity and seeks suggestions regarding strategies for improving sleep on-orbit for future flyers. 
2011: Determine if additional studies are needed 
2012-2014: Ground based studies, if deemed necessary 
2020-2023: Validate recommendations on lunar surface 
Deliverables:  
Recommended updates to flight rules and requirements 
Inform Standards to protect sleep, minimize fatigue, and maintain performance. 
Required Delivery Milestone: Updates to HSRF/Medical Operations provided in 2011. Subsequent updates (if 
deemed necessary) provided in 2014, and following Lunar validation in 2023 for Lunar Ops and Mars Ops 
Development.  
Required Platforms: Primarily ground effort with validation on lunar surface. This includes a data mining effort 
in collaboration with CB and Med Ops. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
2020-2023: Validate recommendations on lunar surface 
20    Very Low  
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Tasks: (Directed Study) 
Determine Sleep Performance Countermeasures for Martian Sol – Flight and Ground Crews  
2008-2010: Ground Studies 
Ground crews supporting Mars robotic missions have chosen to maximize the use of the rovers on the surface of 
Mars by adopting the Mars sol.  As a result, these engineers and scientists live/work on a 24 hour and 39 minute 
schedule. After 10 days, these individuals are shifted by six and a half hours. Trying to maintain such a schedule 
has proven challenging for crews.  Those supporting the Mars Pathfinder, Spirit and Opportunity Rovers have 
struggled with fatigue and other issues.  NASA BHP is conducting a directed study with the ground crew 
supporting the Mars Phoenix Scout Lander.  This study will evaluate countermeasure effectiveness for attempting 
to manage sleep over a Mars schedule. 
2011: Determine if additional studies are needed. If so,  
2013-2015: Ground Studies: Crews Supporting Mars Mission 
Follow-up study from Phoenix Mars Lander, implementing “lessons learned” and new relevant aims to protocol. 
Deliverables:  
Recommendations to aid flight rules and requirements for Ops 
Recommendations to aid flight rules and requirements for Ops ground and flight crews during Mars missions 
Required Delivery Milestone: Recommendations based on evidence to inform Mission Ops in 2010 and 2015. 
Lunar validation in 2023 for Lunar Ops and Mars Ops Development. 
Required Platforms: Ground effort with validation on Lunar surface. 
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RISK OF PERFORMANCE ERRORS DUE TO POOR TEAM COHESION AND 
PERFORMANCE, INADEQUATE SELECTION/TEAM COMPOSITION, 
INADEQUATE TRAINING, AND POOR PSYCHOSOCIAL ADAPTATION –  
CRITICALITY: LUNAR POST – D, MARS – I  
 
Human performance errors may occur due to problems associated with working in the space environment 
and incidents of failure of crews to cooperate and work effectively with each other or with flight 
controllers have been observed.  Interpersonal conflict, misunderstanding and impaired communication 
may impact performance and mission success.  However, the history of spaceflight crews regarding team 
cohesion, team performance, and ground-crew interaction has not been systematically documented.  
Tools, training, and other support methods should be provided to reduce the likelihood of this risk and 
improve crew performance, crew cohesion, and crew-ground interaction. 
Operational Relevance Assessment and Recommendations 
While little empirical data have been collected regarding the impact of interpersonal and intrapersonal 
factors on spaceflight performance, it is possible that crew conflict could jeopardize long duration 
Exploration Missions. Reports from MIR reveal that several missions may have been terminated earlier 
than planned due to interpersonal frictions between crewmembers, and some veteran NASA astronauts 
have reported crew conflict during previous space travels. Understanding the potential negative impacts 
of interpersonal and intrapersonal issues from spaceflight and relevant, high fidelity analog environments 
is critical for identifying actions required to help crewmembers succeed during new types of missions 
(e.g., Mars Missions). Few individuals have spent one year or longer in isolated and confined 
environments, and a Mars Mission could be as long as three years in duration. Thus, observations and 
“lessons learned” from previous space missions and from relevant analog environments are important 
sources of information required to inform these efforts. In preparation for Exploration Missions, BHP 
research focuses on preventing and mitigating the risk of performance errors due to inadequate Team 
Cohesion and Performance, Inadequate Selection/Team Composition, Inadequate Training, and Poor 
Psychosocial Adaptation.  Monitoring tools, countermeasures, training requirements, and 
selection/composition recommendations are needed to aid flight crews and ground support teams so that 
optimal performance may be realized.  
Strategy for Mitigation 
The risk mitigation strategy of the BHP Element follows the larger strategy of the HRP “from Evidence to 
Products” principle, while being driven by Operations. BHP holds an annual working group of subject 
matter experts who work with BHP and Medical Operations to identify gaps in knowledge and gaps in 
mitigation.  Specific tasks are defined to address the gaps and provide clear, specific deliverables for 
Constellation, ensuring an evidence and operationally based end item. Working with research and 
operational experts, BHP systematically identifies the appropriate analog to address the gaps prior to 
validating in spaceflight.  To ensure relevancy, stakeholders are engaged in the process at the beginning. 
Findings from BHP research inform operations and standards as well as update the evidence base for the 
BHP Risks.   
The strategy for mitigation for this area of research is to develop an empirical-based approach to first 
identify the most relevant and serious threats to team performance, team cohesion, and crew-ground 
interaction.  Utilizing a common set of criteria will allow for the systematic review and analysis of 
knowledge as well as current practices/policies in implementing BHP operations.  Once these threats have 
been identified, the most effective ways to monitor and measure these threats as well as the identification 
of optimal countermeasures to mitigate these threats will be determined.  To further mitigate the risk, 
specific factors have been identified (e.g., crew composition, communication, autonomy, etc.) as highly 
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relevant to long duration space missions.  Thus, these gaps will focus specifically on understanding the 
true impact of these factors on long duration missions.  
Gaps 
BHP Gap Team1: What are the most likely and most serious threats to crew cohesion, crew 
performance, and crew-ground interaction expected for exploration missions? (Priority 1) 
The most serious and relevant threats to crew performance, crew cohesion, and crew-ground interaction 
have not been systematically analyzed and documented.  This approach will take an empirically based 
approach to identify which threats are most relevant and serious to the set criteria. As noted in the Team 
Evidence Book, existing threats may negatively affect cohesion and crew-ground interaction, both of 
which ultimately preclude optimal performance.  Thus, it is necessary to identify those threats that are 
most likely to influence these criteria negatively. 
Tasks: (Directed Study, BHP In-House) 
Systematic Query: Crew History  
2010: Literature/Ops Review 
Review of existing crew information and literature from analogs to examine small groups in extreme 
environments. 
2011: Develop Questionnaire 
Develop questionnaire for current and future long-duration crews regarding their experiences, emphasizing 
interpersonal factors. Systematically implement questionnaire and analysis. 
Deliverables: Crew History Report – provides recommendations based on existing spaceflight and analog 
experience of crews, including training, in-flight, and post-flight events. 
Required Delivery Milestone: Initial Crew History Report based on current anecdotal evidence and analog 
evidence delivered in 2010. Updates to HSRF/Medical Operations made in 2012 (once 30 subjects have been 
evaluated), with subsequent updates following every four years. Report/Recommendations required by 2014 for 
Human Risk Forum/Lunar Med Ops and 2023 for Lunar Habitat Mission Ops.  
Required Platforms: Ground based data collection 
 
Tasks: (BHP In-House) 
Risk Assessment: Crew Cohesion 
2009-2010: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to crew cohesion. 
Deliverables: Crew Cohesion Report – provides a summary of literature and current operations and identifies 
most relevant and serious threats in relation to crew performance.  Also includes a recommendation based on 
evidence gathered on whether studies are needed.   
Required Delivery Milestone: Initial Crew Cohesion Report based on literature review and assessment of 
current practices delivered at the end of 2010.  Report/Recommendations required by the beginning of 2011 to 
determine if studies are needed.  If applicable, HSRF/Medical Ops Update for Lunar Long in 2019, Mars Update 
in 2023.  
Required Platforms: Ground based data collection 
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Tasks: (BHP In-House) 
Risk Assessment: Crew Performance 
2009-2010: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to crew performance. 
Deliverables: Crew Performance Report – provides a summary of literature and current operations and identifies 
most relevant and serious threats in relation to crew performance.  Also includes a recommendation based on 
evidence gathered on whether studies are needed.   
Required Delivery Milestone: Initial Crew Performance Report based on literature review and assessment of 
current practices delivered at the end of 2010.  Report/Recommendations required by the beginning of 2011 to 
determine if studies are needed.  If applicable, HSRF/Medical Ops and Mission Ops Update for Lunar Long in 
2019, Mars Update in 2023.  
Required Platforms: Ground based data collection 
 
Tasks: (BHP In-House) 
Risk Assessment: Crew-Ground Interaction 
2009-2010: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to crew-ground interaction. 
Deliverables: Crew-Ground Interaction Report – provides a summary of literature and current operations and 
identifies most relevant and serious threats in relation to optimal crew-ground interaction.  Also includes a 
recommendation based on evidence gathered on whether studies are needed 
Required Delivery Milestone: Initial Crew-Ground Interaction Report based on literature review and assessment 
of current practices delivered at the end of 2010.  Report/Recommendations required by the beginning of 2011 to 
determine if studies are needed.  If applicable, Mission Ops Update for Lunar Long in 2019, Mars Update in 
2023.  
Required Platforms: Ground based data collection 
BHP Gap Team2: What are the most optimal ways to monitor and measure crew cohesion, crew 
performance, and crew-ground interaction for exploration missions? (Priority 1) 
Given the importance of threats identified in the first gap in relation to crew performance, crew cohesion, 
and crew-ground interaction, monitoring tools and other measures will need to be developed to assess 
these relationships.  During Exploration Missions, and especially during a Mars Mission, real time 
communication between the crew and flight surgeons will not be available as it is now on ISS. Flight 
surgeons have stated the need for unobtrusive monitoring tools that are transparent to crews, require 
minimal crew time or effort, and that help detect if crews are having difficulties coping with the 
spaceflight environment by utilizing indicators of performance, cohesion, and crew-ground interaction.  
The aim of the current gap is to identify the most optimal tools that will detect changes in crew cohesion, 
crew performance, and/or crew-ground interaction.  One task specifically relates to the creation of a tool 
that will monitor changes in crew cohesion.  Monitoring tools identified in the Risk of Behavioral and 
Psychiatric Conditions may also provide an assessment of team cohesion. These tools (e.g., voice 
acoustics and facial expression recognition) will be validated in ground studies through 2010, and 
validated in flight through 2017 if deemed necessary (more information can be found in BMed3). 
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Tasks: (NRA) 
Assess measures for Monitoring Crew Cohesion  
2009-2012: Test Measures in Analogs:  
Activities include evaluating various existing techniques for assessing team cohesion through crew 
communication, validating these techniques in analog and/or operational environments (i.e. during astronaut 
training), and validating on ISS.  
2013: ISS Prep 
2014-2016: ISS Validation Studies:  
Preferred techniques will be developed into Requirements for an automated, unobtrusive tool to be utilized during 
Exploration Missions. 
2017-2023: Ground and Flight Studies, if needed 
If after undergoing validation utilizing ISS Studies these techniques are found to be not effective, additional 
ground studies and flight validation studies to identify optimal tools will be conducted. The optimal technological 
tools from these studies will be validated in lunar studies. New Requirements will then be delivered by 2023 for 
informing Human Subjects Risk Forum/Med Ops and Input to Mars Ops Development. 
Deliverables:  
Requirements for Crew Communications Technology (unobtrusive, passive measures that assesses changes in 
crew communication patterns as a measure of modified cohesion). 
Updates to Standards (if applicable). 
Required Delivery Milestone: This deliverable is to support long duration Lunar and Mars. Update therefore to 
Human Subjects Risk Forum/Med Ops in 2017, and in 2023 (for input into Lunar long and Mars Ops 
development.)  
Required Platforms: Ground studies to adapt technology for spaceflight and may include analog studies in 
Isolated, Confined and Extreme (ICE) Environments and/or studies in operational environments. Validate on ISS, 
as the ISS will emulate the transit environment to Mars.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
25    Low Very Low 
 
Tasks: Tools to measure crew cohesion/performance (SBIR) 
2009: Phase I Requirements Development 
Develop requirements for developing an automated technology that will unobtrusively detect changes in crew 
cohesion/performance during exploration missions. 
2010- : TBD 
Deliverables:  
Requirements for measures of cohesion/performance for exploration missions 
Required Delivery Milestone: TBD 
Required Platforms: Ground development.  
 
Tasks: (BHP In-House) 
Assess Additional Measures for Monitoring Crew Cohesion 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to those measures that best assess crew cohesion. 
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Deliverables: Monitoring Tool/Measures Report – provides a summary of literature and current operations and 
identifies optimal measures and monitoring tools for crew cohesion.  Also includes a recommendation based on 
evidence gathered on whether future studies are needed.   
Required Delivery Milestone: Initial Monitoring Tool/Measures Report based on literature review and 
assessment of current practices for crew cohesion completed at the end of 2011.  Report/Recommendations 
required by the beginning of 2012 to determine if studies are needed.  If applicable, Human Subjects Risk 
Forum/Mission Ops Update for Lunar Long in 2019, Mars Update in 2023. 
Required Platforms: Ground based data collection. 
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Tasks: (BHP In-House) 
Assess Additional Measures for Monitoring Crew Performance 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to those measures that best assess crew performance. 
Deliverables: Monitoring Tool/Measures Report – provides a summary of literature and current operations and 
identifies optimal measures and monitoring tools for crew performance.  Also includes a recommendation based 
on evidence gathered on whether future studies are needed.   
Required Delivery Milestone: Initial Monitoring Tool/Measures Report based on literature review and 
assessment of current practices for crew performance completed at the end of 2011.  Report/Recommendations 
required by the beginning of 2012 to determine if studies are needed.  If applicable, HSRF/Med Ops and Mission 
Ops Update for Lunar Long in 2019, Mars Update in 2023.  
Required Platforms: Ground based data collection. 
 
Tasks: (BHP In-House) 
Assess Additional Measures for Monitoring Crew-Ground Interaction 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to those measures that best assess crew-ground interaction. 
Deliverables: Monitoring Tool/Measures Report – provides a summary of literature and current operations and 
identifies optimal measures and monitoring tools for crew-ground interaction.  Also includes a recommendation 
based on evidence gathered on whether future studies are needed.   
Required Delivery Milestone: Initial Monitoring Tool/Measures Report based on literature review and 
assessment of current practices for crew-ground interaction completed at the end of 2011.  
Report/Recommendations required by the beginning of 2012 to determine if studies are needed.  If applicable, 
Mission Ops Update for Lunar Long in 2019, Mars Update in 2023. 
Required Platforms: Ground based data collection. 
BHP Gap Team3: What additional approaches would enhance current in-flight interventions and 
countermeasures for supporting crew cohesion, crew performance, and crew-ground interaction 
for exploration missions? (Priority 1) 
Once the threats have been identified and the optimal ways to measure and monitor these threats and their 
impact on crew performance, crew cohesion, and crew-ground interaction has been developed, it may be 
necessary to develop additional countermeasures that enhance current practices to mitigate these threats, 
particularly for long duration exploration missions.  The Team Evidence Book clearly states that 
countermeasures are needed in order to reduce any negative impact on crew performance.   Thus, the 
development of strategies and countermeasures, including development of training protocols and new 
monitoring methods and tools, may be addressed in this gap. 
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Tasks: (BHP In-House) 
Identify Optimal Countermeasures to Support Crew Cohesion 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies to 
identify optimal countermeasures to support crew cohesion 
Deliverables: Countermeasure Report – provides a summary of literature and current operations and identifies 
optimal countermeasures to support crew cohesion.  Also includes a recommendation based on evidence gathered 
on whether future studies are needed.   
Required Delivery Milestone: Initial Countermeasure Report based on literature review and assessment of 
current practices for crew-ground interaction completed at the end of 2011.  Report/Recommendations required 
by the beginning of 2012 to determine if studies are needed.  If applicable, HSRF/Medical Ops Update for Lunar 
Long in 2019, Mars Update in 2023. 
Required Platforms: Ground based data collection. 
 
Tasks: (BHP In-House) 
Identify Optimal Countermeasures to Support Crew Performance 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies to 
identify optimal countermeasures to support crew performance 
Deliverables: Countermeasure Report – provides a summary of literature and current operations and identifies 
optimal countermeasures to support crew performance.  Also includes a recommendation based on evidence 
gathered on whether future studies are needed.   
Required Delivery Milestone: Initial Countermeasure Report based on literature review and assessment of 
current practices for crew-ground interaction completed at the end of 2011.  Report/Recommendations required 
by the beginning of 2012 to determine if studies are needed.  If applicable, HSRF/Medical Ops and Mission Ops 
Update for Lunar Long in 2019, Mars Update in 2023. 
Required Platforms: Ground based data collection. 
 
Tasks: (BHP In-House) 
Identify Optimal Countermeasures to Support Crew-Ground Interaction 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies to 
identify optimal countermeasures to support crew-ground interaction 
Deliverables: Countermeasure Report – provides a summary of literature and current operations and identifies 
optimal countermeasures to support crew-ground interaction.  Also includes a recommendation based on evidence 
gathered on whether future studies are needed.   
Required Delivery Milestone: Initial Countermeasure Report based on literature review and assessment of 
current practices for crew-ground interaction completed at the end of 2011.  Report/Recommendations required 
by the beginning of 2012 to determine if studies are needed.  If applicable, Mission Ops Update for Lunar Long in 
2019, Mars Update in 2023. 
Required Platforms: Ground based data collection. 
 
Tasks: (TBD) 
Inform SHFH: Psychosocial Food Requirements Food Ops (TBD) 
2011-2014: Activities TBD 
Deliverables: Recommendations based on evidence gathered 
Required Delivery Milestone: Information to SHFH TBD 
Required Platforms: Ground based data collection. 
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BHP Gap Team4: What are the most optimal ways to compose crews to ensure crew cohesion, 
optimize crew performance, and facilitate crew-ground interaction for exploration missions? 
(Priority 2) 
Group composition plays an important role in team performance: research included in the Team Evidence 
Book indicates that team composition is a key differentiating factor between high- and low-success teams.  
Furthermore, research demonstrates that composition can also influence cohesion and interpersonal 
interaction among crewmembers.  Therefore, it seems necessary to examine and implement practices to 
secure the best crew composition for Exploration Missions.  BHP places this gap as a second priority 
within the Team Risk to address recommendations for team composition for Exploration Missions.  
Tasks: (BHP In-House (Review); NRA (ISS Study)) 
Crew Composition Studies 
2010-2011: Literature/Ops Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies to 
identify optimal composition factors that influence crew cohesion, crew performance, and crew-ground 
interaction.  Collaborate with BHP Ops. 
2011-2012: ISS Prep 
2012-2019: ISS Studies 
Assess composition factors of ISS crew and how those are related to measures of cohesion, performance, and 
crew-ground interaction. Develop composition recommendations for Exploration Missions.  This task is 
anticipated to last approximately eight years in order to allow for an adequate number of teams (as opposed to 
individual subjects.)  
2022-2025: Lunar Studies 
Follow-up validation of composition recommendations on lunar missions; will want to validate recommendations 
using the context of a lunar environment. 
Deliverables:  
Recommendations regarding optimal team composition. 
Update Standards. 
Required Delivery Milestone: Recommend Update to Inform HSRF/Medical Ops for Lunar Habitat missions in 
2019 and 2025.   
Updated Standards for Crew Composition by 2019 for Lunar Long and Mars. 
Required Platforms: This effort involves ground studies and data mining effort, as well as an ISS study with in-
flight questionnaires and assessment of composition.  Also, plan to validate using lunar studies.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
2012-2019: ISS Studies 
15 teams    Low Very Low 
2022-2025: Lunar Studies 
5 teams    Low Very Low 
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Tasks: (TBD) 
Validate Measures for Composition 
Conducting ground studies to determine which composition tools optimally predict crew cohesion, crew 
performance, and crew-ground interaction.  Plan to validate these tools utilizing lunar long missions. 
2014-2021: Ground Studies 
Tentatively plan to incorporate knowledge gained from previous task (review literature and Ops assessment) and 
use a ground study setting to validate the composition tool. 
Deliverables:  
Recommendations regarding optimal measures for team composition for long duration exploration missions. 
Update Standards. 
Required Delivery Milestone: Inform HSRF/Med Ops for Lunar Habitat missions in 2021.  Recommendations 
required by 2025. 
Required Platforms: This effort is primarily ground studies although lunar studies will also be utilized to 
validate the tool. 
BHP Gap Team5: What are the optimal ways to train crews, leaders, and ground support to ensure 
crew cohesion, optimize crew performance, and facilitate crew-ground interaction for exploration 
missions? (Priority 2) 
Crews on ISS are diverse (multiculturally, racially, etc.), and this diversity will most likely continue for 
Exploration Missions.  As noted in the Team Evidence Book, finding adequate time for crews to train 
together continues to remain a challenge.  Current plans for astronaut teams include reducing the times 
spent together training even further, and subsequently these changes will likely increase conflict and 
performance-related decrements.  
These factors make it essential to determine what acceptable alternatives to traditional team training 
methods (i.e. virtual team training) exist. In addition, the type of team training activities (role playing, 
etc.) and the duration of the training are important factors in designing the most efficient and effective 
training model that will improve crew performance, crew cohesion, and crew-ground interaction. It is 
critical to capture what type, dose, style and length of training can most adequately cover multiple 
competencies to ensure efficiency of the astronauts’ time while promoting mastery of the required 
competencies for a successful mission.  
Tasks: (Directed) 
Training Studies: Crew Cohesion and Crew Performance 
2009-2013: Evaluate Training 
Evaluate training using analog studies (and/or studies in operational environment) to validate optimal training 
methods. Analogs may include NEEMO and HMP.  
2013-2014: ISS Prep 
2014-2018: ISS Studies 
Evaluate Training Requirements during spaceflight on ISS to determine if Training Requirements are adequate.  
If further Training Requirements are needed, studies will commence and will be followed by a phase of 
simultaneous in-flight and lunar studies.  The optimal training tools from these studies will be validated in lunar 
studies. New Requirements will then be delivered by 2023 for informing Human Subjects Risk Forum/Med Ops 
and Input to Mars Ops Development. 
Deliverables:  
Recommendations, crew training for team cohesion and optimal performance. 
Information to ExMC and SHFH 
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Required Delivery Milestone: Recommendations to Inform Mission Ops by 2013. Studies will be completed by 
2018(status provided in 2015 with subsequent updates.)  
Required Platforms: Activities include assessing training in analog and/or operational environments), and 
validating on ISS and in lunar studies.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
5 teams    Medium Medium 
 
Tasks: (TBD) 
Training Studies: Crew-Ground Interaction 
2010-2013: Evaluate Crew-Ground Interaction 
Evaluation for Crew-Ground Interaction TBD 
Deliverables:  
Requirements for crew-ground interaction TBD 
Update to Standards, if applicable. 
Required Delivery Milestone: TBD 
Required Platforms: TBD 
BHP Gap Team6: How does increased work autonomy impact crew cohesion, crew performance, 
and crew-ground interaction for exploration missions? (Priority 3) 
As crews begin operations for long duration missions beyond low Earth orbit, they will need to exercise 
increasing command and control of their daily activities. The distance for Mars Missions will result in 
loss of capability for real-time communication, downlink, and commanding. Likewise, the crew will have 
to augment and adapt their schedules based on real time changes in their schedules. Medical Operations 
has requested a study of crew autonomy while we are still in low Earth orbit, to identify the impact (if 
any) of increased autonomy on crew dynamics and performance. 
Tasks: (Directed) 
Task: Impact of Increase Work Autonomy on Performance 
2008-2010: Analog Studies 
Conduct studies in NEEMO to evaluate impact of increased autonomy on cohesion and performance.  
2009-2010: RCS 
Conduct studies in the Russian-Chamber 105 day study, observing impact of increased autonomy on cohesion and 
performance. 
2010: Autonomy Workshop 
Conduct Autonomy Workshop to examine preliminary results from analog studies and further define role of 
autonomy in Mars exploration and its effects on crew performance and crew dynamics. 
2010-2011: Prep 
2011-2015: ISS Studies 
Studies on ISS to observe crew performance and cohesion, working under a low autonomy condition versus a 
high autonomy condition. 
If evidence exists that increased autonomy impacts crew dynamics and performance, the need for 
countermeasures in addition to what BHP has developed/is developing, will be considered.  Recommendations 
will be provided and ground and flight studies will then commence with plans to validate in lunar missions. 
Deliverables: Recommendations based on the impact (if any) of increased autonomy in analogs and spaceflight. 
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Required Delivery Milestone: ISS data collection to be completed by 2016. Inform Mission Ops for planning 
Lunar Habitat missions in 2016.  
Required Platforms: Requires analogs (NEEMO, RCS) and ISS.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
18    Medium Medium 
 
Tasks: (Re-directed NRA) 
SPIFe 
2009-2011: SPIFe Tool 
Conduct studies to develop SPIFe in relation to increases in autonomy. 
If tool is ready for spaceflight by 2011, will then be used with findings from task above in ISS studies.  If not, will 
then conduct analog studies. 
Deliverables: Recommendations based on the impact (if any) of increased autonomy in analogs and spaceflight. 
Required Delivery Milestone: ISS data collection to be completed by 2016. Inform Mission Ops for planning 
Lunar Habitat missions in 2016.  
Required Platforms: May require ISS.  
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Tasks: (TBD) 
Autonomy, Cohesion, and Performance Review 
2010-2011: Literature Review 
Review of past and current literature and assessment of operations to ascertain current best practices/policies in 
relation to autonomy and its impact on cohesion and performance in isolated environments. 
Deliverables: Autonomy Report- provides a summary of literature and current operations and identifies changes 
in autonomy in relation to cohesion and performance.  Also includes a recommendation based on evidence 
gathered on whether studies are needed.   
Required Delivery Milestone: Initial Autonomy Report based on literature review and assessment of current 
practices completed at the end of 2011.  Report/Recommendations required by the beginning of 2012 to 
determine if studies are needed.   
Required Platforms: Ground based data collection TBD. 
BHP Gap Team7: What aspects of communication impact crew cohesion, optimize crew 
performance, and facilitate crew-ground interaction for exploration missions? 
When considering the context of long duration missions, communication is likely to be a key factor to 
positive interpersonal interactions and will likely influence crew cohesion, crew performance, and crew-
ground interaction.  This is especially true when considering the communication delay between 
crewmembers and ground control during long duration missions.  Data summarized in the Team Evidence 
Book suggests that communication can affect interactions among crewmembers when dealing with task-
related issues and/or interpersonal-related issues.  Thus, it is necessary to identify in what way 
communication may impact the identified criteria. 
Tasks: (NSBRI) 
Conflict Management for Crew Cohesion 
NSBRI funded the development of a technology that guides astronauts through conflict resolution. 
2009-2012: Analog Tests 
The effectiveness of this technology should be evaluated in analogs, such as the Antarctic, where groups of 
individuals are stationed for months at a time, in extreme, isolated environments where conflict has been known 
to occur.  
2012-2013: ISS Prep 
2013-2015: ISS Studies 
The technology should then be made available on ISS, and its effectiveness with astronauts, when used, should be 
evaluated.  
If flight data collected reveals that additional countermeasures are needed to address cohesion and 
communication, additional studies will be developed to help design and test new strategies.  If necessary, will 
utilize ground and flight studies, with a desire to validate those optimal countermeasures in lunar missions. 
Deliverables:  
Technologies that provide conflict management support and guidance for crewmembers, particularly for 
autonomous operations. 
Updates to Standards, if applicable. 
Required Delivery Milestone: In-flight validation of Conflict Management Technology to begin in 2012, with 
technology delivered by 2015.  
Required Platforms: Conflict management technology to be evaluated in analogs, including the Antarctic.  
Flight validation of technology to occur on ISS. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
25    Medium Medium 
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Tasks: (Directed Studies) 
Optimal Communication Strategies: Crew-Ground Interaction 
2010-2011: Literature/Ops Review 
Conduct a review of best practices for optimal communication strategies, between and within groups, from the 
military and other agencies.  
Will obtain and analyze data of communications between space and ground crews as well as conduct a literature 
review in order to develop recommendations for improved communication strategies related to performance of 
mission objectives. 
Deliverables:  
Recommendations for optimal communication strategies 
Updates to Standards, if applicable. 
Required Delivery Milestone: Initial Crew Communication Report based on literature review and assessment of 
current practices delivered at the end of 2011.  Report/Recommendations required by the beginning of 2012 to 
determine if additional studies are needed.   
Required Platforms: Analysis of ISS/MOD communications can be collected / analyzed from the ground.  
 
Tasks: (NSBRI) 
Optimal Communication Strategies: Crew Performance 
2008-2013: Lab Studies 
Conduct lab studies that examine the impact of environmental stressors, incentives, and crew configuration 
changes on communication and performance within simulated space crews and between simulated space and 
ground crews. 
Deliverables:  
Recommendations for optimal support system for Exploration 
Updates to Standards, if applicable. 
Required Delivery Milestone: Human Subjects Risk Forum to be informed by 2014 with Recommendations for 
Optimal Communication Strategies  
Required Platforms: Ground studies TBD.  
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RISK OF ERRORS DUE TO POOR TASK DESIGN –  
CRITICALITY: LUNAR OUTPOST – D, MARS – I  
If roles and responsibilities for accomplishing tasks are not clearly defined, there will be a risk of serious 
errors of omission or commission. This risk may relate to interaction between multiple crewmembers, to 
interactions between crew, robotics, and automation, and between crew and ground control.  
Understanding the characteristics of the elements involved, how each communicates, and establishing 
guidelines to adhere to during task design and procedure development are all essential to mission success. 
Operational Relevance and Risk Context  
One of the most critical enablers of human presence in space is human systems standards that provide for 
crew health as well as standards for habitability, environmental, and human factors. The Space Flight 
Human System Standards – SFHSS – (and the companion Human Integration Design Handbook – HIDH) 
require that each human spaceflight program derive program-specific, verifiable requirements to comply 
with the standards, and require that each human spaceflight program establish a human factors process 
involving health and human factors experts. This is to ensure identification of any standards in the SFHSS 
that are not applicable (or altered) and the rationale for non-applicability; that all program level health and 
human factors requirements are based on the HIDH, cited empirical evidence, or known best practices; 
and that end-items are in compliance with SFHSS, and agency and program level requirements and 
specifications.  
The activities cited reflect the need to work toward the mitigation of identified SHFE risks by continuing 
to inform the standards, by engagement in the development of the requirements that will implement the 
standards based upon the resulting products, as well as providing content to the HIDH that will serve as 
the implementation guide. In addition, products resulting from these activities may provide valuable 
information to spaceflight programs that can inform the requests for trade studies.  
To ensure operational relevance of the deliverables from the tasks, all tasks leaders will identify 
stakeholders who will work with them in framing the questions and approach. The stakeholders will 
participate by identifying specific issues requiring research or technology development, by reviewing 
progress, and by suggesting operational evaluations. Depending on the specific tasks, stakeholders may 
include engineers or operations personnel.  
Strategy for Mitigation 
The approach to mitigating this risk is to develop an understanding of the factors that contribute to this 
risk, identify gaps in our knowledge about these factors, and prioritize these gaps based on various criteria 
systematically applied.  Then the highest priority gaps are addressed through directed or solicited research 
depending on the time frame and the complexity and specificity of the gap.  Where there is a disconnect 
between critical gaps that should be addressed and a lack of funding, efforts are made to re-examine the 
programmatic priorities to ensure those of highest concern are being investigated.  
The risk associated with designing tasks focuses specifically on the process of assigning roles and 
responsibilities to individual crewmembers, a group of crewmembers, automation, and ground support 
alone or in combination.  The Behavioral Health and Performance Element has primary responsibility for 
addressing risks related to team dynamics.  SHFE specifically studies issues in designing tasks to be 
performed jointly by humans and automation, or deciding how much responsibility to assign to an 
automated system.  The approach to mitigating this risk is to develop and specify “best practices” for 
human-automation function allocation; -crew-automation interface design,  ,  how to incorporate 
considerations of crew workload and situational awareness in mixed-initiative operations concept design, 
and determining methods to ensure effective levels of trust between the crew and automation while 
avoiding unacceptable levels of crew complacency. 
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The strategy for addressing this risk is intertwined with the strategies for addressing the Risk of Reduced 
Safety and Efficiency Due to an Inadequately Designed Vehicle, Environment, Tools or Equipment, and 
the Risk of Errors due to Inadequate Information.  The work described under this risk focuses on planning 
how a given task or mission objective will be accomplished.  This risk addresses how to decide what 
skills, tools, equipment and information are needed to accomplish a task, and what amounts of automation 
or human involvement are required.  The Risk Due to an Inadequately Designed Vehicle, Environment, 
Tools, or Equipment captures the factors that lead to inappropriate human interfaces for the habitat and 
equipment.  Work under the Risk of Errors due to Inadequate Information contributes to the crew having 
adequate knowledge, skills, and information at the time the task needs to be performed.   
The specific selection choices of the highest priority gaps and tasks are based primarily on gap analyses.  
The SHFE project updates its gap analyses on an annual basis.  This is necessary as research results and 
continual information drawn from crew debriefings has the potential of discovering additional gaps in 
knowledge.  These updates assist in the preparation for the annual Standing Review Panel. The original 
analysis carried out in 2006 was published as NASA/TP-2007-213739 (“Space Human Factors 
Engineering Gap Analysis Project Final Report,” C. Hudy and B. Woolford, 2007).   An update was 
completed in spring 2007.  The gaps are identified through reviews of the literature, of crew debrief 
summaries, and through interviews with more than a hundred users of human factors standards and 
guidelines, representing Engineering, Mission Operations, Flight Medicine, Training, the Crew Office, 
and others.  We place particular emphasis on interviewing representatives from Constellation Program 
Office, the Human-System Integration Group, the Orion Project Office, the Cockpit Display Working 
Group, and other programmatic users of our products.  The ‘small’ gaps or specific concerns identified 
from these sources are aggregated into more appropriate levels for which a specific task can be designed.  
For example, numerous users report gaps in design for workload:  lack of consistency of definition; lack 
of easy to use methods to assess workload; lack of a way to verify that a requirement for workload has 
been met.  These various individual-level concerns are captured in a gap, “There is no standardized non-
intrusive measure of workload.”   
After all concerns are mapped to gaps, the gaps are prioritized according to a number of criteria.  Key 
criteria are importance to Constellation Program and need date.  When we identify ‘TBRs’ or ‘TBDs' in 
the Human Systems Integration Requirements, for example, these are assigned a very high priority.  
Ratings are solicited from management representatives of the offices from which gaps were identified.   
After prioritization, the gaps that can be addressed within the budget are initiated through directed 
research or solicited through research announcements.  Directed research is chosen for time critical 
results.  Solicitations are used for gaps that are longer term and that can benefit from wider participation. 
Gaps  
SHFE 1.1.1.2.1:  How can standard measures or tools be developed that can unobtrusively measure 
workload?  
Tasks: (SHFE – Directed, Collaboration with HRP BHP) 
Development of Workload and Human Performance Evaluation Methods 
Available research shows that the relationship between workload and performance is a nuanced one.  Simple 
approaches that attempt to maintain overall workload at an intermediate value are unlikely to achieve the desired 
results.  The successful management or evaluation of workload must include a consideration of the nature of 
individual tasks that operators must perform, the combinations of tasks that are performed during a work period, 
priorities among tasks, and individual differences among operators.  This task will look at the relationship 
between workload and performance with the goal of producing more effective methods for evaluating proposed 
designs and operating procedures for space applications. 
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Tasks: (SHFE – Directed, Collaboration with HRP BHP) 
Development of Workload and Human Performance Evaluation Methods (cont’d) 
Deliverables:  
A review of all workload measurement techniques, simple task analysis techniques, and operator performance 
metrics. 
A simple-to-use guide offering practical guidance in using these techniques when evaluating designs and 
procedures for using automation systems. 
Preliminary development of an empirical evaluation of the guide/techniques that are produced. 
Flight validation and analysis of workload guide and techniques. 
Assessment of new workload allocation technology and design capabilities for application to Habitat.  
Required Delivery Milestone: 
FY09 Final Review of Workload Measurement Techniques 
FY09 Guidelines for Using Workload Measurement Techniques 
FY09 Preliminary Evaluation of Workload Guidelines and Techniques 
FY10 Workload Allocation Recommendations to Orion CDR 
FY11 Design solutions for workload allocation for Lander SRR 
FY11 Transmittal of preliminary results to BHP 
FY13 Prelim flight results/recommendations to Lander PDR 
FY15 CR to HSIR, HIDH requirements prior to Lander CDR 
FY18 Information/recommendations regarding potential new technology applications for Habitat 
FY19 Requirements/design solutions for Habitat  
Required Platforms: Ground: Laboratory Test beds, ISS Flight Validation  
SHFE 1.1.1.3.1: How do we design tasks to ensure adequate situational awareness? 
Tasks: (SHFE – New Directed Research or NRA) 
Situational Awareness Evaluation 
Situational awareness is a complex concept that combines both consciously identifying all salient aspects of a 
current state, and connecting those aspects to prior knowledge about the task.  It focuses on the connections 
between perceptions and long-term memory – are the important cues perceived? Are they matched to the 
appropriate responses?  Issues with respect to situational awareness arise when tasks are complex and cues to the 
exact state of the system are not sufficiently strong.  In partially automated tasks, deficiencies in recognizing the 
state of the automated system or the state of the environment are common sources of errors that can result in loss 
of mission objectives.  This task will identify the best available methods to assess situational awareness and 
develop an approach to evaluating task and equipment designs to ensure that sufficient cues for situational 
awareness are available. 
Deliverables:  
Review of situational awareness techniques and analysis tools as well as operator performance metrics 
Preliminary development of metric evaluation system and guide to measure situational awareness 
Required Delivery Milestone: 
FY13 Design recommendations for Lander PDR 
FY15 CR to HIDH to add design solutions/requirements for enhancement of situational awareness 
FY15 Design solutions to Lander CDR 
FY15 Design solutions for Habitat CDR 
Required Platforms: Ground: Laboratory Test beds  
HRP-47065 
 
175 
SHFE 1.1.2.1.1:  How can performance, efficiency, and safety guidelines be developed for 
appropriate task automation and the effective allocation of tasks between humans and automation? 
Tasks: (SHFE – Directed) 
Automation Interface  
The automation design community needs methods that are usable by designers early in the design process to meet 
demands for the development and testing of automation for space exploration. The objective of this task is to 
develop a set of methodologies and tools to automate the design and evaluation of the human-computer 
interaction concepts. The research plan is to integrate existing foundational research results into Human 
Automation Interaction (HAI) methods and tools usable by designers. 
Deliverables:  
Documentation of Application Domain – To adequately model the process and perform the task decomposition, 
researchers have to develop a deep knowledge of the domain, the process, and culture of the organization. This is 
vital to ensuring that the resulting method/toolset is compatible with the end-users enterprise environment. 
Process Modeling and Metrics Instrumentation- To develop process information and metrics that adequately 
describe characteristics of Human Automation Interaction performance. 
Task Decomposition – Continue to develop and validate a usable task decomposition and analysis application 
Human Performance Modeling – A human performance analysis capability that does not require Human 
Automation Interaction expertise to use. The intention is that the required data for the tool will be generated by 
the task decomposition and analysis tool  
Tool Integration – Develop and validate an automation prototyping environment that is useful for Constellation. 
Integrate the methods that have been developed in the previous tasks into tool suites that are usable by designers 
without requiring extensive Human Computer Interaction expertise.  Provide quantitative assessments of the 
performance of an automation design and its interface for a specific task on a given design. 
Demonstration & Testing – All of the studies are focused on delivering tools to help designers make better 
Human-Automation Interaction decisions early in the operations concept design process. Specifically, as 
described earlier, the first year of the task will focus on developing tools that are usable by the ISS Attitude 
Direction and Control team. 
Assessment of new technology and capabilities – Evaluation of new tools that can enhance developed tools to 
further aid users in allocation of tasks.  Additionally, test and validate enhancements in simulated environments to 
determine efficacy and applicability. 
Required Delivery Milestone: 
FY09 Final report on beta analysis package for ISS ADCO application domain. 
FY09 Final report on generation of computational human performance model. 
FY09 Validated task decomposition/analysis application and final report. 
FY10  Human performance analysis capability 
FY10 Validated automation prototyping environment. 
FY10 Final report on demonstration and test of automation integration tools. 
FY13 Design recommendations to Lander PDR regarding new technology/capabilities to enhances current tool 
FY15 Requirements to Lander and Habitat CDR for implementation of tool enhancements 
Required Platforms: Ground: Laboratory Test beds  
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SHFE 1.1.2.2.1: How can we develop standard measurement techniques and metrics for evaluating 
the quality of user interfaces with specific attention to the usability of an interface?  
**** These tasks also address the Risk of Error Due to Inadequate Information 
Tasks: (SHFE – Directed) 
Usability Evaluation**** 
Usability measures and metrics that will help formulate verifiable usability requirements based on quality 
components. Usability refers to the quality of an interface or hardware. It can be represented by five quality 
components: learnability, efficiency, memorability, errors, and satisfaction (Nielsen, 2003). Learnability refers to 
the ease of accomplishing basic tasks when users encounter the design for the first time. Efficiency is the time 
needed to accomplish a task after users are already familiar with the design. Memorability can be measured by the 
change in performance following a period of not using the interface. Errors can be counted during task execution 
and rated based on severity. User satisfaction is a metric indicating how pleasant the design is to use. Some of 
these can be represented by objective measures, while others are subjective. However, they provide a good 
picture of the overall usability of a system. Furthermore, they can provide evidence for any return on investment 
that may result from redesigns of a system, thus making usability and human factors quantifiable. 
Deliverables:  
Develop and propose usability metrics that can be applied in the space science area, along with recommended 
usability methodologies for collecting the metrics. The focus will be on challenges such as error definition, 
acceptable error rates, and error classification and weighting.  
Research and develop a consistency scale that can be validated and standardized. 
Field test and validate usability measures, metrics, and methodologies in one or more real life projects. Document 
methodology and measurement techniques in a standardized way that will help NASA practitioners to used them 
in a reliable way. Define requirements language based on proposed usability metrics.  
Continuous assessments of advancements in State of the Art technology determination of appropriate 
applicability areas for Lander and Habitat. 
Required Delivery Milestone: 
FY09 Report on Proposed Usability Measures and Metrics 
FY09 Summary Report on Usability Field Testing, Methodology and Measurement Techniques 
FY10 Usability recommendations to Orion CDR 
FY11 Usability recommendations to Lander SRR, design solution to Lander PDR 
FY13 Design enhancement recommendations to Lander PDR 
FY15 Design solutions to Lander CDR 
FY16 Design solutions to Habitat CDR 
FY18 Design improvements to Habitat 
Required Platforms: Ground: Laboratory Test beds  
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SHFE 3.1.2.2.a:  How do we ensure that the displays and control designs and technology developed 
for the operational environments of the Cx Program will improve performance and reduce errors? 
Tasks: (SHFE – Directed) 
Information Presentation – Displays (Visual and Auditory)**** 
Optimal displays are critical to crew performance and vehicle operations.  Displays must meet the crew’s needs 
and be easy to use, particularly as Exploration mission operations venture farther from the Earth and real-time 
ground-based operational assistance becomes degraded or unavailable.  The focus for visual displays is 
readability and usability of text, and effective display navigation.  The focus of auditory displays is caution and 
warning system alarms. This is a requirements development activity, supplemented by some research or 
validation activities on the ground and in flight. This will result in the development of guidelines, requirements, 
and validation techniques for advanced information display solutions currently contemplated for the various 
Constellation Program spacecraft systems consistent with the smaller cockpit environments of the Orion CEV, the 
Lander, and surface rovers. These requirements and appropriate information will be provided to Orion, 
Constellation documentation (CxP70024 Human System Integration Requirements; Orion Display Standards) and 
the Space Flight Human System Standards Human Integration Design Handbook. 
Deliverables:  
Display design requirements  
Display design recommendations 
Assessment, selection, and test of display design enhancements that will maximize capability of Habitat 
Required Delivery Milestone: 
FY09 Display requirements and design recommendations to Orion PDR 
FY09 CR to HSIR, HIDH, Orion Display Standards documentation prior to Orion CDR 
FY10 Display design recommendations to Orion CDR 
FY11 Display requirements to Lander SRR 
FY13 Display design recommendations to Lander PDR 
FY15 CR to HSIR, HIDH prior to Lander CDR 
FY15 Design solutions to Lander CDR 
FY17 Design enhancement recommendations for Habitat 
FY19 Design enhancement solutions for Habitat displays 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
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Tasks: (SHFE – Directed) 
Information Presentation – Controls**** 
The development of proper controls is critical to preventing errors during human spaceflight.  This becomes 
especially important when the majority of the controls will be software based.  Crewmembers must be very aware 
of what they are manipulating on the screen, and must be able to do so under vibration and high-g, as well as in 
microgravity.  They must be able to operate controls ungloved and with pressurized gloved hands.  During launch 
and entry, crews will have no choice other than to use a remote cursor control device.  If the input control devices 
are inadequate for any of the above operational scenarios, crew safety will be compromised and operational 
capability will be compromised. These requirements and appropriate information will be provided to Orion, 
Constellation documentation (CxP70024 Human System Integration Requirements; Orion Display Standards) and 
the Space Flight Human System Standards Human Integration Design Handbook. 
Deliverables:  
Control design requirements  
Control design recommendations 
Assessment, selection, and test of control design enhancements that will maximize capability of Habitat 
Required Delivery Milestone: 
FY09 Control requirements and design recommendations for Orion PDR 
FY10 Control design solutions for Orion CDR  
FY10 CR to HSIR, HIDH, Orion Display Standards Documentation prior to Orion CDR 
FY11 Control requirements to Lander SRR 
FY13 CR to update control requirements in HSIR, HIDH prior to Lander PDR 
FY13 Control design recommendations to Lander PDR 
FY15 CR to HSIR, HIDH for update to control requirements prior to Lander CDR 
FY15 Design solutions for Lander CDR 
FY17 Design enhancement recommendations to Habitat controls 
FY19 Design enhancement solutions to Habitat controls 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
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RISK OF ERROR DUE TO INADEQUATE INFORMATION – CRITICALITY: LUNAR 
OUTPOST – D, MARS – I  
Information presentation, acquisition, and processing significantly affect human task performance. The 
extent to which information needed to support a task or mission operation can be easily accessed and 
easily processed is vital to all space missions.  Therefore, further research regarding proper information 
presentation will enable development of requirements and guidelines to optimize presentation of 
information, its timeliness, the user’s level of awareness of the information, modes of information 
presentation, proper information comprehension, training methods, and development of procedures.  
Operational Relevance and Risk Context  
One of the most critical enablers of human presence in space has been ensuring that there are human 
systems standards in place that will provide for crew health as well as standards for habitability, 
environmental, and human factors. The Space Flight Human System Standards – SFHSS – (and the 
companion Human Integration Design Handbook – HIDH) require that each human spaceflight program 
derive program-specific, verifiable requirements to comply with the standards, and require that each 
human spaceflight program establish a human factors process involving health and human factors experts. 
This is to ensure that there will be identification of any standards in the SFHSS that are not applicable (or 
altered) and the rationale for non-applicability; that all program level health and human factors 
requirements are based on the HIDH, cited empirical evidence, or known best practices; and that end-
items are in compliance with SFHSS, and agency and program level requirements and specifications.  
The activities cited reflect the need to work toward the mitigation of identified SHFE risks by continuing 
to inform the standards, by engagement in the development of the requirements that will implement the 
standards based upon the resulting products, as well as providing content to the HIDH that will serve as 
the implementation guide. In addition, products resulting from these activities may provide valuable 
information to spaceflight programs that can inform the requests for trade studies.  
To ensure operational relevance of the deliverables from the tasks, all tasks leaders will identify 
stakeholders who will work with them in framing the questions and approach. The stakeholders will 
participate by identifying specific issues requiring research or technology development, by reviewing 
progress, and by suggesting operational evaluations. Depending on the specific tasks, stakeholders may 
include engineers or operations personnel.  
Strategy for Mitigation 
The approach to mitigating this risk is to develop an understanding of the factors that contribute to this 
risk, identify gaps in our knowledge about these factors, and prioritize these gaps based on various criteria 
systematically applied.  Then the highest priority gaps are addressed through directed or solicited research 
depending on the time frame and the complexity and specificity of the gap.  Where there is a disconnect 
between critical gaps requiring addressing and a lack of funding, efforts are made to re-examine the 
programmatic priorities to ensure those of highest concern are being investigated.  
The risk associated with error due to inadequate information focuses on identifying the causes of risk, for 
example, the lack of situational awareness that might be due to poorly designed interfaces or tasks, and 
the subsequent development of information presentation standards for reducing operator errors in 
spaceflight through adequate understanding of the causes and mitigations of the errors.  As the topic of 
inadequate information is comprehensive, the approach to mitigating this risk is to focus on the display of 
information, the types of controls that interface between the human and the displays, and the procedures 
to accomplish tasks. 
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It is not possible to separate the strategy for mitigating this risk from the strategy for dealing with the risk 
of Errors due to Poor Task Design.  The information that is needed to perform a task at a given time 
depends substantially on the nature of the task and the crewmembers’ roles and responsibilities.  The 
work described under this risk presumes the task is well designed and focuses on the problems of 
ensuring the necessary information is presented in such a way as to enable timely, accurate performance. 
The specific selection choices of the highest priority gaps and tasks are based primarily on gap analyses.  
The SHFE project updates its gap analyses on an annual basis.  This is necessary as research results and 
continual information drawn from crew debriefings has the potential of discovering additional gaps in 
knowledge.  These updates assist in the preparation for the annual Science Review Panel.  The original 
analysis carried out in 2006 was published as NASA/TP-2007-213739 (“Space Human Factors 
Engineering Gap Analysis Project Final Report,” C. Hudy and B. Woolford, 2007).   An update was 
completed in spring 2007.  The gaps are identified through reviews of the literature, of crew debrief 
summaries, and through interviews with more than a hundred users of human factors results, representing 
Engineering, Mission Operations, Flight Medicine, Training, the Crew Office, and others.  We place 
particular emphasis on interviewing representatives from Constellation Program Office, the Human-
System Integration Group, the Orion Project Office, the Cockpit Display Working Group, and other 
programmatic users of our products.  The ‘small’ gaps or specific concerns identified from these sources 
are aggregated into more appropriate levels for which a specific task can be designed.  For example, 
numerous users report gaps in design for workload:  lack of consistency of definition; lack of easy to use 
methods to assess workload; lack of a way to verify that a requirement for workload has been met.  These 
various individual-level concerns are captured in a gap, “There is no standardized non-intrusive measure 
of workload.”   
After all concerns are mapped to gaps, the gaps are prioritized according to a number of criteria.  Key 
criteria are importance to Constellation Program and need date.  When we identify ‘TBRs’ or ‘TBDs' in 
the Human Systems Integration Requirements, for example, these are assigned a very high priority.  
Ratings are solicited from management representatives of the offices from which gaps were identified.   
After prioritization, the gaps that can be addressed within the budget are initiated through directed 
research or solicited through research announcements.  Directed research is chosen for time critical 
results.  Solicitations are used for gaps that are longer term and that can benefit from wider participation. 
Gaps 
SHFE 3.1.1.a: How can we develop objective training measures to determine operator proficiency 
during and after ground training?   
Tasks: (SHFH – Directed) 
Training for Effective Space Flight Resource Management  
Ground-based pre-flight training and in-space just-in-time training and task rehearsal will continue to be an 
important driver for exploration missions. On-board training systems will enhance the autonomy and 
effectiveness of exploration crews. Long-duration missions preclude the possibility of easily substituting new 
crewmembers from the ground that have been specially trained on specific emerging problems, new tasks, and 
scientific or mission operations. 
Human spaceflight will continue to depend even more on the deep knowledge astronauts acquire of the 
idiosyncrasies of the flight systems they live with and the tasks they have to perform. However, given the nature 
of the missions, onboard training opportunities for individuals and teams will be necessary, such as in 
reconfigurable training and mission rehearsal systems. These systems will enable the crews to keep their skill 
levels up to par and to develop new skills or practice new procedures to resolve new challenges as they arise. 
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Deliverables:  
Develop an MOD-specific non-technical (i.e., independent of spacecraft systems) framework (such as a game 
structure) that can be used to train SFRM skills (such as situation awareness, communication, and decision-
making). 
Development of training events using the SFRM Paper Sim that could be used to reliably predict the likelihood of 
a trainee’s success in acquiring good SFRM skills. 
Required Delivery Milestone:  
FY09:  SFRM Generic Paper Sim – Proof of Concept Study 
FY09: Interim delivery of SFRM tool to Mission Ops and MOD 
FY10:  SFRM Generic Paper Sim – Predictive Training Events Concept Study. 
FY10: Delivery of final SFRM tools for Mission Ops PDR and MOD 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups  
 
Tasks: (SHFH – New Directed Study or NRA) 
Training Proficiency Metrics and Methods Development 
Space Flight Resource Management (SFRM) training is based on years of study and experience with industries 
other than space. Although there are very good reasons to feel confident in this approach, it is critical to assess the 
effectiveness of the changes to the Mission Operations flight controllers’ training flow. As the changes are 
introduced into the training, the study will be tracking students’ performance and continuously evaluating the 
success of the training. However, it will take time to appreciate the full effect of the new training approach. It will 
require having enough flight controllers who complete the new training flow and start working on console to be 
able to compare the results of this new training with those obtained in the previous training flow. This will 
provide for a continuous feedback loop and ongoing revisions and improvements to the new training program as 
soon as it is implemented. 
A training continuum spans a full range from initial training, to recurrent and refresher training, to just-in-time 
training (JITT). Previous work examined aspects of the initial medical training, focused on JITT, explored the 
issues relevant to refresher training, and will now address requirements for the full medical training continuum 
and develop metrics to assess training methods and proficiency. 
Deliverables:  
Assessment and development of training metrics to evaluate training methods and proficiency in other focus areas 
such as vehicle and habitat 
Required Delivery Milestone:  
FY14: Prelim metrics to training proficiency assessment delivered for Missions Ops PDR 
FY14: CR to HIDH to add requirements for training metrics prior to Mission Ops CDR 
FY15: Results of validation of metrics for training proficiency assessment to Lander CDR 
FY16: Training metrics for training proficiency assessment to Habitat CDR 
FY18: Training metrics for training proficiency assessment, continued development, Habitat project 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
Ground:  DESERT RATS  
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SHFE 3.1.1.b:  How do we develop training methods and tools for space medical application if time 
is minimal?   
Tasks: (SHFH – Directed) 
Training for Effective Medical Operations 
Ground-based pre-flight training and in-space just-in-time training and task rehearsal will continue to be an 
important driver for exploration missions. On-board training systems will enhance the autonomy and 
effectiveness of exploration crews. Long-duration missions preclude the possibility of easily substituting new 
crewmembers from the ground who have been specially trained on specific emerging problems, new tasks, and 
scientific or mission operations. 
Human spaceflight will continue to depend even more on the deep knowledge astronauts acquire of the 
idiosyncrasies of the flight systems they live with and the tasks they have to perform. However, given the nature 
of the missions, onboard training opportunities for individuals and teams will be necessary, such as in 
reconfigurable training and mission rehearsal systems. These systems will enable the crews to keep their skill 
levels up to par and to develop new skills or practice new procedures to resolve new challenges as they arise. 
Deliverables:  
Exploratory Evaluation of Tools of Just-In-Time Training for an Emergency Procedure- provides a better 
understanding of performance times and types of errors associated with display devices. 
Evaluation of the Flight Surgeon Performance Support Tool prototype – “Flight Surgeon Response to ISS 
Emergencies.” A detailed task analysis examining the role of the flight surgeon during an on-board emergency 
will be completed. The task analysis will contribute to updated design options. 
Computer implementation for Just-in-Time training – The paper prototype that will be evaluated in FY09 will be 
implemented in a computer program in FY10. This implementation will allow the Flight Surgeon to have access 
to the tool on their laptop computers, and will allow us to embed layers of information providing further details 
beyond the necessary immediate actions. 
A training continuum spans a full range from initial training, to recurrent and refresher training, to just-in-time 
training. FY10 explores the issues relevant to refresher training. 
Required Delivery Milestone:  
FY09:  Summary Report on Just-In-Time Training Comparison 
FY09:  Flight Surgeon Design Decision Support Tool evaluation report 
FY09: Interim delivery of medical procedure/training process to Mission Ops and SD 
FY10:  Integrated Decision Support in (JIT) Training tool for Medical Operations: A Computer implementation. 
FY10:  Develop an evaluation plan for refresher training and conduct evaluations 
FY10: Delivery of final medical procedures/training process to Mission Ops PDR and ExMC 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups  
SHFE 3.1.2.a:  How can a capability for semi-autonomous planning and dynamically replanning of 
crew schedules be developed? 
Need for on-board crew to semi-autonomously plan and dynamically replan their schedules and activities. 
Scheduling, rescheduling, and real-time changes are done manually and are labor intensive.  
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Tasks: (SHFE – Directed, Partnership with HRP BHP) 
Science Planning Interface to Engineering (SPIFe) – Scheduling Tool  
Future mission concepts will require a significantly more efficient planning process and tools. The ultimate goal 
of this effort is to allow an on-board crew to semi-autonomously plan and dynamically replan their activity. Based 
on a firm understanding of ground-based replanning in several domains, the activity will be well positioned to 
understand and develop tools for on-board use. The SPIFe tool considers a wide range of the dynamic resources 
constraining schedule and allows the crewmember to schedule tasks and check that the resources required to 
execute the task will be available, and that there are no unintended consequences of scheduling the task at a 
particular time (such as not being able to execute another required task at a later time). Development of this tool 
is almost complete, and then a decision will be made regarding its utility for spacecraft operations planning and if 
required, the tool will be validated in an operationally intensive ground analog (e.g. NEEMO). A functional 
prototype could be run alongside existing tools to collect valuable data on the tool and its capability to optimize a 
schedule. 
Deliverables:  
The product is an understanding of at least one additional Constellation analog domain that will implement tools 
and processes that improve planning efficiency by an order of magnitude, and to understand and prototype tools 
that can be used for tactical on-board re-planning by the crew of Constellation missions. 
Refinement of tool for ground analog autonomy study by HRP BHP 
Required Delivery Milestone:  
FY09:  Mission Operations PDR-Initial Capability 
FY09: Delivery of SPIFe tool to BHP for continued use in NEEMO and similar ground analog missions 
Required Platforms:  
Ground:  NEEMO 
Ground:  Flight Analogs Bed rest Study 
SHFE 3.1.2.2.a:  How do we ensure that the displays and control designs and technology developed 
for the operational environments of the Cx Program will improve performance and reduce errors? 
***** This task also addresses the Risk of Reduced Safety and Efficiency Due to an Inadequately 
Designed Vehicle, Environment, Tools, or Equipment and the Risk of Error Due to Poor Task 
Design 
Tasks: (SHFE – Directed) 
Information Presentation – Displays (Visual and Auditory)**** 
Optimal displays are critical to crew performance and vehicle operations.  Displays must meet the crew’s needs 
and be easy to use as Exploration missions may face the greatest autonomy challenge to date.  The focus of visual 
displays is readability and usability of text, as well as display navigation.  The focus of auditory displays is 
alarms. This is a requirements development activity, supplemented by some research or validation activities on 
the ground and in flight. This will result in the development of guidelines, requirements, and validation 
techniques for advanced information display solutions currently contemplated for the various Constellation 
Program spacecraft systems consistent with the smaller cockpit environments of the Orion CEV, the Lander, and 
surface rovers. These requirements and appropriate information will be provided to Orion, Constellation 
documentation (CxP70024 Human System Integration Requirements; Orion Display Standards) and the Space 
Flight Human System Standards Human Integration Design Handbook. 
Deliverables:  
Display design requirements  
Display design recommendations 
Assessment, selection, and test of display design enhancements that will maximize capability of Habitat 
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Required Delivery Milestone: 
FY09 Display requirements and design recommendations to Orion PDR 
FY09 CR to HSIR, HIDH, Orion Display Standards documentation prior to Orion CDR 
FY10 Display design recommendations to Orion CDR 
FY11 Display requirements to Lander SRR 
FY13 Display design recommendations to Lander PDR 
FY15 CR to HSIR, HIDH prior to Lander CDR 
FY15 Design solutions to Lander CDR 
FY17 Design enhancement recommendations for Habitat 
FY19 Design enhancement solutions for Habitat displays 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
***** This task also addresses the Risk of Reduced Safety and Efficiency Due to an Inadequately 
Designed Vehicle, Environment, Tools, or Equipment and the Risk of Error Due to Poor Task 
Design 
Tasks: (SHFE – Directed) 
Information Presentation – Controls**** 
The development of proper controls is critical to preventing errors during human spaceflight.  This becomes 
especially important when the majority of the controls will be software based.  Crewmembers must be very aware 
of what they are manipulating on the screen, and must be able to do so under vibration and high-g, as well as in 
microgravity.  They must be able to operate controls ungloved and with pressurized gloved hands.  During launch 
and entry, crews will have no choice other than to use a remote cursor control device.  If devices are inadequate 
for any of the above operational scenarios, crew safety will be compromised and risk loss of productivity. These 
requirements and appropriate information will be provided to Orion, Constellation documentation (CxP70024 
Human System Integration Requirements; Orion Display Standards) and the Space Flight Human System 
Standards Human Integration Design Handbook. 
Deliverables:  
Control design requirements  
Control design recommendations 
Assessment, selection, and test of control design enhancements that will maximize capability of Habitat 
Required Delivery Milestone: 
FY09 Control requirements and design recommendations for Orion PDR 
FY10 Control design solutions for Orion CDR  
FY10 CR to HSIR, HIDH, Orion Display Standards Documentation prior to Orion CDR 
FY11 Control requirements to Lander SRR 
FY13 CR to update control requirements in HSIR, HIDH prior to Lander PDR 
FY13 Control design recommendations to Lander PDR 
FY15 CR to HSIR, HIDH for update to control requirements prior to Lander CDR 
FY15 Design solutions for Lander CDR 
FY17 Design enhancement recommendations to Habitat controls 
FY19 Design enhancement solutions to Habitat controls 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups 
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SHFE 3.1.2.2.a How do we ensure that the displays and control designs and technology developed 
for the operational environments of the Cx Program will improve performance and reduce errors? 
Tasks: (NSBRI – Sensorimotor Adaptation Team) 
Sensorimotor Display and Controls – Enhancing the Safety of Human/Machine Cooperation During Lunar 
Landing (SM11) 
Lunar landing depends on the selection and identification of an appropriate location that is level and free of 
hazards, along with a stable controlled descent to the surface. During crewed landings, astronauts are expected to 
interact with automated systems, based upon improved terrain maps and sensor updates, to perform tasks such as 
manual re-designation of landing point, adjustment of descent trajectory or direct manual control. However, 
sensorimotor limitations, both vestibular and visual, are likely to interfere with performance and safety. This 
integrated project examines the nature of the anticipated spatial disorientation and terrain perception limits as they 
affect the transition from automatic to manual control and develops advanced display countermeasures to 
overcome these limitations. 
Deliverables:  
Examination of the nature of anticipated sensorimotor difficulties (e.g., spatial disorientation, limits on terrain 
perception) as they affect the transition from automatic to manual control. 
Development and evaluation of advanced display countermeasures for enhancing situation and terrain awareness 
and for overcoming performance limitations caused by reduced visibility associated with lunar lighting, terrain 
reflectivity and the absence of atmosphere utilizing Draper Laboratory's fixed-base lunar lander cockpit simulator 
for full human-in-the-loop evaluation.  
Evaluation of the effectiveness of the cockpit displays during human-in-the-loop manual control in the NASA 
Johnson Space Center Tilt-Translation Sled during "critical" and "hover" tasks testing the tilt-translation and tilt-
gain illusions of altered acceleration sensitivity as it applies to lunar gravity following a period of weightlessness.  
Performance of a series of evaluations of the displays using the U.S. Army Aeromedical Research Laboratory’s 
six-degree-of-freedom helicopter simulator as a lunar landing analog for replicating lunar lighting and the various 
parameters associated with dust "brownout" conditions. 
Required Delivery Milestone:  
FY10: Input to Lander SRR regarding design requirement for interfaces, displays, and C&W Systems 
FY11: CR to HIDH to update design requirements prior to Lander PDR 
FY12: Data obtained from research study shared with HHC Element 
FY12: Design solutions to Lander PDR 
Required Platforms:  
Ground:  Laboratory Test beds 
Ground:  Tilt-Translation Sled 
Ground:  6 DOF Helicopter Simulator 
 
Tasks: (NSBRI Sensorimotor Adaptation Team) 
Advanced Displays for Efficient Training and Operation of Robotic Systems (SM12) 
The goal is to improve the efficiency of robotic training through the modification of current procedures and 
development of new teaching tools. Improved training methods provide a framework for designing future in-
flight training procedures during long-duration missions. The project will also demonstrate how individual 
differences affect performance of a critical operational skill and will provide initial designs of controls, displays, 
and procedures that better match the operators’ cognitive skills with task demands. The long term objectives of 
this project are: to develop tests of astronaut spatiomotor abilities that predict the need for remedial training or 
performance in final telerobotic qualification tests; and to improve teleoperation training techniques and develop 
new teleoperator interfaces that improve the efficiency of teleoperation training and flight operations. 
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Deliverables:  
To improve NASA teleoperation training efficiency by scientifically customizing remedial training based on the 
measured spatial abilities of individual astronauts. We have examined whether NASA JSCs current Aptitude for 
Robotics Test (ART) predicts the need for remedial work in Generic Robotic Training (GRT) and Shuttle 
manipulator training or whether additional psychometric tests will sharpen performance predictions. 
To perform a series of experiments using the MIT Remote Manipulation System Simulator to quantify how a 
trainees individual spatial and manual control abilities, use of camera views and choice of hand controller 
reference frame impacts learning and final level of performance as a primary operator. Secondary operator 
performance in a clearance detection and estimation task is assessed using a signal detection/situation awareness 
probe paradigm. 
Required Delivery Milestone:  
FY10: Recommendations to Orion CDR for interface design, displays, and C&W systems in relation to spatial 
orientation 
FY11: Input to Lander SRR regarding design requirements for interfaces, displays, and C&W systems 
FY11: Results from research shared with HHC Element 
FY11: CR to HIDH to update design requirements prior to Lander PDR 
FY12: Design solutions to Lander PDR 
Required Platforms:  
Ground:  MIT Remote Manipulation System Simulator 
Ground:  Basic Operational Robotics Instructional Systems (BORIS) training virtual environment 
SHFE 3.1.2.2.1.2: How can we develop standard measurement techniques and metrics for 
evaluating the quality of user interfaces with specific attention to the usability of an interface?  
**** These tasks also address the Risk of Error Due to Poor Task Design 
Tasks: (SHFE – Directed) 
Usability Evaluation**** 
Usability measures and metrics that will help formulate verifiable usability requirements based on quality 
components. Usability refers to the quality of an interface or hardware. It can be represented by five quality 
components: learnability, efficiency, memorability, errors, and satisfaction (Nielsen, 2003). Learnability refers to 
the ease of accomplishing basic tasks when users encounter the design for the first time. Efficiency can be defined 
as time needed to accomplish a task after users are already familiar with the design. Memorability can be 
measured by the change in performance following a period not using the interface. Errors can be counted during 
task execution and rated based on severity. User satisfaction is a metric indicating how pleasant the design is to 
use. Some of these can be represented by objective measures, while others are subjective. However, they provide 
a good picture of the overall usability of a system. Furthermore, they can provide evidence for any return on 
investment that may result from redesigns of a system, thus making usability and human factors quantifiable. 
Deliverables:  
Develop and propose usability metrics that can be applied in the space science area, along with recommended 
usability methodologies for collecting the metrics. The focus will be on challenges such as error definition, 
acceptable error rates, and error classification and weighting.  
Research and develop a consistency scale that can be validated and standardized. 
Field test and validate usability measures, metrics, and methodologies in one or more real life projects. Document 
methodology and measurement techniques in a standardized way that will help NASA practitioners to used them 
in a reliable way. Define requirements language based on proposed usability metrics.  
Continuous assessments of advancements in State of the Art technology determination of appropriate 
applicability areas for Lander and Habitat. 
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Required Delivery Milestone: 
FY09 Report on Proposed Usability Measures and Metrics 
FY09 Summary Report on Usability Field Testing, Methodology and Measurement Techniques 
FY10 Usability recommendations to Orion CDR 
FY11 Usability recommendations to Lander SRR, design solution to Lander PDR 
FY13 Design enhancement recommendations to Lander PDR 
FY15 Design solutions to Lander CDR 
FY16 Design solutions to Habitat CDR 
FY18 Design improvements to Habitat 
Required Platforms: Ground: Laboratory Test beds  
SHFE 3.1.2.2.2.1 (SM11):  Can crewmember spatiomotor abilities be more accurately predicted 
and countermeasures and training techniques developed to mitigate spatial disorientation during 
spaceflight?  
Tasks: (NSBRI – Sensorimotor Adaptation Team) 
Modeling and Mitigating Spatial Disorientation in Low-Gravity Environments (SM11) 
The goal of this industry-university research and technology development project is to extend Alion's spatial 
disorientation (SD) mitigation software, originally developed for aeronautical use, to NASA applications in the 
Shuttle, Crew Exploration Vehicle, Lunar Surface Access Module (LSAM), and Mars exploration mission 
programs. Alion's Spatial Disorientation Analysis Tool (SDAT) is used for post-hoc analyses of aircraft trajectory 
data mishaps from the United States Navy, United States Air Force, and National Transportation Safety Board to 
determine the presence or absence of vestibular SD.  
The Spatial Orientation Aiding System (SOAS) is a real-time cockpit aid that has been evaluated in simulators 
with rated pilots. Both tools incorporate models of the vestibular system and assessor heuristics to predict the 
epoch and probability of an SD event such as leans, coriolis or graveyard spiral illusions, and any other disparities 
between actual and perceived pitch attitude (somatogravic), roll rate or yaw/heading rate. SOAS assesses multi-
sensory workload to determine the types of countermeasures to trigger and when to trigger them. SDAT also will 
help human factors engineers analyze past Shuttle landing incidents and will aid CEV/LSAM landing and ascent 
trajectory planning. It can aid LSAM cockpit displays, caution and warning system design, workload evaluation, 
and crew training and mission simulation. SDAT could assist flight surgeons with post-flight medical debriefings. 
Deliverables:  
Enhance the utility of SDAT/SOAS by including comprehensive mathematical models for vestibular and visual 
sensory cues, help translate CNS gravitoinertial force resolution into perceived tilt and translation estimates, and 
revalidate existing aeronautical data sets 
Extend the models to describe zero gravity and Shuttle/LSAM landing illusions, validating the models using 
Shuttle data sets and existing (e.g. ROTTR) theory  
Extend SDAT/SOAS to consider multiple visual frames of reference (inside and outside), panel and heads-up 
(HUD) orientation displays, the effects of visual attention and sensory workload, and the cognitive costs of 
mental rotation and reorientation. The enhanced SDAT/SOAS from Aims 1-3 will be validated via flight 
experiments 
SOAS will be tailored for a lunar landing using multi-sensory workload to choose appropriate countermeasures 
and their timing.  
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Required Delivery Milestone:  
FY10: Recommendations to Orion CDR for interface design, displays and C&W systems in relation to spatial 
orientation 
FY11: Input to Lander SRR regarding design requirements for interfaces, displays, and C&W systems 
FY11: CR to HIDH to update requirements prior to Lander PDR 
FY11: Input to Lander PDR regarding design solutions for interface design, displays and C&W systems in 
relation to spatial orientation 
FY11: Research results delivered to HHC Element 
Required Platforms:  
Ground – Parabolic Flight 
Ground – Simulators 
 
Tasks: (NSBRI – Sensorimotor Adaptation Team,) 
Enhancement of Spatial Orientation Capability of Astronauts on the Lunar Surface (SM11) 
The scientific goal of this project is to develop a Lunar Astronaut Spatial Orientation and Information System 
(LASOIS) that will enhance an astronaut's spatial orientation capability and reduce sensorimotor risks during 
manned and landed lunar mission operations. Supported by LASOIS, astronauts will be capable of overcoming 
disorientation in lunar surface operations caused by microgravity and the altered visual environment through 
spatial information provided by the Earth control center and collected by a coordinated group of sensors from 
lunar orbit, descending path and ground. The developed spatial orientation strategy, system, and training will 
allow astronauts to have a systematic preparation for complex mission scenarios where spatial operations, 
efficient interactions and communications are required among the Earth-based control center, lander(s), lunar 
vehicle(s), outposts and astronauts. This capability is extremely important for lunar operations that will have an 
extensive traversing region (around 100 km). This project directly supports the key sensorimotor risk by 
providing the advanced LASOIS to reduce/remove the disorientation risk. Risks can be significantly reduced by 
improving the spatial orientation capability through use of the proposed LASOIS system. 
Deliverables:  
To investigate methods for removal and/or alleviation of astronaut disorientation in a lunar surface operations 
setting by using integrated information technology, and psychological and cognitive research on spatial 
orientation and navigation;  
To develop the LASOIS; and  
To train astronauts to enhance their spatial orientation capability in a LASOIS-supported simulated lunar 
environment. 
Required Delivery Milestone:  
FY10: Recommendations to Orion CDR for interface design, displays and C&W systems in relation to spatial 
orientation 
FY11: Input to Lander SRR regarding design requirements for interfaces, displays, and C&W systems 
FY11: CR to HIDH to update requirements prior to Lander PDR 
FY11: Input to Lander PDR regarding design solutions for interface design, displays and C&W systems in 
relation to spatial orientation 
FY11: Research results delivered to HHC Element 
Required Platforms: TBD 
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SHFE 3.1.2.3.2:  How do we develop computer interface requirements that will ensure the 
commonality of the interface designs across multiple Constellation vehicles?   
Tasks: (New SHFE – Directed) 
Interface Design and Commonality 
As the development of Constellation vehicles (Orion, Lander, surface system habitats, rovers) spans years, it is 
fairly certain that technologies will advance and multiple contractors will be involved in the design development 
and eventual construction. With the desire to use the most current hardware and software system technology and 
materials, there is a risk that disconnects between the vehicles will occur – disconnects that have the potential to 
demand increased training for the crew, limited utility amongst and between the vehicles if replacements and 
spares are required, and that interface conventions may not be common.  A simple hardware example is a light 
switch that when activated in the upward direction is an indicator for “on” in one vehicle, but when activated 
upward is an indicator for “off” in another vehicle.  This will introduce confusion and risks for the safety of the 
crew, as well as their performance.  What is desired are common conventions across these interfaces no matter 
where they are utilized?  Computer interfaces are no different in approach.  Common computer interface design 
solutions and standards need to be developed. 
Deliverables:  
Development, assessment and validation of proposed solutions/ standards for design of common interfaces 
Required Delivery Milestone:  
FY10:  Development of proposed solutions/standards  
FY11:  Lander SRR common computer interface requirements 
FY12:  CR to provide initial information for human system standards (HIDH and HSIR) 
FY13:  CR to update final standards/solutions for human system standards and design handbook (HIDH and 
HSIR). 
FY13: Design solutions to Lander PDR 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups  
SHFE 3.2.2.2.2:  How can we integrate multiple types of information and prioritize it appropriately 
to ensure mission success?   
Tasks: (New SHFE – Directed Study or NRA) 
Information Integration and Presentation 
During critical events, or when acquiring a new skill, information ‘overload’ can be as harmful as lack of 
information.  The purpose of this task is to develop systematic methods of integrating information from multiple 
sources and providing it in a prioritized way that supports the crewmember’s immediate needs.  Organization 
schemes, coding schemes will be developed and evaluated in simulators and in flight tests. 
Deliverables:  
Assessment and development of information integration and prioritization model. 
Flight/simulation validation of model. 
Data analysis. 
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Required Delivery Milestone:  
FY13: Initial information and approach delivered for Lander PDR 
FY15: CR to HSIR, HIDH to provide initial requirements prior to Lander CDR 
FY16: Initial study results and recommendations to Lander CDR 
FY16: CR to HSIR and HIDH to provide final requirements to Lander and Habitat 
FY17: Final results from data analysis to Lander and Habitat 
Required Platforms:  
Ground: Laboratory Test beds  
Ground: Mockups  
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RISK OF IMPAIRED ABILITY TO MAINTAIN CONTROL OF VEHICLES AND 
OTHER COMPLEX SYSTEMS –  
CRITICALITY: LUNAR OUTPOST – D, MARS – I  
 
It has been shown that long duration Spaceflight alters sensorimotor function which manifests as changes 
in locomotion, gaze control, dynamic visual acuity, and perception. These changes have not specifically 
been correlated with real time performance decrements.  The possible alterations in sensorimotor 
performance are of interest for Mars missions due to the prolonged microgravity exposure during transit 
followed by landing tasks. This risk must be better documented and NS changes must be better correlated 
with performance issues. 
Context of Risk for Exploration 
New evidence regarding landing performance indicates that research into these types of issues is not a 
high priority for Shuttle or ISS.  However, since Mars operational scenarios are still TBD, it is agreed that 
the ISS should be utilized to gather the data required to define the research that might be needed to enable 
future Mars mission operations.  Therefore, this risk is considered to have a higher priority than the others 
within the sensorimotor discipline do.  Spaceflight data should be collected (RMS, SSRMS, docking, 
glove box ops, Soyuz landings, etc.).  In addition, performance related to neurosensory dysfunction 
should be used to determine the need for further research and countermeasure development.   
Strategy for Mitigation 
Space normal must first be defined for this risk; hence, data mining tasks are ongoing.  Once space 
normal is defined, the data will be presented to the Human System Risk Forum and it will be decided if 
countermeasures need to be developed.  In addition, the NRA solicitation process was utilized to obtain 
proposals to determine any manual and visual control deficits.   
Gaps 
SM1: What is the relationship between the mode of in-flight exercise and post-flight sensorimotor 
performance?  The sensorimotor team should data mine to determine if data exist for this gap. 
Task: (NxPCM – via directed study) 
Sensorimotor Performance Data Mining 
It is proposed that the type and amount of in-flight exercise performed by crewmembers may influence post-flight 
disturbance in balance and locomotion.    Exercise logs for both US and Russian crewmembers will be evaluated 
to determine the relationship between the types of in-flight exercise performed and post-flight sensorimotor 
performance. 
Deliverables: Data will be collected and passed to HSRF.  It will also be used to inform ECP of any exercise and 
sensorimotor issues and used to provide any updates to the sensorimotor standard. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Access to Flight Medicine, JSC Biomedical Research Laboratory data, and LSDA 
databases is necessary for the data mining study. 
SM2: What is the time course of recovery of sensorimotor function after long duration space flight?  
This data can be used to make scheduling recommendations for planetary post-landing operations. 
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Task: (NxPCM – via directed study) 
Sensorimotor Performance Recovery Data Mining 
After long duration space flights, astronauts require time to return to pre-flight sensorimotor performance.  This 
study will compile the recovery data from previous long duration astronauts to determine the average amount of 
time that is required for sensorimotor function recovery. 
Deliverables: Data will be collected and passed to HSRF.  It will also be used to inform Flight Medicine of any 
recommended recovery protocols and used to provide any updates to the sensorimotor standard. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Access to Flight Medicine, JSC Biomedical Research Laboratory data, and LSDA 
databases is necessary for the data mining study. 
SM4: Can previous performance data be correlated with clinical observations?  Attempts should be 
made to obtain ISS EVA performance data from previous missions.  If that is not feasible, a strategy 
should be developed to gather forward data.  No research should be undertaken until this evidence is 
obtained.   
Task: (NxPCM – via directed study) 
Performance Data Mining 
This study will compile data recorded from previous missions regarding ISS EVAs.  The purpose of this data-
mining task is to gain additional operational data. Lessons learned from this analysis can be applied to the 
Constellation Program to ensure that the evidence for sensorimotor changes in crew performance as a result of 
space flight is thoroughly assessed.   
Deliverables: Initial product is space normal data from a data-mining task.  If results indicate that no data exist, 
then data should be obtained using ISS flight studies. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Access to Flight Medicine, JSC Biomedical Research Laboratory data, and LSDA 
databases is necessary for the data mining study. 
ISS may be required to obtain space normal data.   
SM5: What are the effects of disorientation and inter-individual differences on supervisory control, 
docking, RMS etc?  Evidence must be gathered to support this gap.  No research should be undertaken 
until this evidence is obtained. 
Task: (NxPCM – via directed study) 
Performance Data Mining 
This study will compile data recorded from previous missions regarding manual control and landing.  The 
purpose of this data-mining task is to gain additional operational data and insight regarding Shuttle landings that 
occurred outside the operational limits to determine the multi-factorial causes that led to the landing outcomes. 
Lessons learned from this analysis can be applied to the Constellation Program to ensure that the evidence for 
sensorimotor changes in crew performance as a result of space flight is thoroughly assessed.  Data will also be 
gathered from available data from RMS operations, EVAs, and Shuttle/Soyuz docking operations relevant to 
manual control.  
Deliverables: Initial product is space normal data from a data-mining task.  If results indicate that no data exist, 
then data should be obtained using ISS flight studies. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Access to Flight Medicine, JSC Biomedical Research Laboratory data, and LSDA 
databases is necessary for the data mining study. 
If data do not exist, the ISS is required.  
HRP-47065 
 
207 
SM6: Can a seated manual/visual performance assessment after long-duration spaceflight be 
completed?  It is necessary to determine if a crewmember can land a vehicle after six months in 
microgravity.  This gap needs to be placed in the context of the expected operating environment of future 
vehicles.  Design of future vehicles should account for human factors in the cockpit and task design to 
avoid provocative movements or physically difficult tasks. 
Task: (NxPCM – via NRA) 
Manual/Visual Control Study – TBD 
Proposals were solicited in the 2008 NRA to answer the following questions.  What is the decrement in 
manual/visual performance following long-duration spaceflight?  What are the mechanisms of the decrement?  
What countermeasures are needed? 
Deliverables: Initial product will be completion of an ISS pre- and post-flight study to determine seated 
manual/visual control performance (i.e., landing a spacecraft).   
Required Delivery Milestone: FY2023 – countermeasure required for exploration missions 
Required Platforms: ISS is required for this study; long-duration crews are needed.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None 2.5 
 
Task: (NxPCM – with ESA) 
Ambiguous Tilt and Translation Motion Cues After Space Flight/Otolith Assessment during Post-Flight Re-
Adaptation 
This experiment is designed to explore the physiological basis for disorientation and tilt-translation disturbances 
reported by crewmembers when making head movements following re-entry, and to evaluate adverse operational 
implications of these disturbances.  In addition, it is intended to examine assess human otolith function by 
measuring: unilateral otolith-ocular responses (OOR); an estimation of subjective visual vertical (SVV) during 
unilateral otolith stimulation; and unilateral vestibular evoked myogenic potentials (VEMP) during post-flight re-
adaptation.  This is a joint HRP/ESA investigation. 
Deliverables: The product will be further information regarding sensorimotor adaptations to spaceflight. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: ISS is required for this study; long-duration crews are needed.   
 
Task: (NSBRI) 
Development of Countermeasures to Enhance Sensorimotor Adaptation 
This study is developing a comprehensive training program that will enhance astronauts' ability to "learn how to 
learn," leading to rapid adaptation to a new gravity environment. The training program involves exposure to 
modified visual flow along with alterations in the support surface designed to enhance subject adaptability. The 
researchers will also determine the short- and long-term (10 days to 6 months) retention rates after the training 
program. 
Deliverables: Initial product will be a ground-based evaluation of a potential countermeasure.   
Required Delivery Milestone: FY2023 – countermeasure required for exploration missions 
Required Platforms: This is a ground-based investigation.   
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SM3: What is the appropriate rehabilitation protocol for sensorimotor function?  There is no 
research required for this gap; it will be taken to HSRF to determine any closeout actions. 
SM10: There are no stated acceptable ranges of cognitive and psychomotor performance.  HHC has 
closed this gap; it has been incorporated into BHP.  Refer to The Risk of Performance Errors Due to Sleep 
Loss, Fatigue, Circadian Desynchronization and Work Overload, Gap Sleep2 for details 
SM13: Incorporate vestibular assessments within the in-flight periodic exams. 
SM15:  Need to adopt a multi-disciplinary approach to identify crewmembers at greatest risk of falls; also 
need to implement and track directed rehabilitation 
SM16:  Need to insure that astronauts at risk of falls are accompanied until the risk diminishes to 
acceptable levels. 
SM17:  Require an astronaut post-flight fall risk assessment that should be a coordinated effort between 
crew surgeons, ASCRs, and discipline researchers.  There is no research required for these gaps; they will 
be taken to HSRF to determine any closeout actions. 
SM11: Need to provide alternate sources for spatial orientation. 
SM12: Need to develop standards for spaceflight cockpit control displays and inputs.  HHC has closed 
these two gaps; they have been incorporated into SHFH.  Refer to the Risk of Error due to Inadequate 
Information gaps SHFE3.1.2.2.2.1 and SHFE3.1.2.2a for details. 
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OUTPOST – D, MARS – C
It is critical that crewmembers be adequately nourished before and during missions.  Critical research 
areas within this risk include validation of the correct nutritional needs; assessment of the stability of 
nutrients during long duration flight; correct packaging and preservation techniques; effects of 
countermeasures on nutrition; and use of nutrients as countermeasures. 
Context of Risk for Exploration 
As mission duration increases, the risk of nutrient deficiencies becomes greater.  Nutrient requirements, 
nutrient delivery requirements, and the need to preserve the nutrient content in food will increase as the 
frequency and duration of EVAs increase and during the very long Mars missions.  Nutritional 
countermeasures can influence all systems. 
Strategy for Mitigation 
Space normal must be defined for this risk; hence, the Nutrition Supplemental Medical Objective (SMO) 
is ongoing.  Once space normal is defined, the data will be presented to the Human System Risk Forum 
and it will be decided if countermeasures need to be developed.  In addition, several studies are ongoing 
to determine the optimal dose of vitamin D. 
Gaps 
N1: Are nutrients in food are stable during space flight?  This gap and all the tasks associated with it 
are being filled by AFT within SHFH; please refer to the Risk of Inadequate Food System, Gap AFT2 for 
further information. 
N2: What is the optimal dose of vitamin D supplementation?  It is unknown if the current vitamin D 
dosage is optimized, further work needs to be completed. 
Task: (NxPCM – via directed study) 
Vitamin D Status in an Antarctic Ground Analog of Spaceflight 
This task will support a vitamin D supplementation study that will evaluate efficacy in this model.  Ultimately, 
the findings will provide long-duration spaceflight crewmembers with evidence-based vitamin D supplement 
recommendations for optimal vitamin D status before, during, and after flight. 
Deliverables: Initial product is ground-based study to determine optimal vitamin D dosing.   
Required Delivery Milestone: No delivery milestone is required for this task. 
Required Platforms: Ground-based models with limited sunlight exposure are necessary for evaluating vitamin 
D supplementation efficacy.  One such model is subjects spending the winter in Antarctica, where UV-B radiation 
levels are zero during the winter.  
 
Vitamin D Supplementation in an Antarctic Ground Analog of Space Flight: Study of Supplementation Protocol 
and Relationship to Immune System Function 
A supplement of 2000 IU/d raised serum 25-hydroxyvitamin D to acceptable levels, but compliance was an issue 
that needs to be overcome. In the study proposed here, we will investigate whether a weekly dose of 10000 IU 
vitamin D could be substituted for this daily 2000-IU dose, and we will investigate the effects of vitamin D 
supplementation on immune function in an environment known to suppress immune function. The proposed 
ground analog study will enable us to provide long duration spaceflight crewmembers with evidence-based 
vitamin D supplement recommendations for optimal vitamin D status before, during, and after flight. 
Deliverables: Initial product is ground-based study to determine optimal vitamin D dosing.   
Required Delivery Milestone: No delivery milestone is required for this task. 
Required Platforms: Ground-based models with limited sunlight exposure are necessary for evaluating vitamin 
D supplementation efficacy.  One such model is subjects spending the winter in Antarctica, where UV-B radiation 
levels are zero during the winter.  
 
Task: (NxPCM – via directed study) 
Vitamin D Supplementation: Evaluation of Dosing Regimen 
In this study, we will investigate whether a weekly or monthly dose of vitamin D could be substituted for a daily 
dose. Data from this study will help us to provide long-duration space flight crewmembers a safe, effective, and 
evidence-based recommendation for vitamin D supplementation to achieve and maintain optimal vitamin D status 
before, during, and after flight. 
Deliverables: Initial product is ground-based study to determine optimal vitamin D dosing.   
Required Delivery Milestone: No delivery milestone is required for this task. 
Required Platforms: Ground-based models with limited sunlight exposure are necessary for evaluating vitamin 
D supplementation efficacy.  One such model is subjects spending the winter in Antarctica, where UV-B radiation 
levels are zero during the winter.  
 
Task: (NxPCM – via Directed Study) 
Nutrition Status Assessment – SMO O16E: Nutrition SMO  
This is a directed study that seeks to expand the Medical Requirement 016L testing in three ways:  1) include in-
flight blood and urine collection, 2) expand nominal testing to include makers of normative markers of nutritional 
assessment, and 3) add an R+30 session to allow evaluation of post flight nutrition and implications for 
rehabilitation.  Additional markers of bone metabolism (helical peptide, OPG, RANKL, IGF-1) will be measured 
to better monitor bone health and countermeasure efficacy.  New markers of oxidative damage will be measured 
(8-iso-prostaglandin F2a, protein carbonyls, oxidized and reduced glutathione) to better assess the type of 
oxidative insults during space flight.  The array of nutritional assessment parameters will be expanded to include 
serum folate, plasma pyridoxal 5'-phosphate, and homocysteine to understand better changes in folate, vitamin B6 
status, and related cardiovascular risk factors during and after flight.  Additionally, stress hormones and hormones 
that affect bone and muscle metabolism will be also measured (DHEA, DHEA-S, Cortisol, testosterone, 
estradiol).  This additional assessment would allow for better health monitoring, and allow for more accurate 
recommendations to be made for crew rehabilitation.  These additional parameters were added due to the 
recommendation of an extramural panel that met to define nutritional standards and requirements in 2005.  If data 
indicate countermeasures are necessary for cardiovascular issues and/or bone loss, additional ground-based 
studies will be initiated.  These countermeasures will be validated on board the ISS 
Deliverables: The SFHSS nutrition standard will be updated and nutritional requirements will be delivered to 
AFT.  Updates regarding nutritional status in-flight will be delivered to the Human System Risk Forum.  All 
deliverables are scheduled for delivery in the FY2011 timeframe. 
Required Delivery Milestone:  ISS is required to ensure that the data represents space normal. 
Nutrition Status Assessment – SMO O16E: Nutrition SMO (cont’d)
Required Platforms: The ISS is required to validate the countermeasure. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew Time/ 
Subject (hrs) 
Post-Flight 
BDC Time (hrs) 
12 None 31 kg/Inc 5.1 kg + TBD 
cold 
stowage/Inc 
22.5 3.2 (Time 
shared with 
Medical 
Operations 
Time) 
N3: How do nutritional status/nutrition requirements change during spaceflight? 
Task:  
Nutrition Status Assessment – SMO O16E: Nutrition SMO 
See this Risk – Gap N1, N2 for details.   
N6: What impact does flight have on oxidative damage? 
N15: Can nutrition/nutrients mitigate O2/radiation risks? 
Task:  
Nutrition Status Assessment – SMO O16E: Nutrition SMO  
See this Risk – Gap N1, N2 for details.   
 
Task: (NxPCM – via directed study) 
NEEMO Rapid Operational Investigation (ROI) study:  Characterization of Oxidative Damage during a 12-day 
Saturation Dive 
Oxidative damage resulting from radiation and or oxygen exposure (e.g., during EVAs) is a concern for space 
travelers.  The underwater analog, NEEMO, is a valuable ground-based model for space flight in terms of 
oxidative damage and changes in iron metabolism.  In six (6) subjects from NEEMO5, there was evidence of 
oxidative damage similar to what is observed during long-duration spaceflight.  In this study, the main objective 
is to confirm and extend the physiological systems that were affected during the previous NEEMO study.  
Oxidative damage will be assessed before, during, and after the 12-day mission in the NEEMO habitat.  As a 
result of this study, we will have a better understanding of the type of oxidative damage that occurs in an elevated 
oxygen environment, and the data can be used to better design countermeasures against this type of damage.   
Deliverables: Initial product is completion of NEEMO study and final report of findings. Study results will be 
combined fed into the solicitation for the oxidative damage study being solicited through NIH. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Ground-based studies, NEEMO underwater analog facility 
 
Oxidative Damage Stud – TBD
This work is to be solicited through NIH. 
Deliverables: TBD 
Required Delivery Milestone: If a countermeasure is required, it is needed as soon as possible. 
Required Platforms: Ground-based studies, ISS required for validation of any needed countermeasures 
N4: Do countermeasures impact nutrition? This gap is closed; nutritional requirements are constantly 
being modified and updated. 
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RISK OF INADEQUATE FOOD SYSTEM – CRITICALITY: LUNAR OUTPOST – D, 
MARS – C  
If the food system does not adequately provide for food safety, nutrition, and acceptability, then crew 
health and performance and the overall mission may be adversely affected.  Furthermore, if the food 
system uses more than its allocated mission resources, then total required mission resources may exceed 
capabilities, the mission deemed unfeasible, or allocation of resources to other systems may be unduly 
constrained. 
The Advanced Food Technology (AFT) Project is responsible for optimizing methods required to 
preserve, package, and ship, stow and prepare the food while still preserving the nutritional value.  The 
nutritional content of the flight food items is not currently measured.  However the retort, irradiation, and 
freeze-drying processes used to produce shelf stable products, reduce the nutrient content.  The nutrient 
levels in prepared foods will be measured to ensure that they meet the requirements of nutrition.  If the 
nutrient levels are not adequate, other preservation methods that maintain the nutrient contents of the 
foods will be investigated.  Further, shelf lives of the current thermostabilized food products have never 
been determined.  Food items with varied formulations and bulk food ingredients have been placed in 
accelerated shelf life testing.  The approach will provide critical information about the quality changes of 
the food items and susceptibility of vitamins in the space food system to adverse environmental factors 
and storage encountered during space missions. 
Reducing the flight resources required for the food system is a major goal due to the significant ratios of 
rocket size to mass per pound of cargo delivered on an exploration mission.  Methods to reduce packaging 
mass and volume overhead will be studied.  These studies must overcome significant challenges of 
storing food for long periods of time (18 months for ISS to 5 years for a long duration exploration mission 
with pre-positioned food).  Food packaging materials must be developed that minimize mass required 
while providing an adequate oxygen and moisture barrier to maintain the required shelf lives. 
Operational Relevance and Risk Context  
The paramount importance of the food system in a long duration manned exploration mission cannot be 
underestimated.  The food system provides not only the nutrients needed for the survival and health of the 
astronauts, but it also enhances the psychological well being of the crew by being a familiar element in an 
unfamiliar and hostile environment.  Inadequacy of a food system can be influenced by four criteria: 
safety, nutrition, acceptability and an imbalance of vehicle resources such as mass, volume and crew time.  
Since quality loss, which includes the critical components of nutrition and acceptability, will occur over 
the shelf life of the food, additional research is needed to improve the understanding of the nutritional 
content of the food when consumed and how much variety, acceptability, and ease of use is required for 
different duration missions.  Research areas may include shelf life studies including the effects of time, 
temperature, and radiation; improvement in food preservation; improvement in food packaging, and 
evaluating the effect of the space environment and length of mission on food acceptability, variety, and 
ease of use.  Research is also required for the food systems necessary to support EVA and contingency 
suited operations.  The research will consider requirements to comply with the mission resources such as 
mass, volume, power, and crew time.   
There is considerable overlap between the food system, nutrition requirements, and crew behavior and 
performance.  The nutrition an astronaut receives is a function of both the nutritional content of the food 
and the amount of food that is actually consumed.  Nutritional requirements are determined by looking at 
the physiological needs of the crew due to microgravity, space radiation, or stress, as examples.  The food 
system delivers nutrition in the food.  Any nutritional losses in the food due to shelf life, exposure to the 
outside environment, or through processing, need to be taken into account.  The acceptability of the food 
system is closely related to crew performance since higher acceptability or variety of the food will 
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improve the well-being of the crewmember.  Crewmembers tend to reduce food consumption when 
confronted with a lack of variety or unacceptable foods.  
Strategy for Mitigation 
The approach the AFT Project has taken is to determine the technology gaps for a given mission.  It may 
be that for missions of short duration there is no need for mitigation.  Another type of mitigation is one 
based on less available upmass and volume allowed for food.  Once the risk for the specific mission has 
been identified, then the AFT Project determines whether there are commercially available technologies 
that can mitigate the risk.  If that is the case, then the project further evaluates the technology to determine 
whether the technology must be modified to approve the technology for flight. 
If there is not a commercially available technology, then the AFT Project must develop the technology by 
initially determining the requirements of the new technology.  Once the requirements are identified, the 
AFT Project determines whether to develop the technology internally in the Space Food Systems 
Laboratory, partner with other HRP Projects, or through a contract with external researchers.  An 
alternative approach, which leverages Human Research Program funding by partnering with the 
Department of Defense Combat Feeding Directorate (DoD CFD), uses a Military Interdepartmental 
Purchase Request (MIPR) between the AFT Project and DoD CFD. 
Gaps  
AFT1: How can the food system deliver the required level of nutrition throughout the mission?  
The nutrition requirements, determined by the Human Health and Countermeasures Element, are 
delivered via the food system and through supplementation.  There are requirements for nominal 
operations and contingency operations, as well as EVAs.  Packaged foods, rehydratables, 
thermostabilized, and irradiated products, are processed, which can reduce the nutritional content. In 
addition, extended storage of these foods and exposure to a variety of environmental conditions such as 
heat, oxygen, and space radiation will often affect the stability of the vitamins.   
Tasks: (AFT – Directed) 
In-Suit Food for Contingency Operations 
HSIR Requirement [HS11008] – The system shall provide the capability for nutrition consumption as specified in 
HS6062 by a crewmember in a pressurized suit during unpressurized vehicle survival operations  
Deliverables:  
Requirements for food structure (gel, bars, thick liquid) and shelf life on suited food delivery system  
Nutrient-dense foods needed for food delivery system 
Required Delivery Milestone: Requirements for food delivery system for EVA Suit Configuration-1 needed by 
SRR.  Foods needed for food delivery for EVA Suit Configuration-1 needed by CDR. 
Required Platforms: Ground  
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Tasks: (AFT – Directed) 
In-Suit Food for Lunar EVA Operations 
HSI Requirement [HS11007] – The system shall provide the capability for nutrition consumption as specified in 
HS6062 during the EVA by a crewmember performing surface EVA operations  
Deliverables:  
Requirements for food structure (gel, bars, thick liquid) and shelf life on suited food delivery system  
Nutrient-dense foods needed for food delivery system 
Required Delivery Milestone: Requirements for food delivery system for EVA Suit Configuration-2 needed by 
SRR.  Foods needed for food delivery for EVA Suit Configuration-2 needed by CDR. 
Required Platforms: Ground  
 
Tasks: (AFT – Directed) 
Effect of Processing on the Nutritional Content of Food  
The nutritional content of the flight food items is not measured for NASA’s flight food. The actual macronutrients 
and some minerals are determined chemically. However, the other nutrients such as vitamins are determined 
through a computer program that calculates the combined nutritional content based on the food products 
formulation. The computer program does not take into account the loss of nutrients during the thermostabilization 
process.  
Deliverables:  
Review literature to better understand the potential effects of the retort, irradiation, and freeze drying processes 
Optimize time/temperature processing conditions for each specific thermostabilized and freeze-dried food product 
that NASA produces 
Measure nutritional content of the finished product at time of production, 1 year and 3 years  
Develop improvements to the current ISS flight food using highly nutritious foods or emerging technologies such 
as high pressure processing and microwave sterilization if nutritional content of the foods do not meet the 
nutritional requirements 
Required Delivery Milestone: Provide nutritional content post-processing and after 1 and 3 years 
FY2015 – Required as a design solution to support the food system for operations on the Lunar surface. However, 
if information is available prior to this, it could be used to influence the food system for the ISS.  
Required Platforms: Ground  
 
Tasks: (NxPCM with collaboration by AFT – Directed) 
Stability of Pharmacotherapeutic and Nutritional Compounds: Stability SMO (Flight)  
This protocol involves investigative physical/chemical analyses of both medications and food items returned from 
STS and ISS along with corresponding lot-matched controls stored on ground in a controlled environment. This 
experiment has two (2) sub-payloads attached to it. See the Risk of Therapeutic Failure Due to Ineffectiveness of 
Medications for the Pharmacology sub-payload. The Nutritional Sub-Payload will identify vitamins and amino 
acids at risk for degradation in the space food supply; identify changes in fatty acids of foods flown on ISS; and 
characterize degradation profiles of the unstable nutrients. This study will provide critical information about the 
preservation of vitamins and nutrients in food during space flight and susceptibility of vitamins in the space food 
system to adverse environmental factors and storage conditions encountered during space missions.  
Deliverables: Analyses will determine whether low earth orbit environment (radiation) affects the nutritional 
content of the food. 
Required Delivery Milestone: The data will determine whether further ground based studies will be required to 
develop a design solution for Lunar mission CDR.  If the results suggest that the loss in nutrients is not due to 
space radiation but instead to time or processing, the results will be fed into the DoD Collaboration task.  
Required Platforms: ISS required for proper radiation doses on food samples.   
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AFT2: How can the nutrition and acceptability of the food system be maintained throughout the 
mission? 
Nutrition and acceptability are related.  The literature suggests that food quality (color, texture, etc.) may 
provide a general indication of nutritional loss of the food.   The activities in this gap are those that 
measure both nutrition and acceptability.  If the food is not acceptable to the crew, the crew will not eat an 
adequate amount of the food and will be compromised nutritionally.  Freeze-dried, thermostabilized, and 
irradiated foods are processed, which can reduce the quality including acceptability and nutritional 
content. In addition, extended storage of these foods and exposure to a variety of environmental 
conditions such as heat, oxygen, and space radiation will often affect the quality of the products.    
Tasks: (AFT – Directed) 
Thermostabilized Shelf-Life Study  
Shelf lives of the current thermostabilized food products have never been determined. Thirteen food items with 
varied formulations have been placed in accelerated shelf life testing. In addition, three bulk ingredients (for 
preparation for a Lunar outpost mission) were placed into accelerated shelf life testing. Sensory and analytical 
changes are measured throughout the three-year test.  
Deliverables: This task will ultimately result in a list of foods and/or preparation methods that maintain their 
stability to support a Lunar mission. It will also identify weaknesses of product types used in the current system 
allowing for enhancement of existing products or development of improved products.  Information about food 
product weaknesses will also support the DoD Collaboration task. 
Required Delivery Milestone: FY2015 – Required as a design solution to support the food system for operations 
on the Lunar surface (Lunar Mission CDR). However, if information is available prior to this, it could be used to 
influence the food system for ISS.  
Required Platforms: Ground  
 
Tasks: (AFT – Directed Study in collaboration with DoD) 
Department of Defense (DoD) Collaboration  
Although NASA’s food requirements are not compatible with those of the commercial food industry, they are 
compatible with those of the Combat Feeding Program (DoD). Both NASA and DoD require long shelf life, shelf 
stable food items with high barrier packaging. Both also require minimal packaging. The DoD Combat Feeding 
Program, when conducting their research, uses collaborations of subject matter experts from industry, 
government, and academia experts. Currently, the DoD has an on-going packaging research program as well as a 
program to investigate emerging preservation technologies.  These preservation technologies should result in 
FDA approval of high-pressure processing and microwave sterilization for shelf stable products. Both processes 
have a high potential for long duration Space Flight missions. 
Deliverables:  
Testing of advanced food packaging and preservation technologies for shelf stable foods 
Recommendations for advanced food packaging and preservation technologies for shelf stable foods  
Required Delivery Milestone: FY2023 (NOTE: Need date for Lunar outpost CDR is TBD) – Food system 
requirements definition needed for long-duration Lunar outpost and Mars Missions. However, if information is 
available prior to this, it could be applied to the ISS food system if it would positively impact its long-term 
nutrient stability or reduce food logistics. 56 HRP-47065 
Required Platforms: Ground  
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Tasks: (Directed Study for Summary; Additional research, if required, will be External Research) 
Effect of Space Radiation on Shelf Life  
Destruction of even a single vitamin in the space food system could be catastrophic to astronauts on a 3-year 
mission to Mars. Although about 60 different foods have been approved for irradiation to ensure the safety of 
these foods from microorganisms, very little testing has been conducted on the effect of radiation on the stability 
of nutritional content.  The Joint Expert Committee on Food Irradiation (JECFI) convened by the Food and 
Agriculture Organization of the United Nations, the World Health Organization, and the International Atomic 
Energy Agency, concluded in 1980 “the irradiation of any food commodity” up to an overall average dose of 10 
kGy “presents no toxicological hazard” and requires no further testing.  In other words, the research has been 
concentrated on the toxicological effects and not nutritional stability. 
Preliminary results from some NASA-funded research indicate that some functionality and quality changes occur 
in foods and food ingredients at lower radiation levels. If results from the ground and flight stability studies 
indicate nutrient loss due to radiation, further research will be required to determine quality changes at 
appropriate dosage levels for Mars and Lunar missions and the appropriate countermeasures. 
Deliverables:  
Summary of radiation effects on food using literature and NASA-funded research.  
If the data suggests that there is a nutritional or quality loss due to radiation exposure to the food, then further 
research will be conducted to determine the changes in quality and nutritional content of foods over time when 
exposed to the appropriate dose of radiation.  
Food system design solutions as countermeasures to the effects of radiation. 53 HRP-47065  
Required Delivery Milestone: Constellation Program informed of food system requirements in 2010. Required as 
a design solution to support food system for ops on lunar surface (Lunar mission CDR).  
Required Platforms:  
Ground based study.  
Further ISS or Lunar testing may be required depending on results from ISS Stability Study and other data 
collected.  
AFT3: How can the acceptability of the food system be maintained throughout the mission?  
If the food is not acceptable to the crew, the crew will not eat an adequate amount of the food and will be 
compromised nutritionally. Anecdotal reports have suggested that the food does not taste the same in 
microgravity. Other reports indicate that the crew craves different foods on-orbit as compared to on-Earth. 
In addition, the crew has reported that they tire of certain foods over the 6-month ISS mission.  
Tasks: (AFT – External research) 
Sensory Qualities in Microgravity  
Determine effect of changes in aroma detection due to fluid shift and lack of air circulation in microgravity.  
Determine effects of “long term acceptability.”  
Validate with ISS study incorporating surveys of food quality and acceptability.  
Deliverables: Requirements for a food system intended for long-duration operations  
Required Delivery Milestone: FY2017 (NOTE: Need date for Lunar Outpost PDR is TBD.)- Food system 
requirements definition needed for long-duration Lunar outpost and Mars Missions. However, if information is 
available prior to this, it could be used to influence the food system for ISS.  
Required Platforms:  
Ground  
Possible validation on ISS  
 
HRP-47065 
 
225 
Tasks: (AFT – External research) 
Variety, Acceptability, and Usability Requirements Development (TBR-7)  
Determine requirements for the food system specific to variety of foods, taste acceptability, and usability 
(performed primarily through taste panels and surveys).  
Deliverables: Requirements on the food system for long-duration operations  
Required Delivery Milestone: FY2017 (NOTE: Need date for Lunar outpost PDR is TBD) – Food system 
requirements definition needed for long-duration Lunar outpost and Mars Missions. However, if information is 
available prior to this, it could be used to influence the food system for the ISS. 
Required Platforms: Ground  
 
Tasks: (BHP – Directed Study or External) 
Psychosocial Requirements of Food Operations (eating together, holiday foods, etc)  
Requirements and guidelines development process requiring little if any research. The requirements development 
will consist of recommendations to mission ops for eating times, group meals, special foods, holiday foods, etc. 
Requirements will be developed in conjunction with the crew office and the AFT Project.  
Deliverables: Requirements of food system and mission operations  
Required Delivery Milestone: FY2017 (NOTE: Need date for Lunar outpost PDR is TBD) – Food system 
requirements definition needed for long-duration Lunar outpost and Mars Missions. However, if information is 
available prior to this, it could be used to influence the food system for ISS. 
Required Platforms: Ground  
AFT4:  What technologies can be developed that will efficiently balance appropriate vehicle 
resources such as mass, volume, and crew time during exploration missions with the safety, 
nutrition, and acceptability requirements?  
The balancing of resources with nutrition and acceptability is dependent on the specific mission. For 
example, the 2-week initial missions to the Moon will consider mission resource utilization of primary 
importance due to the small usable volume in the vehicle. Since the missions are shorter, nutrition and 
acceptability may not be as critical.  Ineffective use of vehicle resources such as mass, waste, and crew 
time can jeopardize mission success. Mass of the packaged food system is based on mass of the food and 
the packaging surrounding the food.  Food packaging produces a significant amount of waste. A 
bioregenerative food system, while providing the crew with fresh foods and using less packaged food, 
will require more crew time, power needs and water. Trade studies will be required to determine the best 
use of resource utilization while balancing the other food system requirements. 
Current preflight procedures and existing research plans incorporate good manufacturing processes 
(GMP) to insure food safety. However, with new processes planned Lunar and Mars missions, GMP will 
need to be developed to reduce the risk of food borne illness.   
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Tasks: (AFT – Directed for Packaging Workshop and Comparative Packaging Study, SBIR is funded through 
SBIR Program and External Research Project) 
Advanced Packaging Material Development  
Currently the packaging used for freeze-dried foods and natural form foods does not have adequate oxygen and 
moisture barrier properties to allow for an 18-month shelf life for ISS. Therefore, those foods are over wrapped 
with a second foil-containing package that has higher barrier properties. The packaging material used for the 
thermostabilized, irradiated, and beverage items contain a foil layer to maintain product quality over at least the 
required 18-month shelf life. Although foil in the packaging material provides excellent oxygen and moisture 
barrier properties, it is not compatible with microwave sterilization and high pressure processing.  These 
emerging preservation technologies have the potential of providing NASA with a higher quality food system.  
The foil layer within the food package may also provide complications if the decision is made to incinerate the 
trash on the Lunar or Martian surface. Therefore, research to develop a packaging material that has the barrier 
properties of foil without the presence of foil is necessary.  
• Comparative Packaging Study – determine whether any current flight packaging can be used as the primary 
package for freeze-dried and natural form foods.  
• Small Business Innovative Research (SBIR) Program – evaluate SBIR deliverables and integrate if acceptable 
with current food system 
• External Research Project – development of new high barrier, foil-free packaging material  
Deliverables: Food packaging technologies that reduce the overall mass and volume required for the food system  
Required Delivery Milestone: FY2015 – Required as a design solution to support the food system for operations 
on the Lunar surface (Lunar Mission CDR).  However, if information is available prior to this, it could be used to 
influence the food system for ISS.  
Required Platforms: Ground  
 
Tasks: (AFT – Directed) 
Packaged food mass reduction trade study 
In order to provide a lower mass and volume food system for the Constellation Program, changes in product 
formulation may be necessary. Changes under consideration include removing some water from the total food 
system, increasing fat content, or increasing nutrient density of the food items.  
Deliverables:  
Trade study to consider options to reduce mass of food. Determine best-case scenario for further development.  
Determine commercial availability of foods with preferred scenario.  
Develop technologies for food product development if not commercially available.  
Required Delivery Milestone: Food system requirements for first Orion mission (2015) 
Required Platforms: Ground  
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Tasks: (AFT – Directed) 
Total System Approach to Packaging Material Selection 
There is a need for a total systems approach when the goal is maximizing shelf life and minimizing packaging 
mass.  The packaging material is only one portion of the system, and must not be considered the main focus of the 
packaging system. Defining and improving key result areas of the packaging process will increase the shelf life of 
foods without increasing total mass. 
Deliverables:  
Define existing packaging system – temperature, heat seal width, times, vacuum, materials, septums, gases, 
packaging design 
Literature review – available materials, pinholes/defects, modified atmosphere or gas flushing, shelf life 
Document possible improvements to existing system 
Recommendations for future work  
Required Delivery Milestone: Packaging options to reduce mass and improve food quality by Lunar mission PDR 
Required Platforms: Ground  
 
Tasks: (AFT – Directed) 
Bulk Overwrap Packaging Alternative 
Using a bulk overwrap system instead of individual package overwrap will save on mass and volume for longer 
duration missions.  The overwrap can also be used as a flexible container to save on mass and volume in the 
shorter duration Orion missions. 
Deliverables:  
Select materials to test 
Develop efficient method for packaging – vacuum packaging, gas flushing, heat sealing 
Evaluate scavenger systems 
Evaluate the possibility of creating innovatively shaped packages 
Compare mass of bulk overwrap system vs. individual overwrap 
Compare mass of bulk overwrap system vs. current ISS rigid container system  
Required Delivery Milestone:  
Required as a design solution to support food system Orion missions as “food container” for Orion CDR 
Food system requirements for Lunar SRR and Mars missions 
Required Platforms: Ground  
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Tasks: (AFT – Directed or External) 
Partial Pressure Effects on Food Processing and Preparation  
Heat and mass transfer are affected by reduced atmospheric pressure. When preparing raw foods into edible 
ingredients, it is necessary to reach a certain temperature/time combination to ensure safety and functionality. It is 
being proposed that the Lunar habitat will maintain an 8-psi atmospheric pressure. At that pressure, the boiling 
temperature for water is 181oF. If incomplete heating does occur, research will be required to determine 
countermeasures.  
Deliverables:  
Determine whether there is incomplete cooking.  
If there is incomplete cooking, what is the mitigation strategy? 
Used as an input to the trade study (see next task).  
Ultimately results in requirements on the Lunar Outpost Food System regarding food preparation and/or 
processing equipment.  
Required Delivery Milestone: Lunar Outpost SRR is scheduled for early FY2012.  At that time, the trade study 
for which this task is to feed into would require completion by end of FY 2011.  This task and the upcoming trade 
study are not scheduled in time to provide input by Lunar Outpost SRR.   
Required Platforms: Ground with validation on ISS or Lunar surface  
 
Tasks: (AFT – Directed) 
Food Processing vs. Packaged Food System Trade Study (TBR-9)  
Preliminary studies suggest total mass of the food system can be reduced if the food system moves towards a 
bioregenerative food system. In a bioregenerative food system, vegetables, and fruit would be grown on the Lunar 
or Mars surface and baseline crops such as soybeans, wheat, rice, peanuts, and dried beans would be grown or 
launched in bulk from Earth. The baseline crops would be processed into edible ingredients. The edible 
ingredients and freshly grown fruits and vegetables would be used in preparing meals in the galley.  Some 
packaged food would likely be required.  
Further studies are required to determine the magnitude of mass savings and the effect on other mission resources 
such as power, crew time, and recycling of water used for food processing. These studies will also identify the 
equipment that would be required to be built for the Lunar surface test.  
A trade study that considers efficiencies and adequacies of the two food systems with a recommendation to the 
Program is required. 
Deliverables:  
Requirements on vegetable, fruit and baseline crops growth – could range from hobby to full bioregenerative food 
system 
Requirements for the Lunar Outpost Food System regarding food preparation and/or processing equipment  
Mass and volume requirements for various levels of food processing and food preparation 
Recommendation to Constellation Program on whether to develop food preparation and food processing 
technologies for the Lunar Outpost 
Required Delivery Milestone: Lunar Outpost SRR is scheduled for early FY2012.  This trade study supports the 
decision process on whether to develop food preparation and food processing technologies and if so, to what 
extent.  This trade study is not scheduled in time to provide input by Lunar Outpost SRR.  
Required Platforms: Ground 
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Tasks: (AFT – Directed or External) 
Develop Processing and Preparation Equipment and Procedures  
If a bioregenerative food system is used, then miniaturized processing equipment will need to be built. It is 
unlikely that there will be commercial equipment appropriately sized for a Lunar or Mars mission. The 
preparation equipment for the galley will likely be commercially available gourmet kitchen appliances that will 
need to be modified for the Lunar missions.  
Deliverables: Food system processing and packaging technologies for a Lunar outpost or Mars mission.  
Required Delivery Milestone:  
FY2019 (NOTE: Need date for Lunar outpost SRR is TBD) to provide design solution for the food system for 
long-duration Lunar outpost and Mars Missions.  
Follow-on validation and optimization for Mars missions to occur in Lunar ops (Date TBD). 
Required Platforms: Ground with validation on Lunar surface  
 
Tasks: (AFT and/or Crop Systems team (TBD) – Directed or External) 
Vegetable Growth  
In order to provide the crew with fresh food on the Lunar surface and Mars missions, fruits, and vegetables will 
be grown hydroponically in environmentally controlled growth chambers. Significant research has been 
conducted to determine growth conditions and plant sensitivities to environmental changes. However, further 
research is required to finalize the environmental conditions for plant growth.  Since the fruits and vegetables may 
be consumed uncooked, research is required to determine the handling procedures pre- and post-harvest to ensure 
safety.  
Deliverables:  
Growth procedures for fresh vegetables and fruits  
Handling procedures to ensure safe, uncooked foods  
Required Delivery Milestone: FY2019 (NOTE: Need date for Lunar outpost SRR is TBD) to provide design 
solution for the food system for long-duration Lunar outpost and Mars Missions.  
Required Platforms: Ground with validation on Lunar surface  
 
HRP-47
230 
HRP-47
231 
HRP-47
232 
HRP-47
233 
HRP-47
234 
HRP-47
235 
HRP-47
236 
HRP-47065 
 
237 
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with Section 2.4 –  
Protect the Crew from Environmental Hazards 
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RISK OF RADIATION CARCINOGENESIS FROM SPACE RADIATION – C X C 
Near-term goals for cancer research focus on reducing the uncertainties in risk projections through the 
development of tissue specific models of cancer risks, understanding the underlying mechanisms of these 
models, and appropriate data collection at the NASA Space Radiation Laboratory (NSRL).  In the long-
term, extensive validation of these models with mixed radiation fields is envisioned and research on 
biological countermeasures and biomarkers will be pursued if needed.  Research on improving cancer 
projections has two major emphases: 1) validating the application of the National Council on Radiation 
Protection (NCRP) model and 2) reducing the uncertainties in the coefficients that enter into the cancer 
projection model.  Validation of the NCRP model relies on studies at the NSRL observing qualitative 
differences in biological damage between HZE nuclei and gamma rays and the establishment of how 
these differences relate to cancer risk.  There are distinct mechanisms of cancer induction across and 
within major tissue sites, and uncertainty reduction requires tissue specific risk estimates.  NRA and 
NASA Specialized Center of Research (NSCOR) selections focus on these major sites:  lung, breast, 
colon, stomach, esophagus, the blood system (leukemias), liver, bladder, skin, and brain.  There are 
differences in radiation sensitivity based on genetic and epigenetic factors and research in these areas aids 
the development of tissue specific cancer models.  
The approach to uncertainty reduction is based on evaluations of the assumptions in the current model for 
projecting cancer incidence and mortality risks for space missions.  The cancer rate is the key assumption 
in the evaluation; representing the probability at a given age and years since exposure of observing a 
cancer.  The life-span study of the atomic-bomb survivors is the primary source for gamma-ray data, 
however more recently meta-analysis of patients exposed to radiation or reactor workers for several 
tissues has become available and is used to check or replace the Japanese data.  Other assumptions in the 
model are made with regard to the transfer of risk across populations, the use of average rates for the US 
population, the age, and age-after exposure dependence of risk on radiation quality and dose-rate, etc.  
Collaborative research with the Department of Energy (DoE) Low Dose Research Program is a key 
component of the strategy.  The DoE program focus is on low Linear Energy Transfer (LET) irradiation; 
however, collaborative grants are selected from proposals that contain one or more Specific Aims 
addressing NASA interests using the NSRL.  This research augments SR research with a number of 
grants using state-of-the art approaches including genetics, proteomics, and transgenic animal models.  
The DoE research is an important component in reaching the goal to identify biomarkers of cancer risk.  
Determining the shape of the dose-response model for cancer induction is a near-term focus that is 
enumerated in biological terms through various cancer Gaps.  In the NCRP model, the dose-response is 
linear and the slope coefficient is modulated by radiation shielding.  Non-targeted models of cancer risk 
describe processes where cells traversed by HZE nuclei or protons produce cancer phenotypes in regions 
of tissues not limited to the traversed cells.  Non-targeted effects are the major mechanism that has been 
identified that is in disagreement with the NCRP model, and leads to a sub-linear dose response.  The 
implications of a sub-linear dose response for cancer risk are large since such a model predicts a reduced 
effectiveness for radiation shielding, and on the importance of mission length.  Research in this area is a 
major focus of studies at NSRL.  For some cancer sites and exposure conditions, e.g., proton exposures, 
the NCRP model may be adequate, and research here is focused on reducing the uncertainties in the 
model through the establishment of tissue specific models of human cancers, and collection of data at 
NSRL for a variety of ground-based analogs for Solar Particle Event (SPE) and Galactic Cosmic Rays 
(GCR).   
Systems biology models provide a framework to integrate mechanistic studies of cancer risk across 
multiple levels of understanding (molecular, cellular, and tissues), and are the most likely approach to 
replace the NCRP model.  Systems biology models are being developed by the Risk Assessment Project 
and several NSCOR’s, and in conjunction with data collection will improve the descriptions of cancer 
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risks and to lay a framework for future biological countermeasure evaluations and biomarker 
identification. 
Operational Relevance and Context of Risks for Exploration 
Permissible exposure limits (PEL) for Space Radiation limit the allowable mission and career exposure to 
the space radiation environment based on the projected risk of developing cancer.  The PEL’s protect 
against the upper 95% percent confidence level in the career radiation limits because the uncertainties in 
risk projection models are significant (>4-fold) such that the use of a median risk estimate could greatly 
over-estimate or under-estimate the actual risk to crews.  
Mission, vehicle, and crew selection requirements are outcomes of the Space Radiation PELs, including 
requirements on vehicle design, mission duration, and age, gender, or past mission history for crew 
selection.  Current estimates of mission duration limits that result from cancer fatality risks alone are 
shown in Table 1, comparing estimates made in 2001 without the benefit of the most recent research 
knowledge, to current estimates. 
Age, yr Females Males 
 Previous 
(2001) 
days 
Current 
(2006) 
days 
Previous 
(2001) 
days 
Current 
(2006) 
days 
30 54 112 91 142 
35 62 132 104 166 
40 73 150 122 186 
45 89 182 148 224 
50 115 224 191 273 
TABLE 1.  INCREASING SAFE DAYS IN SPACE WITH REDUCTION IN UNCERTAINTIES 
Research to reduce uncertainties in risk projection models are expected to increase NASA’s ability to 
select crew, extend mission duration, and reduce cost through possible reductions in shielding 
requirements.  Improved knowledge of dose-rate and radiation effects will allow for EVA time lines to be 
extended in deep space and on the lunar or Mars surface.  Furthermore, research approaches that narrow 
uncertainties in risk models will no-doubt evolve into countermeasure discovery and validation 
approaches that have large benefits on crewmembers.  
The NASA PEL’s for fatal cancer risk may be exceeded for several lunar scenarios including a large SPE, 
cumulative career exposure, and mission length dependent on crew age and gender.  The Operational 
relevance of these conditions is obviously critical and could delay, reduce the length of missions, or make 
the costs to prevent PEL violation far too excessive.  Reducing the uncertainties in risk projections 
through NSRL research, which are part of the radiation PELs, could possibly alleviate cancer risk 
projections below PELs.  Possible mitigation approaches such as parasitic radiation shielding are very 
costly for SPE’s and may prove prohibitive for GCR.  The final solution may be a combination of 
uncertainty reduction, shielding, mission length, and crew selection with effective biological 
countermeasures.  Biological countermeasures to mitigate the risk or improve treatment are in early stages 
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of development and projections of their effectiveness highly uncertain.  The NASA PELs for fatal cancer 
risk are projected to be violated under all possible Mars scenarios at this time making the radiation cancer 
risk critical as the mission cannot be undertaken without further breakthrough leading to uncertainty 
reduction in risk projection models or to the development of biological countermeasures.   
Dependent on new research results, the cumulative risk from CNS and Degenerative when combined 
with Cancer risks will likely have major negative impacts on mission design, costs, schedule, and crew 
selection.  Thus risk projection model development and PELs will begin with Cancer Risks, but 
eventually incorporate projection capabilities for Acute, CNS, and Degenerative Tissue Risks. 
Strategy for Mitigation 
SRPE plans to conduct a phased implementation approach to reduce the uncertainty associated with space 
radiation effects and develop countermeasure recommendations in support of Lunar and Mars vehicle and 
mission planning.  A breakthrough research strategy is utilized because of the large scientific challenges 
needed to understand and mitigate human risks to space radiation.  Examples of breakthroughs that have 
occurred in recent years are the hallmark molecular changes in cancer stem cells in cancer research.  
Breakthroughs create large perturbations in research plans and schedules, and have large benefits to 
achieving SPRE goals.  Future breakthroughs are expected, albeit not possible to predict. 
Biological countermeasure research will be conducted at a low level in the near-term, however will be 
increased after experimental (biological) models of human risks are established and uncertainties are 
significantly reduced.  This is due to a need to understand the biological targets for countermeasures and 
to ensure the ability to assess properly their potential effectiveness.  Similar phased approaches are 
followed for biomarker research.  
The SRPE established a scientific approach that follows a progression of activities designed to feed the 
development of an integrated risk model with acceptable uncertainty for exploration missions, followed 
by activities targeting risk mitigation and monitoring.  These activities are not necessarily implemented in 
serial, but emphasis is placed on 1 to 3, the successful completion of which should facilitate model 
development to enable mission durations required for currently planned lunar missions.  Successful 
completions of 4 to 7 are needed to enhance model development to enable Mars missions.  Items 4 to 7 
are being pursued at a minimal level in the current program.  As activities essential for lunar missions are 
completed, greater effort will be spent in activities essential for Mars missions. 
The activities required to develop the cancer risk projection model are as follows: 
1) Establish Mechanisms of Cancer and CM Action 
2) Develop Tissue and Risk Specific Experimental Models  
3) Understand radiation quality effects on biological damage to quantify risk 
4) Understand the dependence of risk on dose-rates in space 
5) Extrapolation from experimental data to humans to quantify risk 
6) Understand individual radiation-sensitivity to quantify risk 
7) Develop countermeasures, technologies, and models for Risk Mitigation and Monitoring 
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Figure 1 graphically illustrates components of the research approach.  
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Figure 1.  Flow Chart of Components in the SRPE Research Approach 
Overview of Research Approach 
The level of tolerance in projection model uncertainties depends on the acceptable level of mortality risk 
(3%) and the projection of risk for each class of mission.  Cancer projections for 40-yr females on STS, 
ISS, and 180-day lunar, and Mars missions are currently estimated at about 0.01, 0.35, 0.7, and 5%, 
respectively.  Therefore, a much lower tolerance can be accepted for lunar or Mars mission than mission 
in LEO to assure risk acceptance levels are not exceeded, and more accurate and mechanistic models of 
risk must be developed for these missions.  This constraint leads to a major goal for research approaches 
followed by SRPE with uncertainties less than 2-fold needed for long-term lunar stays, and less than 
+50% for a Mars mission.  See Figure 2 for the timeline for reducing uncertainties. 
In order to understand whether research has achieved the level of tolerance in cancer risk projections 
required; interactions are needed between risk assessment research and biological mechanisms and data 
research.  The first Gantt chart in Appendix D shows a major decision point in the research plan related to 
assessment of uncertainty reduction.  If sufficient uncertainty reduction is achieved in the near-term, 
research on biological countermeasures and minor tissue sites is envisioned to occur in 2014 and out.  
Biological Risk Research 
The large number of GCR nuclei type, energies, SPE doses, and dose-rates, in combination with the 
multiple tissue and cancer types makes the performance of large-scale animal or 3D human cell culture 
studies of cancer risk at NSRL prohibitive.  Therefore, a mechanistic approach is needed and has been 
segmented into major mechanistic research areas (Gaps Cancer 1, 2, and 7-9).  These areas may find 
synergy in the types and range of biological models employed however will differ in the complicated 
hypothesis questions being addressed.  Ultimately, mechanistic studies must progress to determine 
quantitative data sets for estimating probabilities for increase risk of carcinogenesis that in conjunction 
with research on Risk Assessment models will be used to extrapolate risks from experimental model to 
risks in astronauts on specific exploration missions. 
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There are distinct mechanisms of cancer induction across and within major tissue sites; thus uncertainty 
reduction requires tissue specific risk estimates (Gap Cancer 3-5).  NRA and NSCOR selections focus on 
current estimates of major sites for cancer risks, which include lung, breast, colon, stomach, esophagus, 
the blood system (leukemias), liver, bladder, skin, and brain.  There are differences in radiation sensitivity 
based on genetic and epigenetic factors (Gaps Cancer 5) and research in these areas aids the development 
of tissue specific cancer models.  Hypothesis directed studies to establish the underlying mechanisms for 
the risks, and the possibility of synergistic effects with SPE’s or other flight factors may also be 
considered.  NRA, NSCOR, or joint DoE-NASA studies in this area will use state-of-the art animal 
models (including transgenic mice) and genetically engineered human cell culture models to answer a 
variety of questions related to the Gaps in biological mechanisms.  These studies are critical in 
establishing the level of proof that underlies NASA risk projection models.  As research understanding is 
improved, extended duration validation studies with a finite number of animal or 3D human cell culture 
models using mixed fields representing GCR and SPE will be performed at NSRL using the existing 
exposure cave or potentially a new cave with improved capability for extended duration GCR 
simulations.  
The cancer risk related NSCOR studies are 5-year studies and allow for long-term animal or sequential 
mechanistic studies with multiple components. 
Risk Assessment 
The SRPE approach to uncertainty reduction is based on studying the current model NASA uses as model 
recommended by the NCRP for projecting cancer incidence and mortality risks for space missions.  This 
model employs the double-detriment life table for calculating the risk of radiation induced cancers against 
the background of cancers in the general population and competing mortality risks.  The cancer rate 
(Hazard function) is the key quantity in the evaluation; representing the probability at a given age and 
years since exposure of observing a cancer.  The NCRP model assumes the cancer incidence or mortality 
rate is scalable to human epidemiology data for gamma rays using a linear-energy transfer dependent 
radiation quality factor, Q(LET), and a dose and dose-rate reduction factor (DDREF).  Other assumptions 
in the model are made with regard to the transfer of risk across populations, the use of average rates for 
the US population, the age, and age-after exposure dependence of risk on radiation quality and dose-rate, 
etc.  These models will be updated as new data from biological mechanism and data are obtained as 
described by Gaps- Cancer 3-7. 
Systems biology models provide a framework to integrate mechanistic studies of cancer risk across 
multiple levels of understanding (molecular, cellular, and tissues), and are the most likely approach to 
replace the NCRP model.  Systems biology models are being developed by the Risk Assessment Project 
and several NSCOR’s, and in conjunction with data collection will improve the descriptions of cancer risk 
and to lay a framework for future biological counter-measure evaluations and biomarker identification 
(Gap Cancer 14). 
Shielding Physics & Dosimetry 
The evaluation of radiation shielding effectiveness for GCR is currently hindered by data on radiation 
quality effects and the shape of the dose-response curve for cancer induction.  However, controlling 
secondary neutron components through material selections and developing computer tools for shielding 
evaluations is a near-term focus for spacecraft design applications as carried out by the Design Tools 
project under Gap Cancer 13.  A goal of the Design Tools project is to provide fast and reliable tools for 
optimization in support of engineering shielding designs.  Radiation physics improvements will be 
developed in support of these analysis efforts (Gap Cancer 11).  SRPE will also support tasks that 
integrate data from lunar or Martian robotic probes to improve analysis capabilities (Gap Cancer 12)  
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Biological Countermeasures 
The long-term phase of research will likely involve research on biological countermeasure (BCM) 
evaluation.  BCM is a lower criticality in the current phase of the program for three reasons: 1) the 
uncertainties in cancer projections prevent the evaluation of the need for BCM.  2) An improved 
understanding of the mechanisms of cancer risk is needed to be able to extrapolate results from BCM 
studies in experimental models to astronauts on exploration missions, and 3) identify effective surrogate 
markers to perform testing of potential BCMs. Research related to Gap Cancer 8 will evolve from new 
knowledge gained from biological mechanisms and risk assessment research.  Current NRA studies with 
anti-oxidants and related agents may be expanded to target specific molecular pathways and tissues, 
which make the largest contribution to cancer risks.  Cell and animal models and appropriate endpoints 
will be identified and combined with new systems biology tools to obtain quantitative projections of 
BCM effectiveness for astronauts in specific exploration missions.  
Gaps 
The following gaps are a culmination of research questions identified through the Bioastronautics 
Roadmap Development, National Academy of Science – Institute of Medicine Review, National Council 
for Radiation Protection Reviews, Recommendations and Reports, Radiation Discipline Working Group 
advisory panel recommendations, annual Radiation PI workshops, and the Sept '06 Discipline Review.   
More recently the National Academy of Sciences (NAS) Institute Of Engineering has reported on 
approaches to Manage Lunar radiation risks (NAS, 2008), and the NAS Institute of Medicine (IOM) has 
reviewed the Evidence based review of the four major risks and associated Gaps. 
Based on the above recommendations, a total of 14 Gaps have been re-formulated for the Risk of 
Radiation Carcinogenesis from Space Radiation.  Due to the reliance on NRA and NSCOR research, 
many tasks address several Gaps, making it difficult to list each task under each gap.  The SPRE has 
chosen to provide a table of Gaps followed by a table of current tasks identifying whether it is solicited, 
directed, or NSCOR (which are all solicited) and the gaps addressed by that research. 
Cancer 1: How can experimental models of tumor development for the major tissues (lung, colon, stomach, 
breast, liver, and leukemias) be developed to represent the major processes in radiation 
carcinogenesis and extrapolated to human risk projections? 
Cancer 2: How can experimental models of tumor development for the other tissues (bladder, skin, esophagus, 
brain, etc) be developed to represent the major processes in radiation carcinogenesis and 
extrapolated to human risk projections? 
Cancer 3: How can models of cancer risk be applied to reduce the uncertainties in radiation quality effects 
from SPE's and GCR? 
Cancer 4: How can models of cancer risk be applied to reduce the uncertainties in dose-rate dependence of 
risks from SPE's and GCR? 
Cancer 5: How can models of cancer risk be applied to reduce the uncertainties in individual radiation 
sensitivity including genetic and epigenetic factors from SPE and GCR? 
Cancer 6: How can models of cancer risk be applied to reduce the uncertainties in the age and gender 
dependence of cancer risks from SPE's and GCR? 
Cancer 7: How can systems biology approaches be used to integrate research on the molecular, cellular, and 
tissue mechanisms of radiation damage to improve the prediction of the risk of cancer and to 
evaluate the effectiveness of CM's?  How can epidemiology data and scaling factors support this 
approach?   
Cancer 8: What biological countermeasures should be used to reduce SPE and GCR cancer risks?  What side 
effects should be tolerated vs. Mission risks? 
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Cancer 9: Are their significant synergistic effects from other spaceflight factors (microgravity, stress, altered 
circadian rhythms, changes in immune responses, depressed nutrition, bone loss, etc.) that modify 
the carcinogenic risk from space radiation? 
Cancer 10: Are space validation experiments needed for verifying knowledge of carcinogenic or other risks 
prior to long-term deep space missions, and if so what experiments should be undertaken? 
Cancer 11: What are the most effective shielding approaches to mitigate cancer risks? 
Cancer 12: What level of accuracy do NASA’s space environment, transport code and cross sections describe 
radiation environments in space (ISS, Lunar, or Mars)?   
Cancer 13: What are the most effective approaches to integrate radiation shielding analysis codes with 
collaborative engineering design environments used by spacecraft and planetary habitat design 
efforts? 
Cancer 14: What are the optimal biodosimetry methods for Lunar and Mars missions, and are biomarker 
approaches needed? 
Tasks: 
NRA’s, NSCOR: 
Peer-Reviewed and directed research to determine mechanisms of radiation carcinogenesis in major tissues.  
(Cancer1) 
NRA’s, NSCOR: 
Peer-Reviewed and directed research to determine mechanisms of radiation carcinogenesis in other tissues.  
(Cancer 2) 
NRA’s, NSCOR: 
Develop countermeasures for cancer risks.  (Cancer 8)  NOTE: Combined with Countermeasure tasks in Acute, 
Degenerative, and CNS risks also. 
NRA’s, NSCOR: 
Research on Spaceflight Synergy.  (Cancer 9) 
NRAs, DOE Low-Dose Collaboration: 
Research to establish new quality functions for space radiation.  (Cancer 3) 
Risk Assessment Directed Study, NRA’s, NSCOR: 
Improve mechanistic understanding for the variability of dose-rate dependencies for cancer.  (Cancer 4) 
Risk Assessment Directed Study, NRA’s, NSCOR: 
NCRP Analysis of individual sensitivity research, Ethics and Legal assessments.  (Cancer 5) 
Risk Assessment Directed Study, NRA’s, NSCOR: 
Determine how genetic and epigenetic factors influence radiation safety.  (Cancer 5) 
Risk Assessment Directed Study, NRA’s, NSCOR: 
Peer-reviewed and directed research to determine age and gender dependencies on cancer risks from SPEs and 
GCR.  (Cancer 6) 
Risk Assessment Directed Study, NRA’s: 
Construct mathematical network models using systems biology approach.  (Cancer 7) 
NCRP: 
Commentary on Cancer Synergistic Risks.  (Cancer 9) 
NCRP/NAS, Risk Assessment Directed Study: 
Determine if spaceflight validation of ground results is necessary.  (Cancer 10) 
SRPE Directed Study: 
Update Design Tools.  (Cancer 11) 
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SRPE Directed Study: 
Improve Nuclear Models/1-D transport.  (Cancer 12) 
SRPE Directed Study: 
Develop Advanced nuclear model and transport codes –Pseudo 3-D codes.  (Cancer 12) 
SRPE Directed Study: 
Develop and validate design tools (Cancer 13).  NOTE: Development of these design tools uses input from all 
radiation research and crosses all radiation risks. 
Deliverables and Required Delivery Milestones: 
Products include integrated risk models to quantify the risk of carcinogenesis; validated space permissible 
exposure limits; countermeasures to mitigate the risk of carcinogenesis; and tools and technologies to 
support the evaluation, mitigation and monitoring of risk/exposure during missions; as well as 
requirement recommendations for lunar sortie and outpost.  Detailed deliverables, as identified in the 
graphics are listed below: 
Product Delivery Date 
Cancer Risk Projection models and Updates supporting Sortie SRR, 
Outpost SRR, and Crew Selection 
2010, 2014, 2020 
Space Radiation Permissible Exposure Limits supporting Sortie SRR, 
Outpost SRR, and Crew Selection 
2010, 2014, 2020 
Countermeasures for SPE supporting Sortie Operations 2018 
Countermeasures for SPE plus GCR supporting Outpost Operations 2023 
Space Radiation Transport Codes supporting Lander and Outpost 
PDR design cycles 2010,2015 
Integrated Radiation Analysis and Design Tool supporting Orion 
Design and Operations 2007, 2012 
Mission and Vehicle Requirement Recommendations supporting 
Lunar Sortie and Outpost SRR 2010, 2014 
Required Platforms: 
NASA Space Radiation Lab (NSRL); 
Mars Robotic Precursor mission/MSL-RAD (Mars2009 & 2017 for solar min) 
ISS (existing nominal ops (MRID) and measurement data) (i.e. NOT research/experimental) 
Project/Organization Responsible for Implementation of Activity: 
SRPE 
Via NRAs, NSCORs, NASA-DoE Collaborative Research, and Directed Studies 
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RISK OF ACUTE RADIATION SYNDROMES DUE TO  
SOLAR PARTICLE EVENTS I x I 
There is a variety of acute radiation syndromes of concern following a large SPE exposure.  Through 
careful evaluation of SPE frequency and size probabilities, dose-rates, likely shielding conditions, and 
dose distribution at specific organs, the SRPE Risk Assessment Project has determined that the likelihood 
of acute risks IVA is extremely small.  There are scenarios, however, during lunar, trans-lunar, or Mars 
EVAs where acute radiation sickness may occur.  Radiation sicknesses, i.e., the prodromal risks, include 
the risks of nausea, vomiting, diarrhea, and fatigue.  These effects are manifested at about 4 to 24 hours 
post-exposure for exposures at sub-lethal doses with a latency time inversely correlated with dose.  
Furthermore, albeit the possibility of acute death through the collapse of the blood forming organs (BFO) 
is negligible, there is a reasonable concern of a compromised immune system due to high skin doses from 
a SPE leading to burns, which could increase the risk to the BFO.  Because the mechanisms of acute risks 
from SPE’s will not differ substantially from X-rays and gamma-rays where experimental models have 
already been developed, research on acute risks is largely a data collection activity with appropriate 
proton energies, doses, and dose-rates to represent major SPEs. 
In the long-term, the SRPE will consider research on fertility, sterility, and hereditary risks from space 
radiation, and may request the NSBRI support these areas because of their unique nature compared to 
other risk areas (Acute Gap 4).  
Operational Relevance and Context of Risks for Exploration 
Acute radiation risks are averted through radiation shielding inside most shielding habitats or lunar 
transfer vehicles; however , radiation exposure limits could be exceeded during deep space transit, 
including Venus swing-by (<0.5 AU) or extensive lunar surface EVAs, making this risk important for 
NASA’s goals.  Disruptions include reducing EVA times by several hours or requiring excessive 
radiation shielding.  EVA programs will have to be significantly reduced if risk assessment not improved 
and countermeasures developed. 
Strategy for Mitigation 
As discussed in the Risk of Radiation Carcinogenesis from Space Radiation, SRPE plans to conduct a 
phased implementation approach to address the acute radiation risk. 
Biological countermeasure research will be conducted at a low level in the near-term, however will be 
increased after experimental (biological) models of human risks are validated.  The SRPE approach that 
follows a progression of activities designed to feed the development of an integrated risk model with 
acceptable uncertainty for exploration missions, followed by activities targeting risk mitigation and 
monitoring is used for the acute risk.  These activities are not necessarily implemented in serial, but since 
the knowledge associated with acute risk is much further along than other risks, emphasis is placed on 1 
to 6, the successful completion of which should facilitate model validation to enable mission durations 
required for currently planned lunar and Mars missions.  The activities required to validate the Acute 
Radiation Syndromes risk projection model are as follows: 
1) Establish Mechanisms of radiation-induced acute radiation syndrome and CM Action 
2) Understand radiation quality effects on biological damage to quantify risk 
3) Understand the dependence of risk on dose-rates in space 
4) Extrapolation from experimental data to humans to quantify risk 
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5) Understand individual radiation-sensitivity to quantify risk 
6) Develop countermeasures, technologies, and models for Risk Mitigation and Monitoring 
Figure 1 graphically illustrates components of the research approach. 
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Figure 1.  Flow Chart of Components in the SRPE Research Approach 
Biological Risk Research 
Research on acute risks related to EVA conditions must factor in the role of dose-rate over an EVA time 
course, the additional exposure IVA for a terminated EVA, and other spaceflight factors that could 
modify expected dose response models for acute risks.  Animal and cell culture models appropriate for 
these acute risks will be used in the research to study protons effects at various doses, dose-rates, and 
proton energies including simulation of solar particle event spectra (Gap Acute 1).  A research emphasis 
on the role of the immune system and possible synergistic effects on acute risks are needed (Gap Acute 
3).  This area is under review by the NCRP.  Because acute risks are manifested soon after exposure and 
there is an existing data based on gamma-ray induced risks, the research is expected to be completed in 
about a 5-year period by the NSBRI team. 
Risk Assessment 
The Risk Assessment Project has developed acute radiation risk models using a logistic scoring approach 
and is modifying these models to account for proton and secondary radiation biological effectiveness 
data.  These models will be updated with results from the proposed NSBRI research team when available.  
A graphical user interface (GUI) of the resulting model will be developed and tested for use in an 
operational setting (Gap Acute 2).  Probabilistic models of SPE are being developed by the Risk 
Assessment project and in coordination with new results from SMD (Gap Acute 5). 
Shielding Physics & Dosimetry 
Optimization of radiation shielding (Gap Acute 6), dosimetry, and alert approaches (Gap Acute 5) is 
supported with operational research in these areas by both SRPE (Design Tools and Risk Assessment 
Projects) and the NSBRI and in collaboration with Space Mission Directorate (SMD) Living with the Star 
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Program (Gap Acute 5).  The Design Tools project will develop tools to minimize shielding mass during 
vehicle design, and the Risk Assessment project will develop probabilistic models appropriate for acute 
risk protection for mission planning purposes.  The development of reliable, lightweight EVA dosimetry 
is a goal of the research. 
Biological Countermeasures 
The important distinctions in the types of biological models, possible BCMs, and exposure conditions 
between acute, and the risks of cancer, CNS, and degenerative risks suggests a unique approach.  
Therefore, the SRPE has requested the NSBRI form a focus team in this area (Gap Acute 7).  This team 
will pursue research on the mechanisms of acute radiation risks and possible BCM development.  Studies 
from radiation oncology of anti-nausea drugs will be considered as well as existing drugs used in 
spaceflight.  The role of synergisms of radiation and other space related insults will be an important thrust 
of this research.  
Gaps 
The following gaps are a culmination of research questions identified through the Bioastronautics 
Roadmap Development, National Academy of Science – Institute of Medicine Review, National Council 
for Radiation Protection Reviews, Recommendations and Reports, Radiation Discipline Working Group 
advisory panel recommendations, annual Radiation PI workshops, and the Sept '06 Discipline Review.   
More recently the National Academy of Sciences (NAS) Institute Of Engineering has reported on 
approaches to Manage Lunar radiation risks (NAS, 2008), and the NAS Institute of Medicine (IOM) has 
reviewed the Evidence based review of the four major risks and associated Gaps. 
Based on the above recommendations, a total of 8 Gaps have been formulated for the Risk Acute 
Radiation Syndromes Due to Solar Particle Events.  As with other, the SPRE relies heavily on NRA and 
NSCOR research, making it difficult to list each task under each gap.  The SPRE has chosen to provide a 
table of Gaps followed by a table of current tasks identifying whether it is solicited, directed, or NSCOR 
(solicited) and the gaps addressed by that research.  The NSBRI has formed the Center for Acute 
Radiation Research similar in function to an NSCOR, thus this task will be identified as an NSCOR. 
Acute – 1: What are the probabilities for various acute effects from SPE’s including RBE's and dose-rate modifiers? 
Acute – 2: What quantitative procedures or theoretical models are needed to extrapolate molecular, cellular, or animal 
results to predict acute radiation risks in astronauts?  How can human epidemiology data best support these procedures 
or models? 
Acute – 3: Are their synergistic effects arising from other spaceflight factors (microgravity, stress, immune status, bone 
loss, etc.) that modify acute risks from space radiation including modifying thresholds for such effects?  (post PPBE) 
Acute – 4:  What are the probabilities of hereditary, fertility, and sterility effects from space radiation? 
Acute – 5: What are the optimal SPE alert and dosimetry technologies for EVAs?   
Acute – 6: What are the most effective shielding approaches to mitigate acute radiation risks, how do we know, and 
implement? 
Acute – 7: What are the most effective biomedical or dietary countermeasures to mitigate acute radiation risks?   
Acute – 8: How can Probabilistic risk assessment be applied to SPE risk evaluations for EVA, and combined EVA+IVA 
exposures? 
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Tasks: 
NCRP/NAS Ground based Research at NSRL: 
Research on prodromal syndrome and skin injury (Acute 1) 
 Define the RBE for protons of relevant energies (Acute 1) 
 Determine dose rate dependence for protons over the relevant range of dose rates (Acute 1) 
NSBRI CARR Ground Based Research at NSRL: 
Determine the dose and dose rate dependencies of ARS from protons (Acute 1) 
NSBRI CARR Ground Based Research at NSRL: 
Determine impact of a large skin dose on the immune system (Acute 1) 
NSBRI CARR Ground Based Research at NSRL: 
Determine alterations of dose response of the blood system (Acute 1) 
NSBRI CARR Ground Based Research at NSRL: 
Determine microgravity and stress impacts on dose-response for prodromal risks (Acute 3) 
NSBRI CARR Ground Based Research at NSRL: 
Determine the efficacy of FDA-approved CMs for radiation doses and dose rates of protons (Acute 7) NOTE: 
Combined with Countermeasure tasks in Carcinogenesis, Degenerative, and CNS risks also. 
NSBRI CARR Ground Based Research at NSRL: 
Determine side effects and alteration of their effectiveness in space (Acute 7) NOTE: Combined with 
Countermeasure tasks in Carcinogenesis, Degenerative, and CNS risks also. 
Risk Assessment Directed Study: 
Development of kinetic models of prodromal and blood systems (Acute 2) 
Risk Assessment Directed Study: 
Development of track models of RBE’s in tissues (Acute 2) 
Risk Assessment Directed Study: 
Couple GI Tract with blood module (Acute 2) 
Risk Assessment Directed Study: 
Couple Acute Risk Software with Real-Time Alert data (Acute 2) 
Risk Assessment Directed Study: 
Develop shielding requirements for Constellation (Acute 6) NOTE: Combined work with shielding requirements 
from other radiation risks. 
NRA: 
Research to address risk of heredity and fertility (Acute 4) 
SRPE Directed Study: 
Determine dosimetry requirements for lunar surface (Acute 5) 
SRPE Directed Study: 
Determine Dosimetry requirements for Lunar and Mars Precursor missions (as needed) (Acute 5) 
 
Deliverables and Required Delivery Milestones: 
Products include acute radiation risk models; validated space permissible exposure limits; 
countermeasures to mitigate acute risks; and tools and technologies to support the evaluation, mitigation 
and monitoring of acute risk/exposure during missions; as well as requirement recommendations for lunar 
sortie and outpost vehicles and mission operations.  Detailed deliverables, as identified in the graphics are 
listed below: 
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Product Delivery Date 
Baseline Acute Radiation Risk Model and Updates supporting Sortie 
and Outpost Mission Operations planning and SRR 2009, 2012, 2015 
EVA alert dosimetry and monitoring supporting sortie operations 2012, 2016 
Validated Space Permissible Exposure Limits (as necessary) supporting 
Mission Ops SRR and operations 2012, 2015 
Dosimetry requirement recommendations for Lunar Surface supporting 
Mission Ops SRR 2012 
Mission/Vehicle/EVA Requirement Recommendations supporting 
Sortie and Outpost program SRR 2011, 2016 
Required Platforms: 
NASA Space Radiation Lab (NSRL) 
Project/Organization Responsible for Implementation of Activity: 
SRPE & NSBRI 
Via NRAs, NSCORs, NASA-DoE Collaborative Research 
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RISK OF ACUTE OR LATE CENTRAL NERVOUS SYSTEM EFFECTS FROM 
RADIATION EXPOSURE I x C 
A critical question for the current phase of research is to understand whether there is a significant risk of 
CNS effects and establish possible threshold doses for specific CNS risks. Central Nervous System (CNS) 
risks from GCR are a concern due to the possibility of single HZE nuclei traversals causing tissue 
damage, as evidenced by the light-flash phenomenon first observed during the Apollo missions. As 
survival prognosis for patients irradiated for brain tumor treatment has improved, patients have shown 
persistent CNS changes at long times after treatment with gamma rays suggesting a possible CNS risk for 
a large SPE. Furthermore, animal studies of behavior and performance with HZE radiation suggest 
detrimental changes may occur during long-term GCR exposures. Currently, there is no projection model 
for CNS risks of concern to NASA. Research at NSRL is using a variety of animal and cellular models to 
study the dose and radiation quality dependence of CNS risks. The extrapolation of model data to 
astronauts will be the major focus of CNS research in the immediate future.  The values of possible 
thresholds for CNS risks and knowledge on how to extrapolate possible thresholds to individual 
astronauts is a key milestone in the long-term research plan to allow development of a CNS-specific risk 
projection model.   
Operational Relevance And Context Of Risks For Exploration 
The NASA PELs for CNS risk was developed based on existing animal data from heavy ion exposures.  
Although animal data and brain cancer irradiation evidence suggests CNS structural and functional 
impacts from radiation exposure, additional research is required to fully understand and quantify this risk.  
This risk has considerable uncertainty associated with it and no acceptable model for projecting CNS risk 
is currently available.  The PEL could be violated under possible scenarios, including following a large 
SPE or long-term GCR exposure, however, without a clear understanding of the CNS risk, it has been 
rated Important for both the lunar and Mars missions.  Ongoing research in this area is intended to 
quantify this risk to determine criticality for both extended duration missions. New research results could 
lead to cumulative risk from CNS and Degenerative tissue Disease which when combined with Cancer 
risks have major negative impacts on mission design, costs, schedule, and crew selection. 
Strategy For Mitigation 
As discussed in the Risk of Radiation Carcinogenesis from Space Radiation, SRPE plans to conduct a 
phased implementation approach to address the CNS risk.  The same breakthrough research strategy is 
utilized due to the large scientific challenges needed to understand and mitigate CNS risks from space 
radiation.  An example of a breakthrough that has occurred in recent years with regard to CNS is the 
discovery of neurogenesis in CNS research.  Breakthroughs create large perturbations in research plans 
and schedules, and have large benefits to achieving SPRE goals. Future breakthroughs are expected, 
albeit not possible to predict. 
Biological countermeasure research will be conducted at a low level in the near-term, however will be 
increased after experimental (biological) models of human risks are established and uncertainties are 
significantly reduced. The SRPE approach that follows a progression of activities designed to feed the 
development of an integrated risk model with acceptable uncertainty for exploration missions, followed 
by activities targeting risk mitigation and monitoring is also used for the CNS risk.  These activities are 
not necessarily implemented in serial, but emphasis is placed on 1 to 3, the successful completion of 
which should facilitate model development to enable mission durations required for currently planned 
lunar missions.  Successful completions of 4 to 7 are needed to enhance model development to enable 
Mars missions.  Items 4 to 7 are being pursued at a minimal level in the current program.  As activities 
essential for Lunar missions are completed, greater effort will be spent in activities essential for Mars 
missions. 
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The activities required to develop the CNS risk projection model are as follows: 
1) Establish Mechanisms of CNS and CM Action 
2) Develop Tissue and Risk Specific Experimental Models  
3) Understand radiation quality effects on biological damage to quantify risk 
4) Understand the dependence of risk on dose-rates in space 
5) Extrapolation from experimental data to humans to quantify risk 
6) Understand individual radiation-sensitivity to quantify risk 
7) Develop countermeasures, technologies, and models for Risk Mitigation and Monitoring 
Figure 1 graphically illustrates components of the research approach.  
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Figure 1. Flow chart of components in the SRPE research approach. 
Biological Risk Research 
A critical question for the current phase of research is to establish possible threshold doses for specific 
CNS risks.  It is likely that although acute CNS risks occur only above a dose threshold (Gap CNS-1) and 
that the lifetime risks for CNS diseases, such as Alzheimer’s, will have distinct dose dependence with the 
additional questions related to latency to disease of primary interest (Gap CNS-2).  The values of possible 
thresholds for CNS risks and knowledge on how to extrapolate possible thresholds to individual 
astronauts will be a key milestone in the long-term research plan.  An important component of this 
research is to factor in the variation of CNS risk with genotype or other CNS injury (Gap CNS-3).  A 
variety of mechanisms must be understood including the roles of neurodegeneration, inflammation, 
microvasculature damage, and changes to specific neuron-chemical pathways.  These research areas will 
have overlaps in usage of NSRL, and potential animal or cellular models employed, however individual 
NRA or NSCOR projects will pursue distinct hypothesis driven research questions leading to distinct 
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endpoints and biological assays.  Hypothesis directed studies to establish the underlying mechanisms for 
the risks (Gap CNS 1-3, 5, 6), and the possibility of synergistic effects with SPE’s or other flight factors 
will also be considered (Gap CNS-8). 
The CNS risk related NSCOR study is a 5-year study allowing for long-term animal or sequential 
mechanistic studies with multiple components. 
Risk Assessment 
Research approaches are establishing the biochemistry of CNS impacts by HZE nuclei.  Since projection 
based on scaling to human data as done for cancer risk is not possible, a systems biology approach for 
individual CNS risks may be needed to form a basis for animal to human extrapolation, and will rely on 
understanding of biochemical changes in the CNS caused by space radiation (Gaps CNS 5, 6).  Because 
of the large number of GCR nuclei types and energies, comprehensive studies under mixed-field SPE or 
GCR simulation conditions for extended time periods (hours to a few weeks) may be needed at NSRL.  
Extended duration studies will be useful in addressing SRPE gaps in synergistic risks from other 
spaceflight factors and radiation damage to the CNS.  
Biological Countermeasures 
Biological countermeasure and biomarker research for CNS risks is a lower priority in the near-term 
research strategy until the nature and magnitude of the CNS risk is more firmly established.  Several 
studies on oxidative damage and anti-oxidants are supported; however, this is not a significant emphasis 
of SRPE’s approach.  The future need for BCM research will be driven by the levels of risk determined 
by current research and may transition to become a major long-term focus. It is expected that the 
mechanistic understanding acquired from near-term research will set the course for effective 
countermeasures approaches in the future as needed (Gap CNS-4).  
Shielding Physics 
The development of new biological understanding of CNS risks will determine if shielding protection for 
CNS is distinct from other shielding approaches to other radiation risks.  Preliminary assessments suggest 
HZE nuclei with Z>10 or slow neutrons may be a higher relative concern for CNS than other risks, and 
may place more emphasis on shielding these components (Gap CNS-7).  
Gaps 
The following gaps are a culmination of research questions identified through the Bioastronautics 
Roadmap Development, National Academy of Science – Institute of Medicine Review, National Council 
for Radiation Protection Reviews, Recommendations and Reports, Radiation Discipline Working Group 
advisory panel recommendations, annual Radiation PI workshops, and the Sept '06 Discipline Review.   
More recently the National Academy of Sciences (NAS) Institute Of Engineering has reported on 
approaches to Manage Lunar radiation risks (NAS, 2008), and the NAS Institute of Medicine (IOM) has 
reviewed the Evidence based review of the four major risks and associated Gaps. 
Based on the above recommendations, a total of 8 Gaps have been formulated for the Risk of Acute or 
Late Central Nervous System Affects from Radiation Exposure.  As with carcinogenesis, the SPRE relies 
heavily on NRA and NSCOR research, making it difficult to list each task under each gap.  The SPRE has 
chosen to provide a table of Gaps followed by a table of current tasks identifying whether it is solicited, 
directed, or NSCOR (which are all solicited) and the gaps addressed by that research. 
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CNS – 1: Is there a significant probability that space radiation would lead to immediate or acute functional 
changes in the CNS during a long-term space mission and if so what are the mechanisms of change? Are there 
threshold doses for these effects?  
CNS – 2: Is there a significant probability that space radiation exposures would lead to long-term or late 
degenerative CNS risks if so what are the mechanisms of change?  
CNS – 3: How does individual susceptibility including hereditary pre-disposition (Alzheimer’s, Parkinson’s, 
apoE) and prior CNS injury (concussion or other) alter significant CNS risks? Does individual susceptibility 
modify possible threshold doses for these risks in a significant way?  
CNS – 4: What are the most effective biomedical or dietary countermeasures to mitigate CNS risks? By what 
mechanisms are the countermeasures likely to work? 
CNS – 5: How can new knowledge and data from molecular, cellular, tissue and animal models of acute CNS 
risks or clinical human data, including altered motor and cognitive function and behavioral changes be used to 
estimate acute CNS risks to astronauts from GCR and SPE? 
CNS – 6: How can new knowledge and data from molecular, cellular, tissue and animal models of late CNS risks 
or clinical human date be used to estimate late CNS risks to astronauts from GCR and SPE? 
CNS – 7: What are the best shielding approaches to protect against CNS risks, and are shielding approaches for 
CNS and cancer risks synergistic?  
CNS – 8: Are there significant CNS risks from combined space radiation and other physiological or space flight 
factors (e.g., sleep deprivation, psychological, microgravity, immune-endocrine systems or other)? 
Tasks: 
SRPE NCRP/NAS: 
Independent review of CNS research results including NSCOR, NRA and DOE-Low Dose. (CNS1) 
SRPE NCRP/NAS: 
NCRP Commentary development to assess synergies between other physiological and space flight factors. 
(CNS8) 
SRPE NRAs, DOE Low-Dose Collaboration: 
Research to determine probability and mechanisms for long-term or late degenerative CNS risks. (CNS2) 
SRPE Risk Assessment Directed Study, NRAs and NSCOR: 
Individual hereditary CNS susceptibility and threshold studies (CNS3) 
SRPE Risk Assessment Directed Study, NRAs and NSCOR: 
Dietary countermeasure development. (CNS4)  NOTE: Combined with Countermeasure tasks in Acute, 
Degenerative, and Carcinogenesis risks also. 
SRPE Risk Assessment Directed Study, NRAs and NSCOR: 
Assessment of molecular, Cellular, tissue and animal models for applicability to CNS risk estimation. (CNS5, 
CNS6) 
SRPE Risk Assessment Directed Study: 
Assessment of shielding for CNS mitigation. (CNS7)  NOTE: Combined work with shielding requirements from 
other radiation risks. 
Deliverables and Required Delivery Milestones: 
Products include risk models to quantify the risk of acute and late CNS effects; validated space 
permissible exposure limits; and countermeasures to mitigate the risk of CNS effects. 
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 Detailed deliverables, as identified in the graphics are listed below: 
Product Delivery Date 
Baseline CNS Risk Model and updates 2017, 2020 
CNS Space Permissible Exposure Limits supporting Outpost SRR and 
Operations 2014, 2020 
Countermeasures for SPE supporting Sortie Operations 2018 
Countermeasures for SPE plus GCR supporting Outpost Operations 2023 
Required Platforms: 
NASA Space Radiation Lab (NSRL) 
Project/Organization Responsible for Implementation of Activity: 
SRPE 
Via NRAs, NSCORs, NASA-DoE Collaborative Research, Directed Studies 
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RISK OF DEGENERATIVE TISSUE OR OTHER HEALTH EFFECTS FROM 
RADIATION EXPOSURE I x C 
Cataracts have long been a research focus of NASA.  More recently, however, several epidemiological 
studies, including results from the atomic-bomb survivors and nuclear reactor workers, have identified a 
significant risk of stroke and coronary heart disease (CHD) for low LET radiation at doses comparable to 
those of an extended lunar mission or a Mars mission, or a short-duration lunar mission with a large SPE.  
An increased risk of cataracts associated with low dose space radiation from past NASA Missions has 
been reported and is being followed up with a clinical study of cataract progression rates in current or 
retired astronauts.  Several NSRL studies of cataract risks are supported to improve the understanding of 
how proton and HZE nuclei induce cataracts, and to identify possible countermeasure approaches.  Since 
the risk of heart disease is a recent finding, preliminary studies in these areas are seeking to establish 
possible distinctions in mechanisms for this risk between protons and HZE nuclei and gamma rays.  
Furthermore, the SRPE will take advantage of studies supported by the European Union in this area, 
which is supporting large-scale mouse studies of CHD.  These studies should present new insights into 
the nature of the low LET (gamma-ray) risk at low dose-rates is comparable to space conditions, and 
identify appropriate mouse strains to be used in future SR studies. 
Operational Relevance And Context Of Risks For Exploration 
The NASA PELs for cataract and heart risks are based on existing human epidemiology data.  Although 
animal and clinical astronaut data show a significant increase in cataracts following exposure and a 
reassessment of atomic bomb data suggests an increase in CHD from radiation exposure, additional 
research is required to fully understand and quantify this risk.   This risk has considerable uncertainty 
associated with it and no acceptable model for projecting degenerative tissue risk is currently available.  
The PEL could be violated under possible scenarios, including following a large SPE or long-term GCR 
exposure, however, without a clear understanding of the risk, it has been rated Important for both the 
lunar and Mars missions.  Ongoing research in this area is intended to quantify this risk to determine 
criticality for both extended duration missions.  New research results could lead to  cumulative risk from 
CNS and Degenerative Tissue Disease which when combined with Cancer risks have major negative 
impacts on mission design, costs, schedule, and crew selection.  
Strategy For Mitigation 
As discussed in the Risk of Radiation Carcinogenesis from Space Radiation, SRPE plans to conduct a 
phased implementation approach to address the degenerative tissue risk.  The same breakthrough research 
strategy is utilized due to the large scientific challenges needed to understand and mitigate degenerative 
tissue risks from space radiation.  Breakthroughs create large perturbations in research plans and 
schedules, and have large benefits to achieving SPRE goals.  Future breakthroughs are expected, albeit 
not possible to predict. 
Biological countermeasure research will be conducted at a low level in the near-term, however will be 
increased after experimental (biological) models of human risks are established and uncertainties are 
significantly reduced.  The SRPE approach that follows a progression of activities designed to feed the 
development of an integrated risk model with acceptable uncertainty for exploration missions, followed 
by activities targeting risk mitigation and monitoring is also used for the degenerative tissue risk.  These 
activities are not necessarily implemented in serial, but emphasis is placed on 1 to 3, the successful 
completion of which should facilitate model development to enable mission durations required for 
currently planned lunar missions.  Successful completions of 4 to 7 are needed to enhance model 
development to enable Mars missions.  Items 4 to 7 are being pursued at a minimal level in the current 
program.  As activities essential for Lunar missions are completed, greater effort will be spent in activities 
essential for Mars missions. 
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The activities required to develop the Degenerative Tissue risk projection model are as follows: 
1) Establish Mechanisms of radiation-induced Cataract and Coronary Heart Disease and CM Action 
2) Develop Tissue and Risk Specific Experimental Models  
3) Understand radiation quality effects on biological damage to quantify risk 
4) Understand the dependence of risk on dose-rates in space 
5) Extrapolation from experimental data to humans to quantify risk 
6) Understand individual radiation-sensitivity to quantify risk 
7) Develop countermeasures, technologies, and models for Risk Mitigation and Monitoring 
Figure 1 graphically illustrates components of the research approach.  
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Figure 1.  Flow Chart of Components in the SRPE Research Approach. 
Biological Risk Research 
Preliminary assignments of PEL’s for Degenerative risks have been assigned based on human 
epidemiology data for gamma ray or x-ray irradiation.  Cell or animal models of degenerative risks will 
be developed and applied to determine the mechanisms for degenerative risks and to determine 
appropriate risk assessment data for models including relative biological effectiveness and dose-rate 
dependencies for different space radiation ions at NSRL (Gaps Degen 1-4).  In the near-term, NRA 
research will support a small number of studies on heart and lens risks.  A long term-focus will be to 
support an NSCOR in this area in 2014 and beyond.  As mission duration increases, there could be 
degenerative risks to other tissues related to digestive diseases and pulmonary changes that become a 
concern.  A long-term goal will be to consider such possible changes in animal validation studies made at 
a possible extended duration GCR facility developed at NSRL in the future.  The NASA Study of 
Cataracts in Astronauts (NASCA) is collecting data on the incidence and progression rates of cataracts in 
over 230 current or retired astronauts.  The possibility of synergistic risks with other flight factors must 
also be considered (Gap Degen -7) 
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Risk Assessment 
An increased risk of cataracts associated with low dose space radiation from past NASA Missions has 
been reported and is being followed up with a clinical study (NASCA) of cataract progression rates in 
current or retired astronauts.  Several NSRL studies of cataract risks are supported to improve the 
understanding of how proton and HZE nuclei induce cataracts, and to identify possible countermeasure 
approaches.  The NASCA study and NSRL research will be used by the Risk Assessment Project to 
project cataract risks for specific space missions.  Risk assessment models for cataract risk will be 
developed (Gap Degen 5) through biophysical models of new or existing radiobiology data.  New models 
for other degenerative risks will be developed after studies of biological mechanisms have matured. 
Biological Countermeasures 
Research on BCMs (Gap Degen 6) for other degenerative risks is envisioned after studies of biological 
mechanisms have matured.  Timelines to begin research on BCM for the Degenerative Risks are 
dependent on progress in Cancer and CNS research within the current SRPE research prioritization plans, 
and perhaps based on the findings of the initial biological mechanisms research phase of the research 
plan. 
Gaps 
The following gaps are a culmination of research questions identified through the Bioastronautics 
Roadmap Development, National Academy of Science – Institute of Medicine Review, National Council 
for Radiation Protection Reviews, Recommendations and Reports, Radiation Discipline Working Group 
advisory panel recommendations, annual Radiation PI workshops, and the Sept '06 Discipline Review.   
More recently the National Academy of Sciences (NAS) Institute Of Engineering has reported on 
approaches to Manage Lunar radiation risks (NAS, 2008), and the NAS Institute of Medicine (IOM) has 
reviewed the Evidence based review of the four major risks and associated Gaps. 
Based on the above recommendations, a total of 7 Gaps have been formulated for the Risk of 
Degenerative Tissue or Other Health Effects from Radiation Exposure.  As with carcinogenesis, the SPRE 
relies heavily on NRA research, making it difficult to list each task under each gap.  The SPRE has 
chosen to provide a table of Gaps followed by a table of current tasks identifying whether it is solicited, or 
directed, and the gaps addressed by that research. 
Degen – 1: How can tissue specific risk models be developed  for the major degenerative tissue risks, including 
heart, circulatory, endocrine, digestive, lens and other tissue systems in order to estimate GCR and SPE risks for 
degenerative diseases?  
Degen – 2: What are the mechanisms of degenerative tissues risks in the heart, circulatory, endocrine, digestive, 
lens and other tissue systems?  What surrogate endpoints do they suggest? 
Degen – 3: What are the progression rates and latency periods for degenerative risks, and how do progression 
rates depend on age, gender, radiation type, or other physiological or environmental factors? 
Degen – 4: How does individual susceptibility including hereditary pre-disposition alter degenerative tissue 
risks?  Does individual susceptibility modify possible threshold doses for these risks in a significant way?  
Degen – 5: What quantitative procedures or theoretical models are needed to extrapolate molecular, cellular, or 
animal results to predict degenerative tissue risks in astronauts?  How can human epidemiology data best support 
these procedures or models? 
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Degen – 6: What are the most effective biomedical or dietary countermeasures to degenerative tissue risks?  By 
what mechanisms are the countermeasures likely to work?  Are these CMs additive, synergistic, or antagonistic to 
other Risks? 
Degen – 7: Are their significant synergistic effects from other spaceflight factors (microgravity, stress, altered 
circadian rhythms, changes in immune responses, etc.) that modify the degenerative risk from space radiation? 
Tasks: 
SRPE Directed Study: 
Epidemiological study of cataract incidence and progression. (Degen 1) 
SRPE Directed Study: 
NCRP Independent review of degenerative tissue research results including NSCOR, NRA and DOE low-dose.  
(Degen 1, Degen 3) 
SRPE NRAs and DOE Low Dose Collaboration and European Union Collaboration: 
Preliminary studies to establish the possibility of differences in mechanisms for stroke and CHD between protons 
and HZE nuclei and gamma rays.  (Degen 2) 
SRPE NRA, NSCOR: 
Studies on progression rates and latency periods for degenerative risks.  (Degen 3) 
SRPE NRA, NSCOR: 
Studies on individual susceptibility, including heredity to degenerative risks.  (Degen 4) 
SRPE NRA, NSCOR: 
Systems biology approaches to extrapolate molecular, cellular, or animal results to predict degenerative tissue 
risks in astronauts. (Degen 5)  NOTE: This systems biology approach overlaps with Cancer 7. 
SRPE NRA, NSCOR: 
Countermeasure development. (Degen 6)  NOTE: Combined with Countermeasure tasks in Acute, 
Carcinogenesis, and CNS risks also. 
SRPE NRA, NSCOR: 
Assess synergies between other physiological and space flight factors. (Degen 7) 
Deliverables and Required Delivery Milestones: 
Products include risk models to quantify the risk of degenerative tissue effects; validated space 
permissible exposure limits; and countermeasures to mitigate the risk of degenerative tissue effects.  
Detailed deliverables, as identified in the graphics are listed below: 
Product Delivery Date 
Cataract Risk Projection Model supporting Outpost SRR 2014 
Baseline Heart Risk Projection Model and updates supporting Outpost 
Operations 2021, 2024 
Space Permissible Exposure Limits supporting Outpost SRR and 
Operations 2014, 2020 
Countermeasures for SPE supporting Outpost Operations 2023 
Countermeasures for SPE plus GCR supporting Outpost Continuous 
Presence 2029 
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Required Platforms: 
NASA Space Radiation Lab (NSRL); 
NOTE: Next generation TEPC will require ISS validation 2010-2012 but this phase is NOT 
part of the SRPE scope – handed off to ops with minimal oversight from SRPE) 
Project/Organization Responsible for Implementation of Activity: 
SRPE - 
 Via NRAs, NSCORs, NASA-DoE Collaborative Research 
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Figure 2:  Timeline for Reducing Uncertainties in Radiation Risks. 
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RISK OF ADVERSE HEALTH EFFECTS FROM LUNAR DUST EXPOSURE -I X N/A 
The toxicological effects of lunar dusts have not been studied in sufficient depth to develop an exposure 
standard for operations on the lunar surface.  Lunar dusts have a high content in the respirable size range, 
they have a high surface area that is chemically reactive, and elemental iron "nano-particles" are 
imbedded in the dust grains.  These unusual properties may cause the respirable dusts to be at least 
moderately toxic to the respiratory system, and larger grains to be abrasive to the skin & eye.  NASA 
needs to set an airborne exposure standard based on scientific evidence so that vehicle designs can 
effectively control exposure. 
Under certain conditions on earth, mineral dust can be highly toxic to the human respiratory system, but it 
is unclear whether exposure to lunar dust will be more or less harmful.  Research into the toxicity of lunar 
dust will provide an evidence base to set exposure standards, which are needed to manage safely 
exposures in lunar habitats and vehicles.  
Context of Risk for Exploration 
The nominal toxicity expected from ordinary mineral dust may be increased for lunar dust by the large 
and reactive surfaces of the dust grains.  Human exposures to mineral dusts during industrial operations 
and from volcanic eruptions give us some sense of lunar dust toxicity, although the earth-based analogs 
have serious limitations.  Animal and cellular studies provide further evidence that mineral dusts can be 
somewhat toxic.  Earth-based research of mineral dust has shown that freshly fractured surfaces are 
reactive and elicit an increased toxic response.  Since lunar dust is formed in space vacuum from highly 
energetic processes, we expect the grain surfaces to be reactive indefinitely until the dust is brought into a 
habitable environment. 
Lunar dust is characterized as fine, charged and reactive dust capable of entering habitats and vehicle 
compartments, where it can threaten crewmember health. Testing is critical for the determination of lunar 
dust toxicity in order to set a permissible exposure limit and risk criteria.  Research areas should include 
identification of lunar dust size, shape, and chemistry, the mode of activation and passivation of lunar 
dust particles, toxicity to the respiratory system, ocular and dermal toxicity and cellular level toxicity.  
Health effects from chronic exposure to lunar dust may be irreversible compromised pulmonary function 
and possible organ disease through relocation of toxic particulates through the bloodstream.  Acute health 
effects include ocular abrasion that might impair crew vision and dermal abrasion that might compromise 
function while suited. 
Operational Relevance Assessment & Recommendations  
The risk of lunar dust exposure was identified during the Apollo missions, when lunar dusts were 
introduced into the Lunar Lander and command module, resulting in direct exposure and occasional 
reports of respiratory, dermal, and ocular irritation.  NASA’s planning for the return to the Lunar surface has an 
EVA schedule that is more rigorous than what was experienced during the Apollo era.  This increased 
duration and frequency of exposure to lunar dust requires that NASA set a permissible exposure limit for 
respirable lunar dust.  Dermal and ocular abrasions can occur during spaceflight.  These can be minimized 
by mitigation through operational procedures, i.e., post-EVA clean up in airlocks, temporary breathing 
apparatus implementation during clean-up exposure periods, and isolation of contaminated suit from 
respirable environment and appropriate filtering design implementations within ECLSS system. 
HRP-47065 
SRPE Research Planning input to HRP IRP- Revision FY09 
283 
Strategy for Mitigation 
To mitigate the potential health risks and formulate a scientifically sound and defensible permissible 
exposure limit for exposure to respirable fractions of lunar dust, we have identified several knowledge 
gaps, and appropriate studies to close these knowledge gaps.  The Lunar Airborne Dust Toxicity 
Assessment Group has been created and utilized to provide expert opinions of NASA proposed gaps and 
research studies.  The proposed research will permit us to gain adequate knowledge to ensure appropriate 
mitigation strategies. 
Gaps 
AEH 1: What are the unique properties of lunar dust that affect physiology?   
Lunar dust particles are unlike terrestrial dusts.  Lunar dusts are known to have a high surface area and 
other distinctive shape and chemical characteristics.  
Tasks: AEH, LADTAG directed study  
Dust Factor Study – Dust Size Factor (Physiology) Studies 
(Directed Studies – Shape & Chemistry Analysis Study; Forensic analysis of Apollo artifacts ) 
Activation Factor Study – (Directed Study – Reactivation studies, solar wind impact studies) 
 
Size, Shape, Chemistry Analysis and Lunar Activation Studies 
Focused studies will be performed to determine the size distribution, unique shape characteristics and chemical 
composition of lunar dust particulate. The results will be used to facilitate the management of lunar dust particles 
in the respirable size range Lunar activation studies will attempt to replicate solar wind, micrometeorite 
bombardment, and lunar processes that cause surface activation of lunar dust.  Understanding the activation and 
passivation processes and their mode of action in the human system will determine potential health effects and 
exposure limits during mission related tasks.  
Deliverables:  
These studies will provide activated dust particles for further toxicity testing. 
Determination of size distribution factor for calculation of permissible exposure limit.  
Recommendations for operational processes and constraints to minimize exposure to lunar dusts. 
Recommendations to be incorporated into Spaceflight Human Systems Standards and MOD planning. 
Recommendation for crew scheduling controls to mission designers.  
Required Delivery Milestone:  PEL required by Lander SDR, FY11 
Required Platforms:  
The activity will be conducted in various ground laboratory studies. 
Validation for planetary Ops is required in Lunar Return Timeframe on the Lunar surface. 
AEH 2: What is the toxicity of respired lunar dust in the respiratory system? 
During the Apollo missions several crews reported anecdotal respiratory issues with lunar dust.  There is 
no scientifically defensible data to support the toxicity of inhaled lunar dusts.  These data are central in 
determining a permissible exposure limit and risk criteria for lunar dusts.  
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Tasks: (AEH, LADTAG – via directed study) 
Pulmonary Toxicity Studies (Dose, Species & Activation Factors) – Inhalation Toxicity, Intratracheal & 
Intrapharyngeal Instillation Testing 
(Directed Studies) 
These studies will determine the distribution of inhaled and instilled dust particles throughout the lung and the 
overall toxicity in the lung tissue.  Gross pathology will be performed as evidence of the degree on lunar dust 
toxicity.  
Deliverables:  
Determination of species, dose and activation factors for calculation of permissible exposure limit. 
Implement design features into spacecraft and operational controls post-EVA  to minimize crew exposure to dust  
Required Delivery Milestone: Provide initial species, dose and activation factors by end of 2009.  PEL Required 
by Lander SDR in FY11   
Required Platforms:  
The activity will be conducted in various ground laboratory studies. 
Validation for planetary Ops in Lunar Return Timeframe. 
AEH 3: What is the mode of action of lunar dust at the respiratory cellular level?  
Respirable particles are suspected to be present on the lunar surface; there is no evidence that exists that 
would show the toxicity of lunar dust if it penetrates the lungs at the cellular level.  The possible 
generation of reactive oxygen species (ROS) will aid in the determination of lunar dust toxicity.  
Scientifically defensible studies will objectively determine cellular level toxicity.  Other relevant 
biomarkers of cellular toxicity will be explored if identified.  
Tasks: (AEH, LADTAG – via directed study) 
Lunar cell culture toxicity testing (Active vs. Non-Active Dusts) 
Human lung cell culture will be tested to determine toxicity of lunar dust particles.  The generation of ROS will 
be one marker of potential toxicity.  Active vs. non-active dust will be tested to determine the differences in 
toxicity due to chemical activation.  
Deliverables: This information may contribute to the determination of both dose and activation factors for 
calculation of permissible exposure limit 
Required Delivery Milestone: Provide required data mid 2010.  
Required Platforms:  
The activity will be conducted in various ground laboratory studies.  
Validation for planetary Ops in Lunar Return Timeframe will be necessary. 
AEH 4: What is the dermal and ocular toxicity of lunar dust? 
During the Apollo missions several crews reported anecdotal dermal and ocular issues with lunar dust 
exposure.  There is no data to support the dermal and ocular toxicity of lunar dusts.  The determination of 
the dermal and ocular hazards is necessary to predict and prevent any visual decrement and vapor barrier 
loss during lunar operations. 
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Tasks: (AEH, LADTAG – via directed study) 
Dermal Toxicity Studies 
Dermal abrasion studies will be performed to determine the degree of dermal toxicity from acute and chronic 
exposure to lunar dust particles.  
Deliverables: Research data indicating the degree of dermal toxicity of lunar dusts.  Based upon these results a 
follow on could include an ocular exposure standards, recommended countermeasures, design and operational 
controls.  
Required Delivery Milestone: Guidelines and treatment information required for Lunar Lander SDR, FY11.  
Required Platforms: The activity will be conducted in various ground laboratory studies.  
 
Tasks: (AEH, LADTAG – via directed study) 
Ocular Toxicity Studies 
Ocular exposure studies will be performed to determine the degree of ocular toxicity from acute and chronic 
exposure to lunar dust particles.  
Deliverables: Research data indicating the degree of ocular toxicity of lunar dusts.  Based upon these results a 
follow on could include an ocular exposure standards, recommended countermeasures, design and operational 
controls.  
Required Delivery Milestone: Guidelines and treatment information required for Lunar Lander SDR, FY11.  
Required Platforms: The activity will be conducted in various ground laboratory studies.  
AEH 5: What are the permissible exposure limits for inhalation of lunar dust? 
Data collected from AEH Tasks 1- 3 will be analyzed for the development of time based exposure limits 
of lunar dust concentration in air.  The standard will cover 6-month episodic exposures, but may include 
other time based exposure limits (acute and chronic) contingent upon the validity of the data.   
Tasks:  Lunar Dust Toxicity Research Program (LDTRP) will convene the LADTAG for assessment of data from 
all LDTRP studies.  Final recommendation(s) of Lunar Dust Health Standards will be developed. 
Deliverables:  
Update PEL based upon research (Time based permissible exposure limits for respirable/airborne lunar dust) and 
studies past 2010. 
Data from AEH4 will be analyzed.  Recommendations for countermeasures and protective measures 
Required Delivery Milestone: Guidelines and treatment information required for Lunar Lander SDR, FY11.  
Required Platforms: The activity will be conducted in various ground laboratory studies.  
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AEH Watch Item/NSBRI Research: What are the effects of lunar gravity on permissible exposure 
limits for inhalation of lunar dust? 
Tasks: (NSBRI – NRA selected task) 
Aerosol Deposition in the Lung in Fractional Gravity 
The hypotheses are that total aerosol deposition in the human lung will be higher in fractional gravity, and that 
aerosol deposition on the lungs of rats will be more peripheral.  The increased deposition and lengthened time 
before clearance may increase the likelihood of lung injury.   
Deliverables: Research data on a potential factor to consider in establishing Permissible Exposure Limits; 
research data on the dynamics of aerosols in the lungs.  
Required Delivery Milestone: Inputs to AEH 5, PEL establishment and updating.  
Required Platforms: The activity will be conducted in various ground laboratory studies including fractional-
gravity flights in the NASA Reduced Gravity Aircraft.  
 
Tasks: (NSBRI – NRA selected task) 
Clearance of Particles Depositing in the Human Lung in Low Gravity 
The deposition of particulate matter in the human lung is known to bring with it both long-term and short-term 
adverse health consequences.  The hypothesis is that clearance rates from the lung of particles deposited in low 
gravity will be substantially reduced compared to that in normal gravity, resulting in increased residence times in 
the periphery of the lung, enhancing their potential to cause lung damage. 
Deliverables: Inputs to AEH 5, PEL establishment and updating. 
Required Delivery Milestone: Inputs to AEH 5, PEL establishment and updating. 
Required Platforms: The activity will be conducted in various ground laboratory studies including fractional-
gravity flights in the NASA Reduced Gravity Aircraft. 
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RISK OF ACCELERATED OSTEOPOROSIS – CRITICALITY: LUNAR OUTPOST – 
D, MARS – I 
Bone mineral loss occurs in microgravity due to unloading of the skeletal system, with average loss rates 
of approximately 1% per month.  It is unclear whether this bone mineral density will stabilize at a lower 
level, or continue to diminish.  It is unknown if fractional gravity, present on the moon and Mars would 
mitigate the loss.  Mission-related bone loss cannot be corrected by post-mission rehabilitation; 
crewmembers could be at greater risk of osteoporosis-related fractures in later life.  Greater understanding 
of the mechanisms of bone demineralization in microgravity is necessary to frame this risk, as well as to 
understand how current and future osteoporosis treatments may be employed. 
Operational Relevance and Risk Context  
Although it is currently possible 1) to track the course of changes in bone mineral density and bone 
quality during long duration missions, 2) to determine if bone losses will occur during a Mars visit, and  
3) knowing such information to determine the risk of fracture upon return to Earth after a Mars mission, 
current capabilities are not in any requirement documents for Lunar or Mars missions.  However, even 
after 6-month missions there are indications that bone quality/strength does not recover as quickly as bone 
mineral density.  This may represent a long-term health effect (increased osteoporosis and fracture risk) 
related to this discordant recovery dynamic.  This information is required to assess long-term health risks 
to returning crew. 
Strategy for Mitigation 
While demineralization of bone during spaceflight is known and requires mitigation; the time course of 
in-flight bone changes, the time course of post-flight recovery and individual susceptibilities have not 
been determined.  The 2007 NASA Research Announcement was utilized to solicit and select proposals to 
gather these space normal data.  In addition, work is ongoing with the Space Medicine Division to obtain 
long-term recovery data.  The long-term goals are to deliver countermeasures during the mission, track 
efficacy, and prevent lifetime health risk.  Due to schedule constraints, countermeasure development has 
been started in parallel with space normal data collection and technology development. 
Gaps 
B10: What is the time course of bone loss during flights >90 days on ISS and during Lunar Outpost 
missions?  Although the degree of loss in bone mineral density during the ISS missions is not of great 
concern, it is not known at what rate losses occur, and it is not currently possible to predict what losses 
will occur during a Mars mission.  Therefore, in-flight monitoring (BMD or other methods) of bone 
metabolism and density/strength, as new state of the art techniques become available, should be examined 
on Shuttle, ISS and during Lunar Sortie and Lunar Outpost missions.  It is recommended that additional 
research on bone loss remain at a low priority until this data is acquired and assessed, and can be used to 
focus any future efforts. 
B1: Is bone strength completely recovered with recovery of BMD?  It is a high priority to determine 
whether changes occur in bone architecture during long-duration spaceflight that, even with recovery of 
pre-flight BMD, adversely impacts long-term risk.  Is this influenced by multiple flights? 
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Task: (NxPCM – via NRA) 
Monitoring of Bone Loss Bio-Markers in Human Sweat a non-invasive, time efficient means of monitoring bone 
resorption markers under micro and partial gravity loading conditions.  
Validation that the rate and extent of unloading-induced bone loss in humans can be assessed by monitoring the 
levels of two bone resorption markers in sweat, namely calcium and collagen breakdown products.  One of the 
approaches tested will be a novel, micro-fabricated fluid collection capillary array, known as the micro-fabricated 
sweat patch (MSP) device, specifically developed for use in microgravity. 
Deliverables: New technology will be developed to assess bone resorption markers.  Assessment of bone markers 
will allow for an update of information to the bone standard.  Data will be shared with ExMC to aid in their work 
on ExMC Gap 4.06. 
Required Delivery Milestone: FY2014 – new bone marker technology delivered to mission operations for lunar 
outpost and Mars planning.   
Required Platforms: Initial work will be performed on the ground for hardware development; the hardware will 
be evaluated in bed rest campaigns.  The ISS will be required to validate the hardware.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 10 10 kg/Inc None 10 0.5 
 
Task: (NxPCM – via NRA) 
Recovery of Bone Quantity and Quality upon Simulated Space Fight as a Function of Exposure Frequency, 
Genetics, and Gender.   
This task will examine the consequences of multiple exposures to simulated weightlessness on long-term quantity 
and quality of trabecular and cortical bone as well as muscle and investigate how recovery periods between 
periods of weightlessness can be optimized. 
Deliverables: This study will provide information to aid in closure of the gaps in the FY2011 timeframe. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study utilizing a rodent hind-limb unloading model.   
 
Task: (NxPCM – via NRA) 
Bone Countermeasure Study – TBD.  This task will examine potential countermeasures for bone. 
Deliverables: This study will provide a validated countermeasure in the FY2018 timeframe. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: Initial work will be performed on the ground in bed rest campaigns.  The ISS will be 
required to validate the countermeasure.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None 31 kg/Inc 4.32 kg/Inc 29.5 8 
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Task: (NxPCM – via NRA) 
Epidemiologic Analyses of Risk Factors for Bone Loss and Recovery Related to Long Duration Space Flight 
This task will make comparisons between bone densities of crewmembers and the population-based data and use 
fracture prediction models derived from the cohort to make estimations on fracture risk among crewmembers.  It 
will also explore the data already gathered to date during the US human space program in order to summarize the 
current state of evidence available on additional risk factors related to bone loss and recovery in microgravity.  
The ultimate goal of this research proposal is to provide evidence-based information that may assist in guiding the 
direction of further research required to understand better the risk of bone loss and fracture among crewmembers 
and the strategies that could be developed to prevent it from occurring. 
Deliverables: This study will provide information to aid in closure of the gaps and will enable the Bone 
Discipline Lead to provide information regarding the SFHSS Bone Standard.  In addition, information will be 
shared with the Space Medicine Division for their Conditions List.  These products will be delivered in the 
FY2011 timeframe. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study data mining-type task. 
B1: Is bone strength completely recovered with recovery of BMD?  It is a high priority to determine 
whether changes occur in bone architecture during long-duration spaceflight that, even with recovery of 
pre-flight BMD, adversely impacts long-term risk.  Is this influenced by multiple flights? 
Task: (NxPCM – via Directed Study) 
Bone Recovery Study – TBD 
This task will examine post-flight changes in bone mineral densities using QCT methodologies.  These 
measurements will occur over a 3-year post-flight period to obtain bone recovery data on crewmembers. 
Deliverables: This study will provide information regarding the SFHSS Bone Standard; it will be delivered in the 
FY2011 timeframe. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This task requires long-duration crewmembers and thus requires the ISS. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
 
Task: (NxPCM – via NRA) 
Contributors to Long-Term Recovery of Bone Strength following Exposure to Microgravity 
This task will characterize: (a) the time course of recovery from simulated microgravity (28d HU), (b) response to 
a second HU exposure (following an initial HU exposure plus recovery), and (c) the effects of exercise on 
recovery dynamics.  The two exercises will be resistance training and treadmill running.  The overall objective is 
to define the relationships between three different, but crucial, types of bone parameters: bone mass, bone mineral 
density, and bone quality 
Deliverables: This study will provide information to aid in closure of the gaps in the FY2011 timeframe. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study utilizing a rodent hind-limb unloading model.   
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N5: Can a single test monitor net bone calcium changes?  Although the degree of loss in bone mineral 
density during the ISS missions is not of great concern, it is not known at what rate losses occur, and it is 
not currently possible to predict what losses will occur during a Mars mission.  Therefore in-flight 
monitoring (other than BMD) of bone metabolism and density/strength, as new state of the art techniques 
become available, should be examined on Shuttle, ISS and during Lunar Sortie and Lunar Outpost 
missions.   
Task: (NxPCM – via NRA) 
Rapid measurements of bone loss using tracer-less calcium isotope analysis of blood and urine 
This task will develop a method to rapidly detect changes in bone mineral balance by measuring the natural (i.e., 
tracer-less) isotope composition of calcium in blood and/or urine.  This method would provide a way to detect 
incipient bone loss before changes in bone density are detectable by conventional X-ray methods.   
Deliverables: New technology will be developed to assess bone resorption markers.  Assessment of bone markers 
will allow for an update of information to the bone standard.  Data will be shared with ExMC to aid in their work 
on ExMC Gap 4.06. 
Required Delivery Milestone:  FY2014 – new bone marker technology delivered to mission operations for lunar 
outpost and Mars planning.   
Required Platforms: Initial work will be performed on the ground for hardware development; the hardware will 
be evaluated in bed rest campaigns.  The ISS will be required to validate the hardware. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None – 
Accounted for 
with Repository 
Task 
3 kg/Inc None – 
Accounted for 
with Repository 
Task 
0.5 
B3: What pharmaceuticals against bone loss are best used and how?  MO5: Determine how can 
osteoporosis treatments be employed?  The efficacy of anti-resorptive agents under weightless 
conditions of spaceflight has not been validated. 
Task: (NxPCM – via Directed Study) 
Bisphosphonates as a countermeasure to space flight induced bone loss, SMO-021 
The purpose of this SMO is to determine whether Bisphosphonates, in conjunction with the routine in-flight 
exercise program, will protect ISS crewmembers from the regional decreases in bone mineral density documented 
on previous ISS flights.  Two dosing regimens will be used:  (1) an oral dose of 70 mg of alendronate taken 
weekly during flight or (2) an IV dose of zoledronic acid 4 mg, administered just once approximately 45 days 
before flight.  Secondary goals will be to document the return to normal bone remodeling post-flight in 
crewmembers who took Bisphosphonates.  If shown to be an effective countermeasure to space flight-induced 
bone loss, Bisphosphonates could prevent or ameliorate several potential bone-related problems.  This study is 
being conducted in conjunction with the Japan Space Agency 
Deliverables: A product will be an effective pharmaceutical countermeasure to mitigate the risk of bone loss.  
This countermeasure will be delivered in the FY2012 timeframe. 
Required Delivery Milestone:  This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog.   
Required Platforms: The ISS is required to validate the countermeasure. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight 
BDC Time (hrs) 
12 None 16 kg/Inc 2.46 kg + TBD 
cold stowage/Inc
29.33 16.5 
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B18:  Is vibration a good countermeasure?  This gap has been closed, the vibration study conducted 
did not protect against bone loss. 
B3: What pharmaceuticals against bone loss are best used and how?  MO5: Determine how can 
osteoporosis treatments be employed?  The efficacy of anti-resorptive agents under weightless conditions 
of spaceflight has not been validated. 
B11: What are the effects of radiation on bone?   
Task: (NSBRI) 
Space Radiation and Bone Loss: Lunar Outpost Mission-Critical Scenarios and Countermeasures  
Astronauts on long lunar missions will face the adverse affects of microgravity, reduced gravity, and radiation 
exposure.  It is known that microgravity causes bone loss since bones of the lower body do not bear weight in 
space as they do on Earth.  The impact of radiation on bone quality and fracture healing in reduced gravity is 
unknown.  Dr. Ted A Bateman is investigating the effect of different types of space radiation on bone to learn 
whether radiation increases the rate of loss.  His team is also testing the protective effects of pharmacological 
countermeasures, such as Bisphosphonates, antioxidants and certain proteins. 
Deliverables: A product will be information regarding bone loss and radiation effects. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study.   
 
Task: (NSBRI) 
Maintaining Musculoskeletal Health in the Lunar Environment  
It is well documented that the human body loses bone and muscle mass during long-duration stays in space such 
as on the International Space Station.  With the United States planning to conduct long-duration missions to the 
moon, scientists must learn what effects lunar gravity, which is one-sixth of Earth's, will have on human muscle 
and bone.  This study is an animal model study to determine if muscle and bone loss on the moon will be as 
severe as it is in microgravity.  The project also seeks to determine if low-dose radiation exposure worsens bone 
and muscle loss in a lunar-gravity environment and if, under these unique conditions, exercise is still effective in 
reducing bone and muscle loss. 
Deliverables: A product will be information regarding bone loss and radiation effects. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study.   
B10: What is the time course of bone demineralization during flights >90 days on ISS and during 
Lunar Outpost missions?  Although the degree of loss in bone mineral density during the ISS missions 
is not of great concern, it is not known at what rate losses occur, and it is not currently possible to predict 
what losses will occur during a Mars mission.  Therefore in-flight monitoring (other than BMD) of bone 
metabolism and density/strength, as new state of the art techniques become available, should be examined 
on Shuttle, ISS and during Lunar Sortie and Lunar Outpost missions.  It is recommended that additional 
research on bone loss remain at a low priority until this data is acquired and assessed, and can be used to 
focus any future efforts. 
B1: Is bone strength completely recovered with recovery of BMD?  It is a high priority to determine 
whether changes occur in bone architecture during long-duration spaceflight that, even with recovery of 
pre-flight BMD, adversely impacts long-term risk.  Is this influenced by multiple flights? 
N14: What nutritional countermeasures can be used to mitigate bone loss? 
HRP-47065 
SRPE Research Planning input to HRP IRP- Revision FY09 
296 
Task: (NxPCM – via NRA) 
Dietary intake can predict and protect against changes in bone metabolism during space flight and recovery 
This task will document how the ratio of acid to base precursors in the diet is related to directional changes in 
markers of bone resorption and formation during flight and recovery from flight.  There is a high likelihood for 
success in predicting the extent of bone loss from dietary intake patterns among astronauts during space flight 
given that this concept is strongly anchored in previous ground-based data from our laboratory and others.  The 
notion of manipulating diet to minimize bone loss could also have significant social and economic impacts for 
NASA and for the general public – especially given the increasing trends for diets that are high in animal protein 
and low in fruits and vegetables.  The proposed experiments will result in a dietary countermeasure for bone loss 
that has no associated risks for side effects, no requirement for payload mass, and no additional crew time 
necessary during flight. 
Deliverables: This task will deliver a validated nutritional countermeasure that will protect against bone loss. 
Required Delivery Milestone:  This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog.   
Required Platforms: The ISS is required to validate the countermeasure. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight 
BDC Time (hrs) 
12 None 31 kg/Inc 4.32 kg + TBD 
cold 
stowage/Inc 
29.33 8 
N7: What are the potassium, magnesium, and phosphorus changes in relation to cardiovascular 
issues and bone loss?  The relationship between bone health and the protein/potassium ratio in the diet 
needs to be further investigated, along with the role of potassium in cardiovascular health during flight.  
Nominal determinations of phosphorus content of the space food system are required, as well as further 
investigation of the mechanism and implications of decreased phosphorus excretion after long-duration 
spaceflight.  Nominal determinations of magnesium content of the space food system are required.  
Task: (NxPCM – via Directed Study) 
Nutrition Status Assessment – SMO O16E: Nutrition SMO  
This is a directed study that seeks to expand the Medical Requirement 016L testing in three ways:  1) include in-flight blood 
and urine collection, 2) expand nominal testing to include makers of normative markers of nutritional assessment, and 3) add 
an R+30 session to allow evaluation of post flight nutrition and implications for rehabilitation.  Additional markers of bone 
metabolism (helical peptide, OPG, RANKL, IGF-1) will be measured to better monitor bone health and countermeasure 
efficacy.  New markers of oxidative damage will be measured (8-iso-prostaglandin F2a, protein carbonyls, oxidized and 
reduced glutathione) to better assess the type of oxidative insults during space flight.  The array of nutritional assessment 
parameters will be expanded to include serum folate, plasma pyridoxal 5'-phosphate, and homocysteine to better understand 
changes in folate, vitamin B6 status, and related cardiovascular risk factors during and after flight.  Additionally, stress 
hormones and hormones that affect bone and muscle metabolism will be also measured (DHEA, DHEA-S, Cortisol, 
testosterone, estradiol).  This additional assessment would allow for better health monitoring, and allow for more accurate 
recommendations to be made for crew rehabilitation.  These additional parameters were added due to the recommendation of 
an extramural panel that met to define nutritional standards and requirements in 2005.  If data indicate countermeasures are 
necessary for cardiovascular issues and/or bone loss, additional ground-based studies will be initiated.  These countermeasures 
will be validated on board the ISS 
Deliverables: The SFHSS nutrition standard will be updated and nutritional requirements will be delivered to AFT.  Updates 
regarding nutritional status in-flight will be delivered to the Human System Risk Forum.  All deliverables are scheduled for 
delivery in the FY2011 timeframe. 
Required Delivery Milestone:  ISS is required to ensure that the data represents space normal 
Required Platforms: The ISS is required to validate the countermeasure. 
# of Subjects Initial Upmass (kg) Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew Time/Subject 
(hrs) 
Post-Flight BDC 
Time (hrs) 
12 None 31 kg/Inc 5.1 kg + TBD cold 
stowage/Inc 
22.5 3.2 (Time shared 
with Medical 
Operations Time) 
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B15: Can exercise hardware and protocol be designed to provide loads necessary to maintain bone 
health?  By directing an exercise protocol to prevent skeletal adaptation to space, we prevent a cascade of 
subsequent physiological changes that may introduce health risks in and of themselves.  For example, 
bone decalcification can increase the risk for renal stones and can also perturb the body's hormonal 
system that conserve calcium in the body and absorb calcium from the diet (in Evidence Book).  Thus, an 
optimal exercise prescription could have crosscutting effects that preserves or maintains over all bone 
health. 
Task: (ECP – via Directed Study) 
Integrated Countermeasure Study – TBD   
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
 
Task: (ECP – via Directed Study) 
ISS Prescription Study – TBD  
This task is referenced under the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance – see gaps M7, M8, M9 and M10 
 
Task: (NSBRI) 
A Quantitative Test of On-Orbit Exercise Countermeasures for Bone Demineralization Using a Bed Rest Analog  
This novel approach involves quantifying typical daily loads to the lower extremities in selected free-living 
volunteer subjects who are moderate exercisers and planning individual exercise prescriptions based on DLS 
theory.  Subjects were randomized to control or exercise groups and confined to 6-degree head-down bed rest in 
the General Clinical Research Center (GCRC) at the Cleveland Clinic for 12 weeks.  During this time, the 
exercise group underwent individualized daily exercise programs in the unique Zero Gravity Locomotion 
Simulator (ZLS) at CCF designed to replace their daily mechanical load stimulus experienced during free living.  
DXA, MRI, and QCT scans were conducted at the start and end of bed rest to assess variations in bone mineral 
density, changes in muscle volume, and regional changes (cortical vs. trabecular) in bone.  Strength 
measurements were collected pre- and post-bed rest, and urinary and serum markers of bone resorption and 
formation were also assessed.  Dietary intake sufficient to maintain constant body weight with a balanced intake 
of macro- and micronutrients was planned and supervised by a registered dietician, and a physician was available 
24 hr/day to attend to any medical needs.  A rehabilitation program was offered to subjects in the 8 weeks 
following bed rest.  The proposed experiment should provide a categorical answer to the question of whether 
intermittent load replacement can adequately protect the musculoskeletal system against hypokinetic osteopenia 
and muscle atrophy and may open a new era in individualized exercise countermeasure planning. 
Deliverables: This study will provide data that will help close this gap.  At the end of this study a decision must 
be made whether or not to pursue this exercise model. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a bed rest study.   
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Task: (NSBRI) 
Monitoring Bone Health by Daily Load Stimulus Measurement during Lunar Missions  
This project will develop and validate a miniaturized accelerometer-based system that could be used during intra- 
and extravehicular task on the lunar surface to monitor the complete daily load stimulus to the lower extremity 
and interpret that information in relation to bone health.  After validation in the enhanced Zero Gravity 
Locomotion Simulator (eZLS) at NASA Glenn Research Center and the lunar bed-rest analog at University of 
Texas Medical Branch, a deliverable of this project will be a system, the Accelerometric Daily Load Sensor 
(aDLS), including a small shoe-mounted unit that will transmit signals to a BioWATCH that could also be used to 
collect data on other physiological systems simultaneously.  On-board software with visual feedback will 
determine how much additional exercise is required each day to maintain bone homeostasis. 
Deliverables: This study will deliver a countermeasure for use on the lunar surface.  If the countermeasure will 
be pursued, it must be validated on the lunar surface 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This study is being conducted in bed rest. 
 
Task: (NSBRI) 
An Integrated Musculoskeletal Countermeasure Battery for Long-Duration Lunar Missions  
The degree to which the musculoskeletal system will maintain its integrity during prolonged sojourns in the 
reduced gravity of the lunar surface is presently unknown.  It is, however, likely that without countermeasures 
there will be adaptive changes in muscle strength, bone mineral density, bone geometry, and sensorimotor status.  
When the combined effects of these changes are considered in the context of the construction and exploration 
tasks that will be performed at the lunar base or at other lunar sites, the risk of injury secondary to a fall is likely 
to be elevated.  To address this fundamental problem, we have constructed a compact platform that integrates a 
time efficient integrated battery of countermeasures that can be conducted in the confines of the lunar habitat to 
minimize the risk of musculoskeletal injury.  Ultimately, we expect that this battery of countermeasures will be 
validated using a 10° head-up bed rest simulation of a lunar mission, although it could also be tested in the 
standard 6 degree head down simulation.  The specific objectives of the countermeasure battery are: to preserve 
muscle strength and cardiovascular fitness; to minimize decrements in postural stability, dynamic balance, and the 
ability to make corrective actions prior to a fall; to preserve functional performance on mission relevant tasks; and 
to minimize bone loss in the proximal femur. 
Deliverables: This study must be reviewed several times before it will deliver a countermeasure.  The hardware 
must be developed and then evaluated in a ground-based study.  It will potentially be evaluated in the lunar 
analog model 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study.  
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RISK OF BONE FRACTURE – CRITICALITY: LUNAR OUTPOST – D, MARS – D 
Bone mineral loss occurs in microgravity due to unloading of the skeletal system, with average loss rates 
of approximately 1% per month.  It is unclear whether this bone mineral density will stabilize at a lower 
level, or continue to diminish.  It is also unknown if fractional gravity, present on the moon and Mars 
would mitigate the loss.  This level of bone loss does not create an unacceptable risk of fractures for ISS 
missions, but longer missions could create higher fracture risk.  The risk of fracture during a mission 
cannot be accurately estimated until mechanisms and probabilities of bone overloading during the 
missions are understood.  Mission-related bone loss cannot be corrected by post-mission rehabilitation; 
crewmembers could be at greater risk of osteoporosis-related fractures in later life.  Greater understanding 
of the mechanisms of bone demineralization in microgravity is necessary to frame this risk, as well as to 
understand how current and future osteoporosis treatments may be employed. 
Context of Risk for Exploration 
Long duration mission DXA scans of astronauts and cosmonauts following long duration missions reveal 
an average monthly rate of BMD loss at 1-1.5% bone mass in lower limbs, hip, spine and pelvis.  QCT 
further delineates a greater percentage loss in the cancellous bone compartment, relative to loss in cortical 
bone, as well as geometric changes in the proximal femur.  Temporal recovery of preflight bone mass 
exceeds the duration of spaceflight exposure with a 50% restoration on the order of 200-250 days, based 
on a mathematical fit of post-flight DXA BMD measurements.  Thus, the recovery model, based upon 
fitted data, suggest that substantial recovery could occur in about 3 years. The fracture risk for bone is 
related to the ratio of applied load to bone to the fracture load of bone.  Thus the increased fracture risk 
induced by spaceflight is suggested collectively by the accelerated loss of bone mass as an adaptive 
response, by the weightlessness and reduced gravity fields experienced during missions and by the loads 
and torques that the skeleton is subjected to during performed tasks of the missions.  The most critical 
work needed for this risk are measures of in-flight changes in bone mass over the course of ISS missions 
so that temporal changes in bone mass can be predicted during Mars missions.  Those data will provide a 
basis for evaluating whether the expected loads/torques to the bones during human performance on a 
mission will exceed the failure load of bone (i.e., fracture load).  This knowledge will drive mission 
operations planning. 
Strategy for Mitigation 
A high risk for fracture is a characteristic of osteoporosis, which is a consequence of the losses in bone 
mass and in structural deterioration.  Therefore, gaps and tasks that fall under the Risk of Accelerated 
Osteoporosis are also mapped to this risk.  The only independent gap for the Risk of Bone Fracture is the 
unknown incidence of vertebral compression fractures.  The task associated with this gap is being 
completed by the Space Medicine Division.  
Gaps 
B2: What new technologies are available for in-flight fracture diagnosis?  This gap is being worked 
within the ExMC Program Element.  Please refer to ExMC gap 4.02 for further information.  HHC is not 
conducting any work in this area. 
B29: What is the risk of vertebral compression fractures?  Data needs to be collected for measures of 
morphological changes to vertebral bodies (for diagnosis of asymptomatic compression fractures) in 
crews after long-duration spaceflight; characterize morphological changes to vertebral bodies with 
longitudinal measures in Astronaut population to characterize changes over time. 
Task: (Space Medicine) 
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Assess Vertebral Compression Fractures (MRID)
This task is being conducted as part of Medical Requirement-035L Bone Densitometry 
Deliverables: One product will be to inform mission operations if the data indicate there are vertebral 
compression fractures in returning crew.  At some point in the data gathering, if indicated, the SFHSS bone 
standard will be updated 
Required Delivery Milestone: Mission operations needs to be informed of data as soon as possible to make any 
modifications to Orion regarding loads on crew 
Required Platforms: ISS is required to collect data on long duration crews.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight 
BDC Time (hrs) 
N/A Resources 
encompassed 
within Space 
Medicine 
N/A Resources 
encompassed 
within Space 
Medicine 
N/A Resources 
encompassed 
within Space 
Medicine 
N/A Resources 
encompassed 
within Space 
Medicine 
N/A Resources 
encompassed 
within Space 
Medicine 
N/A Resources 
encompassed 
within Space 
Medicine 
B10: What is the time course of bone demineralization during flights >90 days on ISS and during 
Lunar Outpost missions?  Although the degree of loss in bone mineral density during the ISS missions 
is not of great concern, it is not known at what rate losses occur, and it is not currently possible to predict 
what losses will occur during a Mars mission.  Therefore in-flight monitoring (other than BMD) of bone 
metabolism and density/strength, as new state of the art techniques become available, should be examined 
on Shuttle, ISS and during Lunar Sortie and Lunar Outpost missions.  It is recommended that additional 
research on bone loss remain at a low priority until this data is acquired and assessed, and can be used to 
focus any future efforts. 
B1: Is bone strength completely recovered with recovery of BMD?  It is a high priority to determine 
whether changes occur in bone architecture during long-duration spaceflight that, even with recovery of 
pre-flight BMD, adversely impacts long-term risk.  Is this influenced by multiple flights? 
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gaps B1-B10 in that 
risk.  
Recovery of Bone Quantity and Quality upon Simulated Space Fight as a Function of Exposure Frequency, 
Genetics, and Gender 
Bone Countermeasure Study – TBD 
Monitoring of Bone Loss Bio-Markers in Human Sweat a non-invasive, time efficient means of monitoring bone 
resorption markers under micro and partial gravity loading conditions. 
Epidemiologic Analyses of Risk Factors for Bone Loss and Recovery Related to Long Duration Space Flight 
B1: Is bone strength completely recovered with recovery of BMD?  It is a high priority to determine 
whether changes occur in bone architecture during long-duration spaceflight that, even with recovery of 
pre-flight BMD, adversely impacts long-term risk.  Is this influenced by multiple flights? 
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gap B1 in that risk.  
Bone Recovery Study – TBD 
Contributors to Long-Term Recovery of Bone Strength following Exposure to Microgravity 
N5: Can a single test monitor net bone calcium changes?  Although the degree of loss in bone mineral 
density during the ISS missions is not of great concern, it is not known at what rate losses occur, and it is 
not currently possible to predict what losses will occur during a Mars mission.  Therefore in-flight 
monitoring (other than BMD) of bone metabolism and density/strength, as new state of the art techniques 
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become available, should be examined on Shuttle, ISS and during Lunar Sortie and Lunar Outpost 
missions.   
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gap N5 in that 
risk.  
Rapid measurements of bone loss using tracer-less calcium isotope analysis of blood and urine 
B3: What pharmaceuticals against bone loss are best used and how?  MO5: Determine how can 
osteoporosis treatments be employed?  The efficacy of anti-resorptive agents under weightless conditions 
of spaceflight has not been validated. 
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gap B1 in that 
risk.  
Bisphosphonates as a countermeasure to space flight induced bone loss, SMO-021 
B10: What is the time course of bone demineralization during flights >90 days on ISS and during 
Lunar Outpost missions?  Although the degree of loss in bone mineral density during the ISS missions 
is not of great concern, it is not known at what rate losses occur, and it is not currently possible to predict 
what losses will occur during a Mars mission.  Therefore in-flight monitoring (other than BMD) of bone 
metabolism and density/strength, as new state of the art techniques become available, should be examined 
on Shuttle, ISS and during Lunar Sortie and Lunar Outpost missions.  It is recommended that additional 
research on bone loss remain at a low priority until this data is acquired and assessed, and can be used to 
focus any future efforts. 
B1: Is bone strength completely recovered with recovery of BMD?  It is a high priority to determine 
whether changes occur in bone architecture during long-duration spaceflight that, even with recovery of 
pre-flight BMD, adversely impacts long-term risk.  Is this influenced by multiple flights? 
N14: What nutritional countermeasures can be used to mitigate bone loss? 
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gap B1, B10 and 
N14 in that risk.  
Dietary intake can predict and protect against changes in bone metabolism during space flight and recovery 
N7: What are the potassium, magnesium, and phosphorus changes in relation to cardiovascular 
issues and bone loss? The relationship between bone health and the protein/potassium ratio in the diet 
needs to be further investigated, along with the role of potassium in cardiovascular health during flight.  
Nominal determinations of phosphorus content of the space food system are required, as well as further 
investigation of the mechanism and implications of decreased phosphorus excretion after long-duration 
spaceflight.  Nominal determinations of magnesium content of the space food system are required.  
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gap N7 in that 
risk.  
Nutrition Status Assessment – SMO O16E: Nutrition SMO  
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RISK OF RENAL STONE FORMATION – LUNAR OUTPOST – D, MARS – D 
Kidney stone formation and passage has the potential to greatly impact mission success and crewmember 
health for long duration missions.  Alterations in hydration state (relative dehydration) and bone 
metabolism (increased calcium excretion) during exposure to microgravity may increase the risk of 
kidney stone formation and it is unclear which mitigation strategy would be the most effective. 
Context of Risk for Exploration 
Countermeasures for renal stone formation must be validated prior to Mars exploration missions because 
of reduced level of care and prolonged evacuation time.  In-flight monitoring must be developed and 
instituted so that crewmembers will have a means to track their renal stone markers.  
Strategy for Mitigation 
Space normal must first be defined for this risk; hence data mining tasks are ongoing.  Once space normal 
is defined, the data will be presented to the Human System Risk Forum and it will be decided if 
countermeasures need to be developed. 
Gaps 
B5:  What is the current state of knowledge regarding renal stone formation?  A comprehensive 
synthesis of all existing data should be compiled, including: the most current clinical knowledge about 
risk factors and prevention strategies; and all prior and current flight data.  The following gaps fall within 
this group. 
B6:  What are the contributing factors other than loss of bone mineral density? 
B7:  Is it necessary to increase crew fluid intake and, if possible, to what extent will it mitigate stone 
formation? 
B8:   Do pharmaceuticals work effectively in spaceflight to prevent renal stones? 
B9:   What is the frequency of post-flight stone formation; the incidence and types of stones; and 
the time course of stone formation?  How does stone formation correlate with food intake and 
hydration status? 
B16:  Can inhibitors of stone formation be sufficiently provided through dietary sources? N13: Can 
renal stone risk be decreased using nutritional countermeasures? 
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Task: (NxPCM – Directed Study) 
Data mining for incidence of renal stone formation following spaceflight  
The evidence establishing the risk factors and/or the likelihood of risk occurrence for renal stone formation is 
either known or in-progress.  This study will compile data related to the risk of renal stone formation from 
medical data and raw research data used for previously published reports) and determine primary and other risk 
factors for renal stone formation, particularly regarding the types of stones formed (to identify the specific risk 
factor and appropriate countermeasure), the correlation with diet and the time course for formation. 
Deliverables: Final report of findings will be combined with the Renal Stone flight study and results will be 
brought to the HSRF in the FY2009 timeframe.  If data (combined with Renal Stone study results) indicate that 
new or additional countermeasures are required, then ground based studies will be solicited to find suitable 
candidate countermeasures.  The best of these countermeasures will then be validated through solicited flight 
studies and the countermeasure will be delivered in the FY2016 timeframe.  All data from this task will be passed 
to Space Medicine for their Conditions List. 
Required Delivery Milestone: If data indicate an issue with renal stones, then a validated countermeasure is 
required as soon as possible 
Required Platforms: If further countermeasures are needed, the bed rest ground analog is required to 
demonstrate countermeasure efficacy.  ISS is required as the Mars transit analog for countermeasure validation if 
new countermeasures are developed.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight 
BDC Time (hrs) 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
 
Task: (NxPCM – NRA) 
Renal Stone Risk During Spaceflight: Assessment and Countermeasure Validation 
The studies planned in this investigation will not only provide a better understanding of the stone-forming risk 
crewmembers experience during and after space flight, but will take the next step to test the efficacy of potassium 
citrate as a countermeasures to reduce this risk.  Based on the known increased risk crewmembers experience, it is 
imperative that countermeasures to reduce or alleviate this risk are developed and tested. 
Deliverables: Final report of findings will be combined with the Renal Stone flight study and results will be 
brought to the HSRF in the FY2009 timeframe.  If data (combined with Renal Stone study results) indicate that 
new or additional countermeasures are required, then ground based studies will be solicited to find suitable 
candidate countermeasures.  The best of these countermeasures will then be validated through solicited flight 
studies and the countermeasure will be delivered in the FY2016 timeframe.  All data from this task will be passed 
to Space Medicine for their Conditions List. 
Required Delivery Milestone: If data indicate an issue with renal stones, then a validated countermeasure is 
required as soon as possible 
Required Platforms: If further countermeasures are needed, the bed rest ground analog is required to 
demonstrate countermeasure efficacy.  ISS is required as the Mars transit analog for countermeasure validation if 
new countermeasures are developed.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
(hrs) 
Post-Flight 
BDC Time (hrs) 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
For Potential 
CM 
development, all 
resources are 
TBD 
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B8:   Do pharmaceuticals work effectively in spaceflight to prevent renal stones? 
Task: (NSBRI) 
The Multisystem Effect of Exercise Training/Nutritional Support During Prolonged Bed Rest Deconditioning: An 
Integrative Approach to Countermeasure Development for the Heart, Lungs, Muscles and Bones  
Sustained exposure to microgravity leads to adaptive changes in the cardiovascular and musculoskeletal systems 
that result in substantial morbidity.  For example cardiovascular deconditioning may lead to orthostatic 
hypotension and syncope.  Atrophy of skeletal muscle will diminish work capacity and may lead to muscle injury.  
Bone demineralization increases the risk of kidney stone formation and may reduce bone strength increasing the 
risk of fracture.  Bone resorption may be particularly severe after long duration space flight with uncertain 
recovery.  Despite in depth study, the optimal countermeasure for each system has not been defined.  More 
importantly, previous work has focused predominantly on one organ system at a time, ignoring the interaction 
among systems, and preventing the development of a specific countermeasure for an individual astronaut that 
might be effective for the heart, muscles and bones.  The global objective of this proposal is to test an integrated 
countermeasure that will be effective against cardiovascular deconditioning, skeletal muscle atrophy, and bone 
demineralization, and that ultimately can be applied practically abroad the International Space Station or a 
mission to Mars. 
Deliverables: Final report of findings will be delivered to HRP who will decide if the proposed countermeasure 
from this study should be validated. 
Required Delivery Milestone: No delivery milestones are required for this task 
Required Platforms: This is a ground-based study being conducted at the Institute of the Principal Investigator.  
N14: What nutritional countermeasures can be used to mitigate bone loss? 
Task: Tasks to fill this gap are cited under Risk of Accelerated Osteoporosis Risk – See Gap N14 in that 
risk.  
Dietary intake can predict and protect against changes in bone metabolism during space flight and recovery 
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RISK OF CARDIAC RHYTHM PROBLEMS – CRITICALITY: LUNAR OUTPOST – D, 
MARS – I  
Heart rhythm disturbances have been seen among astronauts.  Most of these have been related to 
cardiovascular disease, but it is not clear whether this was due to pre-existing conditions or effects of 
space flight.  It is hoped that advanced screening for coronary disease has greatly mitigated this risk.  
Other heart rhythm problems, such as atrial fibrillation, can develop over time, necessitating periodic 
screening of crewmembers’ heart rhythms.  Beyond these terrestrial heart risks, some concern exists that 
prolonged exposure to microgravity may lead to heart rhythm disturbances.  Although this has not been 
observed to date, further surveillance is warranted. 
Context of Risk for Exploration 
Missions may be impacted by the occurrence of a clinically significant dysrhythmia.  It is important to 
define “space normal” for this risk so that appropriate countermeasures can be developed if needed. 
Strategy for Mitigation 
Space normal must first be defined for this risk; hence data mining tasks are ongoing.  Once space normal 
is defined, the data will be presented to the Human System Risk Forum and it will be decided if 
countermeasures need to be developed. 
Gaps 
CV1: What are the in-flight alterations in cardiac structure and function?  This is a high priority gap 
for this risk.  The task is already underway in collaboration with outside investigators.  The studies 
include in-flight Holter monitoring and ultrasound assessment of cardiac structure and function.  Further 
research into this risk is not recommended until the results from this effort are known. 
CV8: Can manifestations of sub-clinical or environmentally induced cardiovascular diseases during 
spaceflight be predicted?  This gap is owned by the Space Medicine Division although it is possible that 
some data gathered from the Integrated Cardiovascular SMO may be of use.   
Task: (NxPCM – directed study) 
Integrated Cardiovascular Study 
This comprehensive study integrates the objectives of two NRA investigations and a SMO and involves both 
intramural and extramural investigators.  Data will be obtained twice pre-flight, at 2 weeks, 4 weeks, and every 1-2 
months during flight, and 3 times post-flight.  In-flight testing will require holter monitoring, 2-d 
echocardiography, and ambulatory blood pressure monitoring.  After completion of this study, the clinical 
expression of cardiac atrophy during long duration spaceflight will be defined clearly, and its significance for 
cardiac systolic and diastolic function at rest and during gravitational transitions will be elucidated.  In addition, 
preliminary information will be obtained regarding ventricular conduction and repolarization that will provide 
either strong clinical reassurance, or pathophysiologic insight into the risk for cardiac arrhythmias.   
Deliverables: The products are quantification of the extent, time course, and clinical significance of any 
spaceflight-related cardiac atrophy and identification of its mechanisms and functional consequences.  This will be 
accomplished by updating the HSRF; updating the cardiovascular risk and informing mission operations of 
requirements to support this risk.  All data will be passed to ExMC in support of ExMC gap 4.19.  If any 
countermeasure is required, the Space Medicine Division will be responsible for its development. 
Required Delivery Milestone: FY2013 – data required to support mission operations SRR. 
Required Platforms: ISS is required for characterization of spaceflight-induced cardiac changes.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
12 None; hardware 
currently on 
board the ISS 
7.5 None 39.5 12 
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N7: What are the potassium, magnesium and phosphorus changes in relation to cardiovascular 
issues and bone loss? 
Task:  
Nutrition Status Assessment – SMO O16E: Nutrition SMO 
See Risk of Accelerated Osteoporosis – Gap N7 
CV1: What are the in-flight alterations in cardiac structure and function?  This is a high priority gap 
for this risk.  The task is already underway in collaboration with outside investigators.  The studies 
include in-flight Holter monitoring and ultrasound assessment of cardiac structure and function.  Further 
research into this risk is not recommended until the results from this effort are known. 
Task:  
The Multisystem Effect of Exercise Training/Nutritional Support During Prolonged Bed Rest Deconditioning: An 
Integrative Approach to Countermeasure Development for the Heart, Lungs, Muscles and Bones  
See Risk of Renal Stones – Gap B8 
CV7: How are fluids redistributed in flight?  This gap is considered to be a medium priority by HHC; 
it is not considered necessary to do research on fluid distribution, because the flight surgeons would be 
able to predict how the body would handle fluid loads.  However, alterations in fluid distribution may 
affect drug distribution and this aspect of the gap should be pursued.  
Task: (NSBRI) 
Braslet Investigation 
The objectives of this study are to validate just-in-time training methodologies for cardiovascular ultrasound 
imaging during long-duration spaceflight and to quantify the effects of the Braslet device on the cardiovascular 
system in ground-based and flight experiments.  
Deliverables: TBD 
Required Delivery Milestone: TBD 
Required Platforms: This is a ground-based study. 
 
Task:  
Braslet 
This task is carried under the Risk of Inability to Adequately Treat and Ill or Injured Crew Member – see ExMC 
gap 3.02.   
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RISK OF ADVERSE HEALTH EFFECTS DUE TO ALTERATIONS IN HOST-
MICROORGANISM INTERACTIONS – CRITICALITY: LUNAR OUTPOST – D, 
MARS – I 
Preventative measures limit the presence of many medically significant microorganisms during a mission; 
however, microbial infection of crewmembers cannot be completely prevented.  Recent evidence from 
spaceflight experiments suggest alterations in microbial characteristics, including virulence (disease-
causing potential), in organisms grown during flight.  The HRP will analyze current spaceflight 
operational and flight experiment data, develop an infectious disease risk assessment model, and convene 
risk and requirement reviews to determine if spaceflight poses any unique risk to the crew.  Including in 
this review is a determination of the efficacy of current mitigation strategies and countermeasures given 
the potential changes in microorganisms and crewmembers and recommendations to current operational 
or design controls. 
Context of Risk for Exploration 
Negative impacts from microorganisms during flight are not uncommon; however, major impacts to crew 
health and performance fortunately do not occur frequently.  Unfortunately, the consequences of 
infectious disease can include loss of mission and loss of crew, and thus the extent of the risk needs 
clarification.  If microbial virulence characteristics do change in a variety of microorganisms during 
flight, then current mitigation strategies would need to be revisited to ensure crew health and mission 
success. 
Strategy for Mitigation 
To mitigate these risks and ensure the use of appropriate microbial health requirements, a requirements 
review should be accomplished using systematic microbial risk modeling that identifies knowledge gaps, 
such as the effect of spaceflight on microbial virulence factors.  The effect of these gaps should be 
evaluated, quantified if possible, and investigated if necessary to develop an appropriate knowledge base 
to model current infectious disease risks and set appropriate microbiological requirements.  The 
knowledge gap concerning limited knowledge of host-microbe interaction during spaceflight will first be 
addressed by a workshop designed to develop a position on the extent of the risk and need for future 
investigations, and, if necessary, a systematic pathway to gain adequate knowledge to ensure appropriate 
mitigation strategies. 
Gaps 
AEH 6: What are the infectious disease risk factors and how do they affect the risk to crew health during 
manned spaceflight missions? 
Selection of appropriate requirements is based on determination of the best model and assumptions for 
spaceflight conditions. 
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Tasks: (AEH, , Directed Study ) 
Microbial Risk Assessment Modeling Study 
A risk assessment based upon historical microbiological monitoring data is being performed by subject matter 
experts in quantitative microbial risk assessment and infectious disease to provide a risk model for expected 
potable water systems in a lunar habitat.  Knowledge for this model is provided by data mining of CHeCS 
operational data, information from the SWAB flight experiment, research data from other ISS experiments, 
exposure assessments based on ECLSS design specifications, and human immune system data provided by the 
Integrated Immune SMO (HHC) and previous flight research.  Closure of knowledge gaps identified by this 
model will facilitate review and updates to water requirements and develop a framework from which evaluation 
of other microbiological requirements can be performed.  After completion of the model, a workshop will be 
convened to review the model, determine any recommended changes to current water requirements, and 
recommend forward studies if necessary.  Successful application of this model to NASA microbial risks would 
suggest expanding this model to other components of microbiology such as food requirements during a lunar 
outpost. 
Deliverables: 
A microbial risk model for quantitative assessment of current infectious disease risk and operational procedures 
Microbial Risk Model – 2011 
Recommendations for operational processes and constraints to minimize exposure to microbial contaminants. 
A workshop report detailing the application of the model to spaceflight programs and recommended changes to 
spaceflight operations and design. 
Workshop review of model and workshop recommendations in 2012. 
Required Delivery Milestone:  
Medical Operations Requirements needed for Mission Operations SRR,  FY13 
Medical Operations Requirements – Mission Operations PDR, FY14-15 
Required Platforms: Modeling efforts are ground-based reviews. 
 
Tasks: (AEH, NRA) 
SWAB Flight Experiment 
During spaceflight, crewmembers are exposed to a wide variety of microorganisms.  Extensive monitoring efforts 
are performed prior to and during flight; however, current methodology is limited and may miss several 
pathogens that could affect crew health and performance.  The SWAB flight experiment uses advanced collection 
and processing techniques to identify pathogens in the spaceflight environment that could not be identified using 
current methodology.  The information from this experiment is used to decrease uncertainty in the Microbial Risk 
Assessment Model. 
Deliverables: 
Completion of the SWAB flight experiment is expected in 2011.  Experiment findings will be incorporated into 
the Microbial Modeling Study. 
Required Delivery Milestone:  
Information needed by Microbial Risk Modeling workshop, FY12. 
Required Platforms: SWAB flight experiment evaluation requires access to water collection on the ISS.  
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Tasks: (AEH; Directed Study) 
Data Mining 
Operational data will be reviewed with the help of the Crew Health Care System manager and with flight 
surgeons to obtain additional data to inform the Microbial Risk Modeling activity. 
Deliverables: 
Data will be incorporated into the Microbial Modeling Study. 
Results required for Microbial Risk Modeling, FY10. 
Required Platforms: This effort is ground based.  
 
Tasks: (AEH, Directed Study) 
Microbial Characteristic Workshop  
A workshop will be held to evaluate current ground and spaceflight data that indicate Salmonella typhimurium 
changes virulence characteristics during spaceflight, based on the NRA flight experiments, MICROBE and 
MDRV.  The workshop will include NASA and non-NASA scientific experts from the fields of bacterial 
pathogenesis, immunology, and space microbiology.  Key questions discussed in the workshop include the 
mechanism or inducer that initiates this response, the potential presence of this mechanism in other 
microorganisms, and the extent of this risk and the necessary forward work. 
Deliverables: 
Final report on recommendations determined at Workshop. 
Results required for Microbial Risk Modeling, FY10. 
Required Platforms: This effort is ground based.  
 
Tasks: HHC, NASA flight experiment research contributing to Microbial Risk Modeling 
Results from the NRA flight experiments, MICROBE and MDRV, that were recently completed, and from the 
HHC / NxPCM Integrated Immune SMO study will be integrated into the workshop and the Microbial Risk 
Modeling activity. 
Deliverables: 
Data to be delivered to the Microbial Risk Modeling activity. 
Results required for Microbial Risk Modeling, FY10. 
Required Platforms: These flight experiments use both STS and ISS.  Details are described under HHC/ 
NxPCB, Gap IM 5.  
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RISK OF CREW ADVERSE HEALTH EVENT DUE TO ALTERED IMMUNE 
RESPONSE – CRITICALITY: LUNAR OUTPOST – D, MARS – I 
Human immune function is altered in- and post-flight, but it is unclear if this change leads to an increased 
susceptibility to disease.  Reactivation of latent viruses has been documented in crewmembers, though 
this reactivation has not been directly correlated with the immune changes or with observed disease.  
Further research may elucidate whether microgravity exposure impairs the immune system, and whether 
this change represents a health risk to crews. 
Context of Risk for Exploration 
While there is post-flight evidence to support this risk, in-flight evidence should also be obtained.  The 
necessary in-flight data should be collected and assessed before further determinations of future research 
direction are undertaken.  Ground-based work should be conducted using the Antarctic station space 
flight analog (best available analog for immunity during >6 months. flight) so that ground control data of 
an appropriate sample size may be obtained.  Validation of an analog directly to flight data would be 
useful for future countermeasures validation.  The laboratory findings are to be correlated to clinical 
findings and follow-up studies are performed to document any latent, long-term effects. 
Strategy for Mitigation 
Space normal must first be defined for this risk; hence data mining tasks in the form of the Integrated 
Immune SMO are ongoing.  Once space normal is defined, the data will be presented to the Human 
System Risk Forum and it will be decided if countermeasures need to be developed.  In addition, because 
head down tilt bed rest is not a valuable analog to spaceflight for this discipline, a good analog for 
immune studies is being sought.   
Gaps 
IM1:  Does spaceflight alter immune function?  This is a high priority for HHC.  This data is currently 
unknown. 
IM2:  Is an improved immune standard needed?  Data must be obtained to determine if the standard is 
accurate and adequate. 
IM5:  What is the time course and etiology of immune changes?  An investigation of individual 
records of in-flight illness for clarification is needed. 
Task: (NxPCM – via NRA) 
1) Flight-Induced Changes in Immune Defenses: ‘Immune Function,’ DSO 498/SDBI 1498 
Shuttle-based study investigating the effects of space flight on 1) neutrophil and monocyte functions 
(phagocytosis, degranulation, oxidative burst capacity, and expression of surface molecules) and 2) natural-killer 
cell and lymphokine-activated killer cell cytotoxicity against target cells, and cytokine production 
2) Incidence of Latent Virus Shedding During Space Flight: ‘Latent Virus,’ DSO 493/SDBI 1493 
Shuttle-based study investigating the frequency of latent virus reactivation, latent virus shedding, and clinical 
disease after exposure to the physical, physiological, and psychological stressors associated with space flight 
3) Space Flight-Induced Reactivation of Latent Epstein-Barr Virus: ‘Epstein-Barr,’ on Shuttle as DSO 493/SDBI 
1493 and ISS as E129 
Shuttle- and ISS-based study investigates the magnitude of immunosuppression as a result of space flight by 1) 
analysis of stress hormones, 2) quantitative analysis of EBV replication using molecular and serological methods, 
and 3) determining virus-specific T-cell immune function. 
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Deliverables: Final reports of findings will be delivered in 2009.  Data from these Shuttle-based immune studies 
will be combined with the ISS-based Integrated Immune SMO to update health standards.  If these studies 
together indicate that a countermeasure is needed, then ground-based countermeasure studies will be solicited and 
performed.  Countermeasures developed from these studies will then be validated on ISS. 
Required Delivery Milestone: These tasks mitigate a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog.  
Required Platforms: ISS is required to complete these studies.   
 
Task: (NxPCM – via directed study) 
Validation of Procedures for Monitoring Crewmember Immune Function: ‘Integrated Immune SMO,’ SMO 
015/SDBI 1900 
The objective of this Supplemental Medical Objective (SMO) is to develop and validate an immune monitoring 
strategy consistent with operational flight requirements and constraints.  There are no procedures currently in 
place to monitor immune function or its effect on crew health.  Immune dysregulation has been demonstrated to 
occur during spaceflight, yet little in-flight immune data has been generated to assess whether or not this may be a 
clinical problem.  This SMO will assess the clinical risks resulting from the adverse effects of space flight on the 
human immune system and will validate a flight-compatible immune monitoring strategy.  The correlation 
between in-flight immunity, physiological stress and a measurable clinical outcome (viral reactivation) will be 
determined for long- vs. short-duration space flight. 
Deliverables: Data from this study will be combined with the Shuttle-based immune studies to update health 
standards.  If results indicate that a countermeasure is needed, ground-based countermeasure studies will be 
solicited and performed.  Then these countermeasures will be validated on ISS.  In addition, all data will be 
shared with other Elements to help address related gaps such as (1) ExMC Gap 4.06 – Lack of capability to 
stabilize and treat bone fractures; (2) ExMC Gap 4.08 – Lack of reusable cold compress and heating pad 
capability made of suitable spaceflight materials; and (3) SHFH Gap related to new Host-Microbe Interactions 
Risk. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: ISS is required to ensure that the data represents space normal and for validation of 
potential countermeasures.  A ground analog (Antarctica, NEEMO, and/or Haughton-Mars) may be used to 
provide additional data. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
17 None 4kg/Inc 4kg/Inc 5.5 2.27 
 
Task:  
Host-Microbe Interactions Study 
This task is being conducted by SHFH to address AEH Gap 2.3 under the Risk of Adverse Health Effects Due To 
Alterations in Host-Microorganism Interactions. 
IM3:  Are there suitable analogs for immune dysregulation? This gap be filled using the Antarctic 
station analog so that adequate sample sizes may be obtained.  Findings using ground-based analogs 
should be related to clinical findings and follow-up studies should be performed to document any latent, 
long-term effects. 
Task: (NxPCM – via directed study) 
NEEMO Rapid Operational Investigation (ROI):  Immune function changes during a spaceflight-analog 10-day 
undersea mission 
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This study measures immune functional changes, physiological stress, viral reactivation and viral specific 
immunity during the NEEMO mission.  NEEMO represents a good analog for some aspects of short-duration 
spaceflight on immunity.  This study will provide data to compare this ground-based spaceflight-analog to actual 
flight data.  If immune dysregulation is observed in the NEEMO crews that is similar to that observed in flight 
crews during/following spaceflight, this analog will be validated for some aspects of spaceflight-associated 
immune dysregulation.  This analog will not supersede the program goal to validate a ground analog for long-
duration spaceflight and immunity.  
Deliverables: Initial product is completion of the NEEMO study and final report of findings.  All results will be 
fed into the Immune SMO data sets. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: NEEMO undersea environment is required to assess the validity of the short-duration space 
analog.   
 
Task: (NxPCM – via directed study) 
3D Tissue Analogs for the Study of Varicella-Zoster Virulence and Infectivity 
This study is concerned with determining if: VZV is alive, active and has the potential to spread.  These data also 
represent the potential for cases of Shingles and Ramsey Hunt Syndrome to be experienced by flight crews in 
long duration exploration.  VZV may assume increased virulence and/or live virus numbers in microgravity.  This 
study will demonstrate the sensitivity of the model and provide an operational deliverable in the form of a reliable 
test for live quantifiable virus.  
Deliverables: The product is completion of the ground-based study and final report of findings.  
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: Ground-based laboratory is required.  
 
Task: (NSBRI) 
Apoptosis and Immune Homeostasis During Hind limb Unloading  
Space flight causes lymphopenia, abnormally low mitogen responses, and reduced production of antibodies and 
cytokines.  Space flight-associated factors such as microgravity, lack of load bearing, stress, and radiation are 
believed to contribute to these effects, but the exact mechanisms are unknown.  Ground-based mouse models such 
as hind limb unloading (HU) and irradiation cause similar effects.  We hypothesize that these changes result from 
lymphocyte apoptosis induced by the cell surface receptor, Fas, in a manner dependent on endogenous opioids.  
Furthermore, we predict that radiation exposure and HU act synergistically.  We have proposed to: 1) elucidate 
the role of Fas and endogenous opioids in the modulation of the immune system by HU and radiation; and 2) 
determine the effect of HU and radiation on lymphocyte dynamics and immune responses.  In addition, because 
autoimmune disease is often associated with stress and radiation exposure, we will determine whether HU and 
radiation promote autoimmunity.  The overall goal is to determine the mechanisms underlying apoptosis-related 
immune modulation using ground-based models. 
Deliverables: The product is completion of the ground-based study and final report of findings.  
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: Ground-based laboratory is required.  
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Task: (NxPCM – via directed study) 
Consequences of Long-term Confinement and Hypobaric Hypoxia on Immunity in the Antarctic Concordia 
Environment (CHOICE – Study) 
In the unique environment of the Concordia station, stress-dependent immune-modulation due to both 
confinement and hypoxia can be simultaneously  investigated  with the following goals: 1) Assessment and 
understanding of stress-associated immune changes that results from confinement living under moderate 
hypobaric hypoxia comparable to those possible living situations in future lunar habitats where air pressure and 
oxygen may be lowered for technical and financial reasons and 2) Work out for the rationale for the development 
of adequate countermeasures to counterbalance the potential risk of confinement and hypoxia-induced immune 
and health changes. 
Deliverables: The product is completion of the ground-based study and final report of findings.  
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This is a ground-based study in the Antarctic.  
IM4:  Can in-flight hardware to evaluate hematology/infection/immunity be developed?  This 
capability must be developed prior to exploration missions.  The need for development of this equipment 
will be further defined when IM1 is filled.  It is not clear that work should begin earlier.  Simple, reliable 
means to evaluate immune function and/or infection (e.g., white cell count) is clinically relevant to long-
duration space missions. 
Task: (ISSMP) 
In-flight Flow Cytometer Project  
Deliverables: The product is an in-flight flow cytometer capable of various immunology/hematology 
measurements. 
Required Delivery Milestone: This task mitigates a risk to a long-duration Mars mission.  The tasks are 
conducted in the 2008-2020 timeframe because of the availability of ISS as a Mars transit analog. 
Required Platforms: This task is ground-based hardware development. 
 
Task: (ExMC) 
Lunar Lab Analysis 
This task is carried under the Risk of Inability to Adequately Treat and Ill or Injured Crew Member – see ExMC 
gap 4.06 
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RISK OF INVERTEBRAL DISK DAMAGE – CRITICALITY: LUNAR OUTPOST – D, 
MARS – I  
Extended exposures to microgravity (and possibly fractional gravity) may lead to an increased risk of 
spinal nerve compression and back pain. 
Context of Risk for Exploration 
Evidence from medical operations indicates that astronauts have a higher incidence of intervertebral disc 
damage than the general population.  Additional work should be done to determine the extent of this 
problem and guide design of re-entry and post-flight protocols as well as future re-entry spacecraft.  
Strategy for Mitigation 
Space normal must first be defined for this risk; hence data mining tasks are ongoing.  Once space normal 
is defined, the data will be presented to the Human System Risk Forum and it will be decided if 
countermeasures need to be developed. 
Gaps 
B4:  What is the incidence of intervertebral disk damage following spaceflight?  The evidence 
provided by the discipline for this risk was the common complaint of back pain by the crewmembers.  
There is conflicting information from the Space Medicine Division regarding the incidence of disc 
damage post-flight.  An assessment of the current database is needed for supporting evidence for this risk.   
Task: (NxPCM – directed study) 
Data mining for intervertebral disk damage 
Additional evidence (research data) needs to be gathered in order to establish whether the lengthening of the spine 
with space adaptation syndrome exacerbates the risk for IVD damage with loading.  The risk for injury may be 
greater during the performance of mission tasks in hypogravity, with accelerated g forces from piloting 
spacecrafts, or with return to gravitational loading on Earth. 
Deliverables: Final report of findings will be brought to the HSRF in the FY2009 timeframe.  If data indicate that 
more data is required are required, then a flight study will be conducted.  If the data indicate an issue exists for 
disk damage, then the bone standard will be updated to include soft tissue damage.  
Required Delivery Milestone: Updates to the health standard should occur as soon as possible. 
Required Platforms: Access to Flight Medicine and LSDA databases is necessary for the data mining study. 
 
Task: (NxPCM – directed study) 
Shuttle Pilot Study – TBD  
Additional evidence will be gathered in order to establish whether the lengthening of the spine with space 
adaptation syndrome exacerbates the risk for IVD damage with loading.   
Deliverables: Final report of findings will be brought to the HSRF in the FY2012 timeframe.   
Required Delivery Milestone: Mission operations needs to be informed of data as soon as possible to make any 
modifications to Orion regarding loads on crew.  If countermeasure development studies are required, a validated 
countermeasure will be delivered in FY2016; which is required for long-duration Exploration missions.   
Required Platforms: This study initially requires Shuttle crew for access to MRI.  ISS crews may be required in 
the future for countermeasure validation. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
4 None TBD TBD TBD TBD (within 
R+7) 
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Task: (NxPCM – directed study) 
IVD Mechanical Countermeasure Study – TBD 
A back brace may be developed for use during landings to protect against intervertebral disk damage.   
Deliverables: A mechanical countermeasure will be delivered in the FY2012 timeframe.   
Required Delivery Milestone: A validated countermeasure is required for long-duration Exploration missions. 
Required Platforms: This study requires ISS crews for countermeasure validation. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
all long duration 
crews 
None 30 30 0.5 hours None 
 
Task:  
Understanding back/neck pain etiology 
This task is carried under the Risk of Inability to Adequately Treat and Ill or Injured Crew Member – see ExMC 
gap 4.03. 
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RISK OF ORTHOSTATIC INTOLERANCE DURING RE-EXPOSURE TO GRAVITY – 
CRITICALITY: LUNAR OUTPOST – D, MARS – I  
Post-flight orthostatic intolerance, the inability to maintain blood pressure while in an upright position, is 
an established, space-related medical problem.  Countermeasures have been successfully identified and 
implemented (fluid loading, compression garments) or being evaluated (Midodrine & others).  
Completion of these efforts will be useful in determining what preventive measures should be used to 
combat orthostatic intolerance during future mission profiles. 
Context of Risk for Exploration 
Twenty percent of Shuttle crewmembers and up to 83% of returning ISS crewmembers suffer 
hypotension and presyncope or syncope during 10 minutes of upright tilt on landing day.  This may 
constitute a risk when crewmembers experience Earth's gravity after exposure to microgravity.  Currently 
available countermeasures are not effective in all crewmembers; in particular, women are more 
susceptible than men are.  While it is well known that crewmembers can be incapacitated by orthostatic 
intolerance after six-month missions when they return to Earth’s gravity, it is not known the degree to 
which this may be ameliorated in the gravity environment on the Martian surface.  Early surface 
operations may require astronauts to be upright and active soon after landing on Mars.  A combination of 
countermeasures, both physical and pharmaceutical, should be pursued for this risk.  It is not known if 
exposure to 1/6 g and 3/8 g will cause orthostatic intolerance or will have mitigating effects on orthostatic 
intolerance upon return to 1 g.   
Strategy for Mitigation 
Space normal is defined for this risk; hence current research efforts for this risk are investigations for the 
efficacy of new countermeasures (i.e., Jobst stockings and pharmacological agents).  The new lunar 
analog currently under development will be utilized to understand the role of the lunar gravity as 
protection from orthostatic intolerance.  In addition, gender effects and the possibility for gender specific 
countermeasures are also being investigated. 
Gaps 
CV3: Is orthostatic intolerance a potential hazard?  This is considered a high priority for HHC, as it 
remains an issue for ISS and other long duration flights.  It is an egress issue, not a vehicle control issue.  
It is not known if exposure to 1/6 g and 3/8 g will cause orthostatic intolerance or will have mitigating 
effects on orthostatic intolerance upon return to 1 g.   
Task: (NxPCM – directed study) 
Midodrine SMO: Test of Midodrine as a Countermeasure against Post-flight Orthostatic Hypotension, SMO-006 
To date, available countermeasures (e.g., G-suit, fluid load) have not sufficiently reduced post-flight orthostatic 
hypotension.  This study is designed to evaluate a new pharmacological countermeasure for protection from post-
flight orthostatic hypotension.  This project will measure the efficacy of Midodrine in reducing the incidence 
and/or severity of orthostatic hypotension in returning astronauts.  Efficacy will be evaluated with an expanded 
operational tilt test.  The tilt test is used to assess the effects of prolonged weightlessness on orthostatic tolerance 
during upright posture, as measured by supine and standing heart rate, blood pressure, stroke volume, cardiac 
output and total peripheral resistance.  
Deliverables: Not applicable 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Not applicable; this study has been discontinued. 
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Task: (NxPCM – directed study) 
Hypovolemia as a Model of Space Flight: Cardiovascular Effects and Countermeasures  
A hypovolemia model that reproduces the plasma volume loss seen on landing day has been developed utilizing a 
regimen of a single dose of IV furosemide, followed by 36 hours of a very low salt diet.  In the astronauts, this 
dehydration regimen reproduces the landing day incidence of orthostatic hypotension and presyncope during tilt 
tests with 100% fidelity.  Future work will include testing the utility of this ground-based model by expanding the 
measurements to include specific hemodynamic and vascular responses, and compare/contrast them with 
measurements from bed rest studies.  Additional activities include validating the Jobst stocking as a method to 
mitigate orthostatic intolerance on landing day, and examine alternate pressure garments if the Jobst stocking is 
not validated as a valid countermeasure against orthostatic intolerance.  In addition, alternate medications to 
mitigate orthostatic intolerance (i.e., octreotide) will be examined using the hypovolemic model.  Follow on 
studies could include validating octreotide in the 6° head-down tilt bed rest model and flight validation of 
octreotide on ISS.  VO2max measurements will also be taken using the hypovolemia model.  These data will be 
combined with the VO2 max SMO occurring on-board the ISS. 
Deliverables: Data will be shared with the HSRF regarding hypovolemia. 
Required Delivery Milestone: None 
Required Platforms: This is a ground-based study utilizing hypovolemia as a model to spaceflight-induced 
changes in plasma volume.   
 
Task: (NxPCM – NRA) 
Gender Differences in Bed Rest:  Autonomic and Neuroendocrine Changes and Vascular Responses in Lower and Upper 
Extremities 
Although the reasons are undefined, female astronauts are more susceptible to post-flight orthostatic hypotension and 
presyncope than are male.  Due to the lack of cardiovascular bed rest studies that have female participation, many 
conclusions about the effects of simulated microgravity on humans are flawed, in that they fail to describe mechanisms 
in the very people who have the most serious problems.  This study focuses on how differences in strategies of arterial 
pressure control in men and women affect orthostatic tolerance both before and after bed rest.  Endothelium-dependent, 
endothelium-independent and adrenergic receptor responses in both arteries and veins will be evaluated, before and after 
bed rest.  In addition, plasma volumes, and hemodynamic and neuroendocrine responses to arterial and cardiopulmonary 
baroreceptor inputs will be measured, in women versus men, before and after bed rest.  Studies have indicated a 
differential response of different vascular beds in animal studies where hind limb-suspended rats show hypertrophic 
remodeling of the vessels in their forelimbs and atrophic remodeling in the vessels of their hind limbs.  This is thought to 
occur because changes in transmural pressures and shear forces with hind limb suspension occur in opposite directions 
in the upper and lower extremities.  These studies have not been repeated in female rats, and nothing like this has been 
performed in humans of either gender.  Since humans are bipedal, bed rest would greatly reduce transmural pressures 
and shear forces in the legs, but not the arms.  If vessel-remodeling follows the patterns in humans as in the rats, large 
changes could occur; this might contribute to orthostatic hypotension after bed rest.  Accordingly, the study will repeat 
the vascular measurements mentioned above in both upper and lower extremities before and after bed rest and relate the 
findings to the occurrence of orthostatic hypotension. 
Deliverables: The initial product is space normal data on gender differences with regards to orthostatic intolerance.  
This information will be used to update the cardiovascular standard to include orthostatic intolerance.  If the results 
indicate that a gender-specific countermeasure is needed, ground-based countermeasure studies will be solicited.  When 
the development is complete the countermeasure will be validated on the ISS and delivered to mission operations.  Data 
gathered from all activities will be fed into lunar surface studies. 
Required Delivery Milestone: FY2020 – countermeasure delivery required for long duration exploration missions. 
Required Platforms: Initially this study requires the bed rest ground analog to microgravity.  If a gender-based 
countermeasure is indicated, the countermeasure will be evaluated in the bed rest microgravity analog and the 
countermeasure will be validated for flight using the ISS.  This is a bed rest study to quantify gender-specific changes in 
orthostatic intolerance.  If a gender-specific countermeasure is required, it will be developed in bed rest and validated on 
board the ISS.  This ISS is required as the Mars transit analog.   
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight BDC 
Time (hrs) 
34 None; this is a 
ground-based 
study 
None; this is a 
ground-based 
study 
None; this is a 
ground-based 
study 
None; this is a 
ground-based 
study 
None; this is a 
ground-based 
study 
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Task: (EC) 
Evaluation of Compression Garments as Countermeasures to Orthostatic Intolerance 
The goal of this study is to evaluate the effectiveness of JOBST® custom compression garments to prevent 
orthostatic intolerance and to compare the JOBST® garment with the Anti-Gravity Suit (AGS) at 1 “click” (0.5 
psi).  Post-spaceflight plasma volume loss contributes, in part, to the development of orthostatic intolerance.  
Thus, we are modeling this phenomenon by using a hypovolemia regimen, developed in the Cardiovascular 
Laboratory, which produces plasma volume losses that are similar to those that occur following spaceflight.  This 
study will compare the outcome of orthostatic challenges (head-up tilt test) conducted in hypovolemic subjects in 
three conditions: 1) no countermeasure, 2) AGS countermeasure (1-click or ~25mmHg) and 3) JOBST® custom 
compression garment countermeasure (gradient pressure with a higher amount of compression at feet 
(~55mmHg) than at thigh (~8mmHg) with an average of 25mmHg over the length of the garment). 
Deliverables: The product from this task is to provide mission operations of requirements for g-suit design. 
Required Delivery Milestone: ASAP – requirements for g-suit design. 
Required Platforms: This is a ground-based study utilizing the hypovolemia model.   
 
Task: (Space Medicine) 
Evaluation of Jobst Gradient Compression Garments as a Countermeasure to Post-Spaceflight Orthostatic 
Intolerance 
Five male crewmembers from STS-122 participated in a 10-min, 80˚ head-up tilt after a 13-day mission.  On 
landing day, February 20, 2008, each crewmember donned a pair of Jobst compression garments prior to tilt.  Tilt 
test data obtained from STS-122 crewmembers (47 ± 2 yrs, 180 ± 2 cm, 86 ± 5 kg) were compared with nine male 
crewmembers who participated in ten-minute post-spaceflight medical operational tilts since NASA’s Return to 
Flight mission (STS-114) on July 26, 2005. 
Deliverables: This task is evaluating Jobst pressure garments on crewmembers. 
Required Delivery Milestone: FY2020 – countermeasure delivery required for long duration exploration 
missions. 
Required Platforms: This study utilized Shuttle crews only. 
 
Tasks:  
Integrated Cardiovascular Study 
See the Risk of Cardiac Rhythm Problems – Gaps CV1 and CV8 
Vestibular-Cerebrovascular Interaction and their Contribution to Post-Spaceflight Orthostatic Intolerance 
This task has been closed out.  It was a heritage NRA that did not provide any deliverables for exploration 
missions. 
CV4: Is 1/6-g exposure protective of 1-g orthostatic tolerance?  It is unknown if the partial gravity 
found on the lunar surface will be protective of orthostatic intolerance.  A lunar analog should be 
developed to determine any protective effects. 
Task:  
Lunar Analog Bed Rest Development 
See HHC Infrastructure Section – Gaps HHC1 and HHC2 
Determination of the magnitude and time course of cardiovascular alterations during a simulated extended stay 
lunar mission 
See HHC Infrastructure Section – Gaps HHC1 and HHC2 
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The Risks in this part of the Appendix  
are aligned with Section 2.5 –  
Provide Adequate Medical Care for the Crew 
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INABILITY TO ADEQUATELY TREAT AN ILL OR INJURED CREW MEMBER – 
CRITICALITY: LUNAR OUTPOST – I, MARS – C 
Mission architecture limits the amount of equipment and procedures that will be available to treat medical 
problems.  Resource allocation and technology development must be performed to ensure that the limited 
mass, volume, power, and crew training time be efficiently utilized to provide the broadest possible 
treatment capability.  This allocation must also consider that not all medical conditions are treatable, 
given the limited resources, and some cases may go untreated. 
Operational Relevance and Risk Context 
NPD 8900.3G – The immediate and long-term responsibilities of NASA with regard to the human space 
flight program require that the Agency provide medical and dental care, observation, and study to 
astronauts, payload specialists, and other space flight participants while on active duty with NASA.  This 
care, observation (to include health monitoring) and study will be provided, utilizing the best current 
guidelines for the clinical practice of medicine and dentistry, and will be comprehensive in scope as 
applicable to the NASA mission.  It will encompass all aspects related to the mission, including 
certification and training, and will include all space flight mission phases (pre-, in-, and post-flight). 
Strategy for Addressing Risk and Gaps 
To address this broad risk, the ExMC has broken it down into seven categories that correspond with the 
seven requirements allocated to the ExMC from the HRP Program Requirements Document (PRD).  Each 
of the seven categories is then analyzed individually to determine where gaps exist in satisfying the PRD 
requirements.  Below are the seven categories into which the risk has been separated and an explanation 
of the strategy for addressing the different categories of gaps. 
1.0  Validate Standards:  The NASA HQ OCHMO standard that pertain to this risk are Crew Selection 
and Retention Criteria.  The Space Medicine Medical Operations Lead for standards, working with the 
ExMC Element Scientist, determines gaps in knowledge in the current Crew Selection and Retention 
Criteria.  Tasks are then identified to close those knowledge gaps. 
2.0  Quantify the Risk:  Because of the limited available operational and research data, incidence rates 
and outcomes for relevant medical conditions have large uncertainties associated with them.  The Space 
Medicine Exploration Condition List is analyzed to determine gaps in our knowledge about medical 
conditions’ incidence rates and outcomes in spaceflight.  Tasks are then assigned to further study, model 
and use analog population data to better quantify the medical conditions.  
3.0  Mitigate the Risk:  Gaps in this section deal with our knowledge about effective training and 
telementoring programs for Exploration missions.  The Space Medicine Medical Operations Lead for 
training, working with the ExMC Element Scientist, determines gaps in knowledge and techniques for 
developing future crew, flight surgeon and biomedical ground controller training and telementoring 
programs.  Tasks are then identified to close those knowledge gaps. 
4.0  Monitor and Treat the Unmitigated Risk:  Based on the Space Medicine Exploration Condition 
List, each condition is analyzed for each Constellation Design Reference Mission (DRM) for the 
capabilities required to monitor and treat the condition.  An analysis is performed to determine where 
gaps exist in current technologies or where efficiencies could be realized in the future.  Based on when a 
technology comes online, either a technology watch is implemented or a technology development project 
is initiated to deliver the technology to enable the mission. 
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5.0  Provide Enabling Capabilities:  Provide data integration and management for HRP to ensure proper 
handling of data (e.g., Life Sciences Data Archive, Mission Extended Medical Enterprise).  Gaps exist 
where these capabilities are either insufficient or incomplete. 
6.0  Comply with Agency Standards:  Follow best practices and programmatic guidelines as levied by 
the HRP PRD.  There are currently no gaps associated with this requirement. 
7.0  Reduce Resource Requirements:  Wherever possible, reduce in-flight and funding resources.  There 
are currently no gaps associated with this requirement. 
Gaps 
ExMC 1.01:  Inadequate and/or immature information on medical screening technology for the 
identification of clinical and sub-clinical pathology 
Tasks: (NASA JSC & NSBRI – Directed Study) 
Science and technology watch for medical screening technology 
Identification of technologies and the medical conditions for which additional preflight medical screening has 
been validated 
Deliverables: Updates to Medical Standards Working Group 
Required Delivery Milestone: N/A  
Required Platforms: Ground based 
ExMC 1.02:  Inadequate information on genetic screening technology 
Tasks: (NASA JSC & NSBRI – Directed Study) 
Science and technology watch for genetic screening methodology to inform future implementation  
The Space Medicine Exploration Condition List will be analyzed to determine if some conditions are suitable 
candidates to be mitigated preflight by genetic screening.  
Deliverables: Updates to Medical Standards Working Group 
Required Delivery Milestone: N/A  
Required Platforms: Ground based 
ExMC 1.03:  Inadequate information on the individual susceptibility to hypobaric environments (e.g., 7.2-
psi lunar habitat) 
Tasks: (NASA JSC & NSBRI – Directed Study) 
Data Mining/Identification of characteristics associated with susceptibility to hypobaric environments  
For Exploration environments where crewmembers will be exposed to months of reduced oxygen partial pressure 
(e.g., 7.2-psi lunar habitat), this study will search to identify and characterize physiological parameters that 
indicate susceptibility to hypobaric environments to ideally create a Spaceflight Human Health Standard. 
Deliverables: Individual Susceptibility to Hypobaric Environments Standard 9/01/2015 
Required Delivery Milestone: Initial Crew Selection for Lunar Missions (2017) 
Required Platforms: Ground based 
ExMC 2.01:  Lack of knowledge about incidence rates, probabilities and consequences relative to 
LOC/LOM for the medical conditions on the Exploration Medical Condition List 
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Description:  One of the major gaps of knowledge with space medicine is quantification of likelihood 
and consequence of medical conditions that could occur in spaceflight.  Total combined duration of 
human spaceflight is brief and limited.  So the body of medical evidence in which to quantify medical 
conditions is small when compared to terrestrial medicine body of evidence. 
The focus of this gap is to generate a list of medical conditions that are of concern for human 
spaceflight, and provide quantifiable data and rationale backing why the medical condition is of 
concern. 
Tasks: (NASA JSC – Directed Study) 
Integrated Medical Model 
Due to limited resource volume constraints of the mission designs (including volume, mass, power, crew time, 
and crew skills), only the most important medical equipment will be stored onboard the space vehicles to 
diagnose and treat illnesses or injuries.  In addition, crew-training time pre-flight is limited to those medical 
procedures most likely to occur.  Because the astronauts are not likely to be trained medical clinicians, their skill 
level must be considered in the treatment of medical procedures.  The likelihood of patient medical conditions 
occurring along with the required resources (including those listed above) to diagnose and treat the conditions 
must be analyzed to determine the level of risk to the astronauts in a quantitative manner.  This allows 
management tradeoffs between resources and acceptable risk levels for various mission scenarios.  The Integrated 
Medical Model (IMM) is a Probabilistic Risk Assessment (PRA) simulation to provide this quantitative risk 
assessment. 
Deliverables: Integrated Medical Model v2.0 9/30/2009 
Required Delivery Milestone: N/A 
Required Platforms: Ground based 
 
Tasks: (NASA GRC – Directed Study) 
Integrated Medical Model (GRC simulations) 
To enhance the IMM’s capability to adequately forecast medical events of concern, but where supporting 
information on the rate of occurrence is lacking, development of external simulation modules is used.  The 
external modules integrate more complete knowledge of external and internal contributors to the event to estimate 
the rate of event occurrence during the exploration class missions simulated in the IMM.  Conditions to be 
modeled require a higher level of fidelity and include those where insufficient space flight data is available and 
there is no clear correlation to a terrestrial analog.  Additionally, medical events with multiple influencing factors, 
including gravitationally dependent physics, physiological changes during the mission, specific mission demands, 
vehicle limitations, crew reaction to critical events and interaction of these factors, can also be included in these 
models as deemed necessary to produce a simulation with adequate accuracy.  The results of this analysis 
contribute significantly to the IMM’s ability to forecast diagnoses and treatment outcomes of an ill or injured 
crewmember. 
Medical events to be model are selected based on the Exploration Medical Capability (ExMC) Project identified 
gaps and prioritized through consensus of the IMM team (JSC, Wyle, GRC) with concurrence from the ExMC 
Element Manager and Element Scientist,.  The current task includes four specific subject areas: 
1. Bone (Hip) Fracture during EVA 
2. Sleep Disturbance requiring medical intervention 
3. Back pain/Lumbar Disk damage 
4. Altitude Sickness requiring medical intervention 
Additional subject areas are added as required by the project during regular content reviews. 
The diverse nature of the topic areas requires interaction with subject matter experts (SME) at JSC, NSBRI, and 
the external medical community.  As part of this task, at least one SME is identified and consulted within each 
topic area throughout the development of the model to ensure that the most pertinent data is used in the simulation 
and that the simulation concept is acceptable to obtain the needed information.  Although no direct dependency on 
work in other projects exists, this modeling scheme does allow for integration of new information as it becomes 
available from these other projects such as Digital Astronaut.  
Deliverables: Probability Density Function modules for IMM 9/30/09 
Required Delivery Milestone: N/A 
Required Platforms: Ground based 
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ExMC 3.01:  Lack of knowledge about effectiveness of NASA medical training programs including 
crewmember and ground support 
Tasks:  
Medical Proficiency Training (SHFE) 
See activity description under Gap SHFE2 
 
Tasks: (NASA JSC) 
Post-flight Medical crew debrief data mining 
This effort will look through past ISS medical and training debriefs to consolidate comments or anecdotes made 
by crewmembers that would influence how medical training was conducted or could be improved. 
Deliverables: Final report 3/30/2009 
Required Delivery Milestone:  
Required Platforms: Ground based 
 
ExMC 3.02:  Lack of knowledge about the state of the art in telementoring/telemedicine 
Description:  Telementoring is the delivery of training and mentoring services across 
telecommunication networks typically in the format of audio and video.  As a subset modality of 
telemedicine, telementoring is focused on providing a means to train operators with the instructor 
physically located in a remote location.  Based on the type of training content, the presentation format 
may vary.  Various formats include teleconference, video conference, or web exchange.  Due to the 
relative novelty of this form of communication, telementoring has only recently started to gain 
momentum as a means to guide and train remote operators.  As such, effective means to communicate 
and techniques to convey information are constantly under development.  This gap is focused on 
understanding the latest on telementoring technologies and techniques as well as media platform on 
which the information is presented. 
Tasks: (NASA JSC:IBMP – Directed) 
Braslet (Duncan) 
Methodologies and data will be created by the international team of experts that could result in significant new 
knowledge and capability, enhancing important areas of operational space medicine such as clinical management 
of volume shifts induced by altered gravity, clinical diagnostic ultrasound in space flight, and telemedicine.  
Completion of this project will enable further investigations of steady-state space cardiovascular physiology in 
long-duration space flight.  This investigation will develop and validate appropriate methodology for studying 
cardiovascular responses to disturbances (for example, gravity change, volume overload, hemorrhage and others) 
using existing ISS resources.  Future use of this methodology will yield valuable physiological and operational 
data for planning and support of missions to the moon and other remote destinations. 
Deliverables: Validation of novel volume status measurement techniques, expanded telemedicine processes, and 
recommendations for forward work 5/31/2009 
Final Report 5/31/2010 
Required Delivery Milestone:  
Required Platforms: ISS 
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Tasks: (Henry Ford Health System; NASA JSC-NRA) 
Ultrasound Diagnosis of Fracture (Dulchavsky) 
Crewmembers on long duration space missions are at significant risk of decreased bone strength despite 
countermeasures.  The radiographic capabilities of future spacecraft are unknown; however, ultrasound is 
currently operational on the ISS.  Preliminary investigations have shown that ultrasound can reliably diagnose 
long bone fractures.  This proposal will evaluate the accuracy of ultrasound in the diagnosis of bony fractures and 
develop “just in time” training methods to allow astronauts to perform and interpret skeletal ultrasound to answer 
the specific aims: 
1. Evaluate the diagnostic accuracy of ultrasound for bony fractures and fracture healing in ground-based studies. 
2. Develop CMO training programs to facilitate skeletal ultrasound to exclude fracture. 
3. Develop remote guidance training programs for the ground cadre. 
Deliverables:  
Feasibility analysis report 6/15/2009 
Space Medicine Training Programs 7/15/2011 
Required Delivery Milestone: 
N/A 
Outpost Medical Kits SRR (6/01/2017) 
Required Platforms: None 
 
Tasks: (NASA JSC – NRA) 
Identify medical conditions that require telementoring/telemedicine 
A review of applicable medical conditions that require telementoring/telemedicine capability for diagnosis or 
treatment.  Once identified, this will map against the current telementoring practices and condition-specific 
telementoring gaps will be developed. 
Deliverables:  
Report and Recommendations 8/01/2010 
Required Delivery Milestone: N/A 
Required Platforms: Ground based 
 
Tasks: (NASA JSC – Directed) 
Data mining for telementoring studies and practices 
This literature search will examine past NASA telementoring studies as well as studies done by academia and 
industry to determine best practices for training.  This activity is a technology watch 
Deliverables:  
Final report 3/31/2009 
Required Delivery Milestone:  
Required Platforms: Ground based 
ExMC 4.01:  Lack of autonomous medical procedure system that includes decision assistance and 
integrates with medical hardware 
Description:  The current spaceflight procedure system is a combination of both paper and electronic 
formats.  The procedures themselves are developed and validated on the ground.  The burden is placed 
on the crewmember to be able to collect, analyze, and interpret data to decide which procedure decision 
pathway to follow.  This can be an issue with medical procedures as the crewmembers often are not 
clinicians.  They are given minimal medical training often months prior to the start of their mission.  
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This gap focuses on reducing the burden of medical data analysis and decision making on the 
crewmember.  An autonomous medical procedure system would assist the crewmember in analyzing 
and interpreting the medical data collected so that the proper decision pathways are followed. 
Tasks: (NASA JSC – Directed) 
Advanced Integrated Clinical System – Guided Medical Procedure System 
Due to the limited medical skills and training of the crew, techniques to help the crewmembers perform medical 
procedures will be required.  This will reduce the time required to perform the procedure, allow the crew to refresh 
their training skills during the mission, and provide the crew with audio and visual information to guide them 
through the procedure efficiently.  This has the possibility to develop into a decision support system.  This directed 
study will help form the requirements and solicitation for future competed efforts. 
Deliverables:  
Requirements and IT solutions identified 7/1/2009 
Inform Orion MedKit procedure system 7/1/2010 
Inform Lander MedKit procedure system 5/1/2014 
Inform Outpost MedKit procedure system 4/1/2017 
Required Delivery Milestone:  
Orion Medical Kits SRR (08/01/2010) 
Orion Medical Kits SRR (08/01/2010) 
Lander Medical Kits SRR (07/01/2014) 
Outpost Medical Kits SRR (06/01/2017) 
Required Platforms: Ground based 
ExMC 4.02:  Lack of non-invasive diagnostic imaging capability and techniques to diagnose 
identified Exploration Medical Conditions 
Description: Exploration Medical Conditions requiring this capability are: Fractures, Dislocations, 
Back Pain, Constipation, Pneumothorax, Urinary retention, dental conditions, eye abrasions and 
kidney stones. 
Due to the normal constraints of spaceflight, most common clinical diagnostic techniques will not be 
available during exploration missions.  That is especially true for imaging diagnostics.  Although 
physicians commonly use X-rays, Magnetic Resonance Imaging (MRI), ultrasound, and other 
techniques, perhaps only ultrasound may be compatible with spaceflight.  Flight surgeons have also 
requested improved imaging hardware operating in the visible portion of the electromagnetic spectrum 
to acquire digital images of skin and body orifices.  Work under this gap will initially focus on 
identifying spaceflight medical conditions where imaging-based diagnosis and/or treatment is required, 
developing an evidence base for determining which technologies are required, and assessing the 
spaceflight readiness of the identified technologies. 
Once the appropriate technologies are identified and readiness determined, the integration lead will 
develop a plan to not only integrate the technologies to the greatest extent possible, but also the groups 
working on those technologies.  Those groups include GRC, JSC, and ARC, as well as the NSBRI.  
The integration lead will also identify relevant work being performed with non-NASA funding and 
leverage NASA work with those efforts. 
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Tasks: (NASA JSC: NSBRI) 
Ultrasound Catalog for Autonomous Medical Care 
Develop an intuitive ultrasound image cataloging system, which incorporates ground acquired ultrasound whole 
body images.  The catalog will acquire ground based crewmember images to use for medical diagnosis in space. 
Develop a mathematical coupling model based on existing ground/in-flight ultrasound data that will allow 
microgravity associated morphometric and topographic changes to be predicted.  Assess the ability of non-
physician crew medical officers (CMO) to acquire and interpret complex ultrasound examinations autonomously 
or with remote guidance.  
Deliverables: Image catalog 3/31/2011 
Required Delivery Milestone: Outpost Medical Kits SRR (06/01/2017) 
Required Platforms: Ground based 
 
Tasks: (NASA JSC: NSBRI) 
Combined Scanning Confocal Ultrasound Diagnostic and Treatment System for Bone Quality Assessment and 
Fracture Healing 
Develop portable, fast, easy-to-use ultrasound-based fracture diagnostic system. 
Develop low-intensity pulsed ultrasound unit for fracture healing to be incorporated into the diagnostic unit. 
Evaluate the capabilities of the combined diagnostic and therapeutic system. 
Evaluate combined diagnostic and therapeutic modalities in an animal model.  
Deliverables: TRL 6 system 10/31/2012 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground based 
 
Tasks: (NASA GRC – Directed) 
Medical Imaging Integration 
ExMC's gap is inability to treat an ill or injured crewmember.  To that end, both topical and internal images of the 
body are frequently required to diagnose pathologies.  GRC will serve as the ExMC Imaging Integrator.  Tasks 
include organizing an Imaging Roadmap and Summits as necessary to integrate the different participants and 
imaging activities including: remote guidance, market surveys/watches, requirements based on the patient 
condition list, managing solicitations, and providing interfaces to NSBRI, major medical centers such as the 
Cleveland Clinic, the University of Texas Medical Center, Stanford University Hospital, the National Institute of 
Biomedical Imaging and Bioengineering, and DoD. 
Deliverables:  
Imaging Technology Requirements Document 6/30/2009 
Integrated Imaging Technology Development Plan 9/30/2009 
Required Delivery Milestone: N/A 
Required Platforms: None 
ExMC 4.03:  Lack of capability to treat back/neck pain/injuries 
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Tasks: (NASA JSC – Directed) 
Understand back/neck pain etiology 
This task focuses on determining the numerous causes of back or neck pain that could occur in spaceflight.  This 
gap associated with this task describes finding a treatment, however there needs to be an effort to determine all 
the causes of the injury before find the best methods for treating those causes. 
Deliverables: Final report 3/31/2009 
Required Delivery Milestone: N/A 
Required Platforms: Ground Based 
ExMC 4.04:  Lack of smart hardware for ventilation with variable oxygenation capability that 
mitigates localized oxygen build up. 
Description:  The proper and adequate operation of a ventilation device and variable oxygen delivery is 
a skill that takes many hours of training.  The Crew Medical Officers (CMO) on CxP missions will 
more than likely be given very limited medical training overall and even more limited training on 
ventilation and variable oxygen delivery.  The training opportunities to teach the CMO on how to 
operate a ventilator will not be adequate enough to provide terrestrial standard of care during a 
medical contingency. 
The purpose of this Gap is to develop hardware that can assist the caregiver in decision support 
involved with operating a ventilator and variable oxygen delivery device.  The entire smart system will 
also need to minimize volume, mass, and power consumption.  By developing a smart hardware system, 
this reduces the cognitive burden on the CMO to operate the ventilator thereby reducing the risk of 
inadequately trained operator.  The smart hardware can manage the ventilation of the patient while the 
CMO can be freed to perform other medical tasks.  This also allows CMO training to focus their 
limited resources on other aspects of their CMO training for tasks that technology cannot overcome. 
Tasks: (NASA JSC – Directed) 
Lightweight Trauma Module (ISSP funded) 
There has been an ongoing partnership with military and industry stakeholders to develop autonomous medical 
capabilities.  AICS projects have included the Lightweight Trauma Module (LTM) and O2 concentrator 
requirements research.  The US Army is expected to provide the funding needed to complete the development of 
a deployable version of the LTM with the delivery of test articles for functional and airworthiness certification the 
following year.  In parallel, the submission to the FDA for 510K clearance for the device and the requirements 
development and design for a version to support the ISS will also be completed. 
Deliverables: Lightweight Trauma Module 
Required Delivery Milestone: N/A 
Required Platforms: Ground Based 
 
Tasks: (NASA GRC:NSBRI – Solicitation) 
O2 Concentrator Development 
Development of TRL 6 system to initially be used with the LTM on ISS and then for Lunar Missions. 
Deliverables: TRL 6 system 3/1/3013 
Required Delivery Milestone: Initial Orion to ISS ops 
Required Platforms: Ground Based 
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Tasks: (NASA GRC – NSBRI Directed) 
Evaluation of O2 concentrators at altitude 
Due to variable vehicle cabin pressures, oxygen concentrator performance can be affected by lower pressures.  
This task will investigate the performance of COTS oxygen concentrators at altitude to determine their 
effectiveness. 
Deliverables: Final report 9/30/2009 
Required Delivery Milestone: Orion Medical Kits SRR (08/01/2010) 
Required Platforms: Ground Based 
 
Tasks: (NASA GRC – Directed) 
Medical Oxygen Fire Safety 
Medical treatment during both ISS and exploration missions may require oxygen therapy.  Current hardware 
increases the oxygen content within the cabin, thus increasing the fire hazard.  Therefore, ExMC is partnering 
with DoD to develop and deploy a device that processes cabin air to increase the local oxygen content.  While 
that makes the cabin safer, the localized concentration may still be a fire hazard, particularly given the lack of 
convection and weak conduction present in spacecraft.  This work will rigorously assess the risk associated with 
oxygen concentrator therapy in an exploration environment.  
Deliverables: Final report 11/1/2009 
Required Delivery Milestone: Orion Medical Kits SRR (08/01/2010) 
Required Platforms: None 
 
ExMC 4.05 – Lack of minimally invasive in-flight laboratory capabilities with limited consumables 
required for diagnosing identified Exploration Medical Conditions. 
Description:  Exploration Medical Conditions requiring this capability are: TBD at a FY09 workshop. 
Analyzing bodily fluids (urine, blood, saliva) on the lunar surface will reduce launch/return 
mass/volume and provide the data near real-time in lieu of post-flight results.  A system to perform this 
analysis in flight is necessary to meet these requirements.  NASA has conducted several trade studies 
analyzing hardware available and developed an Excel-based tool to quantify the ability of hardware to 
meet mission requirements.  To reduce system mass and volume, NASA is investigating developing 
concepts and hardware for reusable systems of this type. 
Such miniaturized systems are dependent upon space medical standards and requirements that will be 
determined based on expert opinion, risk assessments and evidence bases.  These standards and 
requirements are critical for engineering and medically qualifying the appropriate system for remote 
space applications.  Since no in-situ medical diagnostic device that involves blood or urine fluid 
analysis is currently operational, it will be important to establish that such a device may be operated 
routinely.  In addition to microfluidic processing systems, non-invasive monitoring devices may also be 
considered. 
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Tasks: (NASA ARC – NSBRI – NRA: HRP – SBIR) 
Lunar Lab Analysis 
Analyzing bodily fluids (urine, blood, saliva) on the lunar surface will reduce launch/return mass/volume and 
provide the data near real-time in lieu of post-flight results.  A system to perform this analysis in flight is 
necessary to meet these requirements.  NASA has conducted several trade studies analyzing hardware available 
and developed an Excel-based tool to quantify the ability of hardware to meet mission requirements.  To reduce 
system mass and volume, beginning with the FY 2007 SBIR call and the FY2008 budget year, NASA will begin 
developing concepts and hardware for reusable systems of this type. 
Such miniaturized systems are dependent upon space medical standards and requirements that will be determined 
based on expert opinion, risk assessments and evidence bases.  These standards and requirements are critical for 
engineering and medically qualifying the appropriate system for remote space applications.  Since no in-situ 
medical diagnostic device that involves blood or urine fluid analysis is currently operational, it will be important 
to establish that such a device may be operated routinely.  In addition to microfluidic processing systems, non-
invasive monitoring devices may also be considered. 
Deliverables:  
TRL 6 system (Lander) 9/30/2014 
TRL 6 system (Outpost) 10/1/2017 
Required Delivery Milestone:  
Lander Medical Kits PDR (07/01/2015) 
Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Micro-gravity flights 
 
Tasks: (NASA GRC:NASA ARC: NSBRI – NRA) 
Reusable Laboratory Capability 
This activity was developed in response to the observation that the size of medical kits for all exploration 
missions would be extremely limited.  When that realization was combined with requirements for medical lab 
testing found in exploration medical operations documents, the need for reusable capability was apparent.  The 
concept was suggested to the element, and was accepted for development. 
This task is performed under the auspices of the general laboratory measurement ability task led by the Ames 
Research Center (ARC). 
Deliverables:  
Inform Lander Lab Analysis downselect decision 9/30/2010 
Inform Outpost Lab Analysis downselect decision 3/30/2013 
Required Delivery Milestone:  
Lander Medical Kits PDR (07/01/2015) 
Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground based; Micro-gravity flights 
 
Tasks: (NASA GRC:NASA ARC: NSBRI) 
In-flight Blood Analysis Technology for Astronaut Health Monitoring 
Development and demonstration of an automated handheld blood count instrument that is capable of performing 
white blood cell counts on a nanoliter sized blood sample using MEMS technology and is easy for an astronaut to 
operate.  The system should analyze a minimum of 1,000 RBCs and 200 WBCs that correspond to processing 
sample volume ~50-100 nL of whole blood.  The sample volume should be precisely measured 5%.  Ability to 
provide both blood count and differential will be demonstrated. 
Deliverables: Engineering prototype 9/30/2011 
Required Delivery Milestone: N/A 
Required Platforms: Ground based; Micro-gravity flights 
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ExMC 4.06:  Lack of capability to stabilize and treat bone fractures 
Description:  Bone mineral loss occurs in microgravity due to unloading of the skeletal system, with 
average loss rates of approximately 1% per month.  It is unclear whether this bone mineral density will 
stabilize at a lower level, or continue to diminish.  It is also unknown if fractional gravity, present on 
the moon and Mars would mitigate the loss.  This level of bone loss does not create an unacceptable 
risk of fractures for ISS missions, but longer missions could create higher fracture risk (excerpt from 
the IRP). 
Current casting methods are problematic for the anticipated operation environment during lunar short 
and long missions.  Modifying existing casting methods or identifying a new technology for casting will 
be essential to meet this gap. 
Tasks: (TBD – Solicitation) 
Development of methods/technologies for treatment of bone fractures 
Technology development effort to address in-flight bone fractures.  Future solicitation will not start until FY11. 
Deliverables: TRL 6 system 3/1/2016 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground based; Micro-gravity flights 
 
Tasks: (TBD – Solicitation) 
Combined Scanning Confocal Ultrasound Diagnostic and Treatment System for Bone Quality Assessment and 
Fracture Healing 
See task under gap ExMC 4.02. 
ExMC 4.07:  Lack of wound care capability to improve healing following wound closure 
Tasks: (TBD) 
Development of methods/technologies for wound care capability 
Technology development effort to address wound care.  Future solicitation will not start until FY11. 
Deliverables: TRL 6 system 3/1/2016 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: TBD 
ExMC 4.08:  Lack of reusable cold compress and heating pad capability made of suitable 
spaceflight materials 
Description:  With longer missions and more labor-intensive tasks expected in the Constellation 
Program, the likelihood of musculoskeletal injuries such as sprains and strains are expected to 
increase.  Standard terrestrial therapeutic response to treating sprains and strains is to provide cold 
compress or heat treatment to the affected area.  Cold compress and/or heat treatment is desired that 
can be stowed in its inactive state in the vehicle’s ambient environment, activated to provide the desired 
therapeutic relief, recharged using available vehicle resources, and restowed in its inactive state for 
future use. 
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Tasks: (NASA ARC – SBIR) 
Development of methods/technologies for providing cold compress and heating pad capability 
Technology development effort to address treatment for sprains/strains.   
Deliverables: TRL 6 system 4/1/2015 
Required Delivery Milestone: Lander Medical Kits PDR (07/01/2015) 
Required Platforms: TBD 
ExMC 4.09:  Lack of medical suction and fluid containment capability for chest tube and airway 
management 
Description:  There is currently no medical suction capability that would work in the space operational 
environment.  Medical suction clears the airway, empties the stomach, decompresses the chest, and 
keeps the operative field clear. 
Tasks: (TBD – Solicitation) 
Development of methods/technologies for medical suction 
Technology development effort to provide medical suction technology.  Future solicitation will not start until 
FY13. 
Deliverables: TRL 6 system 10/1/2017 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground Based 
ExMC 4.10:  Lack of rapid vascular access capability to treat identified Exploration Medical 
Conditions. 
Description:  Exploration Medical Conditions requiring this capability are: TBD  
In a medical contingency, the ability to gain access to the patient’s vascular system to provide 
medications or fluid can be critical.  However, the current techniques for rapidly gaining access 
require training and skill that cannot be afforded to the Crew Medical Officers (CMO). 
This Gap is focused on finding technologies or techniques that can allow a minimally trained care 
provider to safely and rapidly establish vascular access in a patient. 
Tasks: (TBD – TBD) 
Development of methods/technologies for rapid vascular access 
Technology development effort to provide rapid vascular access technology.  Future solicitation will not start 
until FY13.  
Deliverables: TRL 6 system 10/1/2017 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground Based 
ExMC 4.11 – Lack of dental care capabilities (on hold) 
Description:  With the exception of the legacy Center Director’s Fund task, this gap is a placeholder 
until it is determined whether or not there is a gap in our current capabilities. 
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Tasks: (NASA JSC – JSC Innovative Partnership Program) 
Innovative Treatments of Dental Emergencies for Lunar and Exploration Missions 
This project is a spinoff of a previously funded JSC Center Director’ Discretionary Fund effort involving 
microwave interactions with nerve-derived cells, myoblasts, and bacteria.  It is currently funded by the JSC 
Innovative Partnership Program office.  It was not selected or reviewed by ExMC or HRP, but does address a gap 
for the Lunar Outpost DRM. 
The lightweight, handheld microwave device to be developed will consist of a focusing antenna capable of killing 
bacteria implicated in tooth decay, curing proprietary composites for tooth repair and reconstruction as well as 
killing diseased pulpal tissue (root canal) without harming the healthy tooth and surrounding gum tissue.  This 
technology uses either C-band or Ka-band microwave energy radiated through a specifically designed antenna to 
sharply focus the beam.  Previous studies done at JSC demonstrated that this energy can ablate nerve-derived 
cells similar to those inside a tooth and, simultaneously, kill any surrounding caries (tooth bacteria). 
Deliverables: Final Report 3/1/2009 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground Based 
 
Tasks: (TBD – TBD) 
Development of methods/technologies for dental conditions  
Technology development effort to provide dental care technology.  Future solicitation will not start until FY13.  
Deliverables: TRL 6 system – 10/1/2017 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground Based 
ExMC 4.12:  Lack of in situ intravenous (IV) fluid generation capability 
Description: Medical operations concepts for both International Space Station (ISS) missions and 
exploration missions include pharmaceuticals that can only be given intravenously.  Additionally, 
several conditions may require intravenous fluid to maintain hydration and electrolyte balance.  
Because of the volume and mass that would be required to treat all conditions specified, NASA prefers 
to generate sterile water for injection in situ on an ad hoc basis.  Currently, no proven technology 
exists that can do this in a spaceflight environment. 
The IntraVenous fluid GENeration (IVGEN) for exploration experiment will develop and conduct a 
microgravity test of a system capable of generating Sterile Water for Injection (SWIS) and mixing that 
water with salt to form normal saline according to the standards set by the United States 
Pharmacopeia. 
Tasks: (NASA GRC – HRP) 
Medical Water Generation & IV Drug Mixing (IVGen) 
Medical operations concepts for both International Space Station (ISS) missions and exploration missions include 
pharmaceuticals that can only be given intravenously.  Additionally, several conditions may require intravenous 
fluid to maintain hydration and electrolyte balance.  Because of the volume and mass that would be required to 
treat all conditions specified, NASA prefers to generate sterile water for injection in situ on an ad hoc basis.  
Currently, no proven technology exists that can do this in a spaceflight environment. 
The IntraVenous fluid GENeration (IVGEN) for exploration experiment will develop and conduct a microgravity 
test of a system capable of generating Sterile Water for Injection (SWIS) and mixing that water with salt to form 
normal saline according to the standards set by the United States Pharmacopeia. 
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Tasks: (NASA GRC – HRP) 
Medical Water Generation & IV Drug Mixing (IVGen) (cont’d) 
Deliverables:  
IVGEN Launch 2/11/2010 
IVGEN Final Report 2/28/2011 
Required Delivery Milestone:  
N/A 
Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: ISS 
ExMC 4.13:  Lack of lithotripsy or other capability to treat a renal stone 
Description:  Kidney stone formation and passage has the potential to greatly impact mission success 
and crewmember health for long duration missions.  Alterations in hydration state (relative 
dehydration) and bone metabolism (increased calcium excretion) during exposure to microgravity may 
increase the risk of kidney stone formation and it is unclear which mitigation strategy would be the 
most effective (excerpt from IRP). 
Given the high probability of kidney stone formation in crewmembers during long duration missions 
the capability to perform Lithotripsy is highly desirable.  Lithotripsy is a medical procedure that uses 
shock waves to break up stones that form in the kidney, bladder, ureters, or gallbladder. 
Tasks: (NASA JSC:NSBRI – NRA) 
Smart therapeutic ultrasound device for mission critical care 
The principal, long-term objective of this proposed effort is to develop a smart medical device that would be 
lightweight, portable, FDA-approved, commercially produced, and capable of addressing a variety of risks 
described in the Bioastronautics Roadmap.  This device would be based upon the platform technology of 
ultrasound, would potentially incorporate other imaging and therapy modalities, and would not require high skill 
levels from the user. 
Deliverables: Engineering prototype 7/31/2012 
Required Delivery Milestone: Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground based 
ExMC 4.14:  Lack of efficient medical consumable inventory tracking system that provides data on 
overall usage and usage rate and integrates securely with vehicle inventory management system 
AND 
ExMC 4.15:  Lack of medication usage tracking system that includes automatic time stamping and 
crew identification 
Description:  When shuttle and ISS medical kits are returned to earth, fewer medical consumables 
remain in the medical kits than would be expected based on reported use by the astronauts.  This gap is 
significant because the possibility exists that exploration missions could be undersupplied and run the 
risk of being able to treat an ill or injured crewmember, particularly given the small volume available 
for the medical kits. 
Work under this gap will identify current practices, develop controls, processes, and technical solutions 
to accurately track the inventory of medical consumables including pharmaceuticals 
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Tasks: (NASA GRC – Directed) 
Consumable Tracking  
When shuttle and ISS medical kits are returned to earth, fewer medical consumables remain in the medical kits 
than would be expected based on reported use by the astronauts.  This is significant because the possibility exists 
that exploration missions could be undersupplied and run the risk of being able to treat an ill or injured 
crewmember, particularly given the small volume available for the medical kits. 
This task will identify current practices, develop controls, processes, and technical solutions to accurately track 
the inventory of medical consumables.  It is a sister task to the Consumable Tracking Task in gap ExMC 4.16, 
which tracks the inventory and consumption of medications. 
Deliverables: TRL 6 system 4/1/2012 
Required Delivery Milestone: Orion Medical Kits CDR (04/01/2012) 
Required Platforms: Ground based 
ExMC 4.16:  Lack of technique or procedure to draw injectable medication into a syringe without 
bubble formation and deliver medication 
Description:  Given the possibility that vehicle failures could result in crew needing to remain in Extra-
Vehicular Activity (EVA) suits for up to 144 hours, and given that medical operations may need to 
provide medications via injection during that time, NASA must develop reliable methods for delivering 
such medications through the EVA suit. 
Key assumptions as part of this effort are that if the crew is in their EVA suits, the cabin atmosphere is 
likely to be absent, or at a greatly reduced pressure.  Such a condition could lead to bubbles in the 
medication and pharmaceutical freezing. 
Tasks: (NASA GRC – Directed, SBIR) 
Injectables 
Given the possibility that vehicle failures could result in crew needing to remain in Extra-Vehicular Activity 
(EVA) suits for up to 144 hours, and given that medical operations may need to provide medications via injection 
during that time, NASA must develop reliable methods for delivering such medications through the EVA suit. 
Key assumptions as part of this effort are that if the crew is in their EVA suits, the cabin atmosphere is likely to 
be absent, or at a greatly reduced pressure.  Such a condition could lead to bubbles in the medication and 
pharmaceutical freezing. 
Deliverables: TRL 6 system 6/1/2011 
Required Delivery Milestone: Orion Medical Kits PDR (06/01/2011) 
Required Platforms: Ground based; Micro-gravity flights; ISS 
 
Tasks: (NASA JSC – Directed) 
ISS injectable medication study for Medical Kit Redesign 
ISSP funded activity looking at efficient methods for medication injections. 
Deliverables: Redesigned ISS Medical Kit with new procedures for injectable medications. 9/30/09 
Required Delivery Milestone: Orion Medical Kits PDR (06/01/2011) 
Required Platforms: Ground based; Micro-gravity flights; ISS 
ExMC 4.17:  Lack of adequate protection for medications to preserve stability and shelf life 
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Description:  It is currently unknown how effective the packaging of medications preserves the stability 
and shelf life of the contents from the effects of spaceflight.  Spaceflight adds the elements of 
microgravity and radiation that are not applicable on the surface of Earth.  This Gap seeks to address 
materials or products that can mitigate spaceflight effects and assist in preservation of medications. 
Tasks:  
NxPCM:  Stability of Pharmacotherapeutic and Nutritional Compounds: Stability SMO (Flight)   
See description under HRP IRP Gap PH9 
ExMC 4.18:  Lack of adequate biomedical monitoring capability for Constellation EVA Suits 
Description:  The crewmembers’ physiological data, if monitored regularly, can indicate to the flight 
surgeons if there is a medical problem.  During EVAs and periodic IVA activities, the flight surgeons 
need the ability to monitor key physiological signals that indicate the crew’s workload and other 
physiologic parameters.  The current system for donning the sensors is time consuming and 
inconvenient, requiring shaving, application of electrodes, and signal checks.  A more efficient system 
will save crew time and reduce the overhead of stowing additional supplies.  This system will be 
achieved through the integration of small, easy to use biomedical sensors that will have the ability to 
measure, store and transmit physiologic parameters during operational and ambulatory scenarios.  
Such a system would also provide a wealth of data for the medical and research communities.  
Coordination with the HHC element for an overall medical and research biomedical sensing plan will 
occur. 
Tasks: (NASA ARC – Directed, SBIR) 
Biomedical Sensors (EVA) 
The crewmembers’ physiological data, if monitored regularly, can indicate to the flight surgeons if there is a 
medical problem.  During EVAs and periodic IVA activities, the flight surgeons need the ability to monitor key 
physiological signals that indicate the crew’s workload and other physiologic parameters.  The current system for 
donning the sensors is time consuming and inconvenient, requiring shaving, application of electrodes, and signal 
checks.  A more efficient system will save crew time and reduce the overhead of stowing additional supplies.  
This system will be achieved through the integration of small, easy to use biomedical sensors that will have the 
ability to measure, store and transmit physiologic parameters during operational and ambulatory scenarios.  Such 
a system would also provide a wealth of data for the medical and research communities.  Coordination with the 
HHC element for an overall medical and research biomedical sensing plan will occur. 
Deliverables: Final requirements for EVA suits 10/1/2010 
Required Delivery Milestone: EVA Suit 2 SRR (03/01/2011) 
Required Platforms: Ground based 
 
Tasks: (NASA JSC: NASA ARC: NSBRI) 
Noninvasive Biosensor Algorithms for Continuous Metabolic Rate Determination 
Develop and validate algorithms to accurately calculate VO2 from NIR spectra collected from muscle 
Develop and validate algorithms to simultaneously calculate muscle temperature 
Support incorporation of the sensor algorithms into the EVA suit testing for noninvasive continuous metabolic 
rate assessment during lunar EVA.  
Deliverables: TRL 6 system 9/30/2011 
Required Delivery Milestone: EVA Suit 2 PDR (08/01/2012) 
Required Platforms: Ground based 
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ExMC 4.19:  Lack of definition of biomedical monitoring requirements for performing periodic 
clinical status evaluations 
Tasks: (NASA ARC – Directed) 
Biomedical Sensors (IVA) 
The crewmembers’ physiological data, if monitored regularly, can indicate to the flight surgeons if there is a 
medical problem.  During periodic IVA activities, the flight surgeons need the ability to monitor key 
physiological signals that indicate the crew’s workload and other physiologic parameters.  The current system for 
donning the sensors is time consuming and inconvenient, requiring shaving, application of electrodes, and signal 
checks.  A more efficient system will save crew time and reduce the overhead of stowing additional supplies.  
This system will be achieved through the integration of small, easy to use biomedical sensors that will have the 
ability to measure, store and transmit physiologic parameters during operational and ambulatory scenarios.  Such 
a system would also provide a wealth of data for the medical and research communities.  Coordination with the 
HHC element for an overall medical and research biomedical sensing plan will occur. 
Deliverables:  
TRL 6 system (Lander) 3/1/2015 
TRL 6 system (Outpost)  12/1/2017 
Required Delivery Milestone: 
Lander Medical Kits PDR (07/01/2015) 
Outpost Medical Kits PDR (04/01/2018) 
Required Platforms: Ground based, NEEMO 
 
Tasks: (NASA JSC, NASA ARC – SBIR) 
Lunar Health Monitor:  A Wearable System to Monitor Astronaut Health Status (Orbital) 
Deliverables: Prototype 6/1/2010 
Required Delivery Milestone: Lander Medical Kits PDR (07/01/2015) 
Required Platforms: Ground based 
 
Tasks: (NASA JSC, NASA ARC – SBIR) 
Lightweight, Wearable Metal Rubber-Textile Sensor for In-Situ Lunar autonomous Health Monitoring 
(NanoSonic) 
Develop and demonstrate a low-weight, non-invasive, reliable and comfortable autonomous health-monitoring 
system for use by astronauts during long-duration space missions and extravehicular activities (EVAs). 
Deliverables: Prototype 6/1/2010 
Required Delivery Milestone: Lander Medical Kits PDR (07/01/2015) 
Required Platforms: Ground based 
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Tasks: (NASA JSC, NASA ARC – SBIR0 
Wearable Health Monitoring Systems (Nyx) 
To build a working prototype of the wearable health monitoring system that will demonstrate: 
the integration of medical sensors, electrodes, electrical connections, circuits, and power supply into a single 
wearable assembly to simplify donning and doffing 
the distribution of electrical circuits around the human torso to reduce bulk and enable it to be worn 
underneath an LCVG 
the facility to easily replace electrodes used to attach to the skin 
the ability to measure biological sensor data and transmit it to an external computing device 
the simplicity of adding medical sensors to the system through use of a digital data-bus to reduce overall 
wiring count. 
Deliverables: Prototype 6/1/2010 
Required Delivery Milestone: Lander Medical Kits PDR (07/01/2015) 
Required Platforms: Ground based 
ExMC 5.01:  Lack of medical data management infrastructure for Exploration Missions 
Description:  In spaceflight, there is a large amount of data generated to understand and monitor the 
health and safety of the crewmember.  Because of the large volume of data, a data management 
infrastructure needs to be deployed to allow users access to the data.  The system needs to be available, 
secure, and ensure data integrity.  This way users can gain valuable insight into health and safety of 
the crew to maintain their health status and ensure mission success. 
Tasks: (NASA JSC – Directed/Infrastructure) 
Mission Medical Information System 
Incorporate medically relevant information into a database system for use in operations as well as for research 
support.  The data sources to be incorporated include MRID’s as well as other mission data.  Currently the data 
resides on an FTP server, in flight surgeon files, some in the Electronic Medical Record (EMR), and some in the 
Longitudinal Study of Astronaut Health (LSAH) database.  Structured data sources such as the EMR and LSAH 
will not be duplicated, but rather joined.  Effort refocused to get data into structured form first and then work on 
data entry at the point of collection.  Effort is co-funded 50/50 with Crew Health and Safety. 
Deliverables: Operational system 9/30/09 
Required Delivery Milestone: N//A 
Required Platforms: Ground based 
 
Tasks: (NASA JSC – Directed/Infrastructure) 
Life Sciences Data Archive (JSC) 
NASA's Life Sciences Data Archive (LSDA) is a web-based, active archive that is continually updated with 
information and data from space flight experiments funded by the NASA.  The archive includes investigations 
from 1961 (Mercury Project) through current missions (ISS and Shuttle) involving human, plant and animal 
subjects.  Effort includes a process to streamline access while protecting confidentiality. 
Deliverables: Information and data provided via the LSDA public and restricted web-based databases 
Required Delivery Milestone: N//A 
Required Platforms: Ground based 
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Tasks: (NASA ASC – Directed/Infrastructure) 
Life Sciences Data Archive (JSC) 
NASA's Life Sciences Data Archive (LSDA) is a web-based, active archive that is continually updated with 
information and data from space flight experiments funded by the NASA.  The archive includes investigations 
from 1961 (Mercury Project) through current missions (ISS and Shuttle) involving human, plant and animal 
subjects.  Effort includes a process to streamline access while protecting confidentiality. 
Deliverables: Information and data provided via the LSDA public and restricted web-based databases 
Required Delivery Milestone: N//A 
Required Platforms: Ground based 
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RISK OF THERAPUTIC FAILURE DUE TO INEFFECTIVENESS OF MEDICATION – 
CRITICALITY: LUNAR OUTPOST – D, MARS – I  
Based on subjective reports, drugs are effective during space flight.  Better record keeping of medication 
use, efficacy, and side effects will be instituted and those records will provide evidence for or against this 
risk.  If medications are found to be ineffective, research will be performed to determine if drug 
metabolism is affected by space flight.  Studies to determine if space flight affects drug stability are 
currently underway. 
Context of Risk for Exploration 
Better recordkeeping of medication use, efficacy, and side effects should be instituted.  This will provide 
evidence for or and should be a precursor to a formal assessment of PK/PD on orbit.  It is thought that the 
reduction in gastrointestinal (GI) motility and function, offered as the first piece of evidence for this gap, 
is not an issue after the first few days of flight.  In general, SD avoids prescribing oral medications during 
this period of the mission.  It is not known to what extent different volumes of distribution might be a 
factor in flight.  Drugs selected for the PK/PD studies should be commonly used, have few side effects, 
and different metabolic pathways.  External consultants should be used to determine which drugs to test 
and to design testing protocols.  SD needs to develop a process and procedures to track systematically 
crew medication use, including subjective comments on efficacy and side effects, particularly for ISS.  It 
is particularly important to know what pharmaceuticals are taken prior to in-flight tasks. 
Strategy for Mitigation 
The overarching strategy for this risk is to obtain better record keeping of medication use, efficacy, and 
side effects.  This includes several data mining tasks that will provide evidence for or against this risk.  If 
there is evidence indicating ineffectiveness of medications, a pharmacokinetics/pharmacodynamics study 
will be performed in flight to obtain further information.  
Gaps 
PH6: Can a standard procedure for prospective analyses of drugs to be considered for flight and 
periodic analyses of drugs that are used for flight be developed?  A Pharmacy and Therapeutics 
Committee should be formed. 
PH10: What are the performance effects of in-flight drugs on exercise, orthostatic tolerance, motor 
control, cognitive function, etc?  Much of this information is available in the literature and should be 
synthesized.  New studies should be undertaken only when there is no existing data or the existing 
information is not relevant.  This effort should be cross-disciplinary and should be the simplest 
monitoring techniques possible to identify performance issues.   
CV6: What influence does in-flight medication use have on physical and cognitive performance?  
This has not systematically documented.  Much of this information is available in the literature and 
should be synthesized.  New studies should be undertaken only when there is no existing data or the 
existing information is not relevant.  This effort should be cross-disciplinary and should employ the 
simplest monitoring techniques possible to identify performance issues. 
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Task: (NxPCM – via directed study) 
Terrestrial Drug Database Review – Data Mining TBD 
Deliverables: The product from this task will be to recommend changes in medication tracking to Flight 
Medicine. 
Required Delivery Milestone: There are no required delivery milestones for this task. 
Required Platforms: Access to necessary pharmacological and Space Medicine databases is required. 
PH7: What are the effects of spaceflight on pharmacokinetics/pharmacodynamics?  Subjective 
reporting indicates that many drugs are effective in flight.  There has been little documentation of the 
ineffectiveness of drugs.  Better recordkeeping of medication use, efficacy and side effects should be 
instituted.  This will provide evidence for or against this gap, and should be a precursor to a formal 
assessment of PK/PD on orbit.  It was thought that the reduction in gastrointestinal (GI) motility and 
function, offered as the first piece of evidence for this gap, was not an issue after the first few days of 
flight.  In general, Flight Medicine avoids oral medications during this period of the mission.  It was not 
known to what extent different volumes of distribution might be a factor in flight.  Drugs selected for the 
PK/PD studies should be commonly used, have few side effects, and different metabolic pathways.  
External consultants should be used to determine the test and to design testing protocol.   
Task: (NxPCM – via NRA) 
Bioavailability and Performance effects of Promethazine (PMZ) during spaceflight   
Promethazine is currently given to treat motion sickness during Shuttle missions.  The side effects associated with 
PMZ include dizziness, drowsiness, sedation, and impaired psychomotor performance.  Anecdotal reports from 
crewmembers indicate that these central nervous system side effects of PMZ are absent or greatly attenuated in 
microgravity.  Recent reviews of medical debriefs indicate that, at least in some crewmembers, there are 
significant central nervous system depressant effects.  In addition, the pharmacokinetics and bioavailability of 
medications administered in microgravity may be different from on Earth, which could significantly alter drug 
efficacy, as well as, the severity of side effects for a given dosage.  This study will systematically evaluate PMZ 
bioavailability, effects on performance, side effects, and efficacy in the treatment of motion sickness to determine 
optimal dosage and best route of administration of PMZ in flight.  
Deliverables: The product is a completed study and report findings. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Space Shuttle is required for assessing spaceflight effects of PMZ. 
 
Task: (NxPCM – via directed study) 
Drug Efficacy Data Mining  
This task will review the available pharmacokinetic/pharmacodynamic data from previous missions to develop 
and understanding of the bioavailability and uptake of pharmaceuticals in a microgravity environment.  If results 
indicate drugs are ineffective, flight studies will be initiated to examine PK/PD. 
Deliverables: Initial product is a final report of findings.  If results indicate that drug effectiveness is diminished 
in flight, ISS pharmaceutical PK/PD studies will be solicited and performed.   
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: Access to Flight Medicine, JSC Biomedical Research Laboratory data, and LSDA 
databases is necessary for the data mining study.  ISS is required as the Mars transit analog for in-flight PK/PD 
studies and for countermeasure validation.   
 
HRP-47065 
 
375 
Task: (NxPCM – via NRA) 
Methods for the Assessment of Gastrointestinal Physiology and Function in a Lunar Analog Environment (Smart 
Pill) 
New capsule endoscopy technology provides a direct measurement of GI transit time as well as GI pH, 
monomotry and temperature.  The effects of altered GI function on the behavior of ingested content have also 
never been studied.  Disposition profiles of drugs like acetaminophen (APAP) serve as effective markers for 
gastric emptying and absorption.  We propose to evaluate influence of reduced gravity on GI function using the 
SmartPill® technology.  
Deliverables: Initial product is a final report of findings.  If results indicate that drug effectiveness is diminished 
in flight, ISS pharmaceutical PK/PD studies will be solicited and performed.   
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: In order to measure GI transit time in microgravity; this task requires head down tilt bed 
rest.  It is an add-on to ongoing bed rest campaigns. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
 
Task: (NxPCM – via NRA) 
Stability of Pharmacotherapeutic and Nutritional Compounds: Stability SMO (Flight) 
The experiment design consists of a protocol that involves investigative physical/chemical analyses of both 
medications and food items returned from STS and ISS along with corresponding lot-matched controls stored on 
ground in a controlled environment.  This experiment has 2 sub-payloads attached to it.  See the Risk of 
Inadequate Nutrition for the nutrition sub-payload information.  The Pharmacology Sub-Payload will identify 
pharmaceutical preparations at risk for degradation that are used by astronauts during space missions; characterize 
degradation profiles of the unstable formulations after exposure to ISS environment; and compare and contrast 
stability of ISS flown medications to their matching controls from the same lot and commercial packing 
conditions.  This study will provide critical information about the susceptibility of vitamins in the space food 
system to adverse environmental factors and storage encountered during space missions. 
Deliverables: Results from this task will be delivered to the HSRF to discuss altered gravity’s effect on GI transit 
time. 
Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: In order to measure GI transit time in lunar gravity; this task requires a lunar analog.  It is 
an add-on to ongoing lunar bed rest campaigns.  
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
PH9:  What is the effect of long-term spaceflight on drug stability and what measures can be 
employed to extend the duration of drug efficacy? 
Task: (NxPCM – via directed study) 
Methods for the Assessment of Gastrointestinal Physiology and Function in a Lunar Analog Environment (Smart 
Pill) 
New capsule endoscopy technology provides a direct measurement of GI transit time as well as GI pH, 
monomotry and temperature.  The effects of altered GI function on the behavior of ingested content have also 
never been studied.  Disposition profiles of drugs like acetaminophen (APAP) serve as effective markers for 
gastric emptying and absorption.  We propose to evaluate influence of reduced gravity on GI function using the 
SmartPill® technology.  
Deliverables: Data for this task will be delivered to the Flight Medicine.  In addition, data will be shared with 
ExMC for their gap 4.18 
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Required Delivery Milestone: There is no required delivery milestone for this task. 
Required Platforms: ISS required for proper radiation doses on pharmaceutical samples. 
 
Task:  
Development of methods/technologies for medication stability and shelf-life 
This task is being conducted by ExMC; see the Risk of Inability to Adequately Treat and Ill or Injured Crew 
Member gap ExMC 4.18 for details.  
PH1:  Inadequate tracking of medication use, indication, efficacy, and side effects 
PH3:  What training methods and reference documents should be employed for training the crew 
and medical team to identify and mitigate side effects and interactions of commonly used 
medications?  These two gaps have been transferred to ExMC; see the Risk of Inability to Adequately 
Treat and Ill or Injured Crew Member gap ExMC 4.15, 4.16 for further information. 
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HUMAN HEALTH COUNTERMEASURES INFRASTRUCTURE 
HHC1: Can partial gravity be simulated on Earth?  In order to begin determining the lunar gravity’s 
effects on human physiology, a ground-based analog should be developed. 
HHC2: How does 1/6-g and 3/8-g influence countermeasures?  It is unknown how the lunar and 
Martian gravities will affect current spaceflight countermeasures.  Utilizing a ground analog for different 
gravities, the gravitational effects can be measured.  
Tasks: (FAP – via directed study) 
Lunar Analog Bed Rest Development 
This study is for the development of a lunar analog.  These lunar mission simulations may or may not include (~3 
day) transit phases between Earth and Moon.  While it may be useful to simulate some impacts of (7-14 day) 
sortie missions, the primary focus will be on longer, outpost missions; thus, simulation durations will generally 
range up to 90 days. 
Deliverables: Lunar analog  
Required Delivery Milestone: This task mitigates a risk to a long-duration lunar and Mars missions.  
Required Platforms: This effort is ground-based analog development, developing a lunar analog model.  The 
model will not be validated until lunar surface mission ops begin the in the 2020 timeframe. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
 
Tasks: (ECP – via directed study) 
Lunar EVA Study – TBD  
ECP with input from EPSP will develop a lunar analog simulation paradigm that will be an add-on to the FAP 
lunar bed rest research platform.  This simulator will take into consideration EVA operations scenarios as well as 
the aerobic and resistive stress induced by lunar EVA.  This study will evaluate the role that EVA will have, if 
any, in protecting muscle function, bone health and aerobic capacity.  There after ECP will sponsor studies that 
aim to identify exercise countermeasures that are required in addition to lunar EVA in order to maintain astronaut 
heath and mission performance. 
Deliverables: This task will determine if proposed lunar EVA activities are protective for muscle and 
cardiovascular performance.  If it is determined that lunar EVA tasks are not protective further lunar 
countermeasures studies will be conducted. 
Required Delivery Milestone: This task mitigates a risk to a long-duration lunar and Mars missions.  
Required Platforms: Lunar Bed Rest add-on 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
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Tasks: (NxPCM – via NRA) 
Determination of the magnitude and time course of cardiovascular alterations during a simulated extended stay 
lunar mission 
The effects of this level of hypovolemia on cardiac function and orthostatic tolerance are not clear.  We propose 
to study the time course of the fluid shifts and plasma volume losses experienced during a simulated trip to, and 
extended habitation on, the Moon.  Additionally, we propose to evaluate the effect of this volume change on 
cardiac function using newer preload-independent echocardiographic techniques.  By acquiring daily 
measurements during the transitional phases of changing gravitational levels, we plan to validate the current 
computational model and further quantify the crew health and performance risks associated with extended 
duration missions to the Moon and other partial Earth gravity environments. 
Deliverables: The deliverable from this task will be to inform the Human System Risk Forum of any protective 
effects from lunar gravity on the cardiovascular system.  If the data indicate lunar gravity is not protective, then 
additional countermeasure development studies may be pursued. 
Required Delivery Milestone: This task mitigates a risk to a long-duration lunar and Mars missions.  
Required Platforms: This is an add-on task to the Lunar Analog Pilot Study. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
 
Tasks: (ECP – via NRA) 
Thermoregulatory Capacity and Exercise Responses Following Prolonged Lunar Analog Bed Rest  
The studies proposed in this application will examine the effect of a Lunar Analog Bed Rest (LABR) model on 
exercise capacity, thermoregulatory function during exercise and the effects of combined thermal and exercise 
challenge on cardiovascular responses during prolonged sub-maximal exercise.  In addition, the effectiveness of 
an exercise-countermeasure throughout bed rest, on expected thermal and cardiovascular alterations, will be 
investigated.  The following hypotheses will be tested: 1) prolonged LABR impairs exercise-thermoregulation, 2) 
prolonged LABR reduces exercise capacity and augments cardiovascular strain during exercise-heat stress, and 3) 
an exercise-countermeasure throughout LABR will preserve thermoregulatory responses and exercise capacity 
associated with LABR.  These data will provide valuable insight into the effects of partial gravity associated with 
lunar living and the potential impact on safety and success of exploratory missions, with focus on both the short-
duration (2 week) Lunar sortie and long-duration Lunar Outpost. 
Deliverables: The deliverable from this task will be to inform the Human System Risk Forum of any protective 
effects from lunar gravity on the cardiovascular system. 
Required Delivery Milestone: This task mitigates a risk to a long-duration lunar and Mars missions.  
Required Platforms: This is an add-on task to the Lunar Analog Pilot Study. 
# of Subjects Initial Upmass 
(kg) 
Upmass 
(kg/subject) 
Downmass 
(kg/subject) 
Crew 
Time/Subject 
Post-Flight 
BDC Time (hrs) 
12 None None None None None 
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APPENDIX B: 
 
TECHNICAL READINESS LEVELS (TRL) 
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Definition of Technical Readiness Levels (TRL) 
 
 
